,Vectors,DOIs,Topics
0,"[-0.0753713  -0.03724902  0.0863414  -0.07403561 -0.00741796 -0.03797922
 -0.04524841 -0.0988018  -0.21704258 -0.02869391  0.09791607 -0.01010523
 -0.04264164 -0.08771401 -0.02501992 -0.06814449  0.03643583  0.10861934
 -0.15192729  0.1067683  -0.01018443 -0.00041335 -0.13170141  0.14501432
  0.1463181   0.06833097 -0.01698837  0.13662314  0.16353382 -0.12841982]",10.1080/08998280.2005.11928039,[]
1,"[ 0.01960948  0.09898837  0.15475273 -0.20484798 -0.19749622  0.14192292
  0.13755524  0.06956051 -0.557009    0.02012314  0.35234213  0.09987001
 -0.13754775 -0.13825572 -0.1887315  -0.15917651  0.20302202  0.03016028
 -0.40113425  0.29824343  0.08289883 -0.05189491 -0.14154413  0.2767419
  0.32484806  0.54542726  0.01876467  0.28765732  0.19479328 -0.30143568]",10.3109/01676830903104660,"['Acute Disease', 'Aged', 'Eye Enucleation', 'Eye, Artificial', 'Female', 'Humans', 'Hypersensitivity', 'Male', 'Orbital Implants', 'Polymers', 'Polymethyl Methacrylate', 'Retrospective Studies']"
2,"[ 0.36866772  0.7895641   0.30403072 -0.37078425 -0.28131896  0.5465566
  1.2921233   0.99441534 -1.9209303  -0.02511367  0.6326003   0.3313748
 -1.1030515  -1.1492556  -1.1451986  -0.85994536 -0.16685197 -0.7429549
 -0.93836445  0.6508155   0.99619526 -0.14176175 -0.35981598  0.607269
  0.9426372   1.4355171   0.81190515  0.15804026  0.5000665  -0.7245499 ]",10.1038/sj.onc.1207036,"['Adenocarcinoma', 'Animals', 'Anoikis', 'Antigens, CD', 'Antigens, Neoplasm', 'Caspases', 'Cell Adhesion Molecules', 'Cell Division', 'Cell Line, Tumor', 'GPI-Linked Proteins', 'Gene Silencing', 'Humans', 'Liver Neoplasms', 'Mice', 'Mice, Nude', 'Neoplasm Metastasis', 'Neoplasm Transplantation', 'Oncogene Protein v-akt', 'Pancreatic Neoplasms', 'RNA, Messenger', 'RNA, Small Interfering', 'Retroviridae Proteins, Oncogenic']"
3,"[ 0.29714307  0.8752997  -0.2242964  -1.0324377  -0.91667575  1.5402713
  0.8202323   0.94690084 -1.9453355   0.8297737   1.075808    0.196515
 -0.3798073  -0.44994026 -0.80029094 -0.45653957  0.56991553 -0.0170371
 -1.3798051   1.1291935   0.81940675 -0.53270525 -0.36039045  0.29884613
  1.0807008   1.8050076   0.1487877   1.0573591   0.32431725 -0.88207436]",10.1038/modpathol.3800247,"['Adult', 'Aged', 'Aged, 80 and over', 'Antigens, CD', 'Antigens, Differentiation, Myelomonocytic', 'Aspergillosis', 'Aspergillus', 'Autopsy', 'Canada', 'Cytomegalovirus', 'Cytomegalovirus Infections', 'Female', 'Herpes Simplex', 'Humans', 'Immunohistochemistry', 'Keratins', 'Lung', 'Lung Diseases, Fungal', 'Male', 'Middle Aged', 'Nuclear Proteins', 'RNA, Viral', 'Reverse Transcriptase Polymerase Chain Reaction', 'Severe acute respiratory syndrome-related coronavirus', 'Severe Acute Respiratory Syndrome', 'Simplexvirus', 'Thyroid Nuclear Factor 1', 'Transcription Factors', 'Viral Matrix Proteins']"
4,"[ 0.6819332   0.5973326   0.08857223 -0.36423263 -0.91207796  0.5084767
  0.65246826  0.754849   -1.5570291  -0.08201317  1.3587826   0.53609735
 -0.6832323  -0.38049594 -1.0453463  -0.59099114  0.8595517  -0.528719
 -1.6623335   0.6472448   0.76554435 -0.46997297  0.11474872  0.22316286
  0.7261962   2.222138    0.16646151  0.891282    0.29205874 -1.008833  ]",10.2174/138620709789824709,"['Animals', 'Computer-Aided Design', 'Drug Design', 'High-Throughput Screening Assays', 'Humans', 'Ligands', 'Protein Binding']"
5,"[ 0.25345033  0.46049687  0.38270116 -0.5053029  -0.38570908  0.5876144
  0.6393882   0.5886577  -1.814292    0.05071669  0.9341137  -0.00365527
 -0.4853245  -0.40586975 -0.48458493 -0.7418372   0.30179033 -0.17424276
 -1.6160784   0.7324017   0.5196883  -0.32391998 -0.2000237   0.54823273
  0.41937283  1.5712844   0.29748043  0.64543283  0.30875674 -0.7867766 ]",10.1111/j.1552-6569.2008.00331.x,"['Adipose Tissue', 'Adult', 'Algorithms', 'Bone Marrow', 'Brain', 'Cerebrospinal Fluid', 'Feasibility Studies', 'Female', 'Health Status', 'Humans', 'Imaging, Three-Dimensional', 'Magnetic Resonance Imaging', 'Male', 'Models, Neurological', 'Nerve Fibers, Myelinated', 'Nerve Fibers, Unmyelinated', 'Phantoms, Imaging', 'Young Adult']"
6,"[ 0.13377604  0.22671421  0.2030564  -0.28768697 -0.33570564  0.30799165
  0.25698018  0.27163136 -0.94722396 -0.02537911  0.7100629   0.27363187
 -0.2748831  -0.20040151 -0.40608758 -0.20392841  0.39719015 -0.14001894
 -0.75211257  0.48369223  0.22019207 -0.17355257 -0.0607288   0.3785213
  0.49327362  1.0489587   0.0163806   0.4312458   0.217258   -0.55526   ]",10.1002/14651858.CD004901.pub2,"['Abortifacient Agents, Nonsteroidal', 'Abortion, Induced', 'Congenital Abnormalities', 'Female', 'Fetal Death', 'Humans', 'Labor, Induced', 'Misoprostol', 'Oxytocics', 'Pregnancy', 'Pregnancy Trimester, Second', 'Pregnancy Trimester, Third', 'Randomized Controlled Trials as Topic']"
7,"[-0.14874159 -0.08113524  0.14721553 -0.13407825 -0.06331087 -0.09276601
 -0.16973354 -0.23409386 -0.29553843  0.02469152  0.15418561 -0.02251577
 -0.0064744  -0.13616213 -0.02428602 -0.1265019   0.04247602  0.25485814
 -0.28610253  0.17035723 -0.03042448 -0.09711037 -0.211382    0.22515857
  0.25635287  0.14504874 -0.14070332  0.30836087  0.25144935 -0.19920444]",10.1001/jama.2010.616,"['Delivery of Health Care', 'Developing Countries', 'Global Health', 'Health Services Needs and Demand', 'Health Services Research', 'Health Status Disparities', 'Healthcare Disparities', 'Human Rights', 'Humans', 'Mental Disorders', 'Mental Health']"
8,"[ 1.2491426   1.0210023   0.5924183  -0.28970772 -0.5019933   0.87407774
  1.1600839   1.5865874  -2.064496   -0.2750387   0.50468844 -0.4322258
 -1.3051966  -1.1651083  -1.3293985  -0.85144943  0.70088434 -0.6905895
 -1.5583924   0.9732144   1.0673584  -0.23255529  0.03117395  0.2494764
  0.65002483  1.7048645   0.756815    0.89303374  0.37398136 -0.59595484]",10.1016/j.regpep.2010.02.007,"['Angiotensin II', 'Angiotensin III', 'Animals', 'Binding Sites', 'Cell Membrane', 'Male', 'Mice', 'Osmolar Concentration', 'Radioligand Assay']"
9,"[ 0.09686473  0.31584662  0.38803267 -0.59679294 -0.77485573  0.4054826
  0.32520625  0.5002059  -1.8392179   0.20994094  1.3404619   0.62706345
 -0.35456795 -0.18973675 -0.58075356 -0.32211745  0.8548869  -0.02424864
 -1.3120521   0.65998566  0.17421089 -0.3373594  -0.223302    0.7951218
  0.93424666  1.9773948   0.01315639  0.7544067   0.42696515 -0.9658908 ]",10.1017/S1461145711000083,"['Antidepressive Agents', 'Depressive Disorder, Major', 'Drug Costs', 'Drug Resistance', 'Drug Substitution', 'Drug Therapy, Combination', 'Drugs, Generic', 'Evidence-Based Medicine', 'Humans', 'Patient Selection', 'Pharmacogenetics', 'Practice Guidelines as Topic', 'Risk Assessment', 'Treatment Outcome']"
10,"[-0.0731902   0.00498202  0.13426596 -0.08132254 -0.05609521 -0.03773692
 -0.01096104 -0.07465166 -0.38609502 -0.04727032  0.19862852  0.01789466
 -0.08492748 -0.05825088 -0.03295506 -0.0802334   0.10951063  0.13946326
 -0.26802436  0.24013035 -0.00104119 -0.00707509 -0.17651677  0.21930438
  0.19201243  0.22262648 -0.01219427  0.28071225  0.25688425 -0.2563976 ]",10.4155/fmc.09.49,"['Computer-Aided Design', 'DNA', 'Drug Discovery', 'High-Throughput Screening Assays', 'Interdisciplinary Communication', 'Models, Biological', 'Pharmacology', 'Proteins', 'Systems Biology']"
11,"[ 0.5637016   0.66619796  0.334383   -0.5265456  -0.7869015   0.8970495
  0.9438714   0.8749601  -2.0567982   0.09335963  1.103269    0.5065772
 -0.88508797 -0.6245313  -1.1916087  -1.0191357   0.16107476 -0.62502575
 -1.6876847   1.3387802   0.56706727 -0.3598655   0.09694346  0.6147676
  0.6397348   1.9182091   0.32517752  0.687214    0.07497162 -1.2158687 ]",10.1007/s00221-010-2266-7,"['Acetylcholine', 'Acetylcholinesterase', 'Animals', 'CA1 Region, Hippocampal', 'CA3 Region, Hippocampal', 'Cerebral Cortex', 'Cholinesterase Inhibitors', 'Galantamine', 'Hypoxia', 'Learning Disabilities', 'Maze Learning', 'Nootropic Agents', 'Physostigmine', 'RNA, Messenger', 'Rats', 'Rats, Sprague-Dawley', 'Space Perception']"
12,"[ 0.161269    0.31299984  0.16199636 -0.29141358 -0.46031305  0.55015314
  0.50869197  0.37377483 -1.6360064   0.11443786  1.1044731   0.16662012
 -0.56627667 -0.34273416 -0.539018   -0.706471    0.64250946 -0.1767137
 -1.1724242   0.7265086   0.24512582 -0.18650785 -0.23943599  0.5543315
  0.73346955  1.5709252   0.03762751  0.7003727   0.35626006 -0.94850796]",10.1002/mrm.22759,"['Biopsy', 'Breast Neoplasms', 'Equipment Design', 'Female', 'Humans', 'Magnetic Resonance Imaging, Interventional', 'Radio Waves']"
13,"[ 0.20033284  0.3085655   0.1480897  -0.5073281  -0.74580586  0.46300668
  0.34626964  0.509606   -1.3481095   0.08650988  1.0542598   0.37251
 -0.39112005 -0.19582817 -0.6199501  -0.36885756  0.5820437  -0.14776379
 -0.9758363   0.56482273  0.4175886  -0.39279464  0.06357673  0.5815308
  0.6736505   1.6401132   0.05138593  0.6285529   0.16175704 -0.65650517]",10.3138/jvme.38.1.5,"['Animals', 'Cooperative Behavior', 'Education, Veterinary', 'Electronic Health Records', 'Humans', 'Interdepartmental Relations', 'Interdisciplinary Communication', 'Internet', 'Medical Informatics Applications', 'Minnesota', 'Organizational Case Studies', 'Schools, Medical', 'Schools, Veterinary', 'Veterinary Medicine']"
14,"[ 0.1600616   0.22842367  0.23986758 -0.35781005 -0.34715837  0.19259772
  0.2051321   0.26302278 -0.99614614 -0.00481605  0.6910249   0.2593223
 -0.252731   -0.17066272 -0.271696   -0.20746794  0.34753633 -0.02806024
 -0.7931331   0.50414824  0.12907024 -0.17220798 -0.2186367   0.3222868
  0.3864281   0.98952395  0.07955326  0.44043115  0.2910792  -0.58175665]",10.1017/S003329171100119X,"['Adult', 'Female', 'Functional Neuroimaging', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Memory, Short-Term', 'Middle Aged', 'Neostriatum', 'Prefrontal Cortex', 'Schizophrenia']"
15,"[-0.04497342 -0.00588503  0.13941278 -0.05392287 -0.01509035 -0.02618483
  0.01572047 -0.05807074 -0.26313838 -0.028413    0.09894177  0.01735087
 -0.03630584 -0.04671083 -0.0384534  -0.06400029  0.05794439  0.10716783
 -0.1770476   0.19173695 -0.00993697  0.02190198 -0.14119644  0.15177359
  0.10627182  0.14414144  0.01764572  0.18266849  0.17564595 -0.1744481 ]",10.1016/j.ophtha.2011.04.025,"['Blindness', 'China', 'Delivery of Health Care', 'Diagnostic Tests, Routine', 'Health Care Reform', 'Health Policy', 'Humans', 'Preoperative Care', 'United States']"
16,"[-0.41814572  0.12627397 -0.01023559 -0.93485683 -0.98022634  0.28261662
 -0.72136986 -0.42204103 -1.8225459   0.75916934  1.5129247   0.1961869
 -0.24780947 -0.9747152  -0.72107625 -1.1280533   0.19721104  0.45554963
 -1.7628195   0.49824977  0.25722447 -1.195611   -0.5446804   0.90478814
  2.01067     1.8914129  -0.64125764  1.1936542   0.70215875 -1.0040798 ]",10.4269/ajtmh.2010.10-0527,"['Bioethical Issues', 'Cultural Characteristics', 'Curriculum', 'Delivery of Health Care', 'Education, Professional', 'Ethics, Medical', 'Global Health', 'Humans', 'International Educational Exchange', 'Practice Guidelines as Topic', 'Public Health']"
17,"[ 0.0269142   0.18191521  0.2058673  -0.19753882 -0.169598    0.16503043
  0.22509879  0.20515105 -0.7048824  -0.02430979  0.42383906  0.09195884
 -0.25582352 -0.21284492 -0.26448712 -0.24451582  0.17864744 -0.00680079
 -0.5781655   0.34998953  0.18239295 -0.09750497 -0.09178597  0.30965942
  0.32095796  0.645419    0.08783241  0.3344573   0.20201546 -0.3925023 ]",10.1016/j.ijporl.2011.06.012,"['Adenoidectomy', 'Adenoids', 'Adolescent', 'Age Distribution', 'Biopsy, Needle', 'Child', 'Child, Preschool', 'Cohort Studies', 'Epstein-Barr Virus Infections', 'Female', 'Herpesvirus 4, Human', 'Humans', 'Immunohistochemistry', 'In Situ Hybridization', 'Infant', 'Male', 'Prevalence', 'Retrospective Studies', 'Severity of Illness Index', 'Sex Distribution', 'Tonsillectomy', 'Tonsillitis', 'United Arab Emirates', 'Young Adult']"
18,"[ 0.15255962  0.2444975   0.22262739 -0.41934636 -0.42026463  0.3462801
  0.40689623  0.34497175 -1.1391889   0.06946239  0.778022    0.19534127
 -0.23641504 -0.2601878  -0.39665526 -0.28933328  0.37375468 -0.09919445
 -0.81209695  0.4603739   0.28243244 -0.20691371 -0.17476337  0.4440618
  0.47946304  1.176331    0.10407838  0.5081626   0.24131788 -0.53567576]",10.1002/ppul.23004,"['Absorptiometry, Photon', 'Adolescent', 'Body Fat Distribution', 'Body Mass Index', 'Child', 'Humans', 'Linear Models', 'Male', 'Muscular Dystrophy, Duchenne', 'Obesity, Abdominal', 'Retrospective Studies', 'Torso', 'Vital Capacity', 'Young Adult']"
19,"[ 0.13440233  0.11413827  0.15715246 -0.23349857 -0.13336267  0.17122805
  0.2508302   0.14695014 -0.85426044  0.06956162  0.46360454 -0.01174136
 -0.13008839 -0.09811405 -0.14563107 -0.11750662  0.23604214  0.10609971
 -0.6085217   0.3867446   0.0909826  -0.24152072 -0.20588426  0.3323237
  0.22526675  0.6609835   0.05073303  0.41192055  0.20086344 -0.42539656]",10.1016/j.psym.2013.12.015,"['Depression', 'Diabetes Complications', 'Diabetes Mellitus, Type 2', 'Disabled Persons', 'Female', 'Humans', 'Male', 'Middle Aged', 'Psychiatric Status Rating Scales', 'Risk Factors', 'Schizophrenia']"
20,"[-0.13628018 -0.0118866   0.39045933 -0.479575   -0.29918778  0.12921563
  0.16555275  0.18603808 -0.99983305  0.12680505  0.7286889   0.2495737
  0.0064736  -0.10787437 -0.21369064 -0.02082945  0.471899    0.0887688
 -0.7621498   0.41266116 -0.08006496 -0.05615558 -0.04885247  0.6630657
  0.1740979   1.0135978   0.08375522  0.5595666   0.3261796  -0.4686583 ]",10.1007/s00134-013-3136-0,"['Adult', 'Aged', 'Cognitive Behavioral Therapy', 'Cognitive Dysfunction', 'Critical Illness', 'Exercise Therapy', 'Feasibility Studies', 'Female', 'Humans', 'Intensive Care Units', 'Male', 'Middle Aged', 'Occupational Therapy', 'Pilot Projects', 'Quality of Life', 'Surveys and Questionnaires', 'Treatment Outcome']"
21,"[ 0.10806564  0.06445978  0.26052657 -0.26094997 -0.22679675  0.1059886
  0.2634256   0.15828116 -0.986868    0.09210858  0.6113985   0.05105351
 -0.16562177 -0.16760367 -0.23925681 -0.21055499  0.35526097  0.11399429
 -0.7294768   0.40628898  0.08341549 -0.1919944  -0.20599033  0.44183818
  0.35876513  0.8999593   0.025625    0.5163378   0.2610115  -0.5400315 ]",10.1097/MED.0b013e32835edbb0,"['Bariatric Surgery', 'Blood Glucose', 'Diabetes Mellitus, Type 2', 'Follow-Up Studies', 'Hyperinsulinism', 'Hypoglycemia', 'Intestinal Absorption', 'Obesity, Morbid', 'Outcome Assessment, Health Care', 'Patient Selection', 'Postoperative Complications', 'Pulmonary Embolism', 'Randomized Controlled Trials as Topic', 'Remission Induction', 'Sepsis', 'Treatment Outcome', 'Weight Loss']"
22,"[ 0.08067791  0.314877    0.4853958  -1.0091245  -1.0838543   0.5931416
  0.37869516  0.7022898  -1.6394014   0.11058261  1.7794781   0.6400767
  0.02849657 -0.0046688  -0.29151896  0.05920083  1.1412091  -0.21839973
 -1.3983263   0.6523036   0.09964775 -0.2508105   0.3678908   1.0069854
  0.49935484  2.6383     -0.02900564  0.92911017  0.09282545 -0.7827895 ]",10.2522/ptj.20110117,"['Algorithms', 'Bed Rest', 'Disability Evaluation', 'Electrodiagnosis', 'Humans', 'Intensive Care Units', 'Mobility Limitation', 'Muscle Fatigue', 'Muscle Weakness', 'Muscular Atrophy', 'Physical Therapy Modalities', 'Polyneuropathies', 'Prognosis', 'Quality of Life', 'Respiration, Artificial', 'Respiratory Muscles']"
23,"[ 1.89521164e-01  3.16351920e-01  1.56708241e-01 -5.09697437e-01
 -4.56525356e-01  3.93538415e-01  4.66019750e-01  4.56751823e-01
 -1.35121453e+00  1.88721076e-01  1.07621205e+00  2.72613704e-01
 -2.00322986e-01 -2.28447318e-01 -6.47646129e-01 -3.27099174e-01
  5.96206903e-01 -1.19276106e-01 -8.20493817e-01  6.70053899e-01
  3.90627384e-01 -2.38314122e-01 -1.15173265e-01  3.87862682e-01
  6.62883759e-01  1.30871630e+00 -4.15853923e-04  5.90196729e-01
  1.02766551e-01 -7.44576037e-01]",10.1111/j.1528-1167.2012.03515.x,"['Child', 'Child Behavior Disorders', 'Child, Preschool', 'Epilepsy', 'Female', 'Humans', 'Male', 'Parent-Child Relations', 'Pediatrics', 'Retrospective Studies', 'Severity of Illness Index', 'Sleep Wake Disorders', 'Surveys and Questionnaires']"
24,"[ 0.02024212  0.14275543  0.2763985  -0.32087275 -0.2961723   0.19395337
  0.22643274  0.20012836 -1.0781922  -0.03276802  0.75898373  0.18536215
 -0.32024536 -0.2572556  -0.35574776 -0.24118309  0.4030185  -0.05190643
 -0.8036767   0.5149591   0.18014422 -0.14606164 -0.1995575   0.49405876
  0.5945232   0.9722176   0.04554795  0.5160443   0.32355747 -0.6072388 ]",10.1161/CIRCULATIONAHA.112.127639,"['Aged', 'Aged, 80 and over', 'Canada', 'Cohort Studies', 'Coronary Artery Bypass', 'Coronary Artery Disease', 'Echocardiography', 'Female', 'Follow-Up Studies', 'Humans', 'Hypertension, Pulmonary', 'Male', 'Middle Aged', 'Morbidity', 'Predictive Value of Tests', 'Preoperative Care', 'Prognosis', 'Retrospective Studies', 'Risk Factors', 'Survival Rate', 'United States', 'Ventricular Dysfunction, Right']"
25,"[ 0.0761152   0.12050527  0.2285912  -0.19584577 -0.09825988  0.14783089
  0.24353391  0.12421234 -0.7714614   0.02833061  0.41584224 -0.02837212
 -0.2033808  -0.22876139 -0.16787145 -0.2681943   0.15979837  0.04188687
 -0.60218346  0.38582563  0.11836945 -0.11021069 -0.17745045  0.30761173
  0.23650223  0.64239335  0.11611604  0.37847346  0.24202865 -0.4145889 ]",10.1016/j.jpeds.2011.06.028,"['Adipose Tissue, Brown', 'Adolescent', 'Adult', 'Age Factors', 'Child', 'Child, Preschool', 'Female', 'Fluorodeoxyglucose F18', 'Humans', 'Infant', 'Male', 'Positron-Emission Tomography', 'Radiopharmaceuticals', 'Young Adult']"
26,"[ 0.43877584  0.96479595  0.24042904 -0.7779314  -1.0009059   0.946059
  0.77144355  1.0459391  -1.7956815   0.22083947  1.4426284   0.7119047
 -0.5798199  -0.48110726 -0.7062482  -0.8414643   0.97689813 -0.43712905
 -1.1550319   0.98566264  0.791958   -0.87607586 -0.00370632  0.6077425
  0.9704407   2.4733548   0.06417977  0.5563751  -0.040147   -0.99263924]",10.1124/dmd.111.041012,"['ATP-Binding Cassette Transporters', 'Disease Progression', 'Fatty Liver', 'Humans', 'Multidrug Resistance-Associated Protein 2', 'Non-alcoholic Fatty Liver Disease']"
27,"[ 0.28407922  0.45195344  0.29496586 -0.5711546  -0.7110822   0.6093985
  0.42273974  0.6227474  -1.48822     0.09991911  1.2347292   0.43460625
 -0.54312515 -0.3301037  -0.69643843 -0.46963263  0.5534532  -0.26152417
 -1.1712372   0.6780894   0.43023542 -0.29894316 -0.22730245  0.5474471
  0.81585306  1.7386233   0.1376064   0.5897475   0.33525032 -0.8244912 ]",10.1109/EMBC.2012.6345890,"['Dielectric Spectroscopy', 'Head', 'Humans', 'Intracranial Hemorrhages', 'Stochastic Processes', 'Stroke']"
28,"[ 0.37971294  1.2582396  -0.3472703  -0.33643755 -0.7921573   1.7924747
  1.0185903   0.8904739  -2.5760987   1.169113    1.4955721   0.02343688
 -0.4935546  -1.0291826  -0.754187   -0.4988572   0.5690282  -0.36424616
 -1.2080239   0.7571547   0.83912826 -0.6733941  -1.0462234   1.0337963
  1.2374166   2.167608   -0.04713341  0.89059824  0.12451643 -1.4111161 ]",10.1038/labinvest.2012.55,"['Administration, Inhalation', 'Animals', 'Bronchoalveolar Lavage Fluid', 'Carbon Monoxide', 'Cytokines', 'Disease Models, Animal', 'Humans', 'Lung', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Neutrophils', 'Respiration, Artificial', 'Respiratory Distress Syndrome', 'Tidal Volume', 'Time Factors', 'Ventilator-Induced Lung Injury']"
29,"[ 9.8064961e-03  1.3147469e-01  2.5196287e-01 -3.1725493e-01
 -1.6160169e-01  1.1327265e-01  2.1262872e-01  7.5940266e-02
 -8.5831153e-01 -4.0105628e-03  4.1444349e-01 -7.7164493e-04
 -1.3458303e-01 -1.4913315e-01 -1.5701970e-01 -1.3141356e-01
  2.4899054e-01  9.7027995e-02 -6.4786345e-01  4.2526010e-01
  1.0698385e-01 -6.5726466e-02 -2.4277419e-01  3.3019745e-01
  3.0933669e-01  6.6285199e-01  1.5849669e-02  5.2074564e-01
  3.1399292e-01 -4.7659108e-01]",10.1097/RHU.0b013e318247bb0d,"['Aged', 'Airway Management', 'Anesthesia', 'Arthritis, Rheumatoid', 'Cervical Vertebrae', 'Decision Support Techniques', 'Female', 'Fiber Optic Technology', 'Humans', 'Joint Instability', 'Male', 'Middle Aged', 'Monitoring, Intraoperative', 'Orthopedic Procedures', 'Outcome and Process Assessment, Health Care', 'Preoperative Care', 'Radiography', 'Retrospective Studies', 'Risk Assessment']"
30,"[-0.03095807  0.02519863  0.2389023  -0.21503614 -0.19556153  0.05267045
  0.12916234  0.03298153 -0.71184474 -0.02058567  0.40403545  0.13371024
 -0.1440361  -0.1179078  -0.12531148 -0.13661796  0.25657764  0.14119785
 -0.4901803   0.3297351   0.05622153 -0.02127529 -0.17815033  0.3784534
  0.33964434  0.56874186 -0.02522632  0.35676962  0.3036339  -0.4019684 ]",10.1007/s12028-012-9785-y,"['Decision Support Techniques', 'Disease Management', 'Glasgow Outcome Scale', 'Humans', 'Quality of Life', 'Risk Assessment', 'Severity of Illness Index', 'Status Epilepticus']"
31,"[ 0.16696435  0.27969855  0.46137348 -0.26734447 -0.30563882  0.25339773
  0.55554473  0.30067602 -1.4473532  -0.0878837   0.76839685  0.02535689
 -0.46774164 -0.33833033 -0.4295873  -0.4867751   0.4275209   0.07308894
 -1.1603955   0.69434386  0.3658709  -0.20133443 -0.28942972  0.6106823
  0.38807333  1.2777568   0.17449261  0.75962585  0.38325125 -0.792146  ]",10.2967/jnumed.112.107995,"['Adult', 'Brain', 'Female', 'Fluorine Radioisotopes', 'Humans', 'Image Interpretation, Computer-Assisted', 'Male', 'Models, Biological', 'Nitriles', 'Pilot Projects', 'Positron-Emission Tomography', 'Pyridines', 'Radiation Dosage', 'Radiopharmaceuticals', 'Receptor, Metabotropic Glutamate 5', 'Receptors, Metabotropic Glutamate', 'Tissue Distribution', 'Whole Body Imaging']"
32,"[-0.01229716  0.05834763  0.43727347 -0.4963731  -0.2812923   0.13079403
  0.22390369  0.3319723  -0.731774    0.01598265  0.5966635   0.15180859
 -0.07280578 -0.11885878 -0.12445692  0.00422906  0.5044256  -0.01971372
 -0.6759548   0.25862187  0.10615439 -0.02533545  0.09187308  0.5974879
  0.09754403  0.94785297  0.06605726  0.5599714   0.16857722 -0.36134237]",10.2522/ptj.20110417,"['Adult', 'Burns', 'Critical Care', 'Early Ambulation', 'Female', 'Humans', 'Intensive Care Units', 'Length of Stay', 'Male', 'Middle Aged', 'Physical Therapy Modalities', 'Proportional Hazards Models', 'Respiration, Artificial', 'Retrospective Studies', 'Treatment Outcome', 'Wounds and Injuries']"
33,"[ 0.66450787  0.3645258   0.84854424 -0.4372545  -0.45875233  0.83081895
  0.47037768  0.41739205 -2.1773248   0.24461332  1.3042022  -0.5586206
  0.18059711 -0.28441054 -0.8305382   0.32106498  1.0015107  -0.24402049
 -1.5434809   0.92549944  0.33900526 -0.8500926  -0.0862485   0.53816557
 -0.19563138  1.9377863  -0.25519797  1.2772473  -0.07866143 -0.71799225]",10.1111/bjh.12177,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Analgesics', 'Bone Diseases, Metabolic', 'Child', 'Chronic Pain', 'Female', 'Fractures, Spontaneous', 'Hemoglobins', 'Humans', 'Iron', 'Iron Chelating Agents', 'Iron Overload', 'Male', 'Middle Aged', 'Pain', 'Pain Measurement', 'Prospective Studies', 'Quality of Life', 'Risk Factors', 'Thalassemia', 'Transfusion Reaction', 'Young Adult', 'alpha-Thalassemia']"
34,"[ 0.6500923   0.6780976   0.01595901 -0.91403174 -0.63314044  0.94880915
  0.9012144   1.1102091  -2.328535   -0.00636576  1.1665963   0.49825346
 -1.0385194  -1.100107   -1.2111071  -0.5806902   0.34292978 -0.6832521
 -1.4911165   0.89753914  0.86973774 -0.817105   -0.34979022  0.5881788
  1.2549965   1.6940383   0.82380784  0.37701505  0.58120877 -1.0355829 ]",10.2334/josnusd.56.157,"['Dental Pulp', 'Fibroblasts', 'Gingiva', 'Humans', 'In Vitro Techniques', 'MicroRNAs', 'Oligonucleotide Array Sequence Analysis', 'Periodontal Ligament']"
35,"[ 0.44126108  0.4447412   0.43575197 -0.6394397  -0.69489247  1.1055331
  0.62044656  0.55091035 -1.6802906   0.10968456  1.3565338   0.46151972
 -0.1758749  -0.52841485 -0.61844754 -0.42782205  0.6038211  -0.38846403
 -1.3732285   0.8793084   0.33504266 -0.34116483  0.32428464  0.5861085
  0.40875557  1.985538    0.12466536  0.5832974  -0.16727528 -0.75514114]",10.1123/japa.2012-0283,"['Accelerometry', 'Activities of Daily Living', 'Aged', 'Aged, 80 and over', 'Female', 'Housing for the Elderly', 'Humans', 'Leisure Activities', 'Middle Aged', 'Motor Activity', 'Physical Fitness', 'Surveys and Questionnaires', ""Women's Health""]"
36,"[-0.01153595  0.03142391  0.19046327 -0.15977053 -0.10795781  0.06367223
  0.0707804   0.00169967 -0.5214749  -0.01733416  0.2995546   0.05388412
 -0.1373161  -0.10998555 -0.10281014 -0.13618267  0.13476042  0.08648816
 -0.40149254  0.30769     0.0629409  -0.04650115 -0.1850522   0.27048355
  0.24722062  0.3837539   0.01339957  0.31376675  0.23140275 -0.300267  ]",10.1038/mp.2014.181,[]
37,"[ 0.12588738  0.2426983   0.24365701 -0.26923615 -0.1554778   0.27615047
  0.47085527  0.24815367 -1.0018907   0.04803727  0.48243615  0.12353803
 -0.32040226 -0.3298776  -0.35366127 -0.3462473   0.21831234 -0.13814366
 -0.7499089   0.41411436  0.2954248  -0.14284156 -0.1321174   0.38760218
  0.3352196   0.8927785   0.19520846  0.35871303  0.22952005 -0.525994  ]",10.1186/s13046-015-0147-4,"['Antineoplastic Agents', 'Cell Hypoxia', 'Cell Line, Tumor', 'Cell Proliferation', 'Deoxyglucose', 'Dose-Response Relationship, Drug', 'Female', 'Genes, Reporter', 'Glucose', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit', 'Imidazoles', 'Lactic Acid', 'Ovarian Neoplasms', 'Pancreatic Neoplasms', 'Poly(ADP-ribose) Polymerases', 'Pyridines', 'Transcription, Genetic', 'p38 Mitogen-Activated Protein Kinases']"
38,"[-0.02106623  0.31485242  0.36075634 -0.43603668 -0.44149515  0.3705688
  0.2760562   0.38040948 -1.4262908  -0.01963417  0.964844    0.2830752
 -0.35711637 -0.45490158 -0.582523   -0.3507177   0.4307441  -0.14512008
 -0.9217784   0.6434361   0.1887723  -0.16633438 -0.2752484   0.66033447
  0.7752656   1.3604137   0.09018656  0.60598403  0.48847565 -0.6723032 ]",10.2217/fvl.12.123,[]
39,"[ 0.7841185   0.47363275  0.5111716  -0.55554277 -0.51143533  0.9324542
  1.9567122   1.2124968  -2.5357857   0.15918519  1.3894746   0.26142752
 -0.10102059 -0.04473571 -1.8284756  -0.88590187  0.9074687  -0.6198782
 -1.684279    1.3649356   0.96988153 -0.42935026  0.4255356   0.36848056
 -0.2774425   2.589472    0.28343865  0.6073603  -0.9602219  -1.3076487 ]",10.1111/jsr.12259,"['Actigraphy', 'Adolescent', 'Adult', 'Biomarkers', 'Blood Pressure', 'C-Reactive Protein', 'Case-Control Studies', 'Female', 'Humans', 'Hydrocortisone', 'Hypothalamo-Hypophyseal System', 'Inflammation', 'Interleukin-6', 'Male', 'Middle Aged', 'Monocytes', 'Norepinephrine', 'Pituitary-Adrenal System', 'Sleep', 'Sleep Initiation and Maintenance Disorders', 'Stress, Physiological', 'Time Factors', 'Young Adult']"
40,"[ 0.31961522  0.5249699   0.45074776 -0.6893892  -0.69864076  0.53405046
  0.848817    0.01628356 -2.2957754  -0.19955379  1.6259111  -0.26814815
 -0.56383246 -0.166633   -0.40685427 -0.06985384  1.1034039  -0.1715004
 -2.3160813   1.2138001   0.36731228 -0.79553676  0.01803897  0.41625467
  0.36076066  2.3591318  -0.32625428  1.3318926  -0.22684747 -1.3652132 ]",10.1016/j.amjcard.2013.11.048,"['Aged', 'Atrial Fibrillation', 'Coronary Artery Bypass', 'Coronary Artery Disease', 'Echocardiography', 'Female', 'Follow-Up Studies', 'Humans', 'Incidence', 'Male', 'Massachusetts', 'Middle Aged', 'Postoperative Complications', 'Predictive Value of Tests', 'Prognosis', 'Quebec', 'Retrospective Studies', 'Risk Factors', 'Survival Rate', 'Ventricular Dysfunction, Right']"
41,"[ 0.09874257  0.27193502  0.1702802  -0.2914734  -0.21472159  0.25660974
  0.40749303  0.31352547 -0.96111     0.07227506  0.5121403   0.0608753
 -0.24218349 -0.26711333 -0.35246524 -0.27442527  0.21629919 -0.07837697
 -0.7399396   0.4192494   0.2170107  -0.14160629 -0.14736795  0.36796176
  0.3469688   0.91970974  0.14983791  0.38659722  0.23827283 -0.50339997]",10.1177/0194599814533083,"['Adult', 'Aged', 'Aged, 80 and over', 'Carcinoma, Squamous Cell', 'Female', 'Humans', 'Indians, North American', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Oropharyngeal Neoplasms', 'Risk Factors', 'Socioeconomic Factors', 'South Dakota', 'Survival Analysis']"
42,"[ 0.34135714  0.45560393  0.2433387  -0.3962568  -0.733172    0.6119978
  0.6540567   0.558507   -1.6661514   0.08805665  1.1898152   0.6958947
 -0.47988683 -0.3413173  -0.76321596 -0.5767408   0.8456685  -0.2588804
 -1.3000288   0.7459884   0.5383281  -0.3409045   0.04965859  0.5148983
  0.9454239   2.0681503   0.21721521  0.5823944   0.20157926 -0.9569224 ]",10.1002/cbic.201402258,"['Adenosine Triphosphatases', 'Alkaloids', 'Biological Products', 'Chromatography', 'Drug Discovery', 'Fungi', 'Humans', 'Naphthoquinones', 'Nuclear Proteins', 'Plants']"
43,"[ 0.11672003  0.70008343  0.4816802  -0.44315097 -0.41650033  1.0366607
  0.9958311   0.9269607  -1.9766357  -0.07780524  1.221117    0.61455005
 -0.7703387  -1.1712426  -1.1602427  -1.0503219   0.45218682 -0.5972924
 -1.282679    0.78381544  0.5967534  -0.35139385 -0.29610294  1.1355045
  1.5339715   1.6639174   0.4929495   0.29731122  0.42226586 -0.70380956]",10.1371/journal.pone.0114549,"['Alveolar Epithelial Cells', 'Analysis of Variance', 'Arsenites', 'Cell Hypoxia', 'Cell Line', 'Energy Metabolism', 'Fluorescent Antibody Technique', 'Gas Chromatography-Mass Spectrometry', 'Glycolysis', 'Half-Life', 'Humans', 'Hypoxia-Inducible Factor 1, alpha Subunit', 'Immunoblotting', 'Lactic Acid', 'Metabolomics', 'Oligonucleotides', 'Real-Time Polymerase Chain Reaction']"
44,"[ 0.28808925  0.3012271   0.15277767 -0.654678   -0.15564665  0.8311888
  1.0723758   1.127302   -2.3364136  -0.12347575  1.3176925   0.56283116
 -1.0206934  -1.1280273  -1.2885547  -0.6184208   0.164443   -0.59280777
 -1.1992702   0.6143382   0.84923077 -0.3666143  -0.4197679   0.6663106
  1.460069    1.2564901   1.080056    0.38636306  0.8804162  -0.89717126]",10.3109/10428194.2014.933218,"['Animals', 'Antigens, Neoplasm', 'Carbonic Anhydrase IX', 'Carbonic Anhydrases', 'Cell Line, Tumor', 'Disease Models, Animal', 'Extracellular Space', 'Gene Expression', 'Humans', 'Hydrogen-Ion Concentration', 'Hypoxia', 'Immunohistochemistry', 'Lymphoma, B-Cell', 'Magnetic Resonance Imaging', 'Tumor Burden', 'Xenograft Model Antitumor Assays']"
45,"[ 0.11894649  0.4122323   0.19524519 -0.71419007 -1.0889629   0.75510705
  0.3860004   0.6621358  -1.6065195   0.21540864  1.4483062   0.7845979
 -0.3177014  -0.2928532  -0.62567496 -0.54841405  0.9241714  -0.28243768
 -1.2975652   0.8096552   0.4328665  -0.45007494  0.30300125  0.4430977
  0.8416565   2.2557788   0.09671605  0.64821327  0.05059078 -0.8621584 ]",10.1093/icb/icv085,"['Animals', 'Biomechanical Phenomena', 'Fishes', 'Motor Activity', 'Water Movements']"
46,"[ 0.02384843  0.01129563  0.4347926  -0.5471255  -0.2202026   0.09659436
  0.17798369  0.19516645 -0.71355695  0.16640177  0.4405982   0.06395181
  0.01996015 -0.09998724  0.00501004  0.03898947  0.45770377  0.0953497
 -0.7131984   0.29526287  0.13736118 -0.05239901 -0.03135327  0.6018906
  0.10499223  0.74667394  0.05907653  0.59952843  0.21161269 -0.3206754 ]",10.1164/rccm.201409-1690OC,"['Age Distribution', 'Coma', 'Comorbidity', 'Delirium', 'Female', 'Hospital Mortality', 'Humans', 'Intensive Care Units', 'Logistic Models', 'Male', 'Middle Aged', 'New York City', 'Prevalence', 'Prospective Studies', 'Respiration, Artificial', 'Respiratory Distress Syndrome', 'Risk Factors', 'Severity of Illness Index']"
47,"[ 0.18831764  0.25671536  0.25623587 -0.4916213  -0.47439677  0.3504948
  0.34930706  0.37573794 -1.3627601  -0.02684489  0.8323758   0.21650885
 -0.410091   -0.41865015 -0.4905986  -0.32841817  0.37524775 -0.21865067
 -0.9477808   0.6187271   0.36062038 -0.23212905 -0.16462986  0.47219893
  0.6549377   1.3421876   0.05301987  0.45619568  0.35612097 -0.6623773 ]",10.1186/s11671-014-0718-x,[]
48,"[ 0.49261233  0.6322393   0.30256745 -0.7561813  -0.43759778  1.3603926
  1.3723454   1.0299124  -2.843245    0.3120218   1.2501798   0.54029477
 -1.0302669  -1.365709   -1.4410987  -0.81247157  0.02691055 -0.6366331
 -1.3870561   0.6923556   0.9435591  -0.44895288 -0.29111242  1.0604631
  1.7472684   2.1783292   0.7461697   0.3450908   0.50416124 -1.345645  ]",10.1007/s12307-015-0166-x,[]
49,"[ 0.40789518  0.84903693  0.372166   -0.7753907  -0.33949733  0.85360205
  0.91717386  0.377691   -1.9800901  -0.12918438  1.0545541   0.31720346
 -0.94110054 -0.79506534 -0.8132599  -0.6540861   0.42858803 -0.35211873
 -2.0852635   1.5869952   0.68662184 -0.13378513 -0.35654616  0.62315625
  1.1119576   2.3706574   0.1645529   1.3015772   0.7703998  -1.5661505 ]",10.1016/j.mrgentox.2014.10.011,"['Benzo(a)pyrene', 'Carcinogens, Environmental', 'Cells, Cultured', 'Chromosome Aberrations', 'Epithelial Cells', 'Exome', 'Female', 'Gene Expression Regulation', 'Genes, Neoplasm', 'Humans', 'Mammary Glands, Human', 'Mutation', 'Neoplasms', 'Sequence Analysis, DNA', 'Young Adult']"
50,"[-0.23755686  1.2671245   0.53371483 -0.24479546  1.027153    0.1391823
  1.7725898   0.692455   -2.786953   -0.19632694  0.16534412 -0.68784356
 -1.6748804  -1.6667475  -1.0678794  -1.297166   -0.8349606  -0.8410724
 -2.4464128   0.50018454  1.1562165  -0.57071084 -0.65888643  1.4192504
  0.5565691   1.2148783   1.5239841   0.5978599   1.2755549  -0.5659481 ]",10.1016/j.cellsig.2014.11.037,"['Actin Cytoskeleton', 'Amino Acid Substitution', 'Animals', 'Arrestin', 'Cell Movement', 'Cells, Cultured', 'Epithelial-Mesenchymal Transition', 'Hyaluronic Acid', 'Mice', 'Neuropeptides', 'Pericardium', 'Protein Binding', 'Proteoglycans', 'RNA Interference', 'RNA, Small Interfering', 'Receptors, Transforming Growth Factor beta', 'cdc42 GTP-Binding Protein', 'rac1 GTP-Binding Protein', 'rho GTP-Binding Proteins', 'rhoA GTP-Binding Protein', 'src-Family Kinases']"
51,"[ 0.0467289   0.10431023  0.23872162 -0.20341948 -0.115094    0.13035013
  0.25479308  0.143372   -0.74974185 -0.00954749  0.3721551   0.03672916
 -0.24213114 -0.20201111 -0.22086127 -0.23661913  0.17217712 -0.00273272
 -0.59447944  0.35970855  0.13535246 -0.10389149 -0.14020045  0.29421884
  0.2315734   0.62848336  0.08494429  0.34376597  0.22273763 -0.3812759 ]",10.1016/j.clinph.2015.11.008,"['Brain', 'Cohort Studies', 'Electroencephalography', 'Female', 'Humans', 'Infant, Newborn', 'Infant, Premature', 'Male', 'Sleep Stages']"
52,"[ 0.18618165  0.48546088  0.39268503 -0.41073075 -0.7757368   0.6868891
  0.6134116   0.7897649  -1.6298809   0.05770339  1.3315065   0.7938985
 -0.44867694 -0.44747722 -0.71497643 -0.710893    0.89690584 -0.40570107
 -1.2847521   0.67360085  0.56309927 -0.22003792  0.1448087   0.62642556
  1.0529706   1.8905311   0.42733538  0.4575567   0.3510467  -0.8107636 ]",10.1021/acschembio.5b00367,"['Adenosine Triphosphatases', 'Antineoplastic Agents, Phytogenic', 'Cell Line, Tumor', 'HEK293 Cells', 'Humans', 'Models, Molecular', 'Neoplasms', 'Nuclear Proteins', 'Proteasome Endopeptidase Complex', 'Withanolides']"
53,"[ 0.02412223  0.2204815   0.18777199 -0.24951835 -0.27040657  0.20013289
  0.21941242  0.14129697 -0.8952409   0.03591106  0.5493234   0.03154672
 -0.20075464 -0.19816557 -0.25192848 -0.30396724  0.23724984  0.06486972
 -0.7394249   0.4734751   0.1650867  -0.17341676 -0.21337637  0.34669432
  0.40763977  0.8573986   0.02663593  0.45883965  0.26835263 -0.5073153 ]",10.1016/j.apmr.2016.04.015,"['Adult', 'Brain Injuries, Traumatic', 'Exercise', 'Exercise Therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Patient Compliance', 'Prospective Studies', 'Trauma Severity Indices']"
54,"[ 0.0686024   0.14774884  0.3007083  -0.36119136 -0.2576715   0.1430847
  0.44670978  0.31516778 -1.2070974   0.05291256  0.67621154  0.25418895
 -0.2832981  -0.19687778 -0.36910614 -0.35854548  0.3507816  -0.01261872
 -0.9169712   0.56626105  0.14298636 -0.15934698 -0.261407    0.5360974
  0.44794983  0.98830444  0.28387755  0.500736    0.32732034 -0.5802655 ]",10.1097/CCM.0000000000001606,"['Animals', 'Baroreflex', 'Blood Pressure', 'Critical Illness', 'Echocardiography', 'Female', 'G-Protein-Coupled Receptor Kinase 2', 'Heart', 'Heart Rate', 'Humans', 'Leukocytes, Mononuclear', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Myocytes, Cardiac', 'NADPH Oxidases', 'Postoperative Complications', 'Random Allocation', 'Rats', 'Rats, Sprague-Dawley', 'Surgical Procedures, Operative', 'Up-Regulation']"
55,"[ 0.28410384  0.4949108   0.3633829  -0.53017426 -0.65333176  0.9172641
  0.8868078   0.77462536 -2.247503    0.11154824  1.4816399   0.36540473
 -0.7666289  -0.5884096  -0.85722744 -0.91977346  0.4964167  -0.26708362
 -1.6254421   0.9124877   0.600193   -0.36268827 -0.27961946  0.82348555
  0.8461405   2.203005    0.5011015   0.7110805   0.26306185 -1.1038939 ]",10.1111/mmi.13534,"['Autophagy', 'Cyclic AMP-Dependent Protein Kinases', 'Gluconeogenesis', 'Glucose', 'Leishmania donovani', 'Macrophages', 'Oxidative Stress', 'Phosphoenolpyruvate', 'Phosphoenolpyruvate Carboxylase', 'Starvation', 'Transcriptional Activation', 'Up-Regulation', 'Virulence', 'Virulence Factors']"
56,"[-0.00980411  0.02445953  0.18057474 -0.18226486 -0.02885284 -0.03081104
  0.07188057 -0.07335964 -0.45429057 -0.04747502  0.16126634  0.0010152
 -0.04913632 -0.05239334 -0.02854272 -0.02325802  0.12511218  0.1364019
 -0.34681803  0.254611   -0.00424068 -0.03010621 -0.16986285  0.16054149
  0.1367538   0.27640066 -0.00928472  0.31683567  0.21104722 -0.2642544 ]",10.1016/j.jval.2014.08.2637,[]
57,"[-0.3400336   1.4507158   0.49249336 -0.19212086  1.160872    0.09750245
  1.925252    0.78940225 -3.0177886  -0.30088854  0.18072455 -0.60227627
 -1.8937842  -1.8704623  -1.1236564  -1.3300731  -0.9719916  -1.053534
 -2.5898256   0.31794453  1.2645465  -0.55478525 -0.514218    1.6075523
  0.6572888   1.1586503   1.6872685   0.56727654  1.5460736  -0.56132203]",10.1080/19336918.2015.1119362,"['Actins', 'Animals', 'Bone Morphogenetic Protein 2', 'Cell Movement', 'Cell Proliferation', 'Gene Expression Profiling', 'Humans', 'Mice', 'Pericardium', 'Polymerization', 'Proteoglycans', 'Receptors, Transforming Growth Factor beta', 'src-Family Kinases']"
58,"[ 0.5516587   0.73604345  0.26912093 -0.65159225 -0.5963972   1.1615274
  0.9069065   0.9373076  -2.0421221   0.22910672  1.2281044  -0.03167976
 -0.49011046 -0.6014534  -0.60643375 -0.5679478   0.30257094 -0.07829708
 -1.5344371   0.6948962   0.7678342  -0.6069307  -0.14289102  0.37874246
  0.67325145  1.8731574   0.3853945   0.5416373   0.0419804  -0.9833373 ]",10.1097/PAS.0000000000000683,"['Aged', 'Aged, 80 and over', 'Biomarkers, Tumor', 'Endometrial Neoplasms', 'Female', 'Gene Rearrangement', 'Humans', 'Immunoglobulin Heavy Chains', 'Immunohistochemistry', 'In Situ Hybridization, Fluorescence', 'Lymphoma, B-Cell, Marginal Zone', 'Middle Aged']"
59,"[-0.05063354  0.00339218  0.13551384 -0.07720344 -0.00859512 -0.04604409
 -0.00752491 -0.06382868 -0.26716107 -0.02998031  0.10657889  0.01567576
 -0.04947605 -0.0636327  -0.00519059 -0.04822743  0.04507331  0.11570001
 -0.16889872  0.18547939 -0.02272727  0.01585539 -0.13490051  0.16117461
  0.11087943  0.11690637  0.01432726  0.17660993  0.17294267 -0.15791605]",10.1016/j.ajog.2015.12.059,[]
60,"[ 0.10239436  0.248919    0.0539997  -0.6782437  -1.0919607   0.56444734
 -0.15858164  0.16065298 -1.2581043   0.3373125   1.3860089   0.49113846
 -0.23886111 -0.44263548 -0.48262888 -0.4832858   0.73566055 -0.0120508
 -1.0080228   0.49421927  0.45504862 -0.8858154   0.04319118  0.59861726
  1.1826079   1.7187827  -0.49092355  0.6604694   0.11759688 -0.76159036]",10.1353/bhm.2015.0116,"['Disease', 'Health', 'Historiography', 'History of Medicine', 'History, 18th Century', 'History, 19th Century', 'History, 20th Century', 'History, 21st Century', 'Humans']"
61,"[ 0.04446406  0.7966786   0.51439965 -0.36369762 -0.27714047  0.82075614
  1.219199    0.87971485 -2.276889    0.21654822  1.2585261   0.31707132
 -0.493909   -1.1099374  -1.0251868  -1.3696947   0.6704218  -0.80827475
 -1.4879733   0.9068901   0.63875777 -0.26511583 -0.5895365   1.001374
  0.974026    1.8028536   0.5674534   0.48707744  0.32462165 -0.81699413]",10.1093/toxsci/kfv191,"['Active Transport, Cell Nucleus', 'Animals', 'Arsenites', 'Cell Differentiation', 'Epithelial-Mesenchymal Transition', 'HEK293 Cells', 'Humans', 'Karyopherins', 'Mice, Transgenic', 'Myocytes, Cardiac', 'Phosphorylation', 'RNA Interference', 'Signal Transduction', 'Smad2 Protein', 'Smad3 Protein', 'Stem Cells', 'Time Factors', 'Transcription, Genetic', 'Transfection', 'Transforming Growth Factor beta2', 'Zinc']"
62,"[ 0.18321085  0.29790887  0.37069035 -0.43245894 -0.26483473  0.3259945
  0.5069739   0.3397909  -1.4206507   0.02787253  0.75688154  0.01649632
 -0.4099115  -0.40302315 -0.53992105 -0.50297403  0.39281175 -0.053188
 -1.1548133   0.7065977   0.38534826 -0.24031125 -0.24580385  0.5274456
  0.45601976  1.2215971   0.14317037  0.6994796   0.31912878 -0.6843724 ]",10.1038/ajg.2016.162,"['Adult', 'Autoantibodies', 'Biomarkers', 'Celiac Disease', 'Diagnostic Techniques, Digestive System', 'Diet, Gluten-Free', 'Early Diagnosis', 'Fatty Acid-Binding Proteins', 'Female', 'GTP-Binding Proteins', 'Gliadin', 'Glutens', 'Humans', 'Intestinal Mucosa', 'Lymphocyte Count', 'Male', 'Middle Aged', 'Protein Glutamine gamma Glutamyltransferase 2', 'Reproducibility of Results', 'Statistics as Topic', 'Transglutaminases']"
63,"[ 1.1278229   0.84946936  0.14518526 -0.26962462 -0.31448367  1.6244805
  1.6665432   1.1623216  -2.4533525   0.37166777  1.0978798  -0.2757479
 -0.5827115  -0.7128797  -0.69746614 -1.495061    0.4790654  -0.07986444
 -2.3256373   0.80951196  0.88383424 -0.5241778   0.28078312 -0.01540758
 -0.11345658  2.1179924   1.0117692   0.44434512 -0.4760591  -1.1943843 ]",10.1021/acs.jnatprod.5b00986,"['Adenosine Triphosphatases', 'Ascomycota', 'Drug Screening Assays, Antitumor', 'Florida', 'Forests', 'Lichens', 'Molecular Structure', 'Nuclear Magnetic Resonance, Biomolecular', 'Nuclear Proteins', 'Oxidation-Reduction', 'Spiro Compounds', 'Stereoisomerism']"
64,"[ 0.315121    0.276291    0.16840145 -0.55830216 -0.6615365   0.97973216
  0.6627387   0.8399634  -1.9447218   0.16938348  1.7128586   0.3448609
 -0.47308397 -0.32929718 -0.8527121  -0.8369793   0.6489365  -0.19811681
 -1.5800399   1.012331    0.5950267  -0.32741523  0.0660364   0.49821377
  0.8122256   1.9811574  -0.01832412  0.88782436 -0.17761207 -1.034083  ]",10.1016/j.orcp.2015.10.009,"['Adiponectin', 'Adult', 'Adult Survivors of Child Adverse Events', 'Antihypertensive Agents', 'Blood Pressure', 'Diet', 'Female', 'Humans', 'Hypertension', 'Insulin Resistance', 'Leptin', 'Male', 'Middle Aged', 'Sex Factors']"
65,"[ 0.25444126  0.2109163   0.40631858 -0.83304054 -0.9717035   0.49393722
  0.42972162  0.60816664 -1.7144673   0.483609    1.3672004   0.79241043
 -0.18039556 -0.14638259 -0.5918999  -0.15125784  0.80273575 -0.22498968
 -1.2913126   0.67724395  0.43181708 -0.63390434  0.00363866  0.97846645
  1.042594    2.1226301   0.05078087  0.6548471   0.33193257 -0.8741077 ]",10.1016/j.jgo.2016.04.004,"['Aged', 'Cognition', 'Cognition Disorders', 'Comorbidity', 'Delirium', 'Dementia', 'Female', 'Humans', 'Informed Consent', 'Male', 'Medical Oncology', 'Mental Status and Dementia Tests', 'Neoplasms', 'Prevalence', 'Severity of Illness Index']"
66,"[-0.00403721  0.07677846  0.31288886 -0.47278714 -0.30967054  0.12607971
  0.16876474  0.07311127 -1.0222349  -0.05702117  0.5319916   0.01290426
 -0.1622497  -0.10127314 -0.19040643 -0.12830843  0.32290053  0.05915548
 -0.8030458   0.5106167   0.1528851  -0.10949212 -0.35121018  0.32321373
  0.45676056  0.8819687  -0.07368869  0.6423056   0.4145674  -0.583489  ]",10.3233/RNN-150634,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Evoked Potentials, Motor', 'Female', 'Humans', 'Male', 'Middle Aged', 'Motor Activity', 'Outcome Assessment, Health Care', 'Prospective Studies', 'Stroke', 'Stroke Rehabilitation', 'Transcranial Magnetic Stimulation', 'Treatment Outcome', 'Upper Extremity', 'Young Adult']"
67,"[ 0.515977    0.5076495   0.32276028 -0.07145774 -1.1761543   0.4555117
  0.7941818   1.1048614  -1.8172557   0.24352616  1.409207    0.64999586
 -0.8506359  -0.02261424 -0.91390646 -0.94268495  0.6602189  -0.23663233
 -1.5635116   0.8323672   0.8938949  -0.19816983  0.20357601  0.34077832
  0.6136864   2.0979478   0.3430969   0.53030944 -0.01079848 -0.93142533]",10.3233/JAD-160916,"['Alzheimer Disease', 'Animals', 'Antipsychotic Agents', 'Calcium-Calmodulin-Dependent Protein Kinase Type 2', 'Disease Models, Animal', 'Doxycycline', 'Excitatory Amino Acid Agonists', 'Exploratory Behavior', 'Female', 'Hippocampus', 'Hyperkinesis', 'Long-Term Potentiation', 'Male', 'Maze Learning', 'Mice', 'Mice, Transgenic', 'Motor Activity', 'N-Methylaspartate', 'Peptides', 'Phosphotransferases', 'tau Proteins']"
68,"[ 0.17353784  0.27033544  0.14293444 -0.35462707 -0.5279087   0.574983
  0.54644096  0.51327884 -1.583735    0.10543364  1.1399655   0.28225112
 -0.3833566  -0.2980867  -0.465469   -0.6020409   0.5275286  -0.14249477
 -1.2427206   0.6553304   0.35723585 -0.23628275 -0.09565623  0.40561292
  0.5591994   1.6128696   0.15405864  0.54486614  0.2289247  -0.822607  ]",10.1021/acs.bioconjchem.6b00482,[]
69,"[ 0.7559946   0.76982856 -0.5231502  -1.0489593  -1.309953    1.1722746
  0.41679513  1.665665   -1.420339    1.1172919   1.9318444   0.8352632
 -0.47026557 -0.43315873 -0.89030474 -0.89639556  0.97794425 -0.51483613
 -0.7805156   0.45113     0.7427449  -0.5924084   0.04216441 -0.55439013
  1.1140547   2.5261166  -0.33735088  0.02755494  0.19329973 -0.5587635 ]",10.1039/c7fd00032d,"['Aerosols', 'Gases', 'Molecular Structure', 'Particle Size', 'Polycyclic Aromatic Hydrocarbons']"
70,"[ 2.0071502   1.0252922   0.49212518 -1.1223545   0.06068093  0.8206136
  2.5630286   0.12251551 -2.2621562   0.08801121 -0.13338587 -1.0427417
  0.5577906   0.72163415 -0.7926301   0.9492308   0.15951729 -0.57545346
 -3.4333055   1.0991974   0.63295823 -1.523182    0.98007554 -1.8436321
 -2.1611106   2.7665195   0.00505736  1.3135384  -1.5635167  -1.1082169 ]",10.1007/s00296-016-3558-4,"['Adult', 'Age Factors', 'Aged', 'Antirheumatic Agents', 'Arthritis, Rheumatoid', 'Female', 'Hispanic or Latino', 'Humans', 'Male', 'Medication Adherence', 'Middle Aged', 'Reminder Systems', 'Self Report', 'Sex Factors', 'White People']"
71,"[ 0.60377234  0.78433865  0.36826855 -0.30394077 -0.09096429  0.8821638
  1.2246372   0.8100338  -1.8346235   0.19045074  0.6363761  -0.3696711
 -0.6194994  -0.8651898  -0.5607984  -1.139317    0.11903275 -0.18033925
 -1.8544446   0.7416464   0.67261714 -0.38739094 -0.10969193  0.34463266
 -0.15190431  1.5748744   0.66084856  0.4884036   0.06431658 -0.86300707]",10.1021/acs.jnatprod.6b00960,"['Alternaria', 'Astragalus Plant', 'Drug Screening Assays, Antitumor', 'Endophytes', 'Humans', 'Molecular Structure', 'Nuclear Magnetic Resonance, Biomolecular', 'Zearalenone']"
72,"[ 0.16065606  0.5084107   0.25083366 -0.40191898 -0.3369195   0.4224531
  0.80769044  0.5556255  -1.6894712  -0.00201719  1.0088462   0.36914983
 -0.48402303 -0.48538104 -0.7409259  -0.6608007   0.38955998 -0.3178188
 -1.326176    0.7325268   0.4221712  -0.21897717 -0.29475668  0.67039084
  0.70264816  1.54485     0.27240795  0.55545     0.4417573  -0.8834803 ]",10.1074/jbc.M117.779447,"['AMP-Activated Protein Kinases', 'Animals', 'Aorta', 'Apolipoproteins E', 'Atherosclerosis', 'Cell Differentiation', 'Cell Proliferation', 'Flow Cytometry', 'Gene Deletion', 'HEK293 Cells', 'Humans', 'Lipoproteins, LDL', 'Macrophage Colony-Stimulating Factor', 'Macrophages', 'Macrophages, Peritoneal', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Monocytes', 'Reactive Oxygen Species', 'Sirolimus']"
73,"[ 0.3112468   0.2239114   0.32936606 -0.27330986 -0.5926307   0.58482754
  0.41581273  0.5734214  -1.0631765   0.00981227  1.1107017   0.7653795
 -0.24294914 -0.39140287 -0.77845156 -0.7614937   0.6204907  -0.4324132
 -0.90409267  0.57507     0.3350787  -0.1208032   0.11626516  0.519632
  1.0520351   1.4136457   0.41396803  0.13434769  0.12037431 -0.48915026]",10.1021/acs.chemrestox.7b00158,"['Adenosine Triphosphatases', 'Animals', 'Arsenic', 'Cells, Cultured', 'Hydrolysis', 'Mice', 'NIH 3T3 Cells', 'Proteasome Endopeptidase Complex']"
74,"[ 0.03231488  0.11366976  0.3311381  -0.27871734 -0.19789408  0.15151738
  0.2208403   0.15010951 -0.8553659   0.02393591  0.439112    0.05350403
 -0.15296103 -0.20001942 -0.18010883 -0.22400948  0.17477703  0.07415172
 -0.6669      0.34649226  0.09789935 -0.08886622 -0.14356475  0.42824045
  0.20321311  0.7598651   0.06213175  0.4524848   0.2918674  -0.442194  ]",10.1016/j.jaip.2016.09.023,"['Adult', 'Aged', 'Aged, 80 and over', 'Angioedemas, Hereditary', 'Anti-Inflammatory Agents, Non-Steroidal', 'Bradykinin', 'Bradykinin B2 Receptor Antagonists', 'Health Personnel', 'Home Care Services', 'Humans', 'Injections, Subcutaneous', 'Middle Aged', 'Patient Preference', 'Prospective Studies', 'Self Administration', 'Time-to-Treatment', 'Treatment Outcome', 'United States', 'Visual Analog Scale', 'Young Adult']"
75,"[ 0.3217797   0.24364148  0.21180366 -0.43529072 -0.6160878   0.66964644
  0.4962586   0.7561698  -1.4488297   0.18547304  1.1159892   0.7438188
 -0.61050004 -0.4415352  -0.7179873  -0.6395154   0.620719   -0.41860634
 -1.0368088   0.49801806  0.50718194 -0.2416839   0.12478201  0.5545672
  1.0405235   1.797195    0.48417932  0.38607082  0.29779246 -0.7723069 ]",10.1128/MCB.00660-16,"['Adenosine Triphosphatases', 'Carrier Proteins', 'Cell Cycle Proteins', 'Cell Line, Tumor', 'Cullin Proteins', 'Humans', 'Kelch-Like ECH-Associated Protein 1', 'NF-E2-Related Factor 2', 'Protein Binding', 'Proteolysis', 'Signal Transduction', 'Ubiquitin', 'Ubiquitination', 'Valosin Containing Protein']"
76,"[ 0.4981693   0.20304628  0.93840766 -1.1321596  -0.9591489   0.28225645
  0.3062513   0.6257464  -1.3661039   0.553476    1.336182    0.42005512
  0.02214964  0.14054261 -0.08193579  0.16503881  1.1219767  -0.29834765
 -1.3914361   0.28279164  0.63713306 -0.60317945  0.46644816  1.131397
 -0.03717234  1.7794083   0.01567578  0.7834082   0.05256165 -0.6814587 ]",10.1007/s00134-017-4860-7,"['Age Factors', 'Antipsychotic Agents', 'Biomedical Research', 'Cognitive Dysfunction', 'Critical Illness', 'Deep Sedation', 'Delirium', 'Evidence-Based Medicine', 'Humans', 'Intensive Care Units', 'Outcome Assessment, Health Care', 'Randomized Controlled Trials as Topic', 'Respiration, Artificial', 'Risk Factors']"
77,"[ 0.32820752  0.40365824  0.31283095 -0.7879963  -0.4803662   0.38277718
  0.82807195  0.9459181  -2.0464454   0.17278056  1.3827864   0.58488196
 -0.52411556 -0.18992826 -0.8546565  -0.6420232   0.7868624  -0.25909433
 -1.7153057   0.7641871   0.2607458  -0.39437085  0.13028538  0.72907794
  0.40217438  2.2475245   0.7988187   0.8335053   0.425675   -0.84177744]",10.1152/physrev.00028.2014,"['Animals', 'Biomechanical Phenomena', 'Critical Illness', 'Disease Models, Animal', 'Energy Metabolism', 'Excitation Contraction Coupling', 'Humans', 'Inflammation Mediators', 'Intensive Care Units', 'Ion Channels', 'Mechanotransduction, Cellular', 'Molecular Motor Proteins', 'Muscle Weakness', 'Muscle, Skeletal', 'Muscular Diseases', 'Polyneuropathies', 'Predictive Value of Tests', 'Risk Factors']"
78,"[ 0.02614799  0.7887863  -0.3583989  -0.3285093  -1.3858083   0.80599403
  0.320046    0.9349731  -2.1269624  -0.2980632   1.8665482   0.27155998
 -0.52511466  0.28700468 -0.47450677 -0.18587151  1.2700043   0.18793741
 -1.3690363   0.9418036   0.5227854  -0.9417341   0.2811685  -0.00629438
  0.98275805  2.9772594  -1.0137879   0.73275536  0.40573406 -1.0618178 ]",10.1016/j.neuroimage.2017.05.060,"['Adult', 'Connectome', 'Electromyography', 'Evoked Potentials, Motor', 'Female', 'Humans', 'Male', 'Motor Cortex', 'Nerve Net', 'Transcranial Direct Current Stimulation', 'Transcranial Magnetic Stimulation', 'Young Adult']"
79,"[ 0.00638282  0.0842481   0.24490291 -0.25784987 -0.22258453  0.13013352
  0.19523327  0.08999053 -0.8481958   0.00999374  0.48519096  0.13101234
 -0.18299411 -0.21288924 -0.22715206 -0.19635127  0.24502452  0.0307873
 -0.58401906  0.395586    0.10493694 -0.09537146 -0.2111909   0.43385842
  0.45995954  0.75264466  0.0221531   0.42837015  0.34363097 -0.44273832]",10.1002/pon.4121,"['Adult', 'Communication', 'Feasibility Studies', 'Female', 'Gastrointestinal Neoplasms', 'Humans', 'Interpersonal Relations', 'Male', 'Middle Aged', 'Patient Satisfaction', 'Pilot Projects', 'Spouses', 'Treatment Outcome', 'Videoconferencing']"
80,"[ 0.28931022  0.05229582  0.3348485  -0.5167608  -0.23279482  0.13947766
  0.35636154  0.18218635 -1.7649077   0.09182063  0.89607495  0.04561422
 -0.35709736 -0.42706794 -0.55893165 -0.40725833  0.49096864  0.13395222
 -1.3038355   0.8874288   0.1101489  -0.32464212 -0.47810477  0.65137404
  0.6006585   1.2748779   0.11145425  0.8750397   0.6002265  -0.96511847]",10.1016/j.apnu.2016.09.014,"['Comorbidity', 'Diabetes Mellitus, Type 2', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mood Disorders', 'Patient Education as Topic', 'Psychiatric Status Rating Scales', 'Severity of Illness Index']"
81,"[-0.04756894  0.00533958  0.13140376 -0.07545921 -0.00665297 -0.0473053
 -0.0041806  -0.06125226 -0.26045173 -0.02944144  0.10247726  0.01100011
 -0.04833633 -0.06314742 -0.00860635 -0.05186471  0.04042982  0.11271369
 -0.16716479  0.18366113 -0.01957886  0.01728683 -0.13042632  0.152491
  0.10443126  0.11618675  0.01767189  0.1721979   0.16526878 -0.15561266]",10.1016/j.jaip.2017.04.021,"['Asthma', 'Humans', 'Hypersensitivity']"
82,"[ 0.37979847  0.21063131  0.1322183  -0.54308474 -1.2233678   0.4376398
  0.8732979   0.64724463 -1.9460003  -0.13593495  1.3940272   0.5149319
 -0.85536915 -0.11004795 -1.0078876  -1.1846185   0.26670408 -0.09898657
 -1.239379    0.739686    0.52643603 -0.34254298 -0.4670737   0.68748766
  1.0667468   1.7851392   0.20483437  0.41677025 -0.05486049 -0.8266149 ]",10.1016/j.expneurol.2017.03.020,"['2,4-Dinitrophenol', 'Animals', 'Body Weight', 'Corpus Striatum', 'Disks Large Homolog 4 Protein', 'Dopamine and cAMP-Regulated Phosphoprotein 32', 'Dose-Response Relationship, Drug', 'Female', 'Guanylate Kinases', 'Humans', 'Huntingtin Protein', 'Huntington Disease', 'Male', 'Membrane Proteins', 'Mice', 'Mice, Transgenic', 'Motor Activity', 'Neurons', 'Oxidative Stress']"
83,"[ 0.0563372   0.25181225  0.16162163 -0.30254588 -0.36902517  0.25435168
  0.32378098  0.2449602  -1.0915543  -0.02642548  0.70229906  0.20709941
 -0.2789723  -0.2433039  -0.43903527 -0.31347978  0.3571328  -0.03376514
 -0.85745865  0.581753    0.23569626 -0.17124745 -0.15426348  0.44577533
  0.56294745  1.0515481   0.04992471  0.52757293  0.35056275 -0.6094259 ]",10.1111/jce.13368,"['Action Potentials', 'Animals', 'Automation, Laboratory', 'Cardiac Catheters', 'Disease Models, Animal', 'Electrophysiologic Techniques, Cardiac', 'Equipment Design', 'Heart Conduction System', 'Heart Rate', 'Predictive Value of Tests', 'Reproducibility of Results', 'Signal Processing, Computer-Assisted', 'Software Design', 'Sus scrofa', 'Time Factors', 'Ventricular Premature Complexes']"
84,"[ 0.12435649  0.4628603  -0.02297632 -0.8505169  -0.6795522   0.95964116
  0.88645566  0.77923864 -2.2777493   0.23004156  1.4753218   0.59434587
 -0.4648265  -0.32046527 -0.8201364  -0.911884    0.29301655 -0.5075043
 -1.4461381   0.7656612   0.744675   -0.5086422  -0.0790049   0.9784816
  1.4034318   2.3445399   0.4166497   0.6577327   0.433153   -0.9103776 ]",10.1002/ijc.30887,"['Animals', 'Biomarkers, Tumor', 'Brain Neoplasms', 'Cell Line, Tumor', 'Chromosome Aberrations', 'Chromosomes, Human, Pair 10', 'Chromosomes, Human, Pair 7', 'Gene Expression Profiling', 'Genomics', 'Glioma', 'Heterografts', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Mice', 'Neoplasm Recurrence, Local', 'Neoplastic Stem Cells', 'Prognosis']"
85,"[ 0.13032018  0.26265863  0.24881193 -0.39136934 -0.4140119   0.3757964
  0.4125992   0.404808   -1.3827376   0.08607955  0.8308654   0.2665081
 -0.33830112 -0.34596905 -0.5641784  -0.37368268  0.41019332 -0.06921821
 -0.95319015  0.58791095  0.29741725 -0.20687324 -0.09575492  0.48867497
  0.5735616   1.2739911   0.16723335  0.5558704   0.34396705 -0.672909  ]",10.1002/cyto.b.21588,"['Algorithms', 'Flow Cytometry', 'Humans', 'Immunophenotyping', 'Phenotype', 'T-Lymphocytes']"
86,"[-0.03519278  0.5210132   0.14867966 -0.3013881  -1.4603006   0.95276904
 -0.10562508  0.7771791  -0.9752705   0.2172403   1.8777312   0.9612789
 -0.0340583   0.1443762  -0.290032   -0.24652064  0.9019159  -0.4169919
 -0.73714083  0.28675652  0.2970453  -0.5511344   0.29408866  0.5787355
  0.86597383  2.0386498  -0.22809693  0.14440341 -0.02285854 -0.52257633]",10.1016/j.ijpsycho.2017.09.005,"['Athletic Injuries', 'Brain Concussion', 'Exercise', 'Gray Matter', 'Humans', 'Motor Cortex', 'White Matter']"
87,"[ 0.08691121  0.25429922  0.3369856  -0.46701548 -0.47725362  0.2928798
  0.41781688  0.22623758 -1.295729    0.22430934  0.8203344   0.27039668
 -0.18027638 -0.29986718 -0.2544778  -0.19448453  0.3050456   0.03815376
 -0.9833508   0.56205654  0.21637623 -0.292685   -0.25692558  0.6406412
  0.6565545   1.3604627  -0.00180694  0.6548641   0.37039354 -0.6779513 ]",10.1002/14651858.CD004064.pub4,"['Anthracyclines', 'Antineoplastic Combined Chemotherapy Protocols', 'Camptothecin', 'Cisplatin', 'Docetaxel', 'Fluorouracil', 'Humans', 'Irinotecan', 'Randomized Controlled Trials as Topic', 'Stomach Neoplasms', 'Taxoids']"
88,"[ 0.00595807  0.06196732  0.08486948 -0.09266421 -0.05937612  0.03950145
  0.0542369   0.02736985 -0.28775567  0.0123675   0.156519    0.03494482
 -0.06170851 -0.06689227 -0.07257079 -0.07398932  0.05835208  0.02517124
 -0.19815023  0.1623418   0.03413888 -0.02765227 -0.05922512  0.11319404
  0.10595442  0.22297195  0.03558612  0.1351036   0.08631496 -0.1466274 ]",10.1016/j.jaci.2017.06.034,"['Epinephrine', 'Food', 'Food Hypersensitivity', 'Humans']"
89,"[-0.02074697  0.05201127  0.1569386  -0.18308319 -0.11410958  0.06820314
  0.07986748  0.02044172 -0.61630696 -0.02664473  0.36291817  0.03549746
 -0.13117068 -0.14423345 -0.12222233 -0.14445059  0.16489814  0.12810375
 -0.43951812  0.32570398  0.03931228 -0.07325084 -0.2072233   0.2659852
  0.289158    0.49812087 -0.0410348   0.35735002  0.30362505 -0.36161417]",10.1001/jamapsychiatry.2017.2431,"['Analgesics, Opioid', 'Humans', 'Opioid-Related Disorders']"
90,"[-0.02954991  0.0260394   0.15557677 -0.11187034 -0.0608363  -0.00391704
  0.05260755 -0.01544395 -0.41177532 -0.03113028  0.20124303  0.02327975
 -0.08344824 -0.0831458  -0.06094261 -0.09731197  0.09927013  0.07487594
 -0.2934351   0.2167119   0.04305695 -0.00946577 -0.12931468  0.22608425
  0.14782596  0.26580057  0.02274306  0.2466686   0.21877801 -0.25314942]",10.1007/s00701-017-3359-x,"['Health Personnel', 'Humans', 'Quality of Life', 'Stroke', 'Sweden']"
91,"[ 0.5504241   0.7321958   0.40607995 -0.38753167 -0.4314463   0.78394294
  1.0347711   0.6321191  -1.8656266   0.285168    1.1976299  -0.06678963
 -0.41918024 -0.5708161  -0.48041406 -0.9259011   0.52491844 -0.22428682
 -1.5611854   0.9328461   0.6217432  -0.5363281  -0.05822272  0.5216432
  0.27127126  1.8872699   0.21211325  0.74753064 -0.03958644 -0.9568171 ]",10.1124/dmd.117.077644,"['Adolescent', 'Adult', 'Aging', 'Area Under Curve', 'Child', 'Chromatography, High Pressure Liquid', 'Cytochrome P-450 CYP1A2', 'Cytochrome P-450 CYP2C9', 'Cytochrome P-450 Enzyme System', 'Female', 'Genotype', 'Humans', 'Male', 'Non-alcoholic Fatty Liver Disease', 'Pharmaceutical Preparations', 'Young Adult']"
92,"[ 0.08220906  0.11307477  0.192051   -0.14098898 -0.07555774  0.09800007
  0.22188717  0.12965648 -0.59113073  0.00636685  0.2700761   0.01774864
 -0.18689777 -0.17049813 -0.11565094 -0.23558822  0.13672139  0.05701093
 -0.5030664   0.2926963   0.11783652 -0.0984167  -0.08955592  0.2310015
  0.10235493  0.45593536  0.09620553  0.27387077  0.17514476 -0.29620376]",10.3390/molecules22122081,"['Angiogenesis Inhibitors', 'Animals', 'Dose-Response Relationship, Drug', 'Fibrinolytic Agents', 'Garlic', 'Halogenation', 'Mice', 'Models, Molecular', 'Molecular Conformation', 'Neovascularization, Physiologic', 'Organic Chemicals', 'Sulfur Compounds']"
93,"[ 2.8429902e-01  3.4086162e-01  4.2159534e-01 -5.0686151e-01
 -3.0497196e-01  3.7456849e-01  7.2326505e-01  2.9333454e-01
 -1.6189713e+00  3.9293498e-04  7.6528442e-01 -6.8574786e-02
 -3.7135264e-01 -3.1052014e-01 -4.4001463e-01 -4.3787125e-01
  3.0725825e-01 -1.1482400e-02 -1.4651246e+00  8.3448619e-01
  3.7149084e-01 -3.5948864e-01 -2.5108856e-01  4.5734107e-01
  2.4132456e-01  1.4940364e+00  1.7395970e-01  7.3505723e-01
  2.4467297e-01 -8.4717882e-01]",10.1136/heartjnl-2017-312024,"['Aged', 'Aortic Valve', 'Aortic Valve Insufficiency', 'Cohort Studies', 'Echocardiography', 'Female', 'Heart Valve Prosthesis', 'Heart Valve Prosthesis Implantation', 'Humans', 'Kidney Failure, Chronic', 'Male', 'Middle Aged', 'Peripheral Arterial Disease', 'Prognosis', 'Retrospective Studies', 'Risk Factors', 'Severity of Illness Index', 'Stroke Volume', 'Survival Analysis', 'United States', 'Ventricular Dysfunction, Left']"
94,"[ 0.00478289 -0.05398585  0.7329144  -0.8137046  -0.3879091   0.01113603
  0.24534181  0.39409763 -1.1734527   0.12024628  0.8462816   0.2554105
 -0.02016353 -0.10114278 -0.12620573 -0.03016245  0.7810602   0.1871849
 -1.1271769   0.52491975  0.06156946  0.05270633  0.00951081  0.8746823
  0.22789222  1.3827463   0.06410813  0.89881516  0.40188766 -0.60165286]",10.1016/j.suc.2017.07.008,"['Antipsychotic Agents', 'Brain Diseases', 'Cognition Disorders', 'Conscious Sedation', 'Critical Care', 'Critical Illness', 'Delirium', 'Early Ambulation', 'Exercise Therapy', 'Family', 'Humans', 'Pain Measurement', 'Stress Disorders, Post-Traumatic', 'Ventilator Weaning']"
95,"[ 0.36244658  0.4570863   0.20488097 -0.75404596 -0.6880396   0.5164387
  0.5682503   0.39405808 -1.9212948   0.20947209  1.1066141   0.11434685
 -0.32180047 -0.49366498 -0.6991009  -0.5739531   0.4293438   0.01917966
 -1.6181433   0.8106847   0.46975407 -0.68764985 -0.2711308   0.483945
  0.7467089   1.9708104  -0.05954218  0.9504823   0.33730206 -1.1112475 ]",10.1007/s10597-018-0242-z,"['Adolescent', 'Adult', 'Affective Symptoms', 'Attitude of Health Personnel', 'Community Mental Health Services', 'Female', 'Humans', 'Male', 'Obesity', 'Overweight', 'Qualitative Research', 'Surveys and Questionnaires', 'Weight Loss']"
96,"[ 0.10676616  0.28169167  0.31193572 -0.83517045 -0.7860674   0.50704455
 -0.03048468  0.4614907  -1.7339153   0.18543616  1.4376901   0.23167512
 -0.43799922 -0.27504686 -0.5322125  -0.51033825  0.53939867  0.14451174
 -1.3470541   0.6410499   0.18264201 -0.51018023 -0.00277449  0.70714694
  0.948716    2.0246387  -0.13554193  0.9581443   0.28823176 -0.9092791 ]",10.1377/hlthaff.2017.1390,"['Adult', 'Female', 'Health Insurance Exchanges', 'Humans', 'Insurance Coverage', 'Insurance, Health', 'Longitudinal Studies', 'Male', 'Medically Uninsured', 'Patient Protection and Affordable Care Act', 'Surveys and Questionnaires']"
97,"[ 0.17837226  0.22622095  0.35407984 -0.2718682  -0.5030995   0.4055443
  0.3596133   0.36700746 -1.3257627   0.05865701  0.9874145   0.40185875
 -0.27061868 -0.35361156 -0.45796195 -0.5648045   0.27830297 -0.06613291
 -0.9430842   0.6106179   0.25962487 -0.27954528 -0.14229694  0.6144895
  0.7612323   1.2399881   0.11549501  0.3720239   0.31062964 -0.585822  ]",10.1128/MCB.00595-17,"['Animals', 'Arsenic', 'Autophagy', 'HeLa Cells', 'Humans', 'Lysosomes', 'Membrane Fusion', 'Mice', 'NIH 3T3 Cells', 'Phagosomes', 'Protein Binding', 'Qb-SNARE Proteins', 'Qc-SNARE Proteins']"
98,"[ 0.11497155  0.13724914  0.17975551 -0.1831677  -0.26458067  0.18076685
  0.1858823   0.17980807 -0.8053447   0.07630108  0.47989193  0.12618163
 -0.19204225 -0.11227936 -0.24496767 -0.1960925   0.3354337   0.03779531
 -0.61645395  0.31885156  0.15749498 -0.11998563 -0.12737474  0.27641168
  0.30256745  0.72280014  0.00170171  0.36770508  0.18026629 -0.45180714]",10.1016/j.jaip.2017.09.016,"['Administration, Oral', 'Adolescent', 'Adult', 'Allergens', 'Arachis', 'Child', 'Child, Preschool', 'Desensitization, Immunologic', 'Double-Blind Method', 'Female', 'Humans', 'Male', 'Peanut Hypersensitivity', 'Plant Proteins', 'Treatment Outcome', 'Young Adult']"
99,"[-0.11361949  0.17474027  0.8898712  -1.5468683  -1.0267396   0.77998954
  0.5176274   1.0772052  -1.2301341   0.35718948  1.7793516   0.8871093
  0.5375608   0.00322615 -0.31755227  0.49982694  1.1874478  -0.34623578
 -1.2588551   0.19927728 -0.28400308  0.01258043  0.8653581   1.165181
 -0.32384056  2.833416    0.2313439   0.6350836  -0.33913386 -0.50500596]",10.1038/s41598-017-17624-3,"['Cardiac Surgical Procedures', 'Cross-Sectional Studies', 'Female', 'Humans', 'Intensive Care Units', 'Length of Stay', 'Male', 'Middle Aged', 'Physical Therapists', 'Regression Analysis', 'Retrospective Studies', 'Time Factors']"
100,"[-0.33269292  0.34467828  0.77368504 -0.05259204 -0.17026643  0.59157157
  0.5860277   0.15264039 -0.51942426 -0.5372513   0.22512685 -0.18345116
 -0.00651899 -0.6000441  -0.24553466 -0.17538881  1.1119934  -0.00612868
 -0.6089783   0.5362119   0.13201685  0.04851698 -0.11794475  0.08121322
 -0.02932011  0.2565896  -0.2789068  -0.15993944 -0.11341143 -0.06887746]",Unknown,"['Accidents, Traffic', 'Adult', 'Aged', 'Ankle Injuries', 'Humans', 'Joint Dislocations', 'Manipulation, Orthopedic', 'Middle Aged', 'Physical Therapy Modalities']"
101,"[ 0.77048767  1.9336661   0.5171314  -0.86732274 -1.4604362   0.97735405
 -0.32997587 -1.4013684  -1.6557584  -0.10759269 -0.7625296  -0.8064151
 -0.16457297 -1.1422342  -0.95489424 -1.5176343   1.0168881  -0.7990332
 -1.4428409  -0.7963882  -0.65103865 -1.2055931  -0.9420759   0.48160353
  0.21691471  0.30292156  0.74874157  1.0124844   0.04922896  0.43888974]",10.1083/jcb.139.7.1719,"['Amino Acid Sequence', 'Animals', 'Base Sequence', 'Carrier Proteins', 'Cell Compartmentation', 'Cell Line', 'Cell Membrane', 'Chlorocebus aethiops', 'Contractile Proteins', 'Endocytosis', 'Endosomes', 'Filamins', 'Furin', 'Humans', 'Lysosomes', 'Microfilament Proteins', 'Models, Biological', 'Molecular Sequence Data', 'Protein Precursors', 'Protein Processing, Post-Translational', 'Receptors, Transferrin', 'Subtilisins', 'Tumor Cells, Cultured']"
102,"[ 0.9607852   1.8583117   1.0909214  -0.20584841 -1.1739515   1.4274042
  0.24930394 -1.094613   -2.3836443  -1.1797664   0.29361197 -0.122235
 -0.6019549  -1.8291676  -0.14775085 -1.2633449   0.5745657   0.04715798
 -0.11937369 -0.05809241 -0.51471543 -0.01704619 -0.32353467  1.7470032
  0.44749534  0.9924008   0.10007566  0.5411832  -0.00629861 -0.4131135 ]",10.1017/s0952523898154159,"['Animals', 'Biotin', 'Connexins', 'Diffusion', 'Fluorescent Dyes', 'Gap Junctions', 'Injections', 'Iontophoresis', 'Isoquinolines', 'Microscopy, Confocal', 'Neurons', 'Rabbits', 'Retina']"
103,"[ 0.02095566  1.4609717   1.1801687  -0.23341781 -0.7921995   2.2323098
  0.71463203 -0.1832876  -2.0660305  -0.38661048  0.53847766 -0.71966153
 -0.13696459 -1.8845489  -0.05484666 -0.7123217   1.3403783   0.39529914
 -0.4552184   0.6543614  -0.31296158 -0.08457638 -0.5668567   1.1415943
  0.9365979   0.7116489  -0.11118416 -0.20755626 -0.37458396 -0.33485752]",10.1111/j.1469-7793.1998.549bt.x,"['Animals', 'Autonomic Nervous System', 'Blotting, Northern', 'Blotting, Western', 'Denervation', 'Electric Stimulation', 'Enzyme Inhibitors', 'Ganglionectomy', 'Immunohistochemistry', 'Jejunum', 'Male', 'Myenteric Plexus', 'NG-Nitroarginine Methyl Ester', 'Nitric Oxide Synthase', 'Oxidopamine', 'Rats', 'Rats, Sprague-Dawley', 'Thiolester Hydrolases', 'Ubiquitin Thiolesterase', 'Vagotomy']"
104,"[ 0.28548452  0.8967497   1.953334    0.11474296 -0.74371505  1.6717117
  0.9123189  -1.1051595  -1.6026254  -1.6717747   0.74139917  1.0513147
 -0.70171255 -1.7626901   0.39338395 -1.0189741   1.8901956   0.36433563
 -0.8635628   1.0342907  -0.19302447 -0.08375739 -0.08213951  0.11573613
 -0.05080926  0.73691005 -0.09426846  0.67788595  0.05320964  0.03448055]",10.1083/jcb.137.6.1229,"['Animals', 'Breast Neoplasms', 'Cell Line', 'Female', 'Golgi Apparatus', 'Humans', 'Mucin-1', 'Polysaccharides', 'Rabbits', 'Sialyltransferases', 'Transfection', 'Tumor Cells, Cultured', 'beta-Galactoside alpha-2,3-Sialyltransferase']"
105,"[-0.629299    0.76356834  1.7787557  -0.23422335 -0.3935751   1.4880177
  1.6483101   0.02755504 -1.9318066  -1.052038    0.7024687  -0.3317458
  0.21625152 -1.496181    0.59416515 -0.829926    2.1408217   0.64157766
 -0.79740083  0.46414065  0.28004918 -0.06150408 -0.02875618  0.9026499
 -0.1848771   1.9986192   0.01446773 -0.34573674 -0.47107932  0.22337368]",10.1084/jem.185.6.1089,"['Animals', 'Aspergillosis, Allergic Bronchopulmonary', 'Aspergillus fumigatus', 'Bronchoalveolar Lavage Fluid', 'Cells, Cultured', 'Crosses, Genetic', 'Cytokines', 'Disease Models, Animal', 'Flow Cytometry', 'Immune Tolerance', 'Interferon-gamma', 'Interleukin-10', 'Interleukin-4', 'Lung', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Receptors, Antigen, T-Cell, alpha-beta', 'T-Lymphocytes']"
106,"[ 1.5785364   1.0460378   0.8864559  -0.7363785  -0.3566715   1.8727043
 -0.21843334 -1.7886807  -1.8972574  -0.9653923  -0.52382797  0.9352635
 -0.01794296 -1.6489162   0.00571794 -0.9615625   1.2154545   0.32966775
  0.5542064   0.4679068  -1.732835   -1.0700785  -0.37677452  1.7181649
  0.37601608  1.4073932   0.9605571   0.2850465   0.14712274  0.39926153]",10.1016/S0002-9440(10)65553-8,"['Animals', 'Apoptosis', 'Clusterin', 'Estradiol', 'Glycoproteins', 'Immunoenzyme Techniques', 'In Situ Hybridization', 'Male', 'Molecular Chaperones', 'Orchiectomy', 'Prostate', 'Prostatic Diseases', 'RNA, Messenger', 'Rats', 'Testosterone']"
107,"[ 0.2449416   1.3761789   0.80349517 -0.6198315  -1.0785127   1.7660673
  0.4103147   0.23421521 -1.8238022  -0.6919837   0.05368946 -0.81603324
 -0.07781698 -1.3488973  -0.47914007 -0.9256397   1.3353173  -0.19122662
 -0.9007221   0.39312887  0.11762509 -0.01054653 -0.13987522  0.93261725
  0.7608854   0.7724741  -0.34588566 -0.06113724 -0.17761904 -0.3364958 ]",10.1016/0899-3289(95)90002-0,"['Adult', 'Black or African American', 'Cocaine', 'Crack Cocaine', 'Diagnosis, Dual (Psychiatry)', 'Female', 'Humans', 'Illicit Drugs', 'Mental Disorders', 'Parenting', 'Personality Assessment', 'Poverty', 'Pregnancy', 'Psychoses, Substance-Induced', 'Psychotropic Drugs', 'Puerperal Disorders', 'Risk Factors', 'Substance Abuse Detection', 'Substance-Related Disorders']"
108,"[ 0.1970092   1.4424719   2.0260735   0.0619483  -0.5061946   1.618236
  1.550133    1.1437824  -2.432418   -1.901786    0.77018183 -0.10928502
 -0.7696887  -1.5926722   0.39642325  0.5949454   2.3304012   0.31596872
 -0.13869981  1.109224    0.5111859   1.4285191   0.43286183  0.8202297
  0.5874464   0.5423069   0.11312602 -0.34979448  0.21064012  0.32778224]",10.1016/S0002-9440(10)65584-8,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Antigens, CD', 'Central Nervous System', 'Child', 'Child, Preschool', 'Endothelium, Vascular', 'Female', 'Humans', 'Immunoenzyme Techniques', 'Infant', 'Infant, Newborn', 'Integrin alpha1beta1', 'Integrin alpha2', 'Integrin alpha3', 'Integrin alpha6beta1', 'Integrin alphaV', 'Integrin beta1', 'Integrins', 'Laminin', 'Male', 'Microscopy, Immunoelectron', 'Middle Aged', 'Multiple Sclerosis', 'Receptors, Laminin']"
109,"[ 1.1642575   1.174285    0.7542986  -0.95472974 -1.1782681   1.5024946
 -1.0924736  -0.93216974 -1.6963197  -0.15584217 -0.49694628 -0.18053886
  0.25585052 -1.1328137  -1.0926399  -1.0658361   1.1255764   0.23538171
 -0.81277055 -0.20155191  0.5456466  -1.2493747  -0.9881116   1.2438852
  0.89490414  1.3522316   1.0089723   0.41833356  0.83558613 -0.67800415]",10.1016/S0002-9440(10)65580-0,"['Adaptor Proteins, Signal Transducing', 'Animals', 'Animals, Newborn', 'Cell Division', 'DNA-Binding Proteins', 'Epidermis', 'Immunoenzyme Techniques', 'In Situ Hybridization', 'LIM Domain Proteins', 'Membrane Proteins', 'Mice', 'Mice, Transgenic', 'Proliferating Cell Nuclear Antigen', 'Protein Serine-Threonine Kinases', 'Receptor, ErbB-2', 'Skin', 'Up-Regulation']"
110,"[-0.10991555  2.3471792   1.3682193  -0.07056766 -1.0879804   1.9168087
  0.48741892  1.8840731  -1.6384836  -0.70411354  0.543588   -2.6421428
  0.13151665 -1.6766305  -1.0228292  -1.3194494   2.076114   -0.26383534
 -1.3831178   1.1141375   0.6192622   0.8010827  -0.18746103  1.05479
  1.0575926   1.0596427  -0.5823787   0.06034367 -0.13150442 -0.6182172 ]",Unknown,"['Adaptation, Physiological', 'Analgesics', 'Animals', 'Brain', 'Buprenorphine', 'Enkephalin, D-Penicillamine (2,5)-', 'Enkephalins', 'Kinetics', 'Male', 'Oligopeptides', 'Radioligand Assay', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Opioid']"
111,"[ 1.439036    2.1532085   0.7150345  -0.48436686 -1.6629155   1.8828549
 -0.8006975  -0.6789188  -1.8044798   0.08807737 -0.01130585 -0.49390703
  0.07147138 -1.7666355  -0.77852917 -1.6701461   0.41087466  0.40313002
 -0.7862557  -0.2140094   0.04338087 -0.3443193  -0.35301718  1.5837587
  0.70886797  1.1206124   0.3868673   0.29455224 -0.2578118  -0.69791585]",10.1016/S0002-9440(10)65588-5,"['Animals', 'Apoptosis', 'Axotomy', 'Cell Nucleus', 'Electron Transport Complex IV', 'Immunoenzyme Techniques', 'Male', 'Microscopy, Electron', 'Mitochondria', 'Neurons', 'Occipital Lobe', 'Oxidative Stress', 'Rats', 'Rats, Sprague-Dawley', 'Retrograde Degeneration', 'Time Factors']"
112,"[ 0.37647074  0.98204255  1.4749588  -0.43579522 -0.04170064  2.477253
  1.6490346   0.06097398 -2.3639495  -0.9040527  -0.05773812  0.7423015
 -0.38445786 -1.9961629   0.9073389  -0.16806486  2.5629034  -0.09909923
  0.1786662   1.479123   -1.1033381   0.35451832 -1.2997022   1.5424219
  0.40480003  1.1908346  -0.11734434 -0.46255496 -0.2574903  -0.59746885]",10.1016/S0002-9440(10)65591-5,"['Adult', 'Cells, Cultured', 'Cervix Uteri', 'Female', 'Gene Expression Regulation', 'Genotype', 'HIV Infections', 'Humans', 'Immunoenzyme Techniques', 'Immunophenotyping', 'Leukocytes, Mononuclear', 'Microscopy, Fluorescence', 'Middle Aged', 'Mucous Membrane', 'Progesterone', 'RNA, Messenger', 'Receptors, Chemokine', 'Time Factors']"
113,"[-0.35493892  1.750296    1.0550966  -0.4587897  -1.7072586   1.6023697
  0.4303624  -0.08547965 -2.1911478  -1.5052682  -0.19750072 -1.5111486
 -0.794679   -1.5296775  -1.9848278  -1.66059     1.5193577  -0.29142016
 -0.9796722   1.4716446  -1.5761318  -0.363278    0.75726426  2.093672
  0.08729779  1.3922851  -2.419762    1.3399053   0.08508755  2.2754085 ]",10.1111/j.1469-7793.1998.667bp.x,"['Adenosine Triphosphatases', 'Animals', 'Cell Differentiation', 'Cloning, Molecular', 'Gene Expression Regulation, Developmental', 'Isoenzymes', 'Male', 'Molecular Sequence Data', 'Muscle Fibers, Skeletal', 'Muscle, Skeletal', 'Myosin Heavy Chains', 'RNA, Messenger', 'Rana pipiens', 'Sequence Homology, Amino Acid']"
114,"[ 0.80439603  1.6865772   0.96216005 -0.40279382 -1.2947496   1.7353489
  0.08690048 -0.6049811  -2.1580222  -0.24527809  0.4569362  -0.2727864
 -0.31362098 -1.5836519  -0.2773967  -1.5258536   0.7619193  -0.09715302
 -0.5318094   0.20430584 -0.3577868   0.06664213 -0.35464618  1.3460491
  0.5532273   0.94510436  0.08583137  0.43138063  0.05346919 -0.23408431]",10.1016/S0002-9440(10)65613-1,"['Animals', 'Coproporphyrins', 'Cytoplasmic Granules', 'Fluorescence', 'Humans', 'Image Processing, Computer-Assisted', 'Isoproterenol', 'Lipofuscin', 'Male', 'Muscle, Skeletal', 'Myocardial Infarction', 'Myocardium', 'Myoglobin', 'Myositis', 'Rats', 'Rats, Wistar', 'Sarcolemma']"
115,"[ 0.16923761  0.13177255  1.1349951   0.4080733  -0.28791815  0.8230141
  2.609997   -1.275885   -1.7541654  -1.0020711   0.69622993 -0.707791
  0.49703228 -1.4412056   0.7501993  -0.7667561   2.6191618   1.4287072
 -0.13138117 -0.68857485 -0.917762   -0.52167714 -0.24889971  1.1946491
 -1.441764    2.4489424   0.31945568 -0.04635872 -0.7690033  -1.0007668 ]",10.1084/jem.186.11.1853,"['Actins', 'Acute Disease', 'Animals', 'Anti-Glomerular Basement Membrane Disease', 'Basement Membrane', 'Capillary Permeability', 'Cell Adhesion', 'Complement C3b', 'Complement System Proteins', 'Endothelium, Vascular', 'Female', 'Immune Complex Diseases', 'Intercellular Adhesion Molecule-1', 'Isoantibodies', 'Kidney Glomerulus', 'Leukotriene B4', 'Macrophage-1 Antigen', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Models, Immunological', 'Neutrophils', 'Proteinuria', 'Receptors, IgG']"
116,"[ 0.93038636  1.7822903   0.6356849  -0.7625426  -1.5659168   1.182179
 -0.0354144  -1.00291    -1.9224019  -0.52458346 -0.10267639 -0.23036423
 -0.3929466  -1.2316917  -0.7475235  -1.9503934   0.9686992   0.15199815
 -0.82486904 -0.5091686  -0.22538047 -0.4016322  -0.42030853  1.6456007
  0.2571894   1.1044979   0.22287723  0.5581365  -0.5455469  -1.1081709 ]",10.1083/jcb.138.6.1289,"['Animals', 'Arabidopsis', 'Caenorhabditis elegans', 'Cell Cycle', 'Cell Cycle Proteins', 'Centromere', 'Chromosomes', 'Cloning, Molecular', 'Drosophila', 'Drosophila Proteins', 'HeLa Cells', 'Humans', 'Insect Proteins', 'Mice', 'Microinjections', 'Molecular Sequence Data', 'Mutation', 'RNA, Antisense', 'Recombinant Fusion Proteins', 'Sequence Homology, Amino Acid']"
117,"[-1.4841895   1.7241182   3.0990422  -0.38284555 -1.1349888   1.8689835
  1.0931653   1.8510559  -1.7312115  -1.092803    1.553287   -1.896576
 -0.40421334 -2.5039754  -0.72778577 -0.85357565  2.5645385  -0.89402574
 -2.9002194   1.9200227   1.0784152  -0.2451714  -0.04511454  0.02746863
  1.7575198   0.22656207 -0.5651939  -0.5006771  -0.13103461  0.26839074]",10.1111/j.1469-7793.1998.473bt.x,"['Analgesics, Opioid', 'Animals', 'Baclofen', 'Bicuculline', 'Enkephalin, Ala(2)-MePhe(4)-Gly(5)-', 'Enkephalins', 'Excitatory Postsynaptic Potentials', 'Female', 'GABA Agents', 'GABA Antagonists', 'GABA-B Receptor Agonists', 'Glycine Agents', 'In Vitro Techniques', 'Male', 'Membrane Potentials', 'Narcotic Antagonists', 'Patch-Clamp Techniques', 'Peptide Fragments', 'Peptides', 'Rats', 'Rats, Wistar', 'Receptors, GABA-A', 'Receptors, Glycine', 'Receptors, Opioid, mu', 'Somatostatin', 'Strychnine', 'Substantia Gelatinosa', 'Synaptic Transmission', 'Tetrodotoxin']"
118,"[ 1.3040209e+00  1.1231652e+00  9.5044512e-01 -1.2483276e+00
 -1.0643954e+00  2.1343341e+00 -4.3297610e-01 -1.1353884e+00
 -2.1253254e+00  8.8593416e-04 -2.5138861e-01 -1.6884083e-01
  1.9644876e-01 -2.0161357e+00 -3.6812422e-01 -1.4796472e+00
  7.6425636e-01  7.7913105e-01 -2.4055472e-01 -4.7477254e-01
  3.5997501e-01 -4.5337346e-01 -3.9463934e-01  1.8182716e+00
  9.2927581e-01  1.6039944e+00  6.6698909e-01 -3.5069180e-03
  2.8134620e-01 -4.8284313e-01]",10.1016/S0002-9440(10)65589-7,"['Animals', 'Basement Membrane', 'Blotting, Northern', 'Collagen', 'Female', 'In Situ Hybridization', 'Lactation', 'Mammary Glands, Animal', 'Matrix Metalloproteinase 3', 'Metalloendopeptidases', 'Mice', 'Mice, Transgenic', 'Neovascularization, Pathologic', 'Polymerase Chain Reaction', 'Pregnancy', 'RNA, Messenger', 'Stromal Cells', 'Tenascin', 'Time Factors', 'Up-Regulation']"
119,"[ 1.390388    2.0806506   0.4350582  -0.44077972 -1.3037301   0.92334586
 -0.40484315 -2.5863824  -2.234546   -1.0858309  -0.31999207  0.04996349
 -0.41856548 -1.0818559  -1.0207678  -2.1666796   0.5650307  -0.20557941
 -0.07048414 -1.1200757  -1.6342572  -0.81312233 -0.19270849  1.9337243
 -0.39719346  0.9828698   0.5212764   1.4304628  -0.38682404 -1.1701748 ]",10.1083/jcb.137.3.563,"['Cell Compartmentation', 'Cell Division', 'Exocytosis', 'Fluorescent Antibody Technique, Indirect', 'Fungal Proteins', 'GTP Phosphohydrolases', 'Gene Deletion', 'Genes, Fungal', 'Golgi Apparatus', 'Intracellular Membranes', 'Microscopy, Electron', 'Mutagenesis, Site-Directed', 'Precipitin Tests', 'Saccharomyces cerevisiae', 'Sequence Alignment', 'Sequence Homology, Amino Acid']"
120,"[ 1.1627673   1.1921602   0.8776738  -0.51564443 -1.4479624   1.3485255
 -0.32171708 -1.1348639  -2.0023417  -0.5509033   0.49657288 -0.3670433
  0.15224603 -1.6627516  -0.80973977 -0.9606043   0.8184753   0.3797372
 -0.38324457 -0.43486056 -0.25299725 -0.94718105  0.04603197  1.3396811
  0.49164158  0.81082857  0.62908566  0.7449025   0.04535411 -0.8077027 ]",10.1083/jcb.145.6.1209,"['Animals', 'Brain', 'Cell Differentiation', 'Cell Size', 'Cells, Cultured', 'Enzyme Activation', 'Fibroblast Growth Factors', 'Myelin Proteins', 'Myelin Sheath', 'Oligodendroglia', 'Phosphorylation', 'Phosphotyrosine', 'Platelet-Derived Growth Factor', 'Proto-Oncogene Proteins', 'Proto-Oncogene Proteins c-fyn', 'Pyrazoles', 'Pyrimidines', 'Rats', 'Rats, Sprague-Dawley', 'Stem Cells', 'Up-Regulation', 'src-Family Kinases']"
121,"[-0.06396294  1.026748    1.2814784   0.05389827 -0.69944024  1.5556818
  1.4522644   0.079123   -2.0499144  -1.1954522   0.51016444 -0.30328944
 -0.39709193 -1.6108762   0.51846397 -0.54456156  1.64312     0.44649014
 -0.3769012   0.16527447 -0.22908854  0.18992428 -0.08896991  1.2428646
  0.30724734  1.2531062  -0.1841893  -0.2563727  -0.69067013 -0.2879908 ]",10.1016/S0002-9440(10)65654-4,"['Animals', 'Capillary Permeability', 'Cell Count', 'Chronic Disease', 'Endothelium, Vascular', 'Evans Blue', 'Female', 'Male', 'Mice', 'Mice, Inbred C3H', 'Mice, Inbred C57BL', 'Neovascularization, Pathologic', 'Pneumonia, Mycoplasma', 'Silver Staining', 'Species Specificity', 'Specific Pathogen-Free Organisms', 'Substance P', 'Trachea', 'Tracheitis', 'Wheat Germ Agglutinins']"
122,"[-0.42216703  1.5934712   2.5066843   0.41929442 -0.9528734   1.6100489
  0.85800165  1.0559639  -1.6944847  -1.0006515   1.4935789  -1.7256155
  0.02249591 -1.6598803  -0.7788096  -0.67246497  2.2627294  -0.258547
 -1.8332831   1.38505     0.45749816  0.26314163 -0.17746009  0.11874448
  0.65613234  0.57656425 -0.38653407  0.39313212 -0.46097013 -0.34697273]",10.1111/j.1469-7793.1998.787ba.x,"['Animals', 'Barium', 'Calcium Channel Blockers', 'Calcium Channels', 'Electric Stimulation', 'Electrophysiology', 'Enkephalin, Ala(2)-MePhe(4)-Gly(5)-', 'Enkephalins', 'Female', 'Immunohistochemistry', 'Male', 'Membrane Potentials', 'Neurons', 'Patch-Clamp Techniques', 'Peptides', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Opioid, delta', 'Receptors, Opioid, kappa', 'Receptors, Opioid, mu', 'Spider Venoms', 'Supraoptic Nucleus', 'omega-Agatoxin IVA', 'omega-Conotoxin GVIA']"
123,"[ 0.54906493  1.5318346   0.86750954 -0.18652819 -0.63174206  1.5537645
  1.0719142  -0.721586   -2.2955966  -1.0026705   0.86380064 -0.29291782
 -0.5514972  -2.144764   -0.10343266 -0.90858454  1.2617732   0.17534947
 -0.11156125  0.3369631  -0.60908824 -0.02081179 -0.352644    1.3099902
  0.19405943  1.0051444  -0.2804564   0.8169274  -0.6482801  -0.44590947]",10.1111/j.1469-7793.1998.203by.x,"['Animals', 'Barium', 'Calcium', 'Cells, Cultured', 'Electric Stimulation', 'Electrophysiology', 'Fluorescent Antibody Technique', 'Gadolinium', 'Immunohistochemistry', 'Intestine, Small', 'Membrane Potentials', 'Mice', 'Muscle Contraction', 'Patch-Clamp Techniques', 'Potassium Channels', 'Proto-Oncogene Proteins c-kit', 'Sodium']"
124,"[ 0.5708495   1.1528006   0.8406268  -0.43270612 -0.80621886  1.1996281
  0.01466535 -0.17895433 -1.4311105  -0.3956741   0.24288331 -0.5275083
 -0.09621792 -1.2022395  -0.39492244 -1.0473886   0.9558688   0.1563304
 -0.5242301   0.06918298  0.11339765 -0.24231382 -0.26791987  0.851466
  0.544663    0.82035995  0.11944634  0.48387173  0.0458885  -0.5415361 ]",10.1111/j.1469-7793.1998.675bg.x,"['Animals', 'Brain Chemistry', 'Cloning, Molecular', 'DNA, Complementary', 'DNA-Binding Proteins', 'Ether-A-Go-Go Potassium Channels', 'Ganglia, Sympathetic', 'Gene Expression', 'Mammals', 'Molecular Sequence Data', 'Potassium Channels', 'Proto-Oncogene Proteins', 'RNA, Messenger', 'Rats', 'Sciatic Nerve', 'Sequence Homology, Amino Acid', 'Transcription Factors', 'Xenopus laevis', 'ets-Domain Protein Elk-1']"
125,"[ 0.97783816  0.9100675   2.221633    0.34616396 -0.38932958  1.4667678
  0.39066452 -0.9714635  -1.81403    -1.2408868   1.1800689  -0.89413285
  0.12023095 -2.3372478  -0.12623632 -0.6476272   1.7805502   0.9273283
 -0.44099727  0.7660969  -1.1676047  -0.05769257 -0.06501337  0.579927
  0.44294375  1.3264096   0.57717735  0.9558988  -0.21435182  0.07166682]",10.1111/j.1469-7793.1998.341bb.x,"['Adenosine Triphosphate', 'Animals', 'Female', 'Hydrogen-Ion Concentration', 'Intracellular Membranes', 'Isomerism', 'Mice', 'Mice, Knockout', 'Purinergic Agonists', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Purinergic', 'Sodium-Hydrogen Exchangers', 'Submandibular Gland', 'Tissue Distribution']"
126,"[ 1.485104    1.2754207   1.7818817  -0.6935435  -0.69994986  1.5168606
  0.01440695 -1.3678814  -2.2485616  -0.8609211  -0.17680508  0.7686317
 -0.46598908 -2.3396792   0.26207903 -1.3428069   0.97422373  0.43802568
  0.6757007   0.3130125  -1.199997   -0.49794886  0.04757768  1.7502615
 -0.21289435  1.3249295   0.17181304  0.40570366  0.008376   -0.23417637]",10.1016/S0002-9440(10)65627-1,"['Cell Division', 'Cells, Cultured', 'DNA Primers', 'DNA-Binding Proteins', 'Female', 'Gene Expression Regulation, Enzymologic', 'HeLa Cells', 'Humans', 'Keratinocytes', 'Ki-67 Antigen', 'Polymerase Chain Reaction', 'Precancerous Conditions', 'Proteins', 'RNA', 'RNA, Long Noncoding', 'RNA, Neoplasm', 'RNA, Untranslated', 'Telomerase', 'Up-Regulation', 'Uterine Cervical Neoplasms']"
127,"[ 0.7463149   2.0372562   1.99811    -0.5175622  -1.6799353   1.8091505
  0.05209201 -0.57982045 -1.8694296  -0.6602247   0.5359668  -0.3633592
 -0.5189436  -1.6203258  -0.23027848 -1.2057823   0.87030995  0.75023335
 -1.1248401  -0.03126514  0.18922858  0.11776619 -0.3732494   1.5468959
  0.40478942  1.1310208   0.35546193  0.06987309  0.19981316 -0.68170184]",10.1016/S0002-9440(10)65602-7,"['Animals', 'Blood-Brain Barrier', 'Brain', 'Cell Death', 'Enzyme Induction', 'Ferritins', 'Histocytochemistry', 'Immunoenzyme Techniques', 'Iron', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Microglia', 'NADPH Dehydrogenase', 'Nitric Oxide Synthase', 'Oxidative Stress', 'Rats', 'Rats, Inbred F344', 'Thiamine Deficiency', 'Time Factors', 'Tyrosine']"
128,"[ 1.1562718   0.8745568   0.5391975   0.2736714  -0.3459737   1.8068995
  0.24488577 -1.1810684  -2.660749   -0.09397149  0.29207796 -0.7805706
  0.04774059 -2.3374226   0.86497843 -0.72697794  0.5911112   1.4598998
  0.70852363 -1.1362815  -0.35935193 -0.16526806 -0.69775087  2.2170994
  0.36181745  1.9157512   0.5151459  -0.35291067 -0.43924522 -1.6095392 ]",10.1016/S0002-9440(10)65619-2,"['Animals', 'DNA Primers', 'Disease Models, Animal', 'Fibroblast Growth Factor 2', 'Humans', 'Immunoenzyme Techniques', 'Infant, Newborn', 'Mice', 'Mice, Knockout', 'Mice, Transgenic', 'Polymerase Chain Reaction', 'Recombinant Fusion Proteins', 'Retina', 'Retinal Neovascularization', 'Retinal Vessels', 'Retinopathy of Prematurity', 'Rhodopsin']"
129,"[-0.33896145  0.8691765   1.4247812  -0.40164518 -0.18001872  2.6395614
  1.7511834   0.45063385 -2.6170275  -1.1112195  -0.07096101  0.43873593
  0.48931485 -1.171441    0.5162889  -0.26762363  2.5550277  -0.3098044
 -1.093471    1.1059194  -0.11522676  0.48705864 -0.65388954  2.3189304
  0.66094077  1.2018303  -0.19323845 -0.28359634 -0.41967428 -0.94147754]",10.1016/S0002-9440(10)65656-8,"['Animals', 'Antigens, Viral', 'CD4 Lymphocyte Count', 'CD4-Positive T-Lymphocytes', 'Cytotoxicity, Immunologic', 'DNA Primers', 'Genes, Viral', 'In Situ Hybridization', 'Lung', 'Macaca fascicularis', 'Macaca mulatta', 'Macaca nemestrina', 'Macrophages', 'Membrane Proteins', 'Pneumonia, Viral', 'Proteins', 'RNA, Viral', 'RNA-Binding Proteins', 'Simian Acquired Immunodeficiency Syndrome', 'Simian Immunodeficiency Virus', 'T-Lymphocytes, Cytotoxic', 'Viral Load', 'Virus Replication']"
130,"[-0.4009776  -0.16751882  0.6535588  -0.22774689 -0.8679895   4.634899
  4.0866256   0.3217916  -4.3236074  -4.033697    0.48937455  4.065116
 -2.2004328  -0.748001    3.9708543  -0.08663465  2.4523103  -0.09505582
  1.8038576   1.6023169   1.0085886   1.8802882  -0.32287803  3.188664
  0.5872226   1.1061268  -0.2107939  -1.293617   -1.6563596  -0.37369457]",10.1016/S0002-9440(10)65604-0,"['Animals', 'B-Lymphocytes', 'CD8-Positive T-Lymphocytes', 'Cyclosporine', 'Drug Therapy, Combination', 'Endothelium, Vascular', 'Enzyme-Linked Immunosorbent Assay', 'Flow Cytometry', 'Genes, MHC Class II', 'Graft Rejection', 'Humans', 'Immunosuppressive Agents', 'Keratinocytes', 'Mice', 'Mice, SCID', 'Microcirculation', 'Polyenes', 'Sirolimus', 'Skin', 'Skin Transplantation', 'T-Lymphocytes', 'Transplantation, Homologous', 'Vascular Cell Adhesion Molecule-1']"
131,"[ 0.78686476  1.8573103   1.529542    0.5308115  -2.958377    4.8599625
 -0.3145253   2.245878   -2.8186235  -0.65593195  2.9407606  -1.7019073
 -0.8024353  -1.9959738  -0.9992438  -0.92469984  0.7989919  -1.1496402
 -1.4546658   1.865635    2.5013757   0.74092346 -1.9168452   0.60495317
  3.5664551  -0.9180078  -1.3450629   0.6036918  -0.08310197 -1.675058  ]",10.1111/j.1469-7793.1998.351be.x,"['8-Bromo Cyclic Adenosine Monophosphate', 'Animals', 'Blotting, Northern', 'Calcium Channels', 'Cell Hypoxia', 'Colforsin', 'Cyclic AMP-Dependent Protein Kinases', 'Down-Regulation', 'Electric Stimulation', 'Electrophysiology', 'Membrane Potentials', 'PC12 Cells', 'Patch-Clamp Techniques', 'RNA, Messenger', 'Radioligand Assay', 'Rats', 'Receptor, Adenosine A2A', 'Receptors, Purinergic P1', 'Reverse Transcriptase Polymerase Chain Reaction']"
132,"[ 0.1078838   1.2044824   1.5003847  -0.5289241  -0.5729861   2.2437534
  1.3543671   0.3938733  -2.247876   -0.8868267   0.56452525 -0.04019703
 -0.63642836 -1.8261361  -0.29090947 -0.33666563  2.1386101   0.06255059
 -0.6159533   0.76582444 -0.2463873   0.30374205 -0.2298291   1.1973218
  0.7210986   1.0669034   0.20547667 -0.1539019  -0.3537136  -0.13461046]",10.1016/S0002-9440(10)65625-8,"['Acute Disease', 'Animals', 'Basement Membrane', 'Bronchoalveolar Lavage Fluid', 'Collagenases', 'Gelatinases', 'Hyperoxia', 'Immunoenzyme Techniques', 'In Situ Hybridization', 'Lung', 'Male', 'Matrix Metalloproteinase 2', 'Matrix Metalloproteinase 9', 'Metalloendopeptidases', 'NF-kappa B', 'RNA, Messenger', 'Rats', 'Rats, Sprague-Dawley', 'Specific Pathogen-Free Organisms', 'Tissue Inhibitor of Metalloproteinase-1', 'Tissue Inhibitor of Metalloproteinase-2', 'Up-Regulation']"
133,"[-0.20139655  0.58995044  2.7301302   0.5980976   0.1194248   1.6735584
  0.77020156  1.1153743  -2.902254   -0.9134708   1.3139381  -1.3976244
  0.56968755 -2.2494352  -0.45857933  0.1441507   2.8290985   1.0607777
 -0.23276639  1.0734582   1.3750944   0.4817414   0.18950239  1.062225
 -0.28402862  0.96501476  0.23286934 -1.2096153   0.22424164 -0.44702083]",10.1016/S0002-9440(10)65669-6,"['Animals', 'Antibodies, Blocking', 'Antibodies, Monoclonal', 'Ascites', 'Cystadenocarcinoma', 'Endothelial Growth Factors', 'Female', 'Humans', 'Immunocompromised Host', 'Immunotherapy', 'Lymphokines', 'Mice', 'Mice, Inbred BALB C', 'Mice, Nude', 'Ovarian Neoplasms', 'Proto-Oncogene Proteins', 'Receptor Protein-Tyrosine Kinases', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factor Receptor-1', 'Vascular Endothelial Growth Factors']"
134,"[ 1.369315    1.7742267  -0.81640714 -2.0866833  -2.0180433   0.9724657
 -0.68596965 -0.7536531  -1.7843437  -0.11092012 -0.95802647 -0.85150087
 -0.47722417 -0.79187226 -1.6573085  -2.1069968   1.1720933  -0.49390233
 -1.474053   -0.6903708   0.10262741 -2.0090532  -0.42924055  1.5464538
  0.38561797  0.9619314   1.3651755   1.3723744   0.8191356  -1.1327629 ]",10.1083/jcb.145.6.1251,"['Actin Depolymerizing Factors', 'Actins', 'Amino Acid Sequence', 'Antibodies', 'Binding Sites', 'Cloning, Molecular', 'Cytoskeleton', 'Fungal Proteins', 'Genes, Lethal', 'Kinetics', 'Microfilament Proteins', 'Models, Molecular', 'Molecular Sequence Data', 'Mutation', 'Polymers', 'Protein Binding', 'Saccharomyces cerevisiae', 'Thermodynamics']"
135,"[ 0.6690441   1.2656679   1.34195    -0.42249343 -0.8805424   1.6324409
  0.4293244  -0.60579187 -2.0951295  -0.93900675  0.23473127 -0.34276456
 -0.2441812  -1.5482203  -0.672003   -1.439265    1.4741833  -0.38671032
 -0.91256475  0.5538203  -0.36771968 -0.28416413 -0.11904774  1.3110689
  0.2444615   0.7942918  -0.09689171  0.47169316 -0.10770342 -0.2247642 ]",10.1016/S0002-9440(10)65650-7,"['Alleles', 'DNA', 'DNA Primers', 'DNA Probes', 'Genes', 'Genotype', 'Hemochromatosis', 'Heteroduplex Analysis', 'Humans', 'In Situ Hybridization, Fluorescence', 'Point Mutation', 'Polymerase Chain Reaction', 'Polymorphism, Genetic']"
136,"[ 0.26753014  0.95701545  0.8629018   0.0444268  -0.46647704  0.74129534
  0.84518796 -1.2962111  -1.3555038  -0.6011674   0.54159975 -0.3090925
  0.35877088 -1.4918423  -0.36776167 -1.2669094   1.6988014  -0.07220877
 -1.314581   -0.19906397 -1.2140509  -1.0391669  -0.10634054  0.79861826
 -0.19175893 -0.19595185  0.03329851  0.64955187 -0.896324   -0.9367829 ]",10.1083/jcb.145.6.1219,"['Amino Acid Substitution', 'Animals', 'Arachidonic Acid', 'Bacillus thuringiensis Toxins', 'Bacterial Proteins', 'Bacterial Toxins', 'Binding Sites', 'Calcimycin', 'Calcium', 'Cell Line', 'Cytosol', 'Egtazic Acid', 'Endotoxins', 'Enzyme Activation', 'Green Fluorescent Proteins', 'Hemolysin Proteins', 'Insecta', 'Luminescent Proteins', 'Nuclear Envelope', 'Okadaic Acid', 'Peptide Fragments', 'Phospholipases A', 'Phospholipases A2', 'Phosphorylation', 'Recombinant Fusion Proteins']"
137,"[-0.06267662  0.8211936   1.3594751  -0.27596322 -0.29487985  1.3686558
  1.4514287  -0.34526634 -2.3817708  -1.4123969   0.5183963   0.50915325
 -0.45806193 -1.3591934   0.5593845  -1.0815414   1.7870398   0.093602
 -0.32736167  0.8127607  -0.20409532  0.5653237  -0.04871259  1.3652819
 -0.03366595  0.81714386 -0.17977674 -0.08826635 -0.44593135 -0.27502584]",10.1084/jem.189.12.1953,"['Animals', 'Cells, Cultured', 'DNA, Viral', 'Disease Models, Animal', 'Herpesvirus 6, Human', 'Humans', 'Immunohistochemistry', 'Immunosuppressive Agents', 'Mice', 'Mice, SCID', 'Microscopy, Electron', 'T-Lymphocyte Subsets', 'Thymus Gland', 'Tissue Transplantation', 'Tropism', 'Virus Replication']"
138,"[ 1.1353003   2.2170618   1.0661309  -0.3730942  -1.5937034   1.9160955
 -1.0886377   0.44854712 -1.7253231  -0.1901036   0.5981951  -1.4439968
 -0.00886593 -1.6227376  -1.0931681  -1.360963    0.6926146   0.03384593
 -0.8883174   0.06354923  0.8012351   0.3274752  -0.0815783   1.1529752
  0.9944554   1.04767    -0.09729743  0.2284076   0.19934118 -0.75452626]",10.1083/jcb.145.6.1265,"['Actins', 'Animals', 'Axons', 'Calcium', 'Cells, Cultured', 'Central Nervous System', 'Chelating Agents', 'Grasshoppers', 'Growth Cones', 'Hydrogen-Ion Concentration', 'Neurons', 'Osmolar Concentration', 'Photolysis', 'Pseudopodia', 'Signal Transduction', 'Time Factors']"
139,"[-1.6467998  -0.05249571  3.863768    0.3752556   0.21742433  1.744017
  3.689095    0.47104084 -1.6204985  -1.7488672   0.44579947  0.21822171
  0.3048426  -1.6781828  -0.7914926  -0.49694878  4.545916   -0.07536469
 -2.208235    2.2554228  -0.22637829  0.27721357 -0.72732866  0.04145183
 -0.5806868   0.0423384  -0.28113806 -0.97541356 -1.4052857  -0.2669342 ]",10.1084/jem.189.12.1863,"['Cell Division', 'Genotype', 'Haplotypes', 'Humans', 'Hypersensitivity, Delayed', 'Interleukin 1 Receptor Antagonist Protein', 'Interleukin-1', 'Interleukin-10', 'Interleukin-4', 'Interleukin-6', 'Leukocytes', 'Mycobacterium tuberculosis', 'Polymorphism, Genetic', 'RNA, Messenger', 'Receptors, Interleukin-1', 'Sialoglycoproteins', 'Tuberculin', 'Tuberculosis']"
140,"[ 0.21825664  1.7898209   0.87110513  0.05391187 -1.6387408   0.48076293
  0.10089552 -0.954603   -1.8823353  -1.2346588   0.23166573 -1.5649757
 -0.4399094  -1.3486805  -0.8764337  -1.5257921   0.7172151  -0.53898674
 -0.9690289  -1.0656093  -0.7274805  -0.24754637 -0.0169887   1.2785392
 -0.19464529  0.44710484 -0.36774057  0.8922504  -0.5633447  -0.9216587 ]",10.1083/jcb.146.1.45,"['Amino Acid Sequence', 'Antibodies', 'Arabidopsis Proteins', 'Biological Transport', 'Blotting, Western', 'Chloroplast Proteins', 'Chloroplasts', 'Cloning, Molecular', 'Hydrogen-Ion Concentration', 'Intracellular Membranes', 'Membrane Proteins', 'Molecular Sequence Data', 'Molecular Weight', 'Peas', 'Plant Proteins', 'SEC Translocation Channels', 'Signal Recognition Particle', 'Zea mays']"
141,"[ 0.4502245   1.5031569   0.83061296 -0.4259501  -1.0979381   0.9579202
  0.57092893 -0.90027726 -1.3408473  -0.8173372  -0.1261226  -0.51836
 -0.32205307 -0.993977   -0.8040576  -1.5937121   1.5844331  -0.10512955
 -0.94935656 -0.02669482 -0.5028521  -0.438367   -0.4064159   0.9952387
 -0.38066116  0.67625475  0.1449023   0.49442258 -0.04773585 -0.4235261 ]",10.1083/jcb.146.3.559,"['Amino Acid Sequence', 'Animals', 'Autoantigens', 'Biological Transport', 'Catalysis', 'Cell Line', 'Cell Nucleolus', 'Endoribonucleases', 'Holoenzymes', 'Humans', 'Mice', 'Molecular Sequence Data', 'Molecular Weight', 'Organelles', 'Protein Sorting Signals', 'RNA Precursors', 'RNA Processing, Post-Transcriptional', 'RNA, Catalytic', 'RNA, Transfer, Ser', 'Ribonuclease P', 'Ribonucleoproteins', 'Sequence Deletion', 'Transfection']"
142,"[ 1.3274336   1.7705891   0.09802018 -0.5864529  -1.4364825   1.038775
 -0.5695066  -1.2530972  -1.5462133  -0.2292609  -0.20759487 -0.42329067
  0.02497783 -1.4438868  -0.79057443 -1.8780273   0.64464194  0.27114585
 -0.6367701  -0.78011656 -0.5722181  -0.86143285 -0.50344896  1.4072485
  0.10713384  1.0735384   0.3235023   0.90655917 -0.49319023 -1.498542  ]",10.1083/jcb.146.1.13,"['Animals', 'Apoptosis', 'Brain', 'Cell Cycle', 'Chromosome Segregation', 'Cloning, Molecular', 'Drosophila melanogaster', 'Epitopes', 'Genes, Essential', 'Genes, Insect', 'Kinetochores', 'Male', 'Meiosis', 'Mitosis', 'Molecular Sequence Data', 'Mutagenesis, Insertional', 'Mutation', 'Neurons', 'Phosphorylation', 'Protein Kinases', 'Protein Serine-Threonine Kinases', 'Spermatogenesis', 'Spindle Apparatus']"
143,"[ 0.45265958  1.4832481   0.2199548  -0.66472316 -1.4230369   1.3927251
  0.13813609 -0.842218   -1.0292681   0.12469534 -0.8227466  -1.220391
 -0.43783042 -1.4534789  -1.3818338  -2.1642659   0.8136323  -0.34081727
 -1.7497325  -1.7210753  -0.7436543  -1.1788657  -0.6761166   1.7139994
  0.61129475  0.41258293  0.21970549  0.6152735  -0.5746327  -1.8439654 ]",10.1083/jcb.146.1.99,"['Amino Acid Sequence', 'Base Sequence', 'Biological Transport', 'Carrier Proteins', 'Cloning, Molecular', 'Conserved Sequence', 'Cytosol', 'Fungal Proteins', 'Gene Deletion', 'Genes, Fungal', 'Genetic Complementation Test', 'Intracellular Membranes', 'Ligases', 'Membrane Proteins', 'Membrane Transport Proteins', 'Methanol', 'Microbodies', 'Molecular Sequence Data', 'Oleic Acid', 'Phenotype', 'Pichia', 'Protein Sorting Signals', 'Recombinant Fusion Proteins', 'Ubiquitins']"
144,"[ 0.08669001  0.97470236  1.7343013   0.53112376 -0.7127965   1.0889918
  0.8571236  -0.41322657 -2.6647608  -1.6251423   0.9926557  -0.15448546
 -0.199966   -1.6449004  -0.1968529  -0.4830482   1.4464676  -0.12131105
 -0.38758543  0.28442186 -0.05707065 -0.25961757 -0.13958025  0.85189885
 -0.09326614 -0.03920553  0.5556279  -0.18795137  0.35223928  0.00606355]",10.1083/jcb.146.1.233,"['Actins', 'Animals', 'Aorta', 'Binding, Competitive', 'Cell Line', 'Cell Movement', 'Cytoskeleton', 'Endothelial Growth Factors', 'Endothelium, Vascular', 'Ganglia, Spinal', 'Glycoproteins', 'Humans', 'In Vitro Techniques', 'Lymphokines', 'Neovascularization, Physiologic', 'Nerve Tissue Proteins', 'Neuropilin-1', 'Pseudopodia', 'Rats', 'Rats, Inbred Lew', 'Receptor Protein-Tyrosine Kinases', 'Receptors, Growth Factor', 'Receptors, Vascular Endothelial Growth Factor', 'Semaphorin-3A', 'Swine', 'Vascular Endothelial Growth Factor A', 'Vascular Endothelial Growth Factors']"
145,"[ 0.86364365  1.5361278   0.74916786 -0.3830632  -1.3115166   1.2102542
 -0.26937458 -0.8314407  -1.5323554  -0.7048159  -0.17192088 -0.34863153
 -0.08010749 -0.85459805 -0.8026831  -1.6326394   1.0436491  -0.2411849
 -1.0402447  -0.10236213 -0.3499163  -0.5104734   0.06172857  1.0174772
 -0.22857429  0.8455259   0.25877     0.65400493 -0.07213833 -0.5567141 ]",10.1083/jcb.146.3.609,"['3T3 Cells', 'Adaptor Protein Complex gamma Subunits', 'Adipocytes', 'Adiponectin', 'Animals', 'Blood Proteins', 'Coatomer Protein', 'Collagen', 'Endoplasmic Reticulum', 'Exocytosis', 'Fluorescent Antibody Technique', 'Glucose Transporter Type 4', 'Golgi Apparatus', 'Insulin', 'Intercellular Signaling Peptides and Proteins', 'Membrane Glycoproteins', 'Membrane Proteins', 'Mice', 'Microtubule-Associated Proteins', 'Monosaccharide Transport Proteins', 'Muscle Proteins', 'Phosphatidylinositol 3-Kinases', 'Phosphoinositide-3 Kinase Inhibitors', 'Proteins', 'Receptors, Transferrin']"
146,"[ 1.2730283   1.5726794   0.51650614 -0.569423   -0.8590583   1.1289307
  0.32249376 -1.2787758  -1.82775    -1.0929494  -0.308146    0.06412192
 -0.37115905 -0.9933467  -0.28624088 -1.487274    0.85559195  0.20866823
 -0.18263838 -0.56029785 -0.61437505 -0.17370936 -0.3042497   1.595063
 -0.13807292  1.6369649   0.8729678   0.83947706  0.42393994 -0.22865325]",10.1083/jcb.145.6.1309,"['Ameloblasts', 'Animals', 'Animals, Newborn', 'Basement Membrane', 'Cell Adhesion', 'Cell Adhesion Molecules', 'Cell Differentiation', 'Cell Survival', 'Cells, Cultured', 'Desmosomes', 'Epidermolysis Bullosa, Junctional', 'Epithelial Cells', 'Gene Deletion', 'Genes, Lethal', 'Humans', 'Incisor', 'Integrins', 'Keratinocytes', 'Laminin', 'Mice', 'Mice, Knockout', 'Protein Isoforms', 'Skin']"
147,"[ 0.49584684  0.8821343   1.6197091  -0.02697363 -1.0500176   0.5019624
  0.08578983 -0.8569653  -1.2591994  -0.64811367  0.5338849  -0.6562835
  0.404312   -1.0827154  -1.0681516  -0.40819192  1.2267812   0.2595123
 -1.297038    0.0720409   0.3133054  -0.75899714 -0.03775551  0.29278457
  0.16268237  0.6190995   0.33311078  0.57111084  0.37733904 -0.42630756]",10.1083/jcb.145.7.1461,"['Animals', 'Binding Sites', 'Calcium-Calmodulin-Dependent Protein Kinases', 'Cell Adhesion', 'Cell Adhesion Molecules', 'Cell Line', 'Crk-Associated Substrate Protein', 'Endothelium, Vascular', 'Enzyme Activation', 'Fibronectins', 'Focal Adhesion Kinase 1', 'Focal Adhesion Protein-Tyrosine Kinases', 'G1 Phase', 'Gene Expression Regulation', 'Growth Substances', 'Humans', 'Integrins', 'JNK Mitogen-Activated Protein Kinases', 'MAP Kinase Kinase 4', 'Mice', 'Mitogen-Activated Protein Kinase Kinases', 'Mitogen-Activated Protein Kinases', 'Mutation', 'Phosphoproteins', 'Phosphorylation', 'Protein Serine-Threonine Kinases', 'Protein-Tyrosine Kinases', 'Proteins', 'Proto-Oncogene Proteins', 'Proto-Oncogene Proteins c-crk', 'Retinoblastoma-Like Protein p130', 'Signal Transduction', 'src Homology Domains', 'src-Family Kinases']"
148,"[-0.00546349  0.43663457  1.9441884  -0.08228074 -0.48405284  0.8584598
  1.3450426  -0.7910641  -1.9629693  -1.3269546   0.5371256   0.05168635
 -0.03394959 -1.658028   -0.8146204  -0.21606152  2.1019003  -0.26963994
 -0.99869823  0.75565284 -0.7546323  -0.6131223  -0.16712852  0.41969386
 -0.2191825   0.3636666  -0.130603    0.4899635   0.14597069  0.28486305]",10.1083/jcb.146.1.149,"['Antibodies', 'Calcium-Calmodulin-Dependent Protein Kinases', 'Cell Adhesion', 'Cell Movement', 'Enzyme Activation', 'Flavonoids', 'Humans', 'Integrins', 'MAP Kinase Kinase 1', 'Mitogen-Activated Protein Kinase Kinases', 'Mutation', 'Myosin-Light-Chain Kinase', 'Phosphorylation', 'Plasminogen Activators', 'Protein Biosynthesis', 'Protein Serine-Threonine Kinases', 'Protein-Tyrosine Kinases', 'Receptors, Cell Surface', 'Receptors, Urokinase Plasminogen Activator', 'Signal Transduction', 'Transcription, Genetic', 'Tumor Cells, Cultured', 'Urokinase-Type Plasminogen Activator', 'Vitronectin', 'ras Proteins']"
149,"[-0.43227056  0.7454621   1.3854501  -0.17787819 -0.4435733   2.0636206
  1.878017   -0.16866899 -1.4300812  -2.0769413   0.23843724  1.1560218
 -0.51739943 -1.2121376   0.8134635   0.0327987   2.3221493   0.12761852
 -0.17580704  1.5404637   0.3454928   0.306131   -0.4913371   0.6715882
 -0.2849699   0.7859015  -0.11074706 -0.03018798 -0.35797307 -0.2601036 ]",10.1084/jem.190.4.479,"['Adult', 'Aged', 'Aging', 'Animals', 'CD4 Antigens', 'Fetal Blood', 'Flow Cytometry', 'Genes, T-Cell Receptor beta', 'Humans', 'L-Selectin', 'Leukocyte Common Antigens', 'Mice', 'Middle Aged', 'Phenotype', 'Receptors, Antigen, T-Cell, alpha-beta', 'Sequence Deletion', 'T-Lymphocyte Subsets', 'Thymus Gland']"
150,"[ 0.7567544   1.1994643   0.34076402 -0.8047107  -1.3660598   1.0756215
 -0.63316745 -0.60600775 -1.4512266  -0.06795134 -0.35897213 -0.47359565
 -0.16625166 -0.80487776 -0.85617036 -1.51379     0.6073487  -0.31832933
 -0.87699395 -0.33485118  0.14351067 -0.7150355  -0.4725868   0.98268175
  0.6443681   0.6475211   0.2167669   0.5565293   0.26327458 -0.5296386 ]",10.1083/jcb.146.4.731,"['Alleles', 'Amino Acid Sequence', 'Animals', 'Carrier Proteins', 'Cloning, Molecular', 'Drosophila Proteins', 'Drosophila melanogaster', 'Gene Expression', 'Genes, Essential', 'Genes, Insect', 'Genetic Complementation Test', 'Guanosine Triphosphate', 'Insect Proteins', 'Larva', 'Membrane Proteins', 'Molecular Sequence Data', 'Mosaicism', 'Mutation', 'Phenotype', 'Receptors, Notch', 'Sequence Homology, Amino Acid', 'Signal Transduction', 'rab GTP-Binding Proteins', 'ras Proteins']"
151,"[ 0.59522617  1.044453    0.9344181  -0.18301792 -0.7120596   1.0151322
  0.7086804  -0.7266207  -1.947372   -0.9636035   0.32320952 -0.13068843
 -0.3061129  -1.762388   -0.29841274 -1.092952    1.1890838  -0.12237757
 -0.03370868 -0.06876361 -0.95046806 -0.10659093 -0.09287801  1.4605178
  0.01710389  0.71787465 -0.2024412   0.38504648 -0.41645005 -0.40435907]",10.1083/jcb.146.4.709,"['Animals', 'CHO Cells', 'Chromatin', 'Chromosomes', 'Cricetinae', 'DNA Replication', 'DNA-Binding Proteins', 'G1 Phase', 'Halogens', 'Minichromosome Maintenance Complex Component 2', 'Mitosis', 'Nuclear Envelope', 'Nuclear Proteins', 'Nucleotides', 'Proliferating Cell Nuclear Antigen', 'Protein Binding', 'Replication Origin', 'Replication Protein A', 'S Phase', 'Telophase', 'Tetrahydrofolate Dehydrogenase', 'Time Factors']"
152,"[-0.14984764  0.58962077  1.0501388   0.09396403 -0.29447716  0.8761997
  1.0907769  -0.49231035 -1.2147971  -1.1532288   0.39183226  0.30758646
 -0.10295822 -1.0972903   0.5011096  -0.492674    1.5249054   0.4860583
 -0.14530869  0.38120338  0.02183519  0.2229587  -0.04686443  0.7218682
 -0.47179547  0.96199036  0.03082988 -0.0312426  -0.07309658 -0.04484707]",10.1084/jem.190.5.691,"['Amino Acid Sequence', 'Animals', 'Antibodies, Antinuclear', 'Autoimmunity', 'B-Lymphocytes', 'Base Sequence', 'DNA', 'DNA, Single-Stranded', 'Gene Rearrangement, B-Lymphocyte, Light Chain', 'Humans', 'Hybridomas', 'Lupus Erythematosus, Systemic', 'Lymphocyte Activation', 'Mice', 'Mice, Inbred BALB C', 'Mice, Inbred MRL lpr', 'Mice, Transgenic', 'Molecular Sequence Data', 'Mutation']"
153,"[-0.02563252  1.0409081   2.6432076  -0.34574708 -0.6582096   0.7756631
  0.01505972 -0.6280416  -0.8342599  -1.0580798   0.56669044 -0.29432428
  0.19570893 -1.1211164  -0.9944667  -0.54976857  2.3603423   0.35511678
 -1.2736146   1.2644541   0.63722605 -1.1689055  -0.02283864  0.22031282
 -0.0936942   0.9761794   0.53008324  0.2660379   0.6335513   0.5414113 ]",10.1083/jcb.146.6.1255,"['Animals', 'CDC2-CDC28 Kinases', 'Calcium-Calmodulin-Dependent Protein Kinases', 'Cell Adhesion', 'Cell Line', 'Cyclin D1', 'Cyclin E', 'Cyclin-Dependent Kinase 2', 'Cyclin-Dependent Kinase Inhibitor p21', 'Cyclin-Dependent Kinases', 'Cyclins', 'Down-Regulation', 'Enzyme Activation', 'Extracellular Matrix', 'Fibroblasts', 'G1 Phase', 'Growth Substances', 'Mice', 'Mice, Inbred C57BL', 'Mitogens', 'Protein Serine-Threonine Kinases', 'RNA, Messenger', 'Signal Transduction', 'Up-Regulation']"
154,"[-1.5002882   1.532849    3.1477232  -0.40357828 -0.6873184   1.0967281
  1.9706404   0.22571172 -1.64582    -1.3743078   0.6997922  -0.5376105
  0.22440939 -1.4642787  -1.2799795  -1.2284833   3.7980604  -0.0053976
 -2.762632    1.6497768   0.5992502  -0.6390961  -0.5457406  -0.17244075
 -0.23730923  0.7124733  -0.24890433 -0.14951602  0.2798652  -0.6480892 ]",10.1084/jem.190.5.717,"['Amino Acid Sequence', 'Animals', 'Base Sequence', 'Carrier Proteins', 'Cation Transport Proteins', 'Cations, Divalent', 'DNA Primers', 'Female', 'Hydrogen-Ion Concentration', 'In Vitro Techniques', 'Ion Transport', 'Iron-Binding Proteins', 'Membrane Proteins', 'Molecular Sequence Data', 'Mycobacterium tuberculosis', 'Oocytes', 'RNA, Bacterial', 'RNA, Messenger', 'Sequence Homology, Amino Acid', 'Xenopus laevis']"
155,"[-1.5106992  -0.10360742  2.1696627   0.87160903  0.1461004   1.2443606
  2.064777   -0.7753459  -0.261892   -1.9940003   0.9958813   0.28083545
  0.5987837  -1.3590261   0.97181374  0.11332833  3.8189368   2.0888813
 -0.665351    0.7886877   0.93674445 -0.597134   -0.6266526   0.04012561
 -1.6256843   2.2893798   0.09787208 -0.02122656 -0.6408101  -1.02681   ]",10.1084/jem.190.5.629,"['Animals', 'Bone Marrow Cells', 'Cell Count', 'Cell Movement', 'Dendritic Cells', 'Female', 'Lymphocyte Culture Test, Mixed', 'Lymphoid Tissue', 'Lymphotoxin beta Receptor', 'Lymphotoxin-alpha', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Mice, Transgenic', 'Phenotype', 'Receptors, Tumor Necrosis Factor', 'Signal Transduction', 'Solubility', 'Spleen', 'Tumor Necrosis Factor-alpha']"
156,"[ 1.0329158   1.3812593   0.49778867 -0.1353044  -1.1595155   1.2320633
  0.28425053 -0.589393   -2.0760312  -0.9682678   0.5776461  -0.24226339
  0.07100219 -1.3907905   0.09202556 -0.4529103   0.5636595   0.35279745
 -0.17089403 -0.4178723   0.05117361 -0.1523021  -0.11691613  1.0619466
  0.5020917   0.27418852  0.08339515  0.0252223  -0.09690873 -0.42780927]",10.1083/jcb.146.5.1173,"['Animals', 'Axons', 'Cell Adhesion', 'Cell Polarity', 'Cell Survival', 'Female', 'Ganglia, Spinal', 'Gene Deletion', 'Leukocyte L1 Antigen Complex', 'Male', 'Membrane Glycoproteins', 'Mice', 'Mice, Knockout', 'Myelin Sheath', 'Myelin-Associated Glycoprotein', 'Nerve Degeneration', 'Nerve Fibers', 'Neural Cell Adhesion Molecules', 'Neurons, Afferent', 'Peripheral Nervous System', 'Pressure', 'Schwann Cells', 'Sciatic Nerve']"
157,"[ 4.1196114e-01  1.3284264e+00  8.1705135e-01 -5.7454383e-01
 -6.5294397e-01  8.8490510e-01  7.5007880e-01 -4.6621981e-01
 -1.4464632e+00 -9.4847292e-01  9.7078057e-03 -6.3106340e-01
 -1.5457273e-01 -9.1002059e-01 -7.0284641e-01 -1.3861257e+00
  1.7521955e+00  6.4030990e-02 -9.7791487e-01  9.4339816e-04
 -3.9117670e-01 -2.3172031e-01 -1.2652470e-01  1.0859555e+00
 -2.7005851e-01  9.4710267e-01  2.3036993e-01  4.6949559e-01
 -5.7091946e-03 -4.4397172e-01]",10.1083/jcb.146.4.755,"['Adaptor Protein Complex alpha Subunits', 'Adaptor Proteins, Vesicular Transport', 'Amino Acid Sequence', 'Amino Acid Substitution', 'Animals', 'Binding Sites', 'Biological Transport', 'Brain', 'Cattle', 'Cell Line', 'Cell Membrane', 'Circular Dichroism', 'Clathrin', 'Coated Pits, Cell-Membrane', 'Glutamine', 'Lysine', 'Membrane Proteins', 'Mice', 'Molecular Sequence Data', 'Mutagenesis, Site-Directed', 'Phosphatidylinositols', 'Protein Structure, Secondary', 'Sequence Deletion', 'Transfection']"
158,"[ 1.2227637   1.8194121   0.9524942  -0.49462056 -1.2942361   2.170097
 -0.24117339 -0.6043035  -2.1061897  -1.1261212   0.5545677  -0.25125527
 -0.19340788 -1.9140855   0.21259357 -0.60272723  0.65335155  0.7434881
 -0.00660426 -0.23589937 -0.09585959 -0.24326849 -0.10861222  1.5846629
  0.99037516  0.8704106   0.20405957 -0.2183634  -0.11311357 -0.4987891 ]",10.1083/jcb.146.6.1365,"['Animals', 'Animals, Newborn', 'Apoptosis', 'Axons', 'Cell Differentiation', 'Cell Division', 'Cell Lineage', 'Cell Movement', 'Cell Nucleus', 'Cell Size', 'Cell Survival', 'Denervation', 'Mitotic Index', 'Myelin Sheath', 'Oligodendroglia', 'Optic Nerve', 'Rats', 'Rats, Sprague-Dawley', 'Retina', 'Retinal Ganglion Cells', 'Stem Cells', 'Time Factors']"
159,"[ 0.6804256   1.8658302   0.8429224  -0.7049128  -1.7398752   1.4781276
 -0.67693746 -0.82122976 -1.9736248  -0.5674948   0.34880152 -0.41953558
 -0.1863485  -1.3395897  -1.0517318  -1.9497387   1.0390722  -0.5252273
 -1.7030805   0.18497464 -0.11819381 -0.41581059 -0.10369579  1.3286504
  0.51314986  0.8546031   0.34381512  0.25550997  0.11823105  0.01900018]",10.1083/jcb.146.6.1211,"['Acetylation', 'Animals', 'Cell Line', 'Cell Polarity', 'Chromatin', 'Chromosome Banding', 'Chromosomes', 'Clone Cells', 'Cricetinae', 'DNA', 'DNA Replication', 'Female', 'Fibroblasts', 'Genome', 'Histones', 'Humans', 'Interphase', 'Karyotyping', 'Mice', 'Mitosis', 'RNA, Messenger', 'Transcription, Genetic']"
160,"[ 1.3260071   0.6745032   1.1241345  -0.66778976 -1.1120385   1.137423
 -0.23007752 -1.3600296  -2.1002018  -0.43834102  0.1065452  -0.0054986
  0.03022781 -1.8010411  -0.62532157 -1.215158    1.1529739   0.5496997
  0.24291492 -0.64194554 -0.84137183 -0.6603956  -0.4299947   1.6585252
  0.14812282  0.8259033   0.49494815  0.5196888  -0.04419085 -1.0195224 ]",10.1083/jcb.147.1.77,"['Animals', 'Cell Line', 'Cell Nucleus', 'DNA-Binding Proteins', 'ErbB Receptors', 'Female', 'Gene Expression Regulation, Developmental', 'Humans', 'Lactation', 'Mammary Glands, Animal', 'Mice', 'Mice, Transgenic', 'Milk Proteins', 'Phosphorylation', 'Precipitin Tests', 'Pregnancy', 'RNA, Messenger', 'Receptor, ErbB-4', 'STAT5 Transcription Factor', 'Sequence Deletion', 'Signal Transduction', 'Trans-Activators', 'Transgenes', 'src Homology Domains']"
161,"[ 0.5537057   1.305472    0.8614674  -0.1922496  -0.7607336   0.8342724
  0.48450467 -1.261975   -1.9340138  -0.8333649  -0.0121619  -0.5462265
  0.09825974 -1.5597494  -0.63825065 -1.7171001   1.4239447  -0.2137706
 -1.0478029   0.08844651 -0.92283314 -0.8262486  -0.40432498  0.7811165
 -0.10721638  0.54433906  0.08212672  0.704769   -0.00470752 -0.20242552]",10.1083/jcb.146.4.801,"['Amino Acid Sequence', 'Animals', 'Chlamydomonas', 'Cosmids', 'Dyneins', 'Flagella', 'Genetic Complementation Test', 'Molecular Motor Proteins', 'Molecular Sequence Data', 'Movement', 'Mutation', 'Phenotype', 'Protein Structure, Secondary', 'RNA, Messenger', 'Sequence Analysis, DNA', 'Sequence Homology, Amino Acid', 'Transformation, Genetic', 'Transgenes']"
162,"[ 0.379654    0.5970496   1.5730587   0.26771724 -0.10941722  1.4539531
  1.3778399  -0.34454513 -2.0684445  -1.1116596   0.75410396 -0.11430983
 -0.12058846 -1.2585199  -0.2698557  -0.70922637  1.7496331   0.26077062
 -0.39242426  0.8314519  -0.4534887  -0.4733924  -0.15656196  1.1159828
 -0.5418123   1.0038964   0.30337778  0.5876705  -0.10129324  0.26884466]",10.1083/jcb.147.1.89,"['Animals', 'Cell Adhesion', 'Cell Adhesion Molecules', 'Cell Division', 'Chick Embryo', 'Down-Regulation', 'Enzyme Activation', 'Fibronectins', 'Humans', 'Integrins', 'Kinetics', 'MAP Kinase Kinase 1', 'MAP Kinase Signaling System', 'Mitogen-Activated Protein Kinase Kinases', 'Mitogen-Activated Protein Kinases', 'Neoplasms', 'Phosphorylation', 'Precipitin Tests', 'Protein Binding', 'Protein Serine-Threonine Kinases', 'Receptors, Cell Surface', 'Receptors, Fibronectin', 'Receptors, Urokinase Plasminogen Activator', 'Tumor Cells, Cultured', 'Urokinase-Type Plasminogen Activator']"
163,"[ 0.72197676  1.3825951   0.16066982 -0.5942206  -0.80546     1.1505693
  0.5586656  -1.4343761  -1.4971634  -0.14502351 -0.47434404 -0.7137622
 -0.10789233 -0.8563947  -0.9232869  -2.1001647   1.272777    0.19005446
 -1.2939147  -1.0544976  -1.2182995  -0.84788615 -0.47268716  1.306623
 -0.17788886  0.96462     0.7599269   1.1089913  -0.3765345  -1.5439619 ]",10.1083/jcb.146.5.993,"['Adaptor Protein Complex 1', 'Adaptor Protein Complex alpha Subunits', 'Adaptor Protein Complex gamma Subunits', 'Adaptor Proteins, Vesicular Transport', 'Alternative Splicing', 'Animals', 'Binding Sites', 'Brain', 'Carrier Proteins', 'Cell Line', 'Cell Membrane', 'Cloning, Molecular', 'Cytosol', 'Dogs', 'Drosophila Proteins', 'Golgi Apparatus', 'Intracellular Membranes', 'Liver', 'Membrane Proteins', 'Mice', 'Microtubule-Associated Proteins', 'Molecular Sequence Data', 'Molecular Weight', 'RNA, Messenger', 'Rats', 'Recombinant Fusion Proteins', 'Sequence Deletion', 'Yeasts']"
164,"[ 0.6248888   1.2291411   0.7033338  -0.6651547  -1.311025    0.7822876
 -0.04028355 -0.5784163  -1.7736362  -0.42414504 -0.06394845 -0.54421556
 -0.0983528  -0.9288995  -0.93558615 -1.8010463   1.324006    0.1018526
 -1.2754726  -0.15381986  0.147015   -0.87201804 -0.49087942  0.85960764
  0.0127388   0.8097804   0.22732356  0.7985126   0.21672744 -0.90167123]",10.1083/jcb.146.6.1303,"['Actins', 'Amino Acid Sequence', 'Animals', 'Armadillo Domain Proteins', 'Cloning, Molecular', 'Cytoskeletal Proteins', 'Cytoskeleton', 'Drosophila Proteins', 'Drosophila melanogaster', 'Epidermal Cells', 'Epidermis', 'Epistasis, Genetic', 'Female', 'Genes, Insect', 'Humans', 'Insect Proteins', 'Larva', 'Male', 'Molecular Sequence Data', 'Mutation', 'Neurons', 'Phosphorylation', 'Proto-Oncogene Proteins', 'Signal Transduction', 'Spindle Apparatus', 'Trans-Activators', 'Transcription Factors', 'Tumor Cells, Cultured', 'Wnt1 Protein']"
165,"[-1.3699833   0.77115417  2.1895258  -0.5314448  -0.15626015  1.4667114
  2.507222    0.83767015 -2.5230424  -0.9643251   0.2924199   0.26833352
  0.41261774 -1.0846874   0.13583706 -0.51075846  2.8764226   0.06984551
 -1.6983333   1.1944823   0.45429018  0.11432321 -0.44528115  1.0408543
  0.12413982  1.6324108  -0.21259435 -0.81444234 -0.23455663 -0.672208  ]",10.1084/jem.190.6.827,"['Animals', 'B-Lymphocytes', 'Herpesviridae Infections', 'Herpesvirus 8, Human', 'Humans', 'Hyperplasia', 'Lymphoproliferative Disorders', 'Macaca mulatta', 'Simian Acquired Immunodeficiency Syndrome', 'Simian Immunodeficiency Virus']"
166,"[ 0.64327997  1.5570033   0.47893405 -0.81332755 -1.2639555   1.124825
 -0.09899152 -0.69657147 -1.2896729   0.17554133 -0.3459868  -0.6132537
 -0.32607853 -1.0390055  -0.79208654 -1.7516358   0.7113249  -0.10771926
 -1.1581694  -0.65250367 -0.17497368 -0.633619   -0.48258817  0.9052858
  0.5602996   0.92787415  0.19647041  0.7760543  -0.23561926 -1.1067642 ]",10.1083/jcb.146.5.1005,"['Amino Acid Sequence', 'Animals', 'Cell Cycle', 'Centrosome', 'Chromosome Segregation', 'Cloning, Molecular', 'Colchicine', 'Cytoskeleton', 'Drosophila melanogaster', 'Female', 'Humans', 'Insect Proteins', 'Microtubule-Associated Proteins', 'Microtubules', 'Mitosis', 'Molecular Sequence Data', 'Mutation', 'Paclitaxel', 'Schizosaccharomyces pombe Proteins', 'Sequence Homology, Amino Acid', 'Spindle Apparatus', 'Xenopus Proteins']"
167,"[ 1.7441951   1.0722944   1.0100363  -0.3801071  -0.63103765  1.342647
 -0.4595131  -1.3706045  -2.7565484  -0.9545621  -0.03899535  1.2678218
 -0.19771034 -1.3695233   0.52286863 -0.8875347   0.11810832  0.597622
  0.4116237   0.16721845 -0.4114465  -0.39985082 -0.34532714  1.7535743
 -0.03008589  0.97470295  0.86524075  0.21913461  0.77169764 -0.02921398]",10.1083/jcb.147.3.631,"['Blotting, Western', 'Breast Neoplasms', 'Cadherins', 'Cell Movement', 'Cell Size', 'Coculture Techniques', 'Cyclohexanones', 'Cytoskeletal Proteins', 'Dose-Response Relationship, Drug', 'Fibroblasts', 'Gene Expression', 'Humans', 'Lipoprotein Lipase', 'Models, Biological', 'Neoplasm Invasiveness', 'Receptors, Fibroblast Growth Factor', 'Signal Transduction', 'Trans-Activators', 'Transfection', 'Tumor Cells, Cultured', 'beta Catenin']"
168,"[ 1.0922703   1.4481597   0.26103282 -0.37136424 -1.464784    1.0700169
 -0.38265812 -1.5109628  -1.6720306  -0.23646934  0.08409726 -0.37265277
 -0.37203544 -1.9612731  -0.5876974  -1.8568281   0.6500963   0.47194433
 -1.0028732  -0.62309325 -0.5806567  -1.2727177  -0.43560818  0.84097505
  0.26257387  1.0119417   0.34104684  0.9750639  -0.50081784 -1.3549898 ]",10.1083/jcb.147.2.351,"['Fungal Proteins', 'HeLa Cells', 'Humans', 'Kinesins', 'Microtubule-Associated Proteins', 'Microtubules', 'Mitosis', 'Molecular Motor Proteins', 'Saccharomyces cerevisiae Proteins', 'Xenopus Proteins']"
169,"[ 1.0742408   1.4624786   0.10033052 -0.19354013 -1.3858998   0.6759684
  0.0872893  -1.5642612  -1.5849823  -0.6097055   0.12414996 -0.24141903
 -0.4255263  -1.5717068  -0.3776839  -1.4780403   0.9380738   0.22235186
 -0.22271632 -1.1199124  -1.177753   -0.79627496 -0.4201878   1.2328594
 -0.07815661  0.81643367  0.00769751  0.89184326 -0.51790446 -1.3437467 ]",10.1083/jcb.147.2.321,"['Animals', 'COS Cells', 'Centrosome', 'Dynactin Complex', 'Microtubule-Associated Proteins', 'Microtubules', 'Protein Binding', 'Tubulin']"
170,"[ 0.26208386  0.94987947  1.084075   -0.40206566 -0.30789962  0.61508244
  1.3499624  -0.9673937  -1.7980515  -1.1651405  -0.13123491 -0.49332586
  0.58355755 -0.789101   -0.18360198 -1.1568313   1.9369975   0.11404869
 -1.0115236   0.01819135 -1.2712516  -0.54487497 -0.21946482  1.5635108
 -0.6511414   1.0513369   0.19483797  0.68376493 -0.49603432 -0.36761573]",10.1084/jem.190.11.1637,"['Animals', 'Antibody-Dependent Cell Cytotoxicity', 'Binding Sites', 'Chlorocebus aethiops', 'Complement C3', 'Complement C3b', 'Herpes Simplex', 'Herpesvirus 1, Human', 'Humans', 'Mice', 'Mice, Knockout', 'Recombinant Proteins', 'Rosette Formation', 'Vero Cells', 'Viral Envelope Proteins']"
171,"[-0.7842064   0.79009575  1.7886544   0.22188099 -0.3294656   1.3193156
  2.1136835  -0.30421945 -1.5440245  -2.142659    0.7043123   0.12678976
 -0.01982473 -1.8462015   0.5927435  -0.6283624   3.024735    0.6336976
 -1.1031997   1.0197089   0.6393943   0.36251506 -0.36322373  0.36793172
 -0.8868502   1.3895954  -0.42731735 -0.5879632  -0.2695343  -0.75499475]",10.1084/jem.190.12.1813,"['Animals', 'Autoimmune Diseases', 'Chemokine CCL2', 'Gene Deletion', 'Gene Expression Regulation', 'Macrophages', 'Mice', 'Mice, Inbred MRL lpr', 'T-Lymphocytes']"
172,"[-0.15039255  0.82152313  1.2457851  -0.17519383 -0.21970749  0.53105235
  1.136676   -0.59753007 -0.90162647 -0.7669003   0.3983198   0.18341763
  0.13009802 -1.0458181  -0.42325786 -1.0911427   1.8649834   0.05499368
 -0.93513393  0.54562366 -0.48071223 -0.52728784 -0.30778882  0.5877776
 -0.18793324  0.6337111   0.2183376   0.44692987 -0.12100007 -0.1637035 ]",10.1083/jcb.147.7.1431,"['Animals', 'COS Cells', 'Cells, Cultured', 'Cytoplasmic Granules', 'Eukaryotic Initiation Factor-2', 'HSP27 Heat-Shock Proteins', 'Heat-Shock Proteins', 'Hot Temperature', 'Humans', 'Male', 'Membrane Proteins', 'Molecular Chaperones', 'Neoplasm Proteins', 'Phosphorylation', 'Poly(A)-Binding Proteins', 'Proteins', 'RNA-Binding Proteins', 'T-Cell Intracellular Antigen-1', 'Tumor Cells, Cultured', 'Ultraviolet Rays']"
173,"[ 0.08312103  0.64319783  1.0256443  -0.19941624 -0.7395957   0.63235676
  0.09879796 -0.41753852 -0.72641706 -0.6656212   0.36525914 -0.08929279
  0.23027846 -0.6322043  -0.6391701  -0.35377207  1.181925    0.08594577
 -0.9535221   0.5128846   0.4720602  -0.4271097  -0.11737481  0.25982043
 -0.04808518  0.5108065   0.18882097  0.22541     0.24857461 -0.14218844]",10.1084/jem.191.2.381,"['Animals', 'B-Lymphocytes', 'CD40 Antigens', 'CD40 Ligand', 'COS Cells', 'Cell Lineage', 'Cells, Cultured', 'DNA-Binding Proteins', 'Dendritic Cells', 'I-kappa B Proteins', 'Lipopolysaccharides', 'Lymphocyte Activation', 'Membrane Glycoproteins', 'Mice', 'NF-KappaB Inhibitor alpha', 'NF-kappa B', 'Phosphorylation', 'Protein Serine-Threonine Kinases', 'Signal Transduction']"
174,"[ 0.5141782   1.3244516   1.1407512  -0.07420406 -0.9692046   1.1075152
  0.6217178  -0.7958907  -1.5189687  -0.31671026 -0.0997668  -0.5715427
  0.06747413 -1.4502157  -0.80551183 -1.6007329   1.4438374   0.41870987
 -0.94237024 -0.38957676 -0.47728142 -0.6261219  -0.43772498  0.89804244
 -0.07022902  1.1179104   0.10263584  0.6814647  -0.24868333 -1.0824614 ]",10.1083/jcb.147.3.645,"['Amino Acid Sequence', 'Animals', 'Brain', 'Cytoskeletal Proteins', 'Dystrophin', 'Dystrophin-Associated Proteins', 'Gene Deletion', 'Immune Sera', 'Membrane Proteins', 'Mice', 'Mice, Transgenic', 'Molecular Sequence Data', 'Muscle Proteins', 'Muscular Dystrophy, Duchenne', 'Nerve Tissue Proteins', 'Neuroglia', 'Neurons', 'Protein Binding', 'Protein Isoforms', 'Rats', 'Solubility', 'Synaptosomes', 'Utrophin']"
175,"[ 0.5284052   1.1385553   1.012872   -0.3200811  -1.0137978   0.70068926
  0.57695526 -1.3575048  -1.887696   -0.90988797  0.39440048  0.11671122
 -0.40493855 -1.7313814  -0.25666368 -1.5153538   1.973842    0.21373
 -0.49049243 -0.18375748 -0.8977847  -0.58106065 -0.04225023  1.2834992
 -0.26340052  0.93675655  0.10231863  0.58616245  0.10934164 -0.7655125 ]",10.1083/jcb.147.6.1261,"['Animals', 'Cell Nucleus', 'Cell Size', 'Centrosome', 'Chromosome Segregation', 'Cloning, Molecular', 'Cytoplasm', 'DNA', 'Dictyostelium', 'Dynactin Complex', 'Dyneins', 'Gene Expression', 'Genes, Essential', 'Golgi Apparatus', 'Interphase', 'Microtubule-Associated Proteins', 'Microtubules', 'Mitosis', 'Models, Biological', 'Phenotype', 'Protein Binding', 'Sequence Deletion', 'Time Factors']"
176,"[ 0.61745125  1.6330264   0.8379077  -0.5121051  -1.176768    1.242092
 -0.17988864 -0.492833   -1.7769322  -0.67146295  0.21888264 -0.22599015
 -0.1858375  -1.0861543  -0.41555324 -1.0276997   0.68489146  0.0132389
 -0.66066664  0.05857832  0.13568091 -0.30970612 -0.24396855  1.1256273
  0.39213943  0.8401288   0.07972534  0.3223518   0.16252975 -0.14944924]",10.1083/jcb.147.3.577,"['Adaptation, Physiological', 'Chemotactic Factors', 'Chemotaxis, Leukocyte', 'Environment', 'Humans', 'Interleukin-8', 'Leukotriene B4', 'Models, Biological', 'Neutrophils', 'Signal Transduction', 'Time Factors', 'Video Recording']"
177,"[ 0.14911823  1.011192    1.3108002  -0.14131871 -0.6195321   1.5167167
  1.0429336  -0.46149755 -1.8698883  -1.0225719   0.7819418   0.51651436
 -0.23832965 -1.4653938   0.43708885 -0.4217672   1.7406504   0.57929003
 -0.42020264  0.24543674  0.18859756 -0.1123951  -0.1231203   0.9395636
  0.23548119  0.9949249   0.19405308 -0.05047514 -0.23740643 -0.58635587]",10.1084/jem.191.3.475,"['ADP-ribosyl Cyclase', 'ADP-ribosyl Cyclase 1', 'Animals', 'Antibodies', 'Antigens, CD', 'Antigens, Differentiation', 'Apoptosis', 'B-Lymphocytes', 'Bone Marrow Cells', 'Gene Expression', 'Genes, bcl-2', 'Germinal Center', 'Immunization', 'Immunoglobulin Variable Region', 'Immunologic Memory', 'In Situ Nick-End Labeling', 'Membrane Glycoproteins', 'Mice', 'Mice, Inbred C57BL', 'Mice, Transgenic', 'Mutation', 'NAD+ Nucleosidase', 'Proto-Oncogene Proteins c-bcl-2']"
178,"[-0.57027787  0.7801004   1.5859078   0.07722016 -0.5737578   1.9183716
  1.2230635   0.19152534 -1.7297754  -2.069379    0.90880275  0.08969663
 -0.04668302 -1.1976506   0.8891749   0.05093867  1.8161347   0.80673236
 -0.89474285  0.66070825  0.7298506  -0.2161336  -0.08856244  0.13790858
  0.13958068  1.1810049  -0.6420757   0.3401439  -0.40996277  0.52707434]",10.1084/jem.190.9.1309,"['Animals', 'Asthma', 'Disease Models, Animal', 'Eosinophilia', 'Flow Cytometry', 'Hypersensitivity', 'Inflammation', 'Interferon-gamma', 'Interleukins', 'Lung', 'Mice', 'Mice, Knockout', 'Mucus', 'Ovalbumin', 'Receptors, Interferon', 'T-Lymphocytes, Helper-Inducer', 'Th1 Cells', 'Th2 Cells']"
179,"[ 0.8165937   1.0715601   0.30902967 -0.07598396 -0.7807936   0.71564
  0.24385594 -0.9791937  -1.3420022  -0.52273405 -0.16441414 -0.43177184
 -0.12005634 -1.0507925  -0.25737533 -1.3156037   0.7778278   0.26854634
  0.01301106 -0.64921147 -0.58695525 -0.35401258 -0.25992683  1.2863182
 -0.33273962  0.79940593  0.30642724  0.60518056 -0.22257543 -0.77467936]",10.1083/jcb.147.6.1145,"['Animals', 'Ankyrins', 'Axons', 'Cell Adhesion Molecules', 'Cell Communication', 'Galactolipids', 'Galactosyltransferases', 'Ganglioside Galactosyltransferase', 'Gene Deletion', 'Glycolipids', 'Membrane Glycoproteins', 'Mice', 'Mice, Knockout', 'Myelin Sheath', 'Nerve Growth Factors', 'Neuroglia', 'Neuropeptides', 'Potassium Channels', ""Ranvier's Nodes"", 'Sciatic Nerve', 'Sodium Channels', 'Spinal Cord']"
180,"[ 0.91961837  1.375906    0.8325826  -0.1016367  -0.9105169   0.8941008
 -0.16139781 -0.7525998  -1.4879973  -0.5591611   0.06668858 -0.38669688
  0.5665939  -1.1331179  -0.7191273  -0.9068728   1.2203805   0.39281562
 -0.5786667  -0.15515777 -0.11387043 -0.49164662 -0.31539166  1.0784794
 -0.1369057   1.0988545   0.67929566  0.02345683 -0.05658516 -0.27411538]",10.1083/jcb.148.2.325,"['Apoptosis', 'Cell Survival', 'Ciliary Neurotrophic Factor', 'Cytokines', 'Ganglia, Sensory', 'Growth Inhibitors', 'Interleukin-6', 'Leukemia Inhibitory Factor', 'Lymphokines', 'NF-kappa B', 'Neurons', 'Nodose Ganglion', 'Receptors, Cytokine', 'Trigeminal Ganglion']"
181,"[-0.04290368  0.5980447   1.7892928   0.07442922 -0.60897404  1.331221
  1.4875438  -0.2520551  -1.555939   -1.3340298   0.5856049   0.4464469
 -0.71711767 -1.4905928   0.09832321 -0.03251985  2.4403336   0.3332012
 -0.8725503   1.0694505   0.12750487 -0.1156015  -0.89534384  0.48825553
  0.07624483  0.27053118 -0.275385    0.52158123 -0.15247382 -0.6127548 ]",10.1084/jem.190.9.1241,"['Antibodies, Monoclonal', 'CD4-Positive T-Lymphocytes', 'CD8-Positive T-Lymphocytes', 'Calcium', 'Cell Line', 'Chemokines, CC', 'Chemotaxis', 'Flow Cytometry', 'Gene Expression Regulation', 'Humans', 'Intestinal Mucosa', 'Lymphocyte Activation', 'Lymphocyte Subsets', 'RNA, Messenger', 'Receptors, CCR', 'Receptors, Chemokine', 'Receptors, Lymphocyte Homing', 'T-Lymphocytes', 'Thymus Gland', 'Transfection']"
182,"[ 0.47342396  1.0073289   0.42714664 -0.65961736 -1.0266169   0.66153294
  0.39185193 -0.9023093  -1.4041888  -0.6323906   0.04606064 -0.5333148
 -0.36510462 -0.6635188  -1.1105753  -1.9277973   1.1899582   0.00786327
 -0.88370293 -0.45682895 -0.52135164 -0.410059   -0.6710006   0.7947737
  0.05913728  0.73828924  0.27605268  0.65679497 -0.33615825 -0.6784068 ]",10.1083/jcb.147.3.471,"['Amino Acid Sequence', 'Anaphase', 'Animals', 'Antibodies, Monoclonal', 'Caenorhabditis elegans', 'Caenorhabditis elegans Proteins', 'Centromere', 'Chromosomal Proteins, Non-Histone', 'Chromosome Segregation', 'Cloning, Molecular', 'Epitopes', 'Fluorescent Antibody Technique', 'Helminth Proteins', 'Histones', 'Kinetochores', 'Meiosis', 'Metaphase', 'Mice', 'Mitosis', 'Molecular Sequence Data', 'Mutation', 'Sequence Alignment', 'Time Factors']"
183,"[ 0.47071782  1.8176068  -0.15989605 -0.4681647  -1.3250046   0.9917345
  0.02905471 -1.5506177  -1.2410474  -0.12961237 -0.99721116 -0.99879026
 -0.21046938 -0.7992137  -1.209729   -2.0627975   1.0836052  -0.17594992
 -1.5439973  -1.1169232  -0.97332484 -1.0869501  -0.6573428   1.9274904
 -0.3492266   0.5021059   0.5683838   0.8394881  -0.26099846 -1.4977266 ]",10.1083/jcb.147.4.761,"['Alleles', 'Amino Acid Sequence', 'Base Sequence', 'Cell Line', 'DNA', 'DNA Primers', 'Humans', 'Membrane Proteins', 'Molecular Sequence Data', 'Mutation', 'Open Reading Frames', 'Peroxins', 'Peroxisomal Disorders', 'Peroxisome-Targeting Signal 1 Receptor', 'Peroxisomes', 'Point Mutation', 'Protein Binding', 'Protein Biosynthesis', 'Receptors, Cytoplasmic and Nuclear', 'Recombinant Proteins', 'Repetitive Sequences, Amino Acid', 'Repetitive Sequences, Nucleic Acid', 'Skin', 'Transfection', 'Zellweger Syndrome']"
184,"[ 0.5579043   1.3563048  -0.3442237  -0.9425591  -0.8439707   1.4862691
  1.2193253  -1.2974478  -1.83011    -0.7115315  -0.25780943 -0.81486356
  0.23058152 -0.626941   -0.50785834 -1.9805623   1.2722169  -0.5302568
 -0.96346986 -0.3130075  -0.8954272  -0.9455682  -0.53188086  1.8529141
 -0.4428581   1.2562048   0.5567562   0.9778152  -0.23113666 -0.01000575]",10.1083/jcb.147.2.417,"['Actins', 'Antigens, Surface', 'Cell Line, Transformed', 'Desmosomes', 'Humans', 'Immunohistochemistry', 'Integrin alpha6beta4', 'Integrins', 'Intermediate Filament Proteins', 'Intermediate Filaments', 'Keratinocytes', 'Plectin', 'Protein Binding', 'Transfection']"
185,"[ 0.40695694  1.5334967   0.88862604 -0.76996934 -1.1853758   1.1663451
  0.46116242 -0.1916105  -1.8869516  -0.62792206  0.11331764 -0.88405037
 -0.13394324 -1.3873668  -0.99365866 -1.3838379   1.5136752  -0.17752394
 -1.3929746   0.2933976  -0.03961413 -0.6834379  -0.11574399  1.077807
  0.5156919   0.5976419   0.22905378  0.5823949   0.25214866 -0.37836462]",10.1083/jcb.148.5.1047,"['Actins', 'Adaptor Proteins, Signal Transducing', 'Alternative Splicing', 'Animals', 'Carrier Proteins', 'Cell Adhesion Molecules', 'Cell Differentiation', 'Cytoskeletal Proteins', 'Cytoskeleton', 'Dynamin I', 'Dynamins', 'Endocytosis', 'GTP Phosphohydrolases', 'HeLa Cells', 'Humans', 'Molecular Sequence Data', 'Nerve Growth Factor', 'Nerve Tissue Proteins', 'Organ Specificity', 'PC12 Cells', 'Phosphoproteins', 'Protein Binding', 'Protein Isoforms', 'Proteins', 'Rats', 'Sequence Homology, Amino Acid', 'Wiskott-Aldrich Syndrome Protein, Neuronal', 'src Homology Domains']"
186,"[-0.36287498  0.9744933   1.8015888   0.0911032  -0.7782863   1.5556325
  0.75832736 -0.16363384 -1.3710628  -1.9703258   0.75346047  0.8265274
 -0.34538665 -1.0640999   0.21648431 -0.11080904  1.7015886   0.6359339
 -0.65450966  0.9300322   1.0002663  -0.41986236 -0.45208594  0.44447577
 -0.16201006  0.54323477 -0.22921245 -0.10672391  0.08995704 -0.3130848 ]",10.1084/jem.191.3.423,"['Animals', 'Antigen-Presenting Cells', 'Apoptosis', 'CD4-Positive T-Lymphocytes', 'CD8-Positive T-Lymphocytes', 'Cell Line', 'Culture Media', 'Dendritic Cells', 'Humans', 'Immune Tolerance', 'Lymphocyte Activation', 'Mice', 'Necrosis', 'Neoplasms', 'Phagocytosis', 'Phenotype', 'Signal Transduction', 'Tumor Cells, Cultured', 'Ultraviolet Rays']"
187,"[ 0.5415128   1.3693111   0.33522516 -0.5196763  -1.13225     0.6437218
  0.18412036 -0.8588824  -1.1932471  -0.5644625  -0.22273794 -0.4532168
  0.01819785 -0.80984914 -0.84951705 -1.5484977   1.0470021  -0.10630985
 -1.0683006  -0.26937556 -0.3455959  -0.935648   -0.38168234  0.96146345
 -0.34187564  0.92485917  0.32241485  0.7279897   0.08589917 -0.63490903]",10.1083/jcb.148.5.871,"['Calcium-Binding Proteins', 'Carrier Proteins', 'Cdc20 Proteins', 'Cell Cycle Proteins', 'Cloning, Molecular', 'Fungal Proteins', 'Genes, cdc', 'Mad2 Proteins', 'Molecular Sequence Data', 'Mutagenesis, Site-Directed', 'Nuclear Proteins', 'Precipitin Tests', 'Protein Kinases', 'Protein Serine-Threonine Kinases', 'Protein Structure, Tertiary', 'Proteins', 'Saccharomyces cerevisiae Proteins', 'Saccharomycetales', 'Sequence Homology, Amino Acid', 'Spindle Apparatus', 'Two-Hybrid System Techniques']"
188,"[ 0.7104159   0.80502564  2.224544    0.2663004  -1.237377    0.3516338
 -0.41681474 -1.0669025  -2.0071836  -1.2274636   0.66700584  0.24374115
  0.06446921 -1.6763778  -1.0490345  -0.49252552  1.0036632   0.09031793
 -1.4286004   0.40515092  0.09344117 -1.1275611   0.0710161   0.31881803
  0.43057114  0.90284777  0.3010714   0.18881945  0.96471745  0.17737749]",10.1083/jcb.147.3.545,"['Animals', 'Apoptosis', 'Caspase 3', 'Caspase Inhibitors', 'Caspases', 'Cell Division', 'Cell Line', 'Cell Survival', 'Cytosol', 'DNA', 'Enzyme Activation', 'Humans', 'Lysophospholipids', 'Mice', 'Peptide Hydrolases', 'Pertussis Toxin', 'Phosphotransferases (Alcohol Group Acceptor)', 'Platelet-Derived Growth Factor', 'Receptors, Cell Surface', 'Receptors, G-Protein-Coupled', 'Receptors, Lysophospholipid', 'Recombinant Fusion Proteins', 'Second Messenger Systems', 'Sphingosine', 'Transfection', 'Virulence Factors, Bordetella', 'fas Receptor']"
189,"[-1.1294984   0.91500187  2.6410322   0.38870105 -0.29360402  1.5878155
  2.317105   -0.38365245 -1.3529544  -3.2293139   1.1807549   1.6768477
 -0.51847005 -1.8665468   0.761872    0.60099626  3.2324116   1.0746405
 -0.4430879   2.0800931   1.0927521   0.15999155 -0.21846478  0.05655339
 -1.1021984   0.45181578 -0.39259994 -0.21269947 -0.1479809  -0.7820805 ]",10.1084/jem.191.3.435,"['Animals', 'Antigen-Presenting Cells', 'Apoptosis', 'Cells, Cultured', 'DNA Fragmentation', 'Dendritic Cells', 'Epithelial Cells', 'Immune Tolerance', 'Immunohistochemistry', 'In Situ Nick-End Labeling', 'Intestines', 'Lymph Node Excision', 'Lymph Nodes', 'Mesentery', 'Microscopy, Confocal', 'Rats', 'T-Lymphocytes']"
190,"[ 1.1562608   1.9780517   0.18905249  0.1555386  -1.3516275   0.6885214
  0.07398181 -2.5217738  -2.1473827  -0.312698   -0.937164   -0.43027985
 -0.62979513 -1.091344   -1.2128806  -2.652147    1.045849   -0.00690574
 -0.1257384  -1.5757747  -2.0265863  -0.32081592  0.04838942  1.6717938
 -0.4958153   0.67366964  0.5874844   1.2582455  -0.6699614  -2.5878315 ]",10.1083/jcb.149.1.55,"['Alleles', 'Biological Transport', 'Cell Membrane', 'Cytoplasmic Granules', 'Endoplasmic Reticulum', 'Fungal Proteins', 'Genes, Fungal', 'Golgi Apparatus', 'Intracellular Membranes', 'Membrane Fusion', 'Membrane Proteins', 'Mutation', 'Recombinant Fusion Proteins', 'SNARE Proteins', 'Saccharomyces cerevisiae', 'Saccharomyces cerevisiae Proteins', 'Temperature', 'Vesicular Transport Proteins', 'rab GTP-Binding Proteins']"
191,"[-0.67586714  1.7351124   2.1706269   0.3207155  -0.11242436  1.0861423
  2.678148   -0.5644466  -0.74457973 -0.544244    0.5872202  -1.565236
  1.3561243  -1.4608078  -0.95652646 -0.2274334   2.473613   -0.94894016
 -3.4514992   1.2664948   0.22083016 -0.11231043 -0.03441796 -1.0826983
 -0.43405277  1.0707735  -0.6982649   0.34273955  0.45528448  1.2133298 ]",10.1083/jcb.147.3.619,"['Actinin', 'Actins', 'Arteries', 'Calpain', 'Cell Adhesion', 'Cell Adhesion Molecules', 'Cell Size', 'Cells, Cultured', 'Collagen', 'Collagenases', 'Crk-Associated Substrate Protein', 'Cytoplasm', 'Cytoskeletal Proteins', 'Cytoskeleton', 'Focal Adhesion Kinase 1', 'Focal Adhesion Protein-Tyrosine Kinases', 'Humans', 'Infant, Newborn', 'Integrins', 'Matrix Metalloproteinase Inhibitors', 'Matrix Metalloproteinases', 'Molecular Weight', 'Muscle, Smooth, Vascular', 'Paxillin', 'Peptide Fragments', 'Phosphoproteins', 'Protein Processing, Post-Translational', 'Protein-Tyrosine Kinases', 'Proteins', 'Receptors, Collagen', 'Retinoblastoma-Like Protein p130', 'Talin', 'Vinculin']"
192,"[ 1.1614888   1.8459053   0.07751311 -0.7272375  -1.2038507   0.9695863
 -0.6111437  -1.2602737  -1.8676261  -0.15797697 -0.5545992  -0.600119
 -0.03761644 -0.6583717  -1.2953389  -2.2657325   0.8455877  -0.14027062
 -0.78005594 -0.43232337 -0.9421586  -1.1490602   0.01526874  1.5816889
  0.0810758   0.7903548   0.55150914  1.2957519   0.207554   -0.7148024 ]",10.1083/jcb.147.4.791,"['Alleles', 'Amino Acid Sequence', 'Amino Acid Substitution', 'Animals', 'Cell Polarity', 'Consensus Sequence', 'Cytoplasmic Granules', 'Dictyostelium', 'Evolution, Molecular', 'Fungal Proteins', 'Genotype', 'Molecular Sequence Data', 'Mutagenesis, Site-Directed', 'Myosin Heavy Chains', 'Myosin Type II', 'Myosin Type V', 'Myosins', 'Phylogeny', 'Recombinant Proteins', 'Saccharomyces cerevisiae', 'Saccharomyces cerevisiae Proteins', 'Schizosaccharomyces', 'Schizosaccharomyces pombe Proteins', 'Sequence Alignment', 'Sequence Homology, Amino Acid', 'Vacuoles']"
193,"[ 0.5499316   1.1120499   0.95958954  0.20633109 -1.2925595   0.6161274
  0.5687851  -1.7520145  -1.6663104  -1.2122272  -0.15158343 -0.6514326
 -0.44596034 -1.4120812  -0.74832433 -1.6699239   1.0325208  -0.07737784
 -0.68477535 -0.733036   -1.5532464  -0.77778083 -0.31347978  1.2771289
 -0.6741709   0.6226399   0.3492995   0.4443118  -0.64599204 -1.1703238 ]",10.1083/jcb.147.3.519,"['Animals', 'Animals, Genetically Modified', 'Axonal Transport', 'Caenorhabditis elegans', 'Caenorhabditis elegans Proteins', 'Calcium-Binding Proteins', 'Cilia', 'Dendrites', 'Dyneins', 'Flagella', 'Genes, Helminth', 'Helminth Proteins', 'Kinesins', 'Kinetics', 'Microscopy, Fluorescence', 'Molecular Motor Proteins', 'Molecular Sequence Data', 'Muscle Proteins', 'Mutation', 'Neurons, Afferent', 'Neuropeptides', 'Phenotype', 'Recombinant Fusion Proteins']"
194,"[ 0.76841146  1.0584922   1.195753    0.10814994 -0.7244854   0.81886405
  0.57200515 -1.0531495  -1.928774   -1.1995839   0.41747105 -0.25264746
 -0.02609541 -1.54618    -0.14131132 -0.9173768   1.4381251   0.45758927
 -0.27438536 -0.165022   -0.71677357 -0.12916479 -0.25731733  1.0899806
 -0.24657585  0.9079086  -0.06617232  0.41855353 -0.03984213 -0.72480303]",10.1084/jem.190.12.1769,"['Animals', 'Cell Movement', 'E-Selectin', 'Gene Deletion', 'Gene Targeting', 'Ligands', 'Membrane Glycoproteins', 'Mice', 'Mice, Inbred C57BL', 'Neutrophils', 'P-Selectin', 'Signal Transduction']"
195,"[ 1.584311    1.7162244   0.0642213  -0.8051313  -1.4849021   0.87384456
 -0.7540329  -1.2917814  -1.7534312  -0.10422158 -0.43814072  0.07938716
 -0.02528903 -0.8240247  -0.799346   -1.8620164   0.07498033  0.5366303
 -0.45163175 -1.1583331   0.08055563 -1.1813245  -0.51973855  1.3036457
  0.12171639  1.2712399   0.6328219   0.63395846  0.26048303 -1.4214376 ]",10.1083/jcb.148.4.703,"['Amino Acid Sequence', 'Animals', 'Animals, Genetically Modified', 'Apoptosis', 'Caspase Inhibitors', 'Caspases', 'Cell Survival', 'Cells, Cultured', 'Cloning, Molecular', 'Drosophila Proteins', 'Drosophila melanogaster', 'Epistasis, Genetic', 'Gene Expression', 'Genes, Insect', 'Inhibitor of Apoptosis Proteins', 'Insect Proteins', 'Molecular Sequence Data', 'Mutation', 'Protein Binding', 'Protein Structure, Tertiary', 'Proteins', 'Proto-Oncogene Proteins c-bcl-2', 'RNA, Double-Stranded', 'RNA, Messenger', 'Sequence Homology, Amino Acid', 'Viral Proteins']"
196,"[ 6.3488942e-01  1.7078080e+00  8.2774323e-01 -6.3685429e-01
 -1.4574063e+00  6.6404027e-01 -9.2208222e-02 -1.2774332e+00
 -1.6194030e+00  2.0105578e-03 -5.0124580e-01 -7.7362746e-01
 -4.7256956e-01 -8.2094276e-01 -1.5331511e+00 -2.2881255e+00
  9.7470212e-01 -3.3793297e-01 -1.4628031e+00 -7.9390085e-01
 -8.8599342e-01 -1.0045056e+00 -4.3389302e-01  9.1705251e-01
  1.9361836e-01  8.9938390e-01  4.6258608e-01  1.0910068e+00
  1.0113988e-01 -1.4282051e+00]",10.1083/jcb.147.4.729,"['Adaptor Proteins, Vesicular Transport', 'Amino Acid Sequence', 'Binding Sites', 'Carrier Proteins', 'Cell Fractionation', 'Cloning, Molecular', 'Fungal Proteins', 'Gene Deletion', 'Genotype', 'Golgi Apparatus', 'Membrane Proteins', 'Molecular Sequence Data', 'Plasmids', 'Protein Binding', 'Recombinant Proteins', 'Restriction Mapping', 'Saccharomyces cerevisiae', 'Saccharomyces cerevisiae Proteins', 'Vesicular Transport Proteins']"
197,"[-0.5408064   0.6547404   2.1619606   0.16127925 -0.48025376  1.5779963
  1.3689991   0.03331776 -1.4026992  -2.0280645   0.90155584  0.6270269
 -0.24927963 -1.3647645   0.38267922 -0.12265915  2.3792672   0.53346956
 -0.69359285  1.3534688   1.0990225   0.10720751 -0.04640772  0.3451325
 -0.14882024  0.6041562  -0.06545153 -0.19199954 -0.02123891 -0.24448015]",10.1084/jem.191.2.225,"['Animals', 'Animals, Newborn', 'Antigen Presentation', 'Antigen-Presenting Cells', 'CD4-Positive T-Lymphocytes', 'CD40 Ligand', 'CD8-Positive T-Lymphocytes', 'Diabetes Mellitus, Type 1', 'Female', 'Histocompatibility Antigens Class II', 'Humans', 'Infant, Newborn', 'Male', 'Membrane Glycoproteins', 'Mice', 'Mice, Inbred NOD', 'Mice, Knockout', 'Mice, Transgenic', 'Nuclear Proteins', 'Signal Transduction', 'Trans-Activators', 'Tumor Necrosis Factor-alpha', 'beta 2-Microglobulin']"
198,"[ 0.7915143   1.9704757   1.0901308  -0.6105018  -1.5193374   1.620959
  0.03356817 -0.03900295 -2.0195787  -0.8477649   0.1212168  -0.30629414
 -0.28800213 -1.0780783  -0.6023685  -0.91295063  1.003435    0.15434638
 -0.8121045  -0.03986438  0.7720818   0.28992176 -0.09797623  0.9748738
  0.67466646  0.90511394  0.11234462  0.21526065  0.32595828 -0.35224742]",10.1083/jcb.148.1.203,"['Antigens, CD', 'Cadherins', 'Cell Movement', 'Cells, Cultured', 'Cytoskeletal Proteins', 'Endothelium, Vascular', 'Humans', 'Lipopolysaccharide Receptors', 'Monocytes', 'Platelet Endothelial Cell Adhesion Molecule-1', 'Staining and Labeling', 'Trans-Activators', 'U937 Cells', 'alpha Catenin', 'beta Catenin']"
199,"[-0.92323446  1.4041618   2.4293516  -0.4529911   0.0490621   0.5676793
  2.4270253   0.2885438  -1.7972685  -1.7258786  -0.17733666 -0.37479138
  0.6985789  -1.5753723  -0.5904477  -1.3264086   2.1829798   0.3347303
 -1.1294047   0.7387127  -1.4412043  -0.1549575  -0.06925473  0.89158386
 -1.1370317   1.4790164   0.44539088 -0.16890694 -0.23504034  0.26996347]",10.1016/S0002-9440(10)64753-0,"['Adolescent', 'Adult', 'Aged', 'Alzheimer Disease', 'Brain', 'Child', 'Clusterin', 'Complement C4', 'Complement C4b', 'Complement Membrane Attack Complex', 'Complement System Proteins', 'Disease Progression', 'Down Syndrome', 'Glycoproteins', 'Humans', 'Middle Aged', 'Molecular Chaperones', 'Peptide Fragments', 'Plaque, Amyloid', 'Time Factors']"
200,"[-0.09335654 -0.28522792  0.51506454  0.17682661  0.1638029   0.91779745
  0.0965417   0.40896618 -1.5284994   0.09729353  0.98953074  0.01570691
 -0.16671972 -0.90026736 -0.16892886 -0.36417982  0.6071301   1.1533045
 -1.0819902   0.54847986 -0.11429179 -0.24517809 -0.01146179  1.2547852
 -0.08458553  0.617374   -0.05375003  0.1304953  -0.01471476 -0.8941908 ]",10.1016/j.amepre.2015.03.033,"['Centers for Disease Control and Prevention, U.S.', 'Evidence-Based Medicine', 'Family Planning Services', 'Humans', 'Practice Guidelines as Topic', 'United States', 'United States Dept. of Health and Human Services']"
201,"[-0.38950786 -0.39089754  0.6577505   0.06241786  0.11330637  0.58593434
  0.34981215  0.23725751 -1.625102   -0.14997157  0.8508325  -0.22557288
 -0.09837759 -1.1493422   0.02148976 -0.32063454  0.45902792  0.9249534
 -1.0843219   0.31104302 -0.22955626 -0.01619481 -0.28454977  1.2858721
 -0.18368725  0.4701368   0.00969855  0.29412293 -0.02937552 -0.8020393 ]",10.1016/j.amepre.2015.03.006,"['Centers for Disease Control and Prevention, U.S.', 'Cooperative Behavior', 'Family Planning Services', 'Humans', 'Male', ""Men's Health"", 'Practice Guidelines as Topic', 'Reproductive Health', 'Sexual Behavior', 'United States', 'United States Dept. of Health and Human Services']"
202,"[ 0.22950333 -0.31141213  0.67741734 -0.09110796  0.3258581   1.2413461
  0.06735425  0.7089294  -1.4418354   0.21622993  1.1441711   0.03060787
 -0.18336885 -0.8291759  -0.5418461  -0.38895884  0.5677831   1.5114621
 -1.2672074   1.0658412  -0.02134671 -0.3192071  -0.1953409   1.3438232
  0.2050221   0.98330575  0.13278235 -0.12276644  0.02166565 -0.9362981 ]",10.1002/cyto.a.22571,"['Animals', 'Automation, Laboratory', 'Biological Assay', 'Embryo Culture Techniques', 'Microfluidic Analytical Techniques', 'Xenopus', 'Zebrafish']"
203,"[-0.25513285 -0.14481713  0.47515097  0.00270495  0.07134492  0.46780482
  0.21735482  0.24493156 -1.1078701  -0.11915466  0.6617578  -0.16838007
 -0.13948002 -0.78984165  0.01122177 -0.29594547  0.45970997  0.9652348
 -0.74806374  0.4239495  -0.18727212 -0.05241055 -0.26532874  0.9267078
 -0.10974313  0.2594134   0.01374535  0.25590643  0.01503652 -0.76145333]",10.1016/j.amepre.2015.03.022,"['Adolescent', 'Clinical Trials as Topic', 'Communication', 'Evidence-Based Practice', 'Family Planning Services', 'Female', 'Humans', 'Parent-Child Relations', 'Pregnancy', 'Pregnancy in Adolescence', 'Program Evaluation', 'Reproductive Health', 'Risk-Taking', 'Sexual Behavior', 'United States']"
204,"[-0.04744193 -0.07692311  0.14776906  0.0184381   0.04828183  0.18766753
  0.07937502  0.09462303 -0.32763082 -0.02114893  0.19736564 -0.02840604
 -0.04566896 -0.1912197  -0.01067612 -0.09742195  0.10095302  0.2860817
 -0.23012258  0.16608714 -0.08216984 -0.03360793 -0.10369395  0.23983026
 -0.02958343  0.14364105  0.02843599  0.06010331  0.04690241 -0.20852701]",10.1001/jamaneurol.2014.405,"['Epilepsy', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Retrospective Studies']"
205,"[-0.02793532 -0.06507807  0.19636486  0.0384242   0.02647753  0.2071746
  0.07066482  0.16919672 -0.40808502 -0.06139811  0.27413714 -0.05077342
 -0.04855369 -0.23248857  0.05060127 -0.12438408  0.16053495  0.33429286
 -0.26308408  0.22990415 -0.08918262 -0.02807177 -0.1119387   0.27965105
 -0.03274474  0.13542376  0.07686818  0.08523689  0.03073543 -0.29421276]",10.1080/14764172.2016.1191647,[]
206,"[ 0.72450405 -0.34704217  0.02304734 -0.2882363  -0.25787807  1.6238204
 -0.19554128  0.6714909  -1.0848768   0.8334299   1.1529769   0.18415812
 -0.04462947 -0.11240958 -0.747885    0.14721476  0.32590598  1.3025289
 -1.0131757   1.410717   -0.92248195 -0.45636487 -0.12580684  0.4148575
  0.3776962   0.9402548   0.33896178 -0.40718144  0.41571924 -0.7749784 ]",10.1016/j.bpj.2012.01.034,"['Animals', 'Heart Ventricles', 'Membrane Proteins', 'Microscopy', 'Myocytes, Cardiac', 'Nanotechnology', 'Protein Transport', 'Rats', 'Ryanodine Receptor Calcium Release Channel']"
207,"[-0.12826192 -0.50717294  0.51340955  0.10030647  0.43454176  2.318047
  0.00419823  0.6614224  -1.815421    0.60727173  1.0004863  -0.13953508
  0.09955964 -0.71696573 -0.97457653 -0.44916865  0.8182496   1.3794191
 -1.468821    1.2353815  -0.5604384  -0.30430967  0.08599101  0.936494
  0.15479037  1.7932323   0.03858854 -0.19031261  0.02101391 -1.3546585 ]",10.1039/c4sm00875h,[]
208,"[-0.08683592  0.3317873   1.994207    0.11286347  0.18160883  0.50178945
  0.90763456  1.5446684  -2.1601603  -1.5348384   0.5398083  -0.9945271
 -0.912873   -1.2511737   0.28345665 -0.956679    0.82164556  2.8659701
 -1.0903071   2.3732424  -0.914793    0.7891786  -1.9733354   0.06672654
 -0.4734269  -0.01915875  0.9380784   1.5508219   1.265398   -2.3755908 ]",10.1016/j.freeradbiomed.2017.08.020,"['AMP-Activated Protein Kinases', 'Adenosine Triphosphate', 'Apoptosis', 'Basic Helix-Loop-Helix Transcription Factors', 'Beclin-1', 'Benzo(a)pyrene', 'Carcinogens', 'Cell Line, Transformed', 'Cytochrome P-450 CYP1B1', 'Dose-Response Relationship, Drug', 'Humans', 'Keratinocytes', 'Membrane Potential, Mitochondrial', 'Mitochondria', 'Mitophagy', 'Oxygen Consumption', 'Reactive Oxygen Species', 'Receptors, Aryl Hydrocarbon', 'Superoxide Dismutase', 'TOR Serine-Threonine Kinases']"
209,"[-0.17637601 -0.25712633  0.4698822   0.03765211  0.12240224  0.47485447
  0.18839513  0.27494332 -0.9899972  -0.05372672  0.51150846 -0.08024336
 -0.10997803 -0.5752276  -0.05667659 -0.2457592   0.31692314  0.73779714
 -0.6675824   0.45325455 -0.22071604  0.0063976  -0.29408556  0.6761647
 -0.04119706  0.3647115   0.06449831  0.18972076  0.14832276 -0.62616277]",10.1016/j.jsr.2016.12.003,"['Awareness', 'Education, Distance', 'Education, Nursing', 'National Institute for Occupational Safety and Health, U.S.', 'Students, Nursing', 'United States', 'Workplace Violence']"
210,"[-6.1806291e-02 -6.6499017e-02  1.7280406e-01  2.6045544e-02
  3.4291919e-02  1.3571304e-01  1.0761834e-01  1.1560888e-01
 -3.5849085e-01 -7.1566336e-02  1.8590677e-01 -7.9679124e-02
 -3.9725855e-02 -1.9126502e-01  3.7885930e-02 -1.2337322e-01
  1.4577577e-01  3.5646442e-01 -2.1681197e-01  2.4094290e-01
 -1.3052249e-01 -3.5106431e-04 -1.7849928e-01  2.0455849e-01
 -4.0856097e-02  7.6029785e-02  8.8379420e-02  1.1863612e-01
  6.1399553e-02 -3.1992602e-01]",10.1007/s12593-015-0173-7,[]
211,"[ 0.29726127 -0.37142265  0.41462436  0.00833448 -0.0855111   1.3389149
 -0.03728528  0.83482444 -1.4304924   0.41561434  1.3362956   0.04156747
 -0.08906372 -0.5337087  -0.61507094 -0.41239694  0.52730596  1.6156895
 -1.2596333   1.5594535  -0.5297401  -0.26726657 -0.37965134  0.9465238
  0.17934525  0.9077139   0.15405032 -0.08020397  0.20802805 -1.2811905 ]",10.1016/j.bpj.2013.04.029,"['Animals', 'Imaging, Three-Dimensional', 'Microscopy, Confocal', 'Molecular Imaging', 'Muscle Fibers, Skeletal', 'Rats', 'Sarcolemma']"
212,"[-0.02916403 -0.23731011  0.47098482 -0.02101795  0.1662173   0.6228978
  0.26226538  0.36427033 -1.1184162  -0.02817666  0.6478876  -0.17428382
 -0.13246472 -0.6245927  -0.05588028 -0.334286    0.4402371   1.0807678
 -0.8318263   0.79377115 -0.37667993  0.00877565 -0.47463924  0.68584394
 -0.06571283  0.47102052  0.1260795   0.26028493  0.15600656 -0.9002821 ]",10.1093/ofid/ofv027,[]
213,"[ 0.57425225 -0.44056982 -0.17103314 -0.14062051 -0.1492488   1.718496
 -0.42461786  1.2481308  -1.0276762   0.4079053   1.5132933  -0.23774393
 -0.16737771 -0.6745164  -1.3085082  -0.43174338  0.86472034  2.1729553
 -1.7067431   2.0445948  -0.7200706  -0.28990504 -0.12384787  1.1664653
  0.3520034   1.0951741  -0.02389998 -0.2749894  -0.08345735 -1.5093503 ]",10.1371/journal.ppat.1004793,"['Chromatin Immunoprecipitation', 'Electroporation', 'Francisella tularensis', 'Gene Expression Regulation, Bacterial', 'Genes, Bacterial', 'High-Throughput Nucleotide Sequencing', 'Immunoblotting', 'Promoter Regions, Genetic', 'Transcription Factors', 'Virulence']"
214,"[ 0.82037675 -0.51649827  0.25241578 -0.13804758 -0.03429662  1.9649318
 -0.1704764   0.9574394  -1.6042439   1.0103153   1.5548966   0.24407168
 -0.14331414 -0.20059988 -0.8152649  -0.14624658  0.4938565   1.7458012
 -1.3046504   1.7581391  -0.9232132  -0.3530534  -0.28603548  0.7251999
  0.21623261  1.3280491   0.38595852 -0.44728017  0.49480602 -0.9930832 ]",10.1016/j.bpj.2009.08.036,"['Animals', 'Caveolin 3', 'Cells, Cultured', 'Fluorescence', 'Heart Ventricles', 'Immunohistochemistry', 'Intercellular Junctions', 'Microscopy, Confocal', 'Microscopy, Fluorescence', 'Myocytes, Cardiac', 'Rats', 'Ryanodine Receptor Calcium Release Channel', 'Sarcolemma', 'Sodium-Calcium Exchanger']"
215,"[ 0.01953387 -0.12127265  0.22486596  0.00516445  0.05189804  0.30842257
  0.07818063  0.1999442  -0.4616781   0.03227346  0.3204284  -0.05163365
 -0.0706386  -0.24025892 -0.06149547 -0.1382368   0.21035294  0.4419541
 -0.34749     0.36059216 -0.12657571 -0.02075189 -0.15753669  0.28738812
 -0.00723141  0.26901668  0.0660632   0.06144931  0.03270722 -0.33157036]",Unknown,"['Aged', 'Aged, 80 and over', 'Biomarkers', 'Education, Continuing', 'Female', 'Fractures, Bone', 'Humans', 'Inflammation', 'Inflammation Mediators', 'Middle Aged', 'Osteoporosis', 'Risk Factors']"
216,"[ 2.6482090e-01 -3.6400494e-01  3.8881874e-01 -1.2599553e-01
  9.2346139e-02  1.0219947e+00  5.4018607e-04  6.3622874e-01
 -1.3788223e+00  2.6484835e-01  1.2713991e+00 -1.7217007e-01
 -1.0177887e-01 -7.1109813e-01 -6.3190395e-01 -4.3254972e-01
  5.1107532e-01  1.6072608e+00 -1.1564149e+00  1.3184495e+00
 -4.8078758e-01 -2.0422447e-01 -3.6809006e-01  9.0379852e-01
  1.5120660e-01  8.2702124e-01  1.6601622e-01 -7.5895956e-04
  1.6706507e-01 -1.2230566e+00]",10.1016/j.bpj.2008.11.002,"['Antibodies', 'Fluorescence', 'Fluorescent Dyes', 'Image Processing, Computer-Assisted', 'Light', 'Luminescent Measurements', 'Microscopy, Fluorescence', 'Models, Theoretical', 'Photobleaching']"
217,"[ 0.11135651 -0.28593436  0.9613176   0.04097004  0.38973773  1.3783007
  0.06414253  0.7537893  -1.5635622   0.15872735  1.0376582  -0.04911438
 -0.26006514 -0.7528313  -0.34590706 -0.55572724  0.53733426  1.4592988
 -1.2659612   1.1871928  -0.13268353 -0.2068634  -0.49141428  1.1969647
  0.30652705  1.1080871   0.16071463  0.08140634  0.2504604  -1.0481117 ]",10.1146/annurev-bioeng-071811-150114,"['Animals', 'Bioelectric Energy Sources', 'Biomedical Engineering', 'Cell Communication', 'Cell Differentiation', 'Cell Movement', 'Cell Proliferation', 'Electric Impedance', 'Epigenesis, Genetic', 'Gap Junctions', 'Humans', 'Neoplasms', 'Regeneration', 'Tissue Engineering']"
218,"[-0.02867897 -0.05309433  0.18853644  0.01544205  0.0407684   0.19815366
  0.08270811  0.148295   -0.37385505 -0.01973092  0.20174737 -0.03333656
 -0.05223364 -0.2296583   0.0300192  -0.11146902  0.12367252  0.31418443
 -0.263426    0.21449353 -0.07886614 -0.0146276  -0.11360076  0.23667605
 -0.0260222   0.1394914   0.06566085  0.09715401  0.01998806 -0.2561191 ]",10.1080/14764172.2016.1197401,[]
219,"[ 0.23919739 -0.52547365  0.46422905 -0.17472377  0.09285586  1.3972557
  0.05592318  0.5675467  -1.5471001   0.61728823  1.3443472   0.17153825
 -0.0060895  -0.444571   -0.7531489  -0.20339032  0.38457525  1.5263791
 -1.2769814   1.3600173  -0.70701534 -0.19121613 -0.42840207  0.90160084
  0.19362426  0.91281533  0.16810253 -0.18785834  0.31013888 -1.0773975 ]",10.1016/j.celrep.2017.12.045,"['Calcium Signaling', 'Cluster Analysis', 'Humans', 'Ryanodine Receptor Calcium Release Channel']"
220,"[ 0.18561447 -0.3889003   0.50159657 -0.0862703   0.22737463  1.1587096
 -0.01231244  0.56411666 -1.3057709   0.31729978  0.98998576 -0.10006135
 -0.03566752 -0.59969044 -0.46256325 -0.33913696  0.49156222  1.3491242
 -1.0666226   0.9451012  -0.06366867 -0.2260423  -0.33761978  0.92416286
  0.1424986   0.9108438   0.12081052  0.02160826  0.08228566 -0.88709575]",10.1039/c8bm00726h,"['Animals', 'Camptothecin', 'Cell Line, Tumor', 'Cell Transformation, Neoplastic', 'Drug Delivery Systems', 'Fluorocarbons', 'Folic Acid', 'Humans', 'Magnetite Nanoparticles', 'Mice', 'Mice, Nude', 'Molecular Imaging', 'Nanostructures', 'Theranostic Nanomedicine', 'Tissue Distribution', 'Ultrasonic Waves']"
221,"[ 0.02850271 -0.27991024  0.4257721   0.07519475  0.14640015  0.7331333
  0.1787974   0.43720436 -1.043437    0.05031959  0.7772663  -0.08437862
 -0.13236842 -0.5851901  -0.18734606 -0.3686604   0.3959725   1.022426
 -0.8016658   0.68824637 -0.19809024 -0.08408297 -0.28122628  0.83320844
  0.01297528  0.5245665   0.13225242  0.11748703  0.00393831 -0.73840094]",10.1039/c9tx00002j,[]
222,"[-0.01077669 -0.04170967  0.15462154  0.00691927  0.05128442  0.15351667
  0.09511327  0.09499506 -0.28867286 -0.03436824  0.16562219 -0.00859991
 -0.03942637 -0.159586   -0.01211768 -0.09411574  0.10630485  0.25775555
 -0.1897674   0.2055809  -0.10554583  0.00065662 -0.09459551  0.17219801
 -0.01916892  0.10153517  0.04016769  0.06269407  0.04165871 -0.2272346 ]",10.1093/ofid/ofz221,[]
223,"[-0.005841   -0.13312344  0.32325715  0.03071107  0.1053265   0.41530037
  0.15362486  0.18943772 -0.71864223  0.00382866  0.37058887 -0.08858065
 -0.10447001 -0.36648548 -0.02858283 -0.19649728  0.26386145  0.5667762
 -0.43512788  0.4152791  -0.20861836  0.00928109 -0.28275093  0.30285683
 -0.04849785  0.32642487  0.07731688  0.17014284  0.14073971 -0.4862217 ]",10.1016/j.jaip.2016.03.008,"['Adult', 'Aged', 'Anti-Bacterial Agents', 'Cephalosporins', 'Female', 'Humans', 'Male', 'Middle Aged', 'Retrospective Studies']"
224,"[ 0.01771595 -0.37858573  0.68100214 -0.07345371  0.27151433  1.0985395
  0.19331308  0.61512816 -1.5244467   0.11363213  1.1006598  -0.02562224
 -0.1175703  -0.7531804  -0.2799333  -0.45131418  0.5967837   1.4020606
 -1.2003335   1.0325758  -0.30341527 -0.10746824 -0.31936428  1.0573652
  0.01905482  0.8705774   0.1436003   0.14755438  0.13541801 -0.9652379 ]",10.1016/j.vaccine.2018.12.042,"['Bangladesh', 'Female', 'Focus Groups', 'Humans', 'Immunization Programs', 'Male', 'Parents', 'Patient Acceptance of Health Care', 'Qualitative Research', 'Refugees', 'Vaccination', 'Vaccination Coverage', 'Vaccination Refusal']"
225,"[ 0.10411683 -0.32447505  0.4875652   0.04847128  0.12526996  0.98672974
  0.17612252  0.5462244  -1.2104927   0.13028213  0.9251492  -0.21022384
 -0.1731539  -0.63905984 -0.3251382  -0.43349782  0.6454048   1.2491771
 -1.0090545   1.0191696  -0.5007252  -0.01385983 -0.36264277  0.7865688
 -0.05215036  0.82921785  0.25336438  0.13580449  0.14935341 -0.9874166 ]",10.1128/AAC.00976-16,"['Amino Acid Sequence', 'Anti-Retroviral Agents', 'Binding Sites', 'DNA Polymerase gamma', 'DNA-Directed DNA Polymerase', 'Female', 'HIV Infections', 'Humans', 'Male', 'Middle Aged', 'Mitochondria', 'Mutation', 'Protein Conformation']"
226,"[-0.80113584 -0.76338106  1.3942424   0.7940315   0.10825653  2.0299969
  0.19306321  0.7981799  -2.9393892   0.5434017   1.1780077   0.4958696
 -0.7493032  -1.9231011   0.2574947  -0.64560956  1.1086011   0.33912155
 -1.7743732  -0.40945736  0.3422623  -0.590655    1.047429    3.1042237
 -0.54190564  1.7683144  -0.40956634  0.2268343  -0.56959075 -0.53557605]",10.1080/13561820.2018.1455649,"['Humans', 'Interprofessional Relations', 'Quality Improvement', 'Reproducibility of Results', 'Students, Health Occupations', 'Curriculum', 'Patient Care Team']"
227,"[ 0.5520769  -0.3010004   0.7493174  -0.3385716  -0.05662131  1.2570142
 -0.3558      0.33993906 -1.2830127   0.4540668   1.9918175  -0.32946593
 -0.56218845 -0.959202   -0.16002293 -0.5266045   0.625443    2.3944137
 -2.1774378   0.5759874   0.09020768  0.01560324 -0.56875926  2.1734843
  0.01823763  1.65411    -0.08800528 -0.4002676  -0.3074078  -1.3771027 ]",10.1016/j.scitotenv.2018.09.204,[]
228,"[ 0.1488035  -0.1560097   0.31007528  0.0325921   0.04239884  0.5808416
  0.19723037  0.3333851  -0.73123366  0.0336257   0.5219768  -0.13459875
 -0.11387727 -0.40337205 -0.16869493 -0.21360841  0.22839586  0.77842367
 -0.56436765  0.73494685 -0.2750399  -0.01690041 -0.3308709   0.36609584
  0.12545377  0.4125516   0.14198108  0.03384286  0.15994251 -0.6587246 ]",10.1111/apha.13285,"['Animals', 'Blood Pressure', 'Fecal Microbiota Transplantation', 'Gastrointestinal Microbiome', 'Gene Expression Regulation', 'Hypertension', 'Lymph Nodes', 'Mesentery', 'Rats', 'Rats, Inbred SHR', 'Rats, Inbred WKY']"
229,"[ 0.16029419 -0.24998777  0.4364465  -0.01351859  0.15243796  0.7959551
  0.02711159  0.56448853 -0.9307053   0.10759078  0.6163982  -0.06034999
 -0.08757014 -0.33723018 -0.29891413 -0.24349014  0.3707402   1.0207825
 -0.6860514   0.9751762  -0.27651677 -0.01002494 -0.37256724  0.45097855
  0.06631407  0.53198975  0.18557028  0.09096477  0.15825592 -0.83315265]",10.1080/15384047.2019.1598762,"['Adenocarcinoma of Lung', 'Animals', 'Biomarkers, Tumor', 'Cell Line, Tumor', 'Cell Proliferation', 'Disease Models, Animal', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Mice', 'MicroRNAs', 'RNA Interference', 'RNA, Circular', 'RNA-Binding Proteins', 'Receptors, Notch', 'Signal Transduction']"
230,"[-0.79607344 -0.564268    0.981669    0.43993732  0.04075363  1.2121398
  0.44108924  0.38749725 -2.7396061   0.12626506  1.1654444   0.2544408
 -0.5447011  -1.4996386   0.2585348  -0.62837124  0.7633971   0.6163825
 -1.6148418  -0.38996798  0.17461577 -0.33400527  0.5252321   2.605838
 -0.3387637   1.1961288  -0.14084978  0.31775865 -0.2542881  -0.61662555]",10.1080/13561820.2019.1569600,"['Humans', 'Interprofessional Relations', 'Interprofessional Education', 'Reproducibility of Results', 'Learning', 'Students, Health Occupations']"
231,"[-0.03972559 -0.13429953  0.47420114  0.07542926  0.1107551   0.6156038
  0.25148293  0.3275036  -0.88445836 -0.08693111  0.58041334 -0.12676112
 -0.12113555 -0.47243917 -0.12437042 -0.28375486  0.4218047   0.97107625
 -0.57423466  0.6741286  -0.19902977 -0.01392233 -0.30203214  0.5791317
 -0.03839461  0.3065871   0.12589236  0.23208255  0.10238916 -0.78878635]",10.1016/j.lfs.2019.116851,"['Anti-Retroviral Agents', 'Carotid Intima-Media Thickness', 'Ethnicity', 'HIV Infections', 'Humans', 'Sex Characteristics']"
232,"[-0.09034476 -0.23612218  0.68055224 -0.294217    0.20159261  0.9842874
  0.33196744  1.0157467  -1.7250118   0.00558263  1.3327091   0.11932647
 -0.44379255 -0.9016347  -0.45437014 -0.23511536  0.86003613  1.8193126
 -1.2436173   1.6024173  -0.7865864   0.01254213 -0.37968647  1.1232738
  0.18507609  0.8279794   0.48832116  0.15973979  0.10087772 -1.62196   ]",10.3892/etm.2018.5724,[]
233,"[ 0.7042481  -0.58371884  0.53643644  0.2514944   0.28973317  2.0051565
 -0.5238311   1.0499649  -1.8135605   0.9613304   1.8973347  -0.47219232
  0.14451957 -0.7983339  -1.4409696  -0.6889703   1.6192728   1.9246974
 -1.1368444   1.9421088  -0.58091867 -0.38692877 -0.20363934  1.1611418
 -0.28664762  1.8686635  -0.03463836 -0.07707734  0.07865648 -1.2949746 ]",10.1016/j.bbr.2019.112145,"['Adolescent', 'Adult', 'Brain', 'Child', 'Female', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Maternal Exposure', 'Mothers', 'Parietal Lobe', 'Pregnancy', 'Prenatal Exposure Delayed Effects', 'Prospective Studies', 'Retrospective Studies', 'Stress, Psychological', 'Substance-Related Disorders']"
234,"[ 0.6877464  -0.3111893   0.3050991  -0.21760061 -0.07635862  1.4412518
 -0.27199647  1.0037802  -1.4517174   0.47453457  1.452122    0.0568846
 -0.27139363 -0.78498644 -0.9767435  -0.2305157   0.6260195   1.664657
 -1.429093    2.1140513  -0.6523333  -0.44070897 -0.4101557   0.9206714
  0.3970261   0.9098804   0.19796203 -0.35071808  0.45818824 -1.3501633 ]",10.1083/jcb.201812076,"['ADAM10 Protein', 'Animals', 'Calcium-Binding Proteins', 'Cell Adhesion Molecules, Neuronal', 'Cells, Cultured', 'Epitopes', 'HEK293 Cells', 'Humans', 'Mice, Inbred C57BL', 'Nanoparticles', 'Neural Cell Adhesion Molecules', 'Neurons', 'Presynaptic Terminals', 'Protein Isoforms', 'Proteolysis', 'Synapses']"
235,"[-0.60401076 -0.72439826  1.1859257   0.65349305  0.23571652  1.2470431
  0.50692934  0.17247708 -2.444353   -0.0888316   1.0843874   0.13636483
 -0.33188197 -1.4842162   0.38817266 -0.53887755  0.46603125  0.26154196
 -1.553547   -0.185245   -0.11930917 -0.04703075  0.2999307   2.4977918
 -0.3564033   1.04346    -0.21941358  0.50849724 -0.3447708  -0.4355214 ]",10.1080/13561820.2018.1505715,"['Humans', 'Arizona', 'Interprofessional Relations', 'Leadership']"
236,"[-9.1468105e-03 -3.4370014e-01  6.5726721e-01 -1.1438606e-01
  2.9413688e-01  1.0581585e+00  2.5648290e-01  5.0379163e-01
 -1.5300076e+00  9.9179387e-02  1.1151336e+00 -6.0707141e-02
 -3.2438453e-02 -7.5289911e-01 -1.4825851e-01 -5.0014657e-01
  5.9074503e-01  1.5106258e+00 -1.3090534e+00  1.0901072e+00
 -4.0038025e-01 -1.1095067e-01 -4.3221754e-01  1.1026618e+00
 -7.3067518e-04  7.2548342e-01  1.8409453e-01  1.9864567e-01
  7.6344430e-02 -1.2232509e+00]",10.1016/j.survophthal.2016.05.006,"['Aged', 'Antifungal Agents', 'Debridement', 'Disease Management', 'Eye Infections, Fungal', 'Female', 'Global Health', 'Humans', 'Immunocompromised Host', 'Morbidity', 'Mucorales', 'Mucormycosis', 'Ophthalmologic Surgical Procedures', 'Orbital Diseases']"
237,"[-0.70571166 -0.62654537  1.0377719   0.6411922   0.01666566  1.2615576
  0.33697906  0.4332269  -2.6109824   0.38384226  1.1169205   0.00388812
 -0.44892344 -1.5155737   0.07572199 -0.65421224  0.8766275   0.57451797
 -1.3872085  -0.16171464 -0.00646048 -0.12029048  0.38178617  2.2304156
 -0.3890618   1.1591543  -0.21011606  0.40374953 -0.25859106 -0.5806604 ]",10.1080/13561820.2018.1458707,"['Humans', 'Preceptorship', 'Interprofessional Relations', 'Health Occupations', 'Students', 'Faculty']"
238,"[-0.23037842 -0.4053848   1.0645992   0.7186571  -0.04270025  1.762108
  0.32812896  1.0120724  -2.4224553   0.16209418  1.0844443  -0.42828876
 -0.3117137  -1.4042614  -0.55314106 -0.6960133   0.53971535  0.9177933
 -1.1425258   1.4272481  -0.6817469   0.4312916  -0.8483045   1.2698189
 -0.43196118  1.3181766  -0.08557411  0.5275892   0.64140564 -0.8967778 ]",10.1080/13561820.2018.1538107,"['Humans', 'Primary Health Care', 'Interprofessional Relations', 'Allied Health Personnel', 'Ambulatory Care Facilities']"
239,"[-0.0602552  -0.19678679  0.45843503  0.07752098  0.07540411  0.60755944
  0.23419648  0.36349833 -1.0150772  -0.03136765  0.515751   -0.16233844
 -0.09182411 -0.5760593   0.0087172  -0.32562476  0.40739727  0.85143477
 -0.64457756  0.61333156 -0.25892797 -0.01190946 -0.30157608  0.58723027
 -0.14574732  0.41521922  0.1510732   0.2603754   0.1069484  -0.6681314 ]",10.1093/ofid/ofz222,[]
240,"[ 0.38049993 -0.5088035   0.2727825  -0.25045356  0.06818929  1.315691
 -0.2907189   0.68223876 -1.3668207   0.42489147  1.6070249  -0.26327857
 -0.12347823 -0.8124056  -1.006305   -0.36439785  0.76535374  1.8804924
 -1.4855918   1.4782059  -0.23383291 -0.4312743  -0.3450599   1.2956978
  0.17945974  1.1414384   0.02336387 -0.29241416 -0.13075326 -1.3627261 ]",10.1111/biom.13297,"['Brain', 'Brain Mapping', 'Humans', 'Magnetic Resonance Imaging']"
241,"[-8.7221497e-01 -4.7375658e-01  1.0515497e+00  5.2840155e-01
  1.7344625e-03  8.0483842e-01  5.1657772e-01  3.2162446e-01
 -2.2222769e+00 -1.9536566e-02  9.0231377e-01 -8.1998117e-02
 -4.1498694e-01 -1.3759729e+00  3.1404024e-01 -4.5380396e-01
  5.4575038e-01  4.9659482e-01 -1.3206061e+00 -2.5982308e-01
 -2.0873339e-01 -3.7549268e-02  1.3122717e-01  1.9893315e+00
 -3.5951826e-01  7.1566731e-01 -3.2830987e-02  4.4332653e-01
 -8.0885619e-02 -6.0327226e-01]",10.1080/13561820.2018.1538115,[]
242,"[ 0.01947903 -0.19345409  0.38993692 -0.03311311  0.11998954  0.55862
  0.13616437  0.379204   -0.8622522   0.04950845  0.6325995  -0.06002185
 -0.08737466 -0.44198462 -0.14055222 -0.27596438  0.35935867  0.9199114
 -0.6869744   0.7562542  -0.26091677 -0.04436203 -0.30892655  0.5642025
  0.00137418  0.42860368  0.1124415   0.10658368  0.10916067 -0.73609656]",10.1016/j.radcr.2019.05.005,[]
243,"[-1.5704408  -0.6999255   1.4754275   1.0483825  -0.03148843  1.7636535
  0.50360596  0.791502   -3.3458223   0.44678918  1.2405068   0.00772804
 -0.9126099  -2.4550672   0.6799261  -0.41874388  0.7210635  -0.13979271
 -2.1415083  -1.5572349   0.23921824 -0.87496716  1.6363459   4.0016627
 -0.76882714  1.5439566  -0.43389884  0.29604912 -0.71882814  0.33652443]",10.1080/13561820.2018.1513465,"['Humans', 'Interprofessional Relations', 'Diabetes Mellitus, Type 2', 'Retrospective Studies', 'Glycated Hemoglobin', 'Students, Health Occupations', 'Hypertension']"
244,"[-1.5036483  -0.9325704   1.335661    0.9052685  -0.04176915  1.0954047
  0.68579096  0.24818799 -3.2669816  -0.16121614  1.2571607   0.08401626
 -0.38119504 -1.9682353   0.49474928 -0.4953087   0.4871103   0.08723564
 -1.7707074  -0.94213283 -0.00612808 -0.10817447  0.5564958   2.8862722
 -0.4141365   0.9539194  -0.15384799  0.5430732  -0.14246014 -0.46447715]",10.1080/13561820.2018.1433642,"['United States', 'Humans', 'Primary Health Care', 'Veterans', 'Interprofessional Relations', 'Health Occupations', 'Quality of Health Care', 'United States Department of Veterans Affairs']"
245,"[-0.266212   -0.19250596  0.47830978  0.14331712  0.04359455  0.33208594
  0.20092452  0.18584251 -0.8954146  -0.06450381  0.38230494 -0.09223187
 -0.12486419 -0.5582247   0.12918635 -0.25182223  0.2613326   0.46825978
 -0.5368713   0.18370469 -0.19296312  0.01788703 -0.15883197  0.66430044
 -0.14979625  0.24254961  0.05140373  0.3030678   0.05643399 -0.44427207]",10.1080/13561820.2018.1560246,"['Humans', 'Social Determinants of Health', 'Interprofessional Relations', 'Health Personnel', 'Health Occupations', 'Outcome Assessment, Health Care']"
246,"[ 0.3449793  -0.19948272  0.6123589   0.04329623  0.53489673  1.645638
  0.05119297  0.59240896 -1.2881771   0.4985539   1.4506732   0.267515
 -0.2066401  -0.8406406  -0.5295658  -0.39568463  1.194388    1.7358619
 -1.5490552   0.9226635  -0.03738677 -0.07878181 -0.10275764  1.6287539
  0.14198439  1.2409959   0.13720463 -0.02132066  0.14520217 -1.1116947 ]",10.1016/j.ijfoodmicro.2018.06.001,"['Food', 'Food Handling', 'Food Microbiology', 'Food Safety', 'Foodborne Diseases', 'Humans', 'Risk Assessment', 'Virus Physiological Phenomena', 'Viruses']"
247,"[-0.43548393 -1.3553752   1.3682652   0.93325424  0.02015798  1.9685706
  0.38973054  0.57325035 -3.6981518   0.38933462  1.6221213  -0.18427882
 -0.6127908  -2.0946338  -0.15959159 -0.38707757  1.1649098   0.64567333
 -2.4686387  -0.21530277 -0.01273651  0.07341205  0.4149822   3.0010138
 -0.17251906  1.8361317  -0.41652128  0.49794373 -0.10877341 -0.5181432 ]",10.1080/13561820.2018.1469476,"['United States', 'Humans', 'Interprofessional Relations', 'United States Department of Veterans Affairs', 'Retrospective Studies', 'Curriculum', 'Primary Health Care']"
248,"[ 1.0598158  -0.42624068  1.8497415  -0.5059437   1.5673578   2.517424
  0.3107139  -0.22792211 -2.8606355   0.8888838   1.034878    0.6597631
  0.18882017 -1.2338462  -0.59226626  0.09987956 -0.03596114  1.890921
 -1.8634496   0.69401675 -0.31821224 -0.38226312 -0.76685065  1.2052386
  1.2373763   1.6474841   0.23944104 -0.48133844  0.8336512  -1.0067613 ]",10.1088/1748-605X/ab452d,"['Animals', 'Biocompatible Materials', 'Cell Proliferation', 'Cell Survival', 'Chitosan', 'Collagen', 'Cross-Linking Reagents', 'Elastic Modulus', 'Gelatin', 'Humans', 'Iridoids', 'Mice', 'Myocardial Contraction', 'Myocardium', 'NIH 3T3 Cells', 'Porosity', 'Pressure', 'Spectroscopy, Fourier Transform Infrared', 'Stress, Mechanical', 'Tensile Strength', 'Tissue Engineering', 'Tissue Scaffolds']"
249,"[ 0.7180386  -0.3778518   0.49104688  0.1509259   0.09649999  2.0391796
  0.21090266  0.8483776  -1.7533963   0.33706236  1.4515629  -0.16082858
 -0.30897284 -0.79153347 -0.76336545 -0.67606264  0.93126076  1.7615037
 -1.5998596   1.8780674  -0.43175048  0.05405515 -0.3058453   1.0185939
  0.08574121  1.7192959   0.10461482  0.22520018  0.20491411 -1.4336828 ]",10.1080/14763141.2020.1795237,"['Humans', 'Biomechanical Phenomena', 'Hip Joint', 'Sports', 'Lower Extremity', 'Range of Motion, Articular']"
250,"[-0.04502698 -0.05280685  0.17939489  0.03051358  0.04311603  0.12554565
  0.09248218  0.08754802 -0.3022265  -0.05740765  0.17555894 -0.06130496
 -0.06932622 -0.16650373  0.03393275 -0.11334855  0.12777077  0.30504063
 -0.20523655  0.19886401 -0.12209006  0.02100322 -0.15009327  0.16616109
 -0.03525923  0.07223865  0.04033117  0.09643122  0.06609265 -0.26258394]",10.1093/ije/dyz173,"['Aged', 'Aged, 80 and over', 'Aging', 'Canada', 'Female', 'Humans', 'Life Style', 'Longitudinal Studies', 'Male', 'Middle Aged', 'Quality of Life']"
251,"[ 0.64055425 -0.79864144  0.3339156  -0.4342945   0.2321545   1.745644
  0.1972061   1.2244782  -1.7229934   0.9697079   2.00639    -0.2360964
 -0.51237464 -0.86166745 -1.7165177  -0.86829984  1.5798612   1.9087216
 -1.1332525   2.7421927  -0.8446442  -0.4832915  -0.5038524   1.5833261
 -0.3687316   1.9831442   0.30654374 -0.65128994  0.2495109  -1.0429949 ]",10.1371/journal.pone.0236261,"['Adolescent', 'Adoption', 'Body Mass Index', 'Child', 'Child Development', 'Child Rearing', 'Child, Preschool', 'Female', 'Gene-Environment Interaction', 'Humans', 'Male', 'Pediatric Obesity', 'Prospective Studies', 'Siblings']"
252,"[-1.6835786  -0.69218415  1.4960601   0.87394834  0.04301491  1.260446
  0.6167128   0.36368623 -3.4925144   0.1446421   1.3458182   0.11161018
 -0.5595941  -2.0647767   0.46711248 -0.6968392   0.9474079   0.17114286
 -1.9321021  -1.0631809  -0.00355703 -0.20254818  0.6346285   3.0597236
 -0.5306393   1.415945   -0.15846393  0.6028324  -0.22934775 -0.42290086]",10.1080/13561820.2020.1798897,"['Humans', 'United States', 'Interprofessional Relations', 'Interprofessional Education', 'Learning', 'Data Collection', 'Motivation', 'Cooperative Behavior']"
253,"[ 0.53804094 -0.60661405  0.47106564  0.19427213 -0.05101174  1.7798929
 -0.08456421  0.8768495  -1.5967157   0.95975333  1.8762486  -0.10921139
 -0.1972561  -0.66247314 -1.151124   -0.8825682   1.1412532   1.6173906
 -1.1437981   1.7203846  -0.45991835 -0.2192207   0.28491396  0.91393346
  0.3642909   1.5933844   0.5665519  -0.15051536 -0.04595118 -1.3741808 ]",10.1080/14763141.2020.1800072,"['Humans', 'Aged', 'Athletic Performance', 'Biomechanical Phenomena', 'Upper Extremity']"
254,"[ 0.7129818   0.08253913  1.6918428  -0.45098642  1.0272834   1.9282129
  0.05409149  0.7612681  -2.4004178   0.21926035  1.949786    0.8874241
 -0.10010819 -0.59305423 -0.72859293 -0.64871454  0.4109493   2.4056594
 -2.1211357   2.8008492  -0.622744   -0.8609387  -1.1445858   0.43985677
  1.2564332   1.656686    0.46549273 -0.55841464  1.1583607  -1.9615549 ]",10.1088/1748-605X/ab9550,"['Adipocytes', 'Animals', 'Cell Differentiation', 'Cell Line', 'Cell Proliferation', 'Cell Survival', 'Collagen', 'Extracellular Matrix', 'Humans', 'Mesenchymal Stem Cells', 'Mice', 'Microscopy, Confocal', 'Polyesters', 'Prosthesis Design', 'Stress, Mechanical', 'Tendons', 'Tensile Strength', 'Tissue Engineering', 'Tissue Scaffolds', 'Water']"
255,"[ 0.64577043 -0.5281669   0.6046344   0.57640105  0.23031995  2.4839222
 -0.00885484  0.92053753 -0.8051627   0.40228483  0.87771946 -0.30217534
 -0.59306073 -0.32487002 -0.14038001 -0.77521944  0.6049144   1.7196004
 -1.1384698   1.154674   -0.5636433   0.17285693 -0.5846714   1.1840827
 -0.06954676  2.4141617   0.7293651   0.13875954 -0.43261307 -1.0452108 ]",10.1016/0008-8749(92)90131-8,"['Animals', 'Cerebral Cortex', 'Cognitive Dysfunction', 'Ethidium', 'Glial Fibrillary Acidic Protein', 'Gliosis', 'Hippocampus', 'Inflammation', 'Male', 'Maze Learning', 'Mitochondria', 'Ocimum basilicum', 'Plant Extracts', 'Rats', 'Rats, Wistar']"
256,"[ 0.9182031  -0.23957919  0.0060281  -0.14556722 -0.02229901  1.2323955
 -0.1096333   0.7118078  -1.1126348   0.53944254  1.4311749   0.14302468
  0.12000852 -0.71581846 -0.8898304  -0.12675416  0.5634699   1.7884806
 -1.0609055   1.3471048  -0.10599007 -0.38413534  0.10133532  0.76002663
  0.3070711   0.9625632  -0.01763485 -0.40389392 -0.01456121 -1.0180787 ]",10.1080/14763141.2020.1797152,"['Humans', 'Male', 'Biomechanical Phenomena', 'Foot', 'Lower Extremity', 'Water Sports', 'Swimming']"
257,"[ 0.10006597 -0.22798105  0.38702223  0.03930149  0.18019396  0.77576345
  0.17250352  0.38987297 -1.0286394   0.00390139  0.8118119  -0.14533329
 -0.1151685  -0.5503363  -0.33836278 -0.40716523  0.40062395  0.9847017
 -0.8410666   0.82758087 -0.43575346  0.03208448 -0.33459955  0.6516655
  0.08590816  0.5964964   0.15300146  0.0802622   0.20205322 -0.7663709 ]",10.1093/cid/ciaa858,"['Borrelia burgdorferi', 'Cell-Free Nucleic Acids', 'DNA, Bacterial', 'Erythema Chronicum Migrans', 'Humans', 'Lyme Disease']"
258,"[ 0.00446875 -0.13434197  0.3196597  -0.03097057  0.12718028  0.3772175
  0.12693186  0.27769566 -0.6829524  -0.00874578  0.44207326 -0.00655107
 -0.10763755 -0.33584866 -0.12127361 -0.20771633  0.22390942  0.7117641
 -0.47027856  0.5768185  -0.20715854 -0.03776718 -0.3101833   0.2906689
  0.06491095  0.26793626  0.09936564  0.07980854  0.2037348  -0.5893028 ]",10.1523/ENEURO.0507-19.2020,"['Animals', 'Mutation', 'Retinal Rod Photoreceptor Cells', 'Retinitis Pigmentosa', 'Rhodopsin', 'Xenopus laevis']"
259,"[ 0.23551708 -0.6272309   0.5884556   0.11059129  0.26994628  1.4445595
  0.08444878  0.8435645  -1.6003758   0.40453643  1.210852   -0.06916498
 -0.16378842 -0.7126381  -0.45640618 -0.4629015   0.59381485  1.5249212
 -1.3624322   1.423398   -0.39884412 -0.09856404 -0.5611938   0.98619866
 -0.01962056  1.051614    0.26178122 -0.04601587  0.1447147  -1.122842  ]",10.1002/humu.23952,"['Amino Acid Sequence', 'Bone and Bones', 'Congenital Disorders of Glycosylation', 'Facies', 'Female', 'Genetic Association Studies', 'Genetic Predisposition to Disease', 'High-Throughput Nucleotide Sequencing', 'Humans', 'Infant, Newborn', 'Loss of Function Mutation', 'Male', 'Musculoskeletal Abnormalities', 'Mutation', 'Mutation, Missense', 'N-Acetylgalactosaminyltransferases', 'Pedigree', 'Phenotype']"
260,"[ 0.11619117 -0.5066116   0.5704256  -0.17830229  0.09640954  0.97761154
  0.17117018  0.45583162 -1.2770694   0.3163994   1.0107664   0.09409156
  0.01746833 -0.67665255 -0.25504026 -0.37783062  0.53364116  1.1824391
 -0.97544014  0.8388985  -0.11559266 -0.0949525  -0.23234296  1.0617129
  0.07003257  0.61119604  0.04636366  0.08988044  0.07068103 -0.89381   ]",10.1002/elsc.201800050,[]
261,"[ 0.06515647 -0.35628545  0.45884177  0.03766438  0.19208881  0.8354395
  0.20962667  0.5572958  -1.3108252   0.08253143  0.9086744  -0.0936336
 -0.10512119 -0.6654098  -0.3757659  -0.44880554  0.5082736   1.3120006
 -1.0285282   1.1567035  -0.41786507  0.04469993 -0.5879432   0.79425466
 -0.00451032  0.61009157  0.18136175  0.08200029  0.2766437  -1.008943  ]",10.1124/mol.119.117267,"['Analgesics, Opioid', 'Endocytosis', 'Enkephalin, Ala(2)-MePhe(4)-Gly(5)-', 'GTP-Binding Protein beta Subunits', 'GTP-Binding Protein gamma Subunits', 'HEK293 Cells', 'Humans', 'Phosphorylation', 'Protein Kinase C', 'Receptors, Opioid, mu']"
262,"[ 0.32186773 -0.32425117  0.61822385 -0.01514222  0.4404182   1.227022
  0.10356962  0.8543881  -1.3916845   0.36043856  0.933291   -0.10603731
 -0.12064383 -0.4525979  -0.6037853  -0.43400574  0.61529446  1.437837
 -1.0624835   1.3730444  -0.23924011 -0.06207192 -0.42453426  0.5936212
  0.05861175  0.96193606  0.10664018  0.09826478  0.25212967 -0.9065259 ]",10.1088/1748-605X/ab95e1,"['Apoptosis', 'Biocompatible Materials', 'Carbon', 'Cell Adhesion', 'Cell Line, Tumor', 'Cell Survival', 'Deoxycytidine', 'Drug Carriers', 'Drug Delivery Systems', 'HeLa Cells', 'Humans', 'Inhibitory Concentration 50', 'MCF-7 Cells', 'Nanomedicine', 'Solubility', 'Gemcitabine']"
263,"[ 0.20317955 -0.30496296  0.4109423   0.02224213  0.23964638  0.96596605
  0.12450086  0.4776971  -1.0422451   0.15928036  0.81417316 -0.05827253
 -0.0539603  -0.4751784  -0.34300494 -0.34988242  0.48756737  1.1728779
 -0.9524281   0.95259583 -0.32277498  0.01708934 -0.3837384   0.6775728
  0.04484476  0.7528268   0.20861046  0.04686027  0.15364558 -0.8904165 ]",10.1371/journal.pntd.0008203,"['Animals', 'Antibodies, Monoclonal', 'Antibodies, Viral', 'Brazil', 'Cohort Studies', 'Dengue', 'Dengue Virus', 'Enzyme-Linked Immunosorbent Assay', 'Honduras', 'Humans', 'India', 'Latin America', 'Mice, Inbred C57BL', 'Sensitivity and Specificity', 'Serogroup', 'Viral Nonstructural Proteins']"
264,"[ 0.23575944 -0.30013806  0.6933932  -0.06053112  0.32143688  0.9891206
  0.08648343  0.6021113  -1.1955214   0.07270072  0.8860217  -0.06209549
 -0.24501625 -0.5145553  -0.3002782  -0.45949107  0.3928072   1.4073483
 -0.9166743   1.1688384  -0.20495349 -0.05954667 -0.50955576  0.8049045
  0.18143402  0.6729145   0.14339593  0.04870684  0.24113393 -0.93844986]",10.1002/1873-3468.13668,"['Adenoviridae', 'Animals', 'Gene Editing', 'Genetic Vectors', 'Helper Viruses', 'Hematopoietic Stem Cell Transplantation', 'Hematopoietic Stem Cells', 'Humans', 'Mice']"
265,"[ 0.4794071  -0.61438835  0.34776884  0.111875    0.14366093  1.3581177
 -0.144107    0.73576725 -1.2444656   0.688047    1.1315637   0.28251153
 -0.01429839 -0.32447878 -0.80175626 -0.41604868  0.64682966  1.2397398
 -1.1250911   1.2345376  -0.2140212  -0.3412035  -0.08802503  0.97202575
  0.17863216  1.3580276   0.07056315 -0.18820776  0.14898513 -0.89736426]",10.1080/14763141.2020.1797150,"['Humans', 'Biomechanical Phenomena', 'Posture', 'Walking', 'Gait', 'Pelvis']"
266,"[-0.07014457 -0.10924286  0.25366557  0.01311152  0.08092765  0.20046031
  0.1421209   0.13762644 -0.48299903 -0.10336445  0.2752341  -0.08056767
 -0.07484502 -0.26859838  0.03614597 -0.1726442   0.15076317  0.4599732
 -0.31227702  0.28098026 -0.14416729  0.02833323 -0.1891585   0.2895355
 -0.0406209   0.12830281  0.05513199  0.15566857  0.12709612 -0.391193  ]",10.1093/infdis/jiab162,"['COVID-19', 'Communicable Diseases', 'Humans', 'Physicians', 'Research Personnel', 'SARS-CoV-2', 'Science', 'Specialization']"
267,"[ 0.7087364  -0.17203163  0.52460617  0.61329925 -0.3021736   1.5073767
 -0.06129089  0.9743008  -1.5890853   0.69259703  1.1390933  -0.10773162
 -0.27253306 -0.43143126 -0.7678325  -1.0668346   0.7883261   1.3396568
 -1.1670128   2.1580467  -0.26438728  0.0475663  -0.56323296  0.25267968
  0.07811365  1.4788492   0.07416002  0.26793918  0.61928654 -0.94965166]",10.1080/14763141.2020.1797863,"['Humans', 'Male', 'Biomechanical Phenomena', 'Muscle, Skeletal', 'Running', 'Quadriceps Muscle', 'Fatigue', 'Torque', 'Muscle Strength']"
268,"[ 0.21689269 -0.4011146   0.23134077  0.00659317  0.10983759  1.1658607
  0.09756591  0.58611333 -1.1851819   0.19032314  1.1701761  -0.09486842
 -0.13325787 -0.5256779  -0.5019717  -0.42330542  0.6869481   1.5516537
 -1.3281144   1.4301705  -0.4110898  -0.16668639 -0.5064781   0.71984893
  0.01608069  0.92790365  0.18267645 -0.12656951  0.04453932 -1.2273645 ]",10.1093/cid/ciaa329,"['Angiotensin II', 'Angiotensin-Converting Enzyme 2', 'Betacoronavirus', 'COVID-19', 'Cardiovascular Diseases', 'Coronavirus Infections', 'Humans', 'Pandemics', 'Peptidyl-Dipeptidase A', 'Pneumonia, Viral', 'Renin-Angiotensin System', 'SARS-CoV-2', 'Severe Acute Respiratory Syndrome']"
269,"[ 0.1766195  -0.25639045  0.41387573  0.09323034  0.02707942  0.97147274
  0.11172049  0.49750113 -1.151892    0.2640876   0.8710376  -0.11067589
 -0.15624979 -0.5578367  -0.4094071  -0.48915732  0.55056703  1.0580375
 -0.85515285  0.9819413  -0.34984723 -0.08128223 -0.264322    0.6001019
  0.07197698  0.8462199   0.1121683   0.08857364  0.22096705 -0.7756057 ]",10.1080/14763141.2020.1797151,"['Humans', 'Male', 'Skating', 'Hockey', 'Biomechanical Phenomena', 'Lower Extremity', 'Leg']"
270,"[ 0.17994538 -0.30232665  0.59593165 -0.09523083  0.24315576  0.9958947
  0.14245798  0.54780465 -1.2764039  -0.02023233  0.88482696 -0.07020273
 -0.21994615 -0.4872156  -0.4344778  -0.36164093  0.6415166   1.4119002
 -1.3527198   1.1499268  -0.42666703 -0.07945041 -0.5849225   0.910552
 -0.01633146  0.87163484  0.23807932  0.10710572  0.084838   -1.12286   ]",10.1016/j.cmet.2021.03.003,"['Animals', 'Cell Line', 'Citric Acid Cycle', 'DNA, Mitochondrial', 'Dimerization', 'Fumarates', 'Humans', 'Leukemia', 'Malate Dehydrogenase', 'Mice', 'Mice, Inbred C57BL', 'Mice, Inbred NOD', 'Mitochondria', 'Protein Binding', 'Protein-Arginine N-Methyltransferases', 'Pyrophosphatases', 'RNA Interference', 'RNA, Small Interfering', 'Ribosomal Proteins', 'Thymidine']"
271,"[ 0.9515388  -0.05339319  0.09998805  0.15856336  0.00501741  1.6837195
 -0.11954805  0.93873227 -1.4152402   0.56615156  1.2702463  -0.09813423
 -0.13854168 -0.8323259  -0.72537816 -0.5413534   0.61761266  1.6769687
 -1.3317791   1.6571794  -0.419686   -0.19601804 -0.09702312  1.1012632
 -0.00314524  1.4471104   0.00190235 -0.22582527  0.21316569 -0.71806073]",10.3390/v12090971,"['Antibodies, Viral', 'Antigens, Viral', 'Chikungunya Fever', 'Chikungunya virus', 'Colombia', 'Enzyme-Linked Immunosorbent Assay', 'Honduras', 'Humans', 'Immunoassay', 'Sensitivity and Specificity', 'Serologic Tests', 'Viral Envelope Proteins']"
272,"[-0.03814293 -0.04920226  0.25536653 -0.0234837   0.09898943  0.16550514
  0.13569823  0.15816319 -0.4099729  -0.10763304  0.235039   -0.001941
 -0.06826845 -0.18941571  0.02326037 -0.16341783  0.10864341  0.4272477
 -0.2763286   0.3654625  -0.16961694  0.04024736 -0.2484329   0.18633543
  0.00208607  0.10582451  0.10443696  0.10024201  0.14072584 -0.36069772]",10.1126/scitranslmed.abb7028,"['Animals', 'CD8-Positive T-Lymphocytes', 'Epidermis', 'Graft vs Host Disease', 'Humans', 'Immunologic Memory', 'Mice', 'Skin', 'T-Lymphocytes']"
273,"[ 0.7762957  -0.35979173  0.29202324 -0.1065309  -0.05377204  0.96550554
  0.26965165  0.63971466 -1.1074108   0.11607819  1.8231841  -0.37631384
  0.06793908 -0.9263797  -1.214333   -0.5173464   0.31406325  1.8689322
 -1.842947    2.1777375  -1.1839739   0.0604757  -0.4635273   1.1666386
  0.71145463  0.44186518  0.5199585  -0.54639137 -0.01458799 -1.1137718 ]",10.1159/000513118,"['Borrelia burgdorferi', 'Complement C5', 'Humans', 'Lyme Disease', 'Microfluidics', 'Neutrophils']"
274,"[ 0.6024071  -0.44218847  0.14603001  0.18592492  0.08270203  1.6545053
 -0.3836702   0.7049631  -1.165548    0.8079579   1.537331   -0.08331021
  0.07657132 -0.47048157 -1.2433755  -0.13637628  0.46813568  1.54665
 -1.1615055   1.3310881  -0.20226093 -0.4661615   0.02377751  0.9546331
  0.11827255  1.0404254  -0.01132747 -0.51670754 -0.01719142 -1.2056136 ]",10.1080/14763141.2020.1797862,"['Humans', 'Athletic Performance', 'Soccer', 'Biomechanical Phenomena', 'Running', 'Spatio-Temporal Analysis']"
275,"[ 0.13404243 -0.33243245  0.7649653  -0.1104042   0.29381654  1.0591409
  0.01398984  0.70391226 -1.565115    0.13542788  1.1036253   0.06682534
 -0.21687658 -0.81779975 -0.30804223 -0.528026    0.6358924   1.654282
 -1.0965955   1.0715162  -0.08126789 -0.20520103 -0.3251297   1.219679
  0.2177088   0.8456542   0.13375805  0.0741915   0.21100643 -1.1454499 ]",10.1016/j.cels.2021.05.008,"['Algorithms', 'Animals', 'Benchmarking', 'Caenorhabditis elegans', 'Cell Lineage', 'Computer Simulation', 'Mice']"
276,"[ 0.04600917 -0.18920664  0.68142915 -0.28310394  0.07754042  1.0056028
  0.02645298  0.41803992 -1.4495573  -0.04831419  1.1631697  -0.21953863
  0.07668228 -0.72065    -0.37716034 -0.23132205  0.24136874  1.4177964
 -1.2138891   1.2110617  -0.14125153 -0.31148082 -0.50191873  1.1538001
  0.35709977  0.27356848  0.10648736 -0.29290584  0.04692204 -1.1117783 ]",10.1016/j.ydbio.2020.08.009,"['Animals', 'Cilia', 'Morphogenesis', 'Nervous System', 'Planarians', 'Stem Cells']"
277,"[ 0.49107456 -0.20464434  0.22439338  0.11855207  0.08553328  1.3996212
 -0.12344392  0.55937105 -1.3931957   0.40717703  1.703357    0.11851697
 -0.07904724 -0.63134074 -1.0118446  -0.5213269   1.110997    1.5256245
 -1.0143943   1.3268151  -0.25673407 -0.288751    0.01191435  0.9631134
  0.09784479  1.2910833   0.29522905  0.04128154  0.12284396 -1.2654715 ]",10.1080/14763141.2020.1797149,"['Humans', 'Female', 'Biomechanical Phenomena', 'Muscle, Skeletal', 'Sports', 'Athletes', 'Baseball', 'Muscle Strength']"
278,"[ 0.47259375 -0.06560171  0.15016608  0.0425308   0.1131951   1.9257966
 -0.02662083  1.0455722  -1.7346287   0.6564647   1.490499   -0.5024387
 -0.10486782 -0.90174925 -0.5304927  -0.24886292  1.1159772   1.7448936
 -1.2915839   1.3577628  -0.11653894 -0.9536132   0.4447541   1.4031961
 -0.03489431  1.6126742  -0.17583545 -0.12947492 -0.36687645 -0.3414178 ]",10.1002/ijc.33487,"['Adult', 'Aged', 'China', 'Decision Support Techniques', 'Female', 'Hepatitis B', 'Humans', 'Incidence', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Prospective Studies']"
279,"[ 0.1717639  -0.17824624  0.4957541   0.02776037  0.16908917  0.6500563
  0.05093496  0.42955562 -0.83229494  0.1013725   0.6085518   0.05827692
 -0.07615507 -0.39573053 -0.19331528 -0.27550098  0.30689606  0.8527488
 -0.5924658   0.79057837 -0.12115037 -0.10573865 -0.21261959  0.6069725
  0.14597382  0.41638085  0.03854831  0.0570015   0.15672043 -0.64752173]",10.1007/s11904-021-00544-3,"['Adaptive Immunity', 'Gastrointestinal Tract', 'HIV Infections', 'Humans', 'Immunity, Innate', 'Lymphocytes', 'T-Lymphocytes']"
280,"[ 0.16498606 -0.20244628  0.41287667 -0.10888496  0.15444891  0.6164467
  0.01312739  0.42227644 -0.85030454  0.09073134  0.6392164   0.03372205
 -0.05358801 -0.32561785 -0.33072966 -0.2754882   0.35002717  1.0187105
 -0.6654337   0.9068872  -0.23166902 -0.08344098 -0.3724072   0.48646054
  0.13314825  0.45124257  0.13935772  0.01669818  0.2130992  -0.7768368 ]",10.1126/sciimmunol.aba6232,"['Adaptive Immunity', 'Adult', 'Aged', 'Aged, 80 and over', 'Biopsy', 'Cell Line, Tumor', 'Cell Separation', 'Dermatitis, Contact', 'Epigenesis, Genetic', 'Female', 'Flow Cytometry', 'Humans', 'Integrin alpha1', 'Killer Cells, Natural', 'Liver', 'Lymphocyte Subsets', 'Male', 'Middle Aged', 'Nickel', 'Patch Tests', 'Primary Cell Culture', 'RNA-Seq', 'Single-Cell Analysis', 'Skin']"
281,"[ 0.3971138  -0.37941992  0.65929586  0.15049635  0.18009268  1.5561674
  0.07618336  0.7827568  -1.8064685   0.45129332  1.4711419  -0.13972722
 -0.27615035 -0.9050839  -0.5328666  -0.4755562   0.6119665   1.6898438
 -1.4505713   1.3065947  -0.4721967  -0.25437525 -0.37603518  1.3583096
  0.10978696  1.2665871   0.05608041  0.05421401  0.23987585 -1.0331309 ]",10.1126/sciadv.aaz5894,"['Animals', 'Conserved Sequence', 'Extracellular Matrix', 'Hydrogels', 'Ligands', 'Peptides', 'Vascular Endothelial Growth Factor A']"
282,"[-0.117324   -0.08393634  0.21477214  0.0321867   0.04174918  0.02619868
  0.1540985   0.05958279 -0.33987218 -0.15048197  0.13078631 -0.08538236
 -0.0433257  -0.22812869  0.06209161 -0.09991542  0.0757488   0.27835092
 -0.20506385  0.17894387 -0.1346158   0.07904053 -0.20191462  0.16424692
 -0.07369401 -0.01554828  0.06476299  0.17196025  0.12225285 -0.25342986]",10.1136/bmj.n1590,"['Antitubercular Agents', 'Humans', 'Middle Aged', 'Primary Health Care', 'Risk Factors', 'Symptom Assessment', 'Tuberculosis', 'Young Adult']"
283,"[-0.0734394  -0.12787107  0.34525743 -0.01320725  0.09641016  0.3795814
  0.14923453  0.2158488  -0.67772347 -0.04434378  0.4490645  -0.05748287
 -0.1005796  -0.38714394 -0.04097304 -0.22495818  0.2671077   0.6396891
 -0.5227374   0.45731428 -0.17473279 -0.02326704 -0.21898511  0.48250604
 -0.03443757  0.31074148  0.07445806  0.11966001  0.13073164 -0.5192561 ]",10.1080/14763141.2020.1795238,"['Humans', 'Biomechanical Phenomena', 'Acceleration', 'Extremities']"
284,"[-0.08590315 -0.04463153  0.18900159  0.00147354  0.05567648  0.07166652
  0.16231912  0.06183518 -0.30690122 -0.10498495  0.12366921 -0.08056492
 -0.0741462  -0.2001659   0.04712919 -0.11999836  0.07480058  0.2759728
 -0.16419597  0.19309245 -0.14912231  0.04220636 -0.1983614   0.11152751
 -0.03183412  0.03540348  0.06623282  0.15473355  0.09415268 -0.22841765]",10.1136/bcr-2021-241878,"['Adult', 'Anti-N-Methyl-D-Aspartate Receptor Encephalitis', 'Autoantibodies', 'Diagnostic Imaging', 'Female', 'Humans', 'Ovariectomy', 'Receptors, N-Methyl-D-Aspartate']"
285,"[ 0.24995017 -0.37399614  0.5701046  -0.2544789   0.23976183  1.2762195
  0.02559574  0.5534648  -1.5082415   0.2885417   1.3125552  -0.08212109
 -0.11501729 -0.847291   -0.7141212  -0.4400528   0.74432814  1.6262434
 -1.301663    1.3279338  -0.38612744 -0.29086134 -0.24285871  1.2527223
  0.08514445  1.0405827   0.13021111 -0.13049647  0.24033289 -1.2636836 ]",10.1007/s11109-021-09738-2,[]
286,"[ 2.88590074e-01 -2.34864980e-01  8.77852023e-01 -1.64289117e-01
  2.86344469e-01  1.19099104e+00  1.66985497e-04  7.70296514e-01
 -1.58366537e+00  1.02760114e-01  1.42146015e+00 -1.85088497e-02
 -1.41525730e-01 -5.96456945e-01 -4.74268645e-01 -4.12055165e-01
  6.26153052e-01  1.72745478e+00 -1.24898422e+00  1.48595035e+00
 -3.37046117e-01 -2.45548055e-01 -6.46905065e-01  9.95223701e-01
  4.07333851e-01  8.76797497e-01  1.47705540e-01 -8.42453539e-02
  4.47563589e-01 -1.14726412e+00]",10.3390/ijms22168482,"['Adult', 'Cells, Cultured', 'Humans', 'Induced Pluripotent Stem Cells', 'Myocardium', 'Myocytes, Cardiac', 'Organoids', 'Transcriptome']"
287,"[ 0.1436866  -0.3074094   0.56830597 -0.05462306  0.1602286   0.9895442
  0.18375891  0.510253   -1.3417857   0.15919054  0.8936872  -0.05464678
 -0.10242246 -0.6824047  -0.2626299  -0.38991377  0.4713609   1.3524691
 -1.0390863   1.0395086  -0.40903798 -0.04870129 -0.42023945  0.82736486
  0.01989666  0.8113263   0.14324662  0.12778924  0.20509967 -0.9574177 ]",10.1136/bcr-2021-242100,"['Cardiac Pacing, Artificial', 'Electrocardiography', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction', 'Pharmaceutical Preparations', 'Ventricular Fibrillation', 'Ventricular Premature Complexes']"
288,"[-0.03917579 -0.05954438  0.13420254 -0.01036119  0.0287641   0.09019566
  0.09647111  0.07159407 -0.26134646 -0.07388981  0.1162113  -0.03645641
 -0.04716564 -0.15888587  0.01537284 -0.08407929  0.08680449  0.27237996
 -0.1678367   0.16766398 -0.09461626  0.0416132  -0.14845628  0.11337497
 -0.04524612  0.04322614  0.05841169  0.0810073   0.08421011 -0.22391433]",10.1136/bcr-2021-243256,"['Dentistry', 'Humans', 'Mediastinal Emphysema', 'Neck', 'Subcutaneous Emphysema']"
289,"[-0.05559865 -0.22253725  0.4272372  -0.05629355  0.12872253  0.4263787
  0.20813543  0.23696686 -0.7924816  -0.10335424  0.51892567 -0.0713269
 -0.08943754 -0.45254835 -0.09370907 -0.26835436  0.28407538  0.8747406
 -0.66078347  0.63620144 -0.24833637  0.04575452 -0.36026978  0.45077938
 -0.04426651  0.2611008   0.10139662  0.18309025  0.19244702 -0.73286974]",10.1002/14651858.CD012720.pub2,"['Adolescent', 'Adult', 'Female', 'Glucocorticoids', 'Humans', 'Male', 'Middle Aged', 'Quality of Life', 'Rotator Cuff', 'Treatment Outcome', 'Young Adult']"
290,"[ 0.07383274 -0.18729433  0.29741326  0.02526572  0.07694142  0.5584018
  0.10700437  0.29538068 -0.795069    0.09372115  0.561499   -0.07815302
 -0.04078258 -0.37828332 -0.20429587 -0.25870198  0.3486308   0.8448288
 -0.5823267   0.67199355 -0.20660394 -0.08687068 -0.19898826  0.42056265
 -0.02345631  0.39047253  0.10697515  0.06387743  0.05416245 -0.6378839 ]",10.1101/2020.11.25.20236646,[]
291,"[ 0.14001791 -0.18978804  0.48750222  0.01697734  0.15923521  0.87290406
  0.123229    0.4698887  -1.1405233   0.14260322  0.80538213 -0.08665012
 -0.09754302 -0.59343123 -0.17518997 -0.33508706  0.4724123   1.1365442
 -0.93409985  0.93232894 -0.24808131 -0.15679933 -0.3205579   0.74292237
 -0.03082141  0.6266301   0.11341898  0.13931094  0.11430936 -0.8569029 ]",10.1136/bcr-2021-242907,"['CD4 Lymphocyte Count', 'Female', 'Fistula', 'HIV Infections', 'Humans', 'Immune Reconstitution Inflammatory Syndrome', 'Tuberculosis']"
292,"[-0.05591543 -0.42178893  0.5498137   0.03783638  0.2632459   1.038312
  0.02613598  0.77070117 -1.6257616   0.4810654   1.1968046  -0.02883062
  0.08457053 -0.93323755 -0.02724233 -0.41121438  0.8751974   1.5022291
 -1.187623    0.5954882  -0.05512145 -0.43304604 -0.10608698  1.7149304
 -0.28055707  0.69834554 -0.05772597  0.24407011 -0.21968795 -0.9461028 ]",10.1016/j.cpr.2020.101924,"['Health Behavior', 'Humans', 'Minority Groups', 'Minority Health', 'Sexual Behavior', 'Sexual and Gender Minorities']"
293,"[ 1.2416602  -0.66769683 -0.02664144 -0.2599684  -0.24418622  2.4702604
 -0.35176533  1.228361   -1.3297502   0.9686851   1.2414185  -0.29984072
 -0.2758539  -0.09916428 -0.8887816   0.06210279  0.36844346  1.779281
 -1.6097126   2.1812484  -0.11065377 -0.56293154 -0.03882398  0.7213354
  0.19659615  1.5376375   0.6831746  -0.79014206 -0.58240885 -0.89054507]",10.3892/ol.2021.12544,[]
294,"[ 1.3826486   0.00552337  1.4189874  -0.14302702  0.9814874   1.7086223
 -1.150209    1.7644109  -1.2152109   0.15323496  0.7721118   0.845741
 -0.3097787  -0.05610818 -0.5797631  -0.25486714  0.5298706   2.2774177
 -1.153189    2.7333179   0.14845276 -0.2722522  -0.12407155  0.49346906
  0.69511884  1.2304186   0.06325214 -0.3151418   0.5975396  -1.2128096 ]",10.3892/ol.2021.12650,[]
295,"[ 1.7954503  -0.11738048 -0.11532654 -0.77581406 -0.4408001   1.857123
 -0.00769086  1.2840023  -0.945369    1.0874771   1.5937866  -0.3698681
  0.12302298 -1.1527041  -1.6818026   0.02589207  0.52060956  2.7165167
 -1.5457101   2.5185883  -0.1882939  -1.1335636  -0.9360515   0.7973963
  0.34406188  1.5752234  -0.34368032 -0.84952104 -0.1155771  -1.3447931 ]",10.1080/10400435.2021.1893237,"['Buttocks', 'Fitness Trackers', 'Humans', 'Pressure', 'Pressure Ulcer', 'Wheelchairs']"
296,"[ 1.2767805e-01 -3.7902236e-02  3.6593217e-01 -1.9961731e-01
 -1.3191741e-03  9.0526956e-01 -1.3666824e-01  7.8689945e-01
 -1.5930290e+00  1.4688069e-01  1.4962250e+00 -2.4423890e-01
 -3.1136596e-01 -9.9623209e-01 -6.5990275e-01 -5.8500284e-01
  8.4393013e-01  1.7617054e+00 -1.3704127e+00  1.2258672e+00
 -2.6225844e-01 -3.7382227e-01 -2.2279303e-01  1.1844661e+00
  9.1168448e-02  8.7745315e-01  6.0402825e-02  2.2078669e-02
 -1.6704202e-01 -1.3681320e+00]",Unknown,[]
297,"[ 0.04141153 -0.26190862  0.3844345  -0.01563151  0.0714379   0.5748312
  0.17012034  0.3492069  -0.8341177   0.0372166   0.65076256 -0.04343343
 -0.0968952  -0.45974037 -0.11537892 -0.21693957  0.33393028  0.8412198
 -0.6833833   0.6596618  -0.3017511  -0.07560877 -0.25881985  0.5947991
 -0.02357833  0.39482048  0.14020516  0.05782784  0.06453256 -0.66565645]",10.1542/hpeds.2021-005866,"['Adolescent', 'Age Factors', 'Body Mass Index', 'COVID-19', 'Causality', 'Cohort Studies', 'Comorbidity', 'Critical Care', 'Female', 'Humans', 'Male', 'Prevalence', 'Pulmonary Embolism', 'Respiration, Artificial', 'Retrospective Studies', 'Risk Factors', 'SARS-CoV-2', 'United States']"
298,"[-0.00339846 -0.23877911  0.5454048  -0.02458889  0.16491917  0.66637164
  0.21521303  0.45169646 -1.1108291   0.02529324  0.7026843  -0.08945601
 -0.15071793 -0.5874454  -0.21005738 -0.32867578  0.43889153  1.0558362
 -0.83064365  0.8066548  -0.26897287 -0.04517875 -0.43406355  0.66820276
  0.00641213  0.5241586   0.10913493  0.1531032   0.16425289 -0.83640146]",10.1097/JSM.0000000000000937,"['Humans', 'Rotator Cuff', 'Genotype', 'Tendinopathy', 'Collagen', 'Athletes']"
299,"[ 0.09905264 -0.4949037   0.74705875 -0.30178657  0.37935278  1.3010643
  0.1557918   0.86258155 -1.5823872   0.1891226   1.3376478   0.09739
 -0.01414202 -0.80393416 -0.65640414 -0.6946523   0.5957147   1.8446586
 -1.4421281   1.494666   -0.4097574  -0.12570544 -0.48436457  1.3356338
  0.0673812   1.0383064   0.19046725 -0.11886053  0.16146179 -1.3624939 ]",10.1016/j.neubiorev.2020.06.024,"['Affect', 'Animals', 'Arousal', 'Emotions', 'Humans', 'Models, Animal']"
300,"[ 0.4613349  -0.34400988 -0.03064529  1.7602372  -0.16061407  0.15163054
 -0.2559351  -0.11710232 -1.1088328   0.27873865  1.5130843   1.5216521
 -0.42912856 -2.0514872  -0.3654418  -1.8721104   0.8230605   1.2001792
 -2.2091753  -0.3332103   0.19141878  0.12760067 -1.4690554   1.3119949
  1.3903972   0.56965834 -0.6058699  -1.6817214   1.2561257  -1.5424103 ]",Unknown,"['Adult', 'Aged', 'Aged, 80 and over', 'Base Sequence', 'Chromosome Aberrations', 'Chromosomes, Human, Pair 17', 'Female', 'Gene Deletion', 'Genes, p53', 'Humans', 'In Situ Hybridization, Fluorescence', 'Leukemia, Lymphocytic, Chronic, B-Cell', 'Male', 'Middle Aged', 'Molecular Sequence Data', 'Pentostatin', 'Polymorphism, Single-Stranded Conformational', 'Survival Rate', 'Vidarabine']"
301,"[-1.2972344  -0.09075573  0.38337076 -0.6704285  -0.07810634  0.47823682
  0.91838163 -0.15809335 -0.9438507   0.27868095  1.123373    0.38232994
  0.80594265 -0.97289354 -0.04672965 -1.2510408   0.97953016  0.59066707
 -1.1830376   0.00474366 -0.21788758 -0.45668787 -0.32287934  0.504547
  1.0620908   0.9534563   0.3048427  -0.6625733   0.33683208 -0.89944714]",10.1007/BF02790482,"['Child', 'Child Health Services', 'Day Care, Medical', 'Health Care Costs', 'Health Services Needs and Demand', 'Humans', 'Mental Health Services', 'Multivariate Analysis', 'Ownership', 'Residential Treatment', 'Schools', 'United States']"
302,"[-1.1021891  -0.19589548  0.3697273  -0.5822555   0.00719558  0.3536934
  0.82859075  0.01416996 -0.61378115  0.14259535  0.75796205  0.3309327
  0.61579174 -0.64837027 -0.0228822  -0.9125254   0.8519472   0.3981372
 -0.906901    0.00976391 -0.17676164 -0.2599986  -0.15926126  0.37108272
  0.9974957   0.7152646   0.4348618  -0.5103272   0.3514135  -0.83230907]",10.1007/BF02790479,"['Health Services Research', 'Hospital Bed Capacity', 'Humans', 'Logistic Models', 'Medicaid', 'Mental Health Services', 'Models, Organizational', 'Nursing Homes', 'Organizational Policy', 'Predictive Value of Tests', 'United States']"
303,"[-0.6553091  -0.09996007  0.27109805 -0.38786662 -0.3330326   0.38528568
  0.647602    0.11215856 -0.29424265  0.27544886  0.9820324   0.5046566
  0.56614673 -0.8358949  -0.2567654  -1.0714215   0.8876835   0.50397897
 -0.87291735 -0.07182362  0.14649524 -0.28794578 -0.16962796  0.29748398
  1.0431808   0.62603337  0.30172697 -0.54584444  0.52672577 -0.57373387]",10.1007/BF02790485,"['Adult', 'Emergency Services, Psychiatric', 'Female', 'Health Services Research', 'Ill-Housed Persons', 'Hospitalization', 'Hospitals, Veterans', 'Humans', 'Length of Stay', 'Male', 'Mental Disorders', 'Mental Health Services', 'United States', 'Veterans']"
304,"[-1.1879488  -0.19570623  0.27397493 -0.29163477 -0.27567017  0.3918924
  0.68944085 -0.1599609  -1.2455971   0.30345866  1.4049165   0.2617335
  0.32782805 -0.9426688  -0.07817927 -1.2786322   0.9451843   0.5761941
 -1.673083   -0.10243486 -0.40357724 -0.26902092 -0.4601621   0.7914448
  1.1324217   0.8568382   0.3570084  -0.6979071   0.32364395 -1.2960042 ]",10.1007/BF02790478,"['Ambulatory Care', 'Behavioral Research', 'Bias', 'Case Management', 'Commitment of Mentally Ill', 'Community Mental Health Services', 'Confounding Factors, Epidemiologic', 'Ethics, Medical', 'Health Services Research', 'Humans', 'Mentally Ill Persons', 'North Carolina', 'Outcome Assessment, Health Care', 'Patient Selection', 'Randomized Controlled Trials as Topic', 'Reproducibility of Results', 'Research Subjects']"
305,"[-0.77739775 -0.00167242  0.5512671  -0.6133098  -0.51953894  0.59249806
  0.87250054  0.52779865 -0.0207066   0.14819369  1.0734398   0.9420828
  0.68176335 -1.3912123  -0.3425731  -1.2086104   0.89866513  0.16493663
 -0.8078618   0.18509337  0.24820203 -0.50200474 -0.20395614  0.35856366
  1.315983    0.63169885  0.87059516 -0.7114865   0.81745    -0.4457473 ]",10.1007/BF02790483,"['Adult', 'Aged', 'Comorbidity', 'Health Care Reform', 'Health Status', 'Humans', 'Israel', 'Mental Disorders', 'Middle Aged', 'Morbidity', 'Patient Discharge', 'Registries']"
306,"[-0.9550645  -0.15080853  0.36405718 -0.55548775 -0.21982536  0.6621735
  0.95005244  0.13492395 -0.6469164   0.27146995  1.1200792   0.39463162
  0.8735062  -0.78733665 -0.23799276 -1.3032873   1.3555098   0.57823914
 -1.5267209  -0.04012673 -0.08046772 -0.3048912  -0.19527626  0.4735824
  1.3885101   1.0509405   0.43929774 -1.0930887   0.47134495 -1.2058718 ]",10.1007/BF02790486,"['Community Mental Health Services', 'Hospitals, University', 'Humans', 'Interinstitutional Relations', 'Internship and Residency', 'Massachusetts', 'Organizational Objectives', 'Psychiatry', 'State Government', 'Total Quality Management']"
307,"[-0.99094975 -0.17926273  0.1963521  -0.19847582 -0.02894841  0.38274142
  0.39479986 -0.06006924 -1.2630768   0.3436196   0.93264586 -0.12090892
  0.29748887 -0.50653166 -0.02404368 -0.82523364  0.4305373   0.6518204
 -1.3338313  -0.18405715 -0.31471756 -0.3223571  -0.46071383  0.7668927
  0.732077    0.6240843   0.09876787 -0.5929938   0.16335036 -1.2929084 ]",10.1007/BF02786328,"['Amino Acid Sequence', 'Arthritis, Rheumatoid', 'HLA-DR Antigens', 'HLA-DR4 Antigen', 'Humans', 'Molecular Sequence Data']"
308,"[ 0.0387389  -0.05496844  0.03289874  0.04359258 -0.02855974  0.01757149
 -0.01083681  0.06939837 -0.15021002 -0.01048478  0.15365262 -0.084089
  0.10219893 -0.0112766  -0.09509084 -0.13746153  0.17109816  0.14855072
 -0.22363548 -0.08511154  0.10803695  0.02578231 -0.0177448   0.07778942
  0.13967709  0.12341173 -0.04255724 -0.20047836  0.01401988 -0.24804707]",10.1007/s11626-997-0026-1,"['Cell Culture Techniques', 'Epithelial Cells', 'Humans', 'Nasal Mucosa']"
309,"[-1.0915337  -0.24978542  0.08267482 -0.30440384  0.3764137   0.52672154
  0.29116    -0.23482351 -1.9651481   0.15182337  0.60583496  0.05435191
  0.89531577 -0.3399169  -0.3604915  -0.17884192  0.6091431   0.8160961
 -2.2271683  -0.5267692  -0.56508183 -0.63903105 -1.1155804   0.56469715
  1.7440706   0.71568674 -0.06994773 -0.8802856   0.68643945 -2.0996501 ]",10.1007/BF02736860,"['Animals', 'Antibodies, Monoclonal', 'Antibody Specificity', 'Antigens, Surface', 'Cerebral Cortex', 'Gene Expression Regulation, Developmental', 'Hippocampus', 'Immunoglobulin G', 'Mice', 'Mice, Inbred BALB C', 'Nerve Tissue Proteins', 'PC12 Cells', 'Phosphorylation', 'Rabbits', 'Rats', 'Rats, Inbred Strains', 'Retina', 'Silver Staining', 'Syntaxin 1']"
310,"[-1.2045544  -0.2906696   0.29013488 -0.03158808 -0.16836694  0.33398312
  0.64968127  0.5567537  -1.7864598  -0.064657    1.0302373  -0.23995352
  0.03474604  0.26196256  0.39222708 -0.96092516  0.57293576  1.2568655
 -1.974763   -0.0706642  -0.4266603   0.02205334 -0.44790566  1.3979372
  0.83380437  0.7190909  -0.13242067 -0.73670286  0.30578524 -1.8027214 ]",10.1007/s11626-997-0029-y,"['Actins', 'Animals', 'Cell Division', 'Cell Membrane Permeability', 'Cells, Cultured', 'Coculture Techniques', 'Endothelium, Vascular', 'Membranes, Artificial', 'Muscle, Smooth, Vascular', 'Peptidyl-Dipeptidase A', 'Polyethylene Terephthalates', 'Proteins', 'Pulmonary Artery', 'Swine', 'von Willebrand Factor']"
311,"[-1.3730713  -0.89446294  1.3175834   0.90025306  0.42692944  0.43034917
  0.23010297 -0.6632544  -2.8879905  -1.5612139  -0.3423142   0.7689646
 -0.40678513  2.1699598  -0.12687045 -1.391336   -1.0679843   2.3267262
 -4.781078   -0.29597312 -1.9695244   0.7334614  -0.33317843  2.3734229
  0.91657704 -0.1643236  -1.1640888  -0.9952254  -0.64021564 -3.3064487 ]",10.1007/BF02736864,"['Animals', 'Base Sequence', 'Blotting, Northern', 'Blotting, Western', 'Choline O-Acetyltransferase', 'Fibroblasts', 'Gene Deletion', 'Gene Expression Regulation, Enzymologic', 'Genes, Reporter', 'HeLa Cells', 'Humans', 'Molecular Sequence Data', 'Neuroblastoma', 'Phosphopyruvate Hydratase', 'Promoter Regions, Genetic', 'Rats', 'Transfection']"
312,"[-0.9815815   0.293595    0.5141254  -0.11521363 -0.10700279  0.55021983
  0.47894135 -0.10693178 -0.8804805   0.6333459   0.9758793   0.89559036
  0.16055143 -1.6781292   0.18138514 -1.2251813   0.9113429   0.4567828
 -0.86405337  0.3755986  -0.30793804 -0.54150414 -0.79094625  0.9026821
  1.0271677   0.43059513  0.20392723 -0.45086706  0.5365107  -0.768648  ]",10.1007/BF02790477,"['Adolescent', 'Adult', 'Alcoholism', 'Ambulatory Care', 'California', 'Female', 'Health Maintenance Organizations', 'Humans', 'Logistic Models', 'Male', 'Markov Chains', 'Outcome Assessment, Health Care', 'Patient Compliance', 'Predictive Value of Tests', 'Prognosis']"
313,"[-1.6076502  -0.18525082 -0.26341367 -0.3467402  -0.3017566   0.7951503
  0.27743784  1.1161557  -1.841302    0.41168573  1.2041363   0.2935918
 -0.6585826  -0.89877105  0.3549791  -1.9475788   0.49188736  1.8772781
 -1.7176331   0.5647752  -0.50989026 -0.8117282  -0.6766736   1.9013405
  0.8726447   1.0313466  -0.15232067 -0.24033658  0.7858946  -1.5812358 ]",10.1007/s11626-997-0032-3,"['Apolipoproteins', 'Caco-2 Cells', 'Cell Differentiation', 'Humans', 'Lipid Metabolism', 'Lipids', 'Lipoproteins', 'Oleic Acid']"
314,"[-1.6764516  -0.30142844  0.6210946  -0.865217   -0.52402616  0.4085947
  0.68702173  0.09572877 -1.5056095   0.5658519   1.7248697   0.3614386
  0.38000798 -0.6109422   0.10103384 -1.2328342   0.38727492  0.82251763
 -1.68815    -0.03324746 -0.72969353 -0.3604162  -0.51634854  0.6639258
  0.81308323  0.78694826  0.572192   -0.68966544  0.54471207 -1.446376  ]",10.1007/BF02916247,"['Adolescent', 'Affective Symptoms', 'Child', 'Child Abuse, Sexual', 'Child Behavior Disorders', 'Child, Preschool', 'Factor Analysis, Statistical', 'Female', 'Humans', 'Male', 'Mandatory Reporting', 'Observer Variation', 'Personality Assessment', 'Psychometrics', 'Reproducibility of Results']"
315,"[-1.5810308  -1.1022071  -0.28766885  0.08798259 -0.31175563 -0.02353962
  0.7687881   0.49096343 -3.0160942   0.25628206  1.3452394  -1.0662465
 -1.1242069   0.64656717  0.8216311  -0.32572266  0.04272102  1.6206042
 -1.8471296  -0.7699578  -1.0336106  -0.11010119 -0.3903605   1.498523
  1.4389002   0.956075   -0.6340393  -0.3529956   0.45989552 -2.9895258 ]",10.1007/BF02736861,"['Animals', 'Cell Differentiation', 'Dose-Response Relationship, Drug', 'Nerve Growth Factors', 'Neurites', 'PC12 Cells', 'Phosphatidylinositol 3-Kinases', 'Phosphotransferases (Alcohol Group Acceptor)', 'Protein Kinase C', 'Protein Kinase C beta', 'Proto-Oncogene Proteins', 'Rats', 'Receptor Protein-Tyrosine Kinases', 'Receptor, Nerve Growth Factor', 'Receptor, trkA', 'Receptors, Nerve Growth Factor', 'Signal Transduction', 'Transcription Factor AP-1', 'Transfection', 'Type C Phospholipases']"
316,"[-2.0338776  -0.5635692   0.26544333 -0.68949497 -0.15106782 -0.04804702
  0.39678222 -0.5645269  -2.5909302   0.93585485  1.8035493  -0.6669419
  0.35479856 -0.80243844  0.45720968 -1.0911078   0.19322772  0.89267063
 -1.9002718  -0.48047256 -0.94466394 -0.06497881 -0.7020372   1.3236369
  0.65588915  1.1178409   0.45009562 -0.09182448 -0.19538207 -1.1149638 ]",10.1007/BF02916246,"['Antipsychotic Agents', 'Depression', 'Humans', 'Models, Statistical', 'Psychiatric Status Rating Scales', 'Psychometrics', 'Regression Analysis', 'Schizophrenia', 'Schizophrenic Psychology']"
317,"[-0.57777005 -0.29287085  0.12845837 -0.21293697 -0.074504    0.16899295
  0.23113504  0.00918489 -0.9023935   0.06067391  0.77902204 -0.13571522
  0.19853929 -0.17084582 -0.1416137  -0.6482641   0.3493747   0.47770083
 -1.1868542  -0.170011   -0.12110533  0.01755334 -0.23462774  0.37903836
  0.6843118   0.45939657  0.02387921 -0.54267865  0.13328041 -0.9940149 ]",10.1007/BF02736863,"['Adenylyl Cyclase Inhibitors', 'Adenylyl Cyclases', 'Animals', 'Base Sequence', 'COS Cells', 'Caenorhabditis elegans', 'Chromosome Mapping', 'Cloning, Molecular', 'DNA, Complementary', 'Gene Expression', 'Molecular Sequence Data', 'Mutation', 'Receptors, Serotonin', 'Sequence Homology, Amino Acid', 'Serotonin']"
318,"[-2.153926   -0.52212197  0.4695648  -0.66348714  0.09298463  0.25076097
  0.69287467 -0.7154532  -1.4025661   0.13822941  1.5165652   0.43006298
  0.28943384 -1.6167614  -0.46203735 -1.1302081   0.5685309   0.21784551
 -1.3442674  -0.03714367 -0.95627284 -0.7623478  -0.8203974   1.0576277
  1.1713445   0.06957467  0.779539   -0.02058168  0.3204371  -1.1583145 ]",10.1007/BF02785917,"['Chemotherapy, Adjuvant', 'Humans', 'Neoplasm Recurrence, Local', 'Pancreatic Neoplasms']"
319,"[-0.8495952  -0.1938488   0.22154468 -0.27425867 -0.1501282   0.21133941
  0.42387673 -0.05937868 -1.2436132   0.5040101   1.403113    0.06757784
  0.38558638 -0.81693846 -0.35335422 -1.1397626   0.55126417  0.65772
 -1.6644517  -0.16565354 -0.23916912 -0.19697036 -0.5550865   0.626656
  0.9618051   0.6245733   0.19087414 -0.84891576  0.3487845  -1.1896664 ]",10.1007/BF02916254,"['Adolescent', 'Adult', 'Dominance, Cerebral', 'Dopamine', 'Female', 'Humans', 'Magic', 'Male', 'Neuropsychological Tests', 'Orientation', 'Reference Values', 'Schizophrenia', 'Schizophrenic Psychology', 'Sensory Deprivation', 'Stereognosis']"
320,"[-0.85703474 -0.22370824  0.31209072 -0.47350785 -0.11622522  0.3476162
  0.7649016  -0.08762538 -0.5293801   0.17380361  1.0276421   0.4909079
  0.8101597  -0.86018074 -0.31055582 -1.0590131   1.119607    0.43834904
 -0.9901673   0.00409988  0.18746829 -0.44304445 -0.1245072   0.26709285
  1.2142131   0.8211726   0.4887002  -0.6241121   0.38587007 -0.9583708 ]",10.1007/BF02898513,"['Adult', 'Chicago', 'Child', 'Child Abuse', 'Ethics, Medical', 'Female', 'Humans', 'Mental Disorders', 'Mental Health Services', 'Parenting', 'Psychometrics']"
321,"[-0.24492314 -0.08319249  0.12412988 -0.04044442 -0.03312716  0.10135765
  0.16590019 -0.02759684 -0.40700626  0.06398297  0.4192749   0.01942457
  0.15941726 -0.26220223 -0.11223749 -0.3363724   0.31136417  0.21773611
 -0.53696287 -0.08472545 -0.05233381 -0.06108435 -0.21308088  0.2336033
  0.36065704  0.17972694  0.06798437 -0.32401174  0.05052378 -0.41079846]",10.1007/BF02785915,"['Acute Disease', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Humans', 'Male', 'Middle Aged', 'Octreotide', 'Pancreatitis']"
322,"[-1.1674956  -0.17265478  0.37586194 -0.50038314 -0.22719418  0.5498358
  0.7228767   0.00791242 -1.1790855   0.12456059  1.3316712   0.17011486
  0.4917855  -0.5674687  -0.26525798 -1.1490693   0.8209488   0.61404383
 -1.8837417  -0.0068307  -0.18089175 -0.2710134  -0.38626647  0.7613114
  0.957139    0.66467553  0.34179735 -0.7998988   0.2980328  -1.163939  ]",10.1007/BF02916248,"['Adolescent', 'Anorexia Nervosa', 'Cell Count', 'Cerebral Cortex', 'Death, Sudden', 'Dendrites', 'Female', 'Humans', 'Nerve Regeneration', 'Neuronal Plasticity', 'Neurons', 'Reference Values']"
323,"[-0.8170588   0.02760581  0.18021491 -0.2643941  -0.26749766  0.10047198
  0.5372667   0.14307599 -1.1451719   1.0741619   1.7842366   0.89262855
 -0.10532009 -1.7885827   0.36470726 -1.1667093   0.46152252  0.5676625
 -1.0729992  -0.2110015  -0.17960031 -0.54875016 -0.8514302   0.8775467
  0.8047201   0.725781    0.38011166 -0.23072018  0.6007067  -0.6055846 ]",10.1007/BF02916249,"['Adult', 'Aged', 'Bipolar Disorder', 'Depressive Disorder', 'Female', 'Humans', 'Male', 'Middle Aged', 'Personality Assessment', 'Personality Development', 'Personality Disorders', 'Personality Inventory', 'Psychometrics', 'Reproducibility of Results']"
324,"[-1.2402453  -0.38363746  0.4433345  -0.37049654 -0.15294842  0.6359093
  0.68393     0.5091006  -1.5322682  -0.12854582  1.0401585   0.2422543
  0.00559615  0.17991932  0.19499011 -1.1697463   0.8084186   1.0992001
 -2.1092715  -0.07780108  0.09511892 -0.3921064  -0.5259637   1.2887218
  0.97802675  0.66263264 -0.09735391 -0.75161415  0.08672289 -1.9166689 ]",10.1007/s11626-997-0031-4,"['Actins', 'Animals', 'Cell Adhesion', 'Cell Movement', 'Cells, Cultured', 'Cricetinae', 'Fibroblasts', 'Fibronectins', 'Ganglia, Spinal', 'Macrophages', 'Male', 'Neurites', 'Neurons', 'Rats', 'Rats, Sprague-Dawley', 'Tendons', 'Vinculin']"
325,"[-1.1853857  -0.2986242   0.26129556 -0.35466152 -0.16485536  0.19489601
  0.4901864  -0.03187454 -1.0705333   0.45222875  1.230995    0.42050278
  0.3181483  -1.1069651  -0.13237438 -1.1502932   0.64950615  0.6512651
 -1.1237836   0.15972453 -0.30301115 -0.333313   -0.63945967  0.5961472
  1.0371052   0.60175204  0.50648534 -0.3610529   0.4712967  -1.003586  ]",10.1007/BF02916250,"['Adult', 'Expressed Emotion', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Patient Readmission', 'Personality Assessment', 'Prospective Studies', 'Psychometrics', 'Reproducibility of Results', 'Schizophrenia', 'Schizophrenic Psychology', 'Treatment Outcome']"
326,"[-1.4686476  -0.23290648  0.5855109  -0.8104215  -0.20739715  0.7224556
  1.6256635   0.26880974  0.25970492  0.3327805   1.0893844   1.2646952
  1.3133136  -1.562487   -0.05186713 -1.6198106   2.0848439   0.43258077
 -0.5128632   0.2977495   0.3501174  -0.72466356  0.1729938   0.08748131
  1.8546939   1.4107451   0.99271125 -0.45239767  0.8524437  -0.79858786]",10.1007/BF02898510,"['Adult', 'Community Mental Health Services', 'Crime', 'Female', 'Health Services Research', 'Humans', 'Male', 'Mental Disorders', 'Police', 'Wisconsin']"
327,"[-0.18233962  0.21803057  0.5634192   0.1789436  -0.7380081   0.48372188
  0.3855849   0.19071312 -1.0111307   1.4091928   2.5247939   1.6547914
 -0.39119634 -2.6575656   0.637816   -1.7685461   0.02966431  0.88190836
 -1.198183   -0.108182   -0.49240837 -0.39305612 -1.1390206   1.1585672
  0.9282999   0.839056    0.38604483 -0.7887785   1.1624892  -0.09199855]",10.1007/BF02916252,"['Adult', 'Antimanic Agents', 'Carbamazepine', 'Female', 'Humans', 'Lithium Carbonate', 'Male', 'Middle Aged', 'Patient Readmission', 'Patient Satisfaction', 'Psychiatric Status Rating Scales', 'Psychotic Disorders', 'Survival Analysis', 'Treatment Outcome']"
328,"[-1.5338466  -0.12546168 -0.04950539  0.4723441  -0.02928475  0.7012275
  0.53289634  0.5761639  -2.782085    0.7467757   1.1260587  -0.38965797
 -0.23769079 -0.8044579   0.78828657 -0.73022175 -0.19956861  1.2795235
 -1.9927785  -0.11194045 -0.96421057 -0.10398588 -1.4854381   2.032796
  1.2452259   0.7473503  -0.16237041 -0.89445287  0.87120014 -2.3723571 ]",10.1007/s11626-997-0033-2,"['8-Bromo Cyclic Adenosine Monophosphate', 'Aurintricarboxylic Acid', 'Breast Neoplasms', 'Carcinoma', 'Cell Survival', 'Cycloheximide', 'Cytosol', 'Epidermal Growth Factor', 'Heat-Shock Proteins', 'Humans', 'Insulin-Like Growth Factor I', 'Isoelectric Point', 'Mitogens', 'Molecular Weight', 'Phosphoproteins', 'Phosphorylation', 'Phosphoserine', 'Protein Synthesis Inhibitors', 'Tetradecanoylphorbol Acetate', 'Time Factors', 'Tumor Cells, Cultured']"
329,"[-1.0515869  -0.30704468  0.31433377 -0.37750936 -0.11802734  0.5626124
  1.0529453   0.33775514 -0.7839014   0.44543278  1.2888154   0.7068673
  0.9298063  -1.1969938   0.07859399 -1.3318636   1.3325808   0.5536663
 -0.9309552   0.06472093 -0.04265191 -0.4396894  -0.25633386  0.5461573
  1.557507    1.1059941   0.46099252 -0.5526844   0.6765695  -1.1314713 ]",10.1007/BF02898512,"['California', 'Capitation Fee', 'Costs and Cost Analysis', 'Delivery of Health Care, Integrated', 'Family', 'Health Policy', 'Humans', 'Mental Health Services']"
330,"[-6.82484533e-04 -1.97421815e-02 -1.12578273e-03  1.99871495e-01
 -9.86228660e-02  5.36645532e-01  1.27336875e-01  1.14572205e-01
 -8.54526937e-01  4.04202908e-01  1.22922468e+00  5.45081139e-01
  1.90258294e-03 -1.21402526e+00 -1.46511579e-02 -1.15822005e+00
  1.10969484e+00  2.40645543e-01 -1.04549336e+00  1.64491385e-01
  1.42145962e-01 -4.53960657e-01 -4.70169097e-01  7.93761671e-01
  8.53278160e-01  6.01339221e-01 -1.65985525e-02 -6.15804791e-01
  3.08054775e-01 -1.07666588e+00]",10.1007/BF02785914,"['Gelatinases', 'Glycoproteins', 'Humans', 'Matrix Metalloproteinase 2', 'Metalloendopeptidases', 'Pancreatic Neoplasms', 'Proteins', 'Tissue Inhibitor of Metalloproteinase-2', 'Tissue Inhibitor of Metalloproteinases']"
331,"[-0.9163288  -0.16982314  0.20194478 -0.12289052 -0.16332473  0.43350518
  0.48592633 -0.06708783 -1.3333793   0.10485798  0.9633652   0.12739965
  0.15996258 -0.33578143 -0.12610598 -1.0027357   0.67677444  0.87010175
 -1.5624354   0.00218885 -0.32106367 -0.26093826 -0.4498261   0.8869491
  0.8890972   0.56664336  0.11273716 -0.61120856  0.11287507 -1.3975282 ]",10.1007/BF02786325,"['Amino Acid Sequence', 'Animals', 'Antigens, CD', 'Humans', 'Killer Cells, Natural', 'Lymphocyte Activation', 'Molecular Sequence Data', 'Protein-Tyrosine Kinases', 'Receptors, IgG', 'Receptors, Immunologic', 'Receptors, KIR', 'Signal Transduction']"
332,"[-1.0236816  -0.19048646  0.30336872 -0.08974773 -0.29708833  0.45272473
  0.5769753  -0.02038012 -1.2660481   0.51548094  1.6187707   0.6049273
  0.1418012  -1.4976279  -0.06983885 -1.5703824   1.1301323   0.7673174
 -1.6474748   0.04994855 -0.1868344  -0.4300409  -0.7100995   1.0210024
  1.2992551   1.0459449   0.2912846  -0.98220885  0.5333143  -1.2847348 ]",10.1007/BF02916253,"['Adult', 'Alcohol Deterrents', 'Alcoholism', 'Aldehyde Dehydrogenase', 'Ambulatory Care', 'Combined Modality Therapy', 'Humans', 'Internal-External Control', 'Long-Term Care', 'Male', 'Middle Aged', 'Patient Care Team', 'Patient Participation', 'Substance Abuse Detection', 'Treatment Outcome']"
333,"[-0.45327777 -0.22135238  0.20072432  0.4877387   0.1270074   0.4635483
 -0.03900569 -0.38094285 -1.1951553   0.19930981  1.5424507   0.47672656
  0.26252785 -1.9167693  -0.7828787  -1.198816    1.5936048   0.01257871
 -1.2944224   0.1451136  -0.03561544 -0.71452993 -0.94322795  1.0233085
  1.2498609   0.36474347  0.0629927  -0.5809866   0.3981577  -1.4263965 ]",10.1007/BF02785921,"['Antineoplastic Combined Chemotherapy Protocols', 'Chemotherapy, Adjuvant', 'Humans', 'Pancreatic Neoplasms']"
334,"[-0.14885107 -0.04869825  0.17605655  0.45735735  0.3529936   0.63364315
 -0.12947927 -0.49094442 -0.43509746 -0.16269581  1.3639228   1.1107608
  0.27164084 -2.5898309  -1.4197588  -0.9282465   2.8641777  -0.35864678
 -1.526284    0.42896262  0.46810228 -1.4187312  -1.1727098   1.1349503
  1.712182    0.08446028  0.5099501  -1.2782009   0.4461567  -1.6373771 ]",10.1007/BF02785919,"['Antibodies, Monoclonal', 'Clinical Trials as Topic', 'Humans', 'Immunologic Factors', 'Pancreatic Neoplasms']"
335,"[-0.07407016 -0.06755719  0.5608054   0.2611353  -0.04206775  0.4647804
  0.43250534 -0.257185   -1.2366301   0.3085653   1.3933446   0.8656798
  0.37175882 -1.6176311  -0.07552189 -1.2475277   1.0510423   0.5905544
 -1.806652    0.31494087 -0.02284941 -0.28210288 -0.6631811   1.1816837
  0.9418905   0.7245888   0.15392813 -1.0557189   0.4042313  -1.0702393 ]",10.1007/BF02742917,"['Aged', 'Contrast Media', 'Female', 'Gadolinium', 'Gadolinium DTPA', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Organometallic Compounds', 'Pancreas', 'Pancreatic Diseases', 'Pancreatic Neoplasms', 'Pentetic Acid', 'Tomography, X-Ray Computed']"
336,"[-0.55867606 -0.02221291  0.3149994   0.03110801  0.1571195   0.59293544
  0.3084512  -0.19736528 -0.7795186   0.20830382  1.3282194   0.6839199
  0.6088489  -1.5775237  -0.6878918  -1.2419659   1.8444704   0.18778224
 -1.541631    0.24843194  0.14809324 -0.6769502  -0.67340124  0.84215844
  1.1957856   0.41309142  0.22619683 -0.8808772   0.24412042 -1.4148213 ]",10.1007/BF02785923,"['Carcinoma, Ductal, Breast', 'Combined Modality Therapy', 'Humans', 'Palliative Care', 'Pancreatic Neoplasms']"
337,"[-1.0719998  -0.20179778  0.17344435 -0.36893234  0.033914    0.3407808
  0.735102   -0.18706869 -1.3781976   0.40057266  1.1869509   0.13694054
  0.2972894  -0.80095744 -0.129741   -1.3604367   0.97124416  0.7604321
 -1.7015941   0.14194457 -0.21842472 -0.21137185 -0.6078673   1.0472828
  0.8947784   0.62235004  0.18797936 -0.87385744  0.07798254 -1.3908836 ]",10.1007/BF02742916,"['Barium Sulfate', 'Contrast Media', 'Humans', 'Intestinal Neoplasms', 'Intestine, Small', 'Tomography, X-Ray Computed']"
338,"[ 0.31403908  0.33863404 -0.0292646   0.86715597 -0.4467778   0.4495588
 -0.02833512  0.16034622 -1.0058337   0.96683836  2.1799173   1.1521503
 -0.4257218  -2.92012    -0.01834031 -1.7840822   1.0516638   0.25791714
 -0.834316    0.1725473  -0.19499283 -0.6603398  -1.1024464   1.1381383
  1.1526653   0.7747018   0.05851881 -0.5228343   1.0512635  -0.8035719 ]",10.1007/BF02785918,"['Antineoplastic Combined Chemotherapy Protocols', 'Fluorouracil', 'Humans', 'Pancreatic Neoplasms']"
339,"[ 0.11165364  0.16356453  0.02970974  1.1207222  -0.3783285   0.5628541
  0.13408998  0.16730186 -0.9520689   1.1103504   2.1131163   1.9218271
 -0.8128995  -3.665896    0.08793183 -1.7851317   0.87221956  0.15253468
 -0.579976    0.5063851  -0.30510497 -0.851253   -1.607928    1.6144266
  1.1583815   0.21012437  0.32602438 -0.44703665  1.2791685  -0.56482863]",10.1007/BF02785920,"['Combined Modality Therapy', 'Humans', 'Pancreatic Neoplasms', 'Retrospective Studies']"
340,"[-0.72596234 -0.22452678  0.16659327 -0.1390216  -0.0635098   0.14523351
  0.38764605 -0.2547775  -1.007716    0.08903598  0.87994015 -0.13455057
  0.33866033 -0.3649518  -0.26835638 -0.6834846   0.7021434   0.4123895
 -1.2699153  -0.15331557 -0.08643559 -0.16800693 -0.3396457   0.5076354
  0.7094925   0.5051196   0.11553073 -0.5696114   0.09557533 -1.013888  ]",10.1007/BF02742924,"['Adolescent', 'Adult', 'Child', 'Diagnosis, Differential', 'Humans', 'Infant', 'Male', 'Scrotum', 'Sensitivity and Specificity', 'Testicular Diseases', 'Testicular Neoplasms', 'Ultrasonography, Doppler']"
341,"[-0.21983261  0.95190877  0.65821207  0.46399787 -0.93249655  0.19571242
  1.2475492  -1.0889165  -1.2435471   0.5969958   1.3648965  -0.25081658
  0.54834396 -0.80678016 -0.60398436 -1.7740746   0.9984432   1.2679098
 -2.4310777  -0.15697782 -0.8053016   0.2446077  -0.5155007   1.0319157
  0.7517429   0.45148796  0.639518   -2.3487852   0.0755628  -0.74546784]",10.1007/BF02742929,"['Aortic Dissection', 'Aorta, Abdominal', 'Aorta, Thoracic', 'Aortic Aneurysm, Abdominal', 'Evaluation Studies as Topic', 'Female', 'Follow-Up Studies', 'Humans', 'Magnetic Resonance Angiography', 'Male', 'Middle Aged', 'Time Factors']"
342,"[-0.6761904   0.10429291  0.46206933  0.26059407 -0.36549643  0.10659817
  0.57272756 -0.05637474 -1.1258253   0.7450381   1.2556368   0.64678824
 -0.06292316 -1.3691161   0.00399569 -1.6532365   0.89698285  0.99406934
 -1.2471305   0.24909954  0.03172942 -0.69867396 -0.67703474  1.3488617
  0.88994014  0.6278085   0.12126    -0.571903    0.26059106 -1.191907  ]",10.1007/BF02742926,"['Angiomyolipoma', 'Carcinoma, Renal Cell', 'Female', 'Hemorrhage', 'Humans', 'Kidney Diseases', 'Kidney Neoplasms', 'Male', 'Middle Aged', 'Rupture, Spontaneous', 'Tomography, X-Ray Computed']"
343,"[-0.7801429   0.15851666  0.7046047   0.19849327 -0.34986737  0.6159531
  0.7157014   0.19324091 -1.1623368   0.16530664  1.6875801   0.60434663
  0.07803706 -1.7218245  -0.2644314  -1.614447    0.7972344   1.1680036
 -2.2468078  -0.1636977  -0.41218308 -0.32143342 -0.8674807   1.4829994
  1.38924     0.59943813  0.21563329 -1.812628    0.72364    -0.87350476]",10.1007/BF02742933,"['Blood Flow Velocity', 'Calcitriol', 'Female', 'Follow-Up Studies', 'Humans', 'Hyperparathyroidism, Secondary', 'Male', 'Middle Aged', 'Parathyroid Glands', 'Regional Blood Flow', 'Renal Dialysis', 'Retrospective Studies', 'Time Factors', 'Ultrasonography, Doppler, Color', 'Uremia']"
344,"[ 0.09040926 -0.03747184  0.05247379  0.0467506  -0.0377271   0.06335828
  0.00473788  0.04682273 -0.11613204  0.03270794  0.20156766 -0.02978286
  0.13786948 -0.06598356 -0.12485179 -0.17750187  0.21136406  0.10583755
 -0.22118382 -0.08142035  0.17171505  0.03478727 -0.05343669  0.0281973
  0.18383734  0.13683693 -0.01758145 -0.23804538  0.03325548 -0.22060281]",10.1007/BF02742922,"['Hodgkin Disease', 'Humans', 'Immunosuppression Therapy', 'Lymphoma, Non-Hodgkin', 'Lymphoproliferative Disorders', 'Organ Transplantation', 'Postoperative Complications']"
345,"[-0.4239987   0.0046859   0.39997223  0.09868359 -0.35793284  0.26113033
  0.5337569   0.03231833 -1.2269896   0.3382311   1.271398    0.47063425
  0.36691004 -1.0377526   0.05752946 -1.3622441   0.7319011   0.8301121
 -1.6884168  -0.03619302 -0.07576469 -0.2171855  -0.5873471   0.8851376
  0.8397684   0.640443    0.2591757  -0.9766535   0.44065785 -0.99782974]",10.1007/BF02742935,"['Breast Neoplasms', 'Contrast Media', 'Female', 'Gadolinium', 'Gadolinium DTPA', 'Humans', 'Lung Neoplasms', 'Magnetic Resonance Imaging', 'Male', 'Melanoma', 'Middle Aged', 'Organometallic Compounds', 'Pentetic Acid', 'Retrospective Studies', 'Spinal Cord', 'Spinal Cord Neoplasms']"
346,"[-0.6406329  -0.12203272  0.46334943 -0.12760805 -0.12207968  0.29234996
  0.5332674  -0.21610571 -1.2207773   0.2789192   1.1829922   0.29372746
  0.40565673 -0.75521    -0.22992045 -1.1630886   0.9667111   0.8305573
 -1.8168263  -0.03169989  0.01569115 -0.1853342  -0.5683813   0.81527007
  0.9177934   0.7167891   0.20470877 -0.94589895  0.33418316 -1.241967  ]",10.1007/BF02742932,"['Bronchopulmonary Sequestration', 'Humans', 'Image Processing, Computer-Assisted', 'Male', 'Middle Aged', 'Tomography, X-Ray Computed']"
347,"[-1.0361959  -0.27824265  0.31006145 -0.27812934 -0.07559327  0.05362605
  0.45341173 -0.33354524 -1.0853164   0.25804704  1.1281184  -0.11251235
  0.24167456 -0.6888416  -0.254341   -0.8784141   0.5939437   0.46175575
 -1.3937352  -0.12796035 -0.34937397 -0.20079851 -0.42927864  0.65707976
  0.76838624  0.4498144   0.23411825 -0.5511803   0.09238654 -1.0548235 ]",10.1007/BF02742925,"['Adult', 'Colic', 'Contrast Media', 'Female', 'Humans', 'Kidney Diseases', 'Male', 'Middle Aged', 'Tomography, X-Ray Computed', 'Urography']"
348,"[-0.72738427 -0.09618792  0.17423044 -0.3110871  -0.11390238  0.46976668
  0.49437582  0.16580252 -1.232764    0.55615574  1.3212974   0.64434844
  0.2334551  -1.2176921   0.05016213 -1.2656913   0.73101854  0.6846325
 -1.3072118   0.11344873 -0.12866369 -0.47842345 -0.5815665   0.7917748
  0.97636265  0.71478415  0.31425563 -0.53779763  0.44024056 -1.0113744 ]",10.1007/BF02900197,"['Adolescent', 'Child', 'Child, Preschool', 'Developmental Disabilities', 'Divorce', 'Emotions', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Psychiatric Status Rating Scales', 'Time Factors']"
349,"[-0.48849642  0.2539093   0.43276197  0.03517588 -0.18196741  0.4975001
  0.72082996 -0.30525035 -0.9264317  -0.03830697  1.1782295   0.5404237
  0.44483063 -1.1657827  -0.620344   -1.3208368   1.4226172   0.68942714
 -2.08368     0.24040927  0.17148621 -0.47892916 -0.70348245  0.9423828
  1.0250599   0.44468763  0.37793624 -1.2967044   0.31652212 -1.4092028 ]",10.1007/BF02742919,"['Biopsy', 'Female', 'Humans', 'Magnetic Resonance Angiography', 'Male', 'Middle Aged', 'Pancreas', 'Pancreatic Neoplasms', 'Portal Vein', 'Preoperative Care', 'Prospective Studies', 'Ultrasonography, Doppler']"
350,"[ 0.09989722  0.16548784  0.35199338  0.25583622 -0.2910557   0.349649
  0.4147185  -0.15342554 -1.0797081   0.41399652  1.2127283   0.3282598
  0.5112012  -1.1076602  -0.15423034 -1.2236104   0.7855536   0.7654246
 -1.680739   -0.18134448  0.02481594 -0.16622798 -0.5880361   0.8680878
  0.9677891   0.72327065  0.17131996 -1.3669635   0.4342696  -0.95045567]",10.1007/BF02742936,"['Case-Control Studies', 'Female', 'Humans', 'Image Processing, Computer-Assisted', 'Intervertebral Disc Displacement', 'Lumbar Vertebrae', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Myelography', 'Nerve Compression Syndromes', 'Sensitivity and Specificity', 'Spinal Nerve Roots', 'Spinal Stenosis']"
351,"[-0.61283404 -0.11975066  0.25917068 -0.2254291  -0.00141726  0.20262015
  0.48745292 -0.1292     -0.74828756  0.16970801  0.7041531   0.21513517
  0.26017058 -0.508563   -0.1656785  -0.8093014   0.6954236   0.45985693
 -1.0488564   0.10423055 -0.02519426 -0.29804677 -0.35040468  0.61943567
  0.61303973  0.37458512  0.22304851 -0.5630236   0.15922317 -0.8268463 ]",10.1007/BF02742927,"['Adrenal Gland Neoplasms', 'Aged', 'Female', 'Hemangioma, Cavernous', 'Humans', 'Magnetic Resonance Imaging', 'Middle Aged', 'Tomography, X-Ray Computed']"
352,"[-1.0027182   0.00438571  0.32495046 -0.28235975 -0.09554772  0.10444269
  0.6731459  -0.53483224 -1.2671103   0.13323714  1.055754    0.32047436
  0.41177705 -0.77247936 -0.46469072 -1.0105683   0.9366232   0.42323148
 -1.804691   -0.03216808 -0.1004854  -0.2073078  -0.57759744  0.6083143
  0.88351905  0.32050636  0.41646338 -0.8738495   0.31679243 -0.9394872 ]",10.1007/BF02742920,"['Adolescent', 'Adult', 'Diagnostic Imaging', 'Female', 'Humans', 'Hyperplasia', 'Liver', 'Liver Diseases', 'Liver Neoplasms', 'Liver Regeneration', 'Magnetic Resonance Imaging', 'Male', 'Retrospective Studies']"
353,"[-0.84083235  0.13145803  0.3120513   0.06390398 -0.39627948  0.41942677
  0.5255935   0.15568075 -0.6775577   0.66559696  1.4117041   0.86293215
 -0.1692391  -1.6065365   0.17910634 -1.535358    0.81856024  0.80694234
 -0.9803645   0.31087127 -0.24142589 -0.90256953 -0.68494695  1.1341379
  0.84470665  0.566795    0.39735702 -0.40519553  0.5910174  -0.71597683]",10.1007/BF02742921,"['Adult', 'Aged', 'Female', 'Gastrectomy', 'Gastrointestinal Agents', 'Glucagon', 'Humans', 'Male', 'Middle Aged', 'Neoplasm Staging', 'Observer Variation', 'Reproducibility of Results', 'Sensitivity and Specificity', 'Stomach', 'Stomach Neoplasms', 'Tomography, X-Ray Computed', 'Water']"
354,"[-1.5412513  -0.21964058  0.41780263 -0.63884676  0.00341469  0.2584949
  0.738761   -0.3729887  -1.2340703   0.24225357  1.4178942  -0.04116106
  0.4928512  -0.596821   -0.20036429 -1.0049412   0.8177147   0.58397657
 -1.9444488  -0.27516764 -0.5882365  -0.22645032 -0.5646343   0.6488201
  0.95780087  0.6552735   0.406028   -0.8676409   0.16173838 -1.3100702 ]",10.1007/BF02742937,"['Breast Neoplasms', 'Calcinosis', 'Female', 'Humans', 'Image Interpretation, Computer-Assisted', 'Mammography', 'Mass Screening', 'Radiographic Image Enhancement', 'Sensitivity and Specificity']"
355,"[-0.92864764 -0.17812648  0.37270308 -0.11581356 -0.09763087  0.38470584
  0.44974008 -0.17965671 -1.0316089   0.25247368  1.1824145   0.08869817
  0.39759445 -0.6401827  -0.31377912 -1.2661763   1.2376373   0.75539833
 -1.6645964  -0.07141206  0.05256953 -0.36304685 -0.50895935  0.9652877
  0.9765929   0.7359982   0.38413167 -0.909527    0.02341088 -1.4536706 ]",10.1007/BF02742931,"['Chronic Kidney Disease-Mineral and Bone Disorder', 'Diagnostic Imaging', 'Humans', 'Lung Diseases', 'Pericarditis', 'Peritoneal Dialysis, Continuous Ambulatory', 'Pulmonary Edema', 'Renal Dialysis', 'Tomography, X-Ray Computed', 'Uremia']"
356,"[ 0.81634545  0.93975323  0.19627602  0.62776285 -1.0096499   0.04707896
  0.9760473  -0.4964844  -1.6870492   1.0357388   1.8329399   1.1922991
  0.22013712 -2.2649913   0.76183677 -1.6030529   0.09255709  1.213768
 -1.6129771   0.09119438 -0.6808875  -0.3295229  -0.7150022   1.1461444
  0.5947285   0.67968845  0.31831646 -1.1262327   0.99155295  0.07463814]",10.1007/BF02742934,"['Contrast Media', 'Drug Combinations', 'Eye', 'Eye Enucleation', 'Eye Neoplasms', 'Gadolinium', 'Gadolinium DTPA', 'Humans', 'Infant', 'Magnetic Resonance Imaging', 'Meglumine', 'Neoplasm Staging', 'Organometallic Compounds', 'Pentetic Acid', 'Preoperative Care', 'Retinoblastoma']"
357,"[-0.61490923 -0.04993401  0.31029543 -0.3065316  -0.16113701  0.35115463
  0.44474784  0.14709678 -0.951465    0.19684461  0.95637333  0.15281306
  0.41884288 -0.71087307 -0.25014243 -0.97713387  0.5899747   0.58591473
 -1.4206359  -0.15073046 -0.02428622 -0.14668414 -0.33658525  0.7055968
  1.0049899   0.4415091   0.22869374 -0.9687766   0.5069111  -0.9433274 ]",10.1007/BF02900198,"['Aged', 'Aged, 80 and over', 'Dementia', 'Female', 'Humans', 'Male', 'Selection Bias']"
358,"[-0.22737399  0.17579134  0.33965656 -0.30464685 -0.29538104  0.734287
  0.42117792  0.04223559 -1.3539494   0.19534867  1.6374438   0.22719648
  0.63869023 -0.9694961   0.1632788  -1.3466457   0.8473135   1.2207417
 -2.4787285  -0.2315726   0.31162715 -0.23534286 -0.5029325   0.61514014
  1.4128244   1.0600246   0.20853955 -1.9461718   0.64851326 -1.3108692 ]",10.1007/BF02900195,"['Adult', 'Brain', 'Humans', 'Image Processing, Computer-Assisted', 'Magnetic Resonance Imaging', 'Male', 'Receptors, GABA-A', 'Tomography, Emission-Computed']"
359,"[-0.39853936  0.09252641  0.52039593  0.41151863 -0.2642926   0.42748496
  0.26754612  0.16692433 -0.9766839   0.5471653   1.7162565   0.85484636
  0.06453589 -1.6621464   0.30534554 -1.2832428   0.40715304  0.7651325
 -1.4460902  -0.03161168 -0.3617452  -0.06600065 -0.874566    1.0537908
  0.92103255  0.5976911   0.46203873 -1.1183527   0.8591759  -0.6121046 ]",10.1007/BF02742938,"['Aged', 'Breast', 'Breast Neoplasms', 'Estrogen Replacement Therapy', 'Female', 'Humans', 'Mammography', 'Mass Screening', 'Middle Aged', 'Postmenopause', 'Retrospective Studies', 'Time Factors']"
360,"[-1.2205675  -0.14055315  0.8265132  -0.5405231  -0.45466465  0.66389775
  0.6821487  -0.01846809 -1.1605068   0.8382331   1.2765418   0.6499887
  0.4011821  -1.2660941   0.1341273  -1.4964851   0.75588924  0.8548523
 -1.3000569   0.07832319 -0.3081261  -0.77042204 -0.7779679   1.2319944
  0.7810264   0.5184651   0.20212272 -0.53603166  0.37576643 -0.9392915 ]",Unknown,"['Adult', 'Benzamides', 'Double-Blind Method', 'Female', 'Humans', 'Male', 'Moclobemide', 'Monoamine Oxidase Inhibitors', 'Phobic Disorders']"
361,"[-1.0729139  -0.0305631   0.6552954   0.43477187 -0.41008097  0.09350906
  0.95428485 -0.4291953  -1.2161607   0.7147881   1.1597965   0.6863436
  0.24575713 -1.4452605  -0.28821394 -1.9443965   0.9820869   0.84209967
 -1.2821995   0.29582074 -0.10726361 -0.24815434 -1.0684098   0.8250232
  1.2154936   0.20496967  0.42105803 -1.2238015   0.27875447 -0.84176826]",10.1007/BF02742930,"['Aged', 'Aged, 80 and over', 'Animals', 'Aorta, Abdominal', 'Aortic Aneurysm, Abdominal', 'Blood Vessel Prosthesis', 'Dogs', 'Follow-Up Studies', 'Humans', 'Male', 'Middle Aged', 'Radiography', 'Renal Artery Obstruction', 'Stents', 'Time Factors', 'Vascular Patency']"
362,"[-0.9871961  -0.27504167  0.22008452 -0.21703424 -0.10057231  0.5990423
  0.7240758   0.33388272 -1.1021407   0.48419303  1.3311363   0.17247097
  0.19006002 -0.80489814 -0.09266133 -1.3988905   1.0118301   0.8004527
 -1.75065     0.15775189 -0.21521074 -0.3529531  -0.332182    0.74411774
  0.9191977   0.8138684   0.20294574 -0.95273376  0.3141857  -0.9855603 ]",10.1007/BF02900199,"['Adolescent', 'Adult', 'Age Distribution', 'Aged', 'Aged, 80 and over', 'Drug Prescriptions', 'Female', 'Humans', 'Iceland', 'Male', 'Middle Aged', 'Prevalence', 'Psychotropic Drugs', 'Sex Factors', 'Social Control, Formal']"
363,"[-1.139673   -0.6118659  -0.28016007 -0.95226693 -0.29401088  0.3176369
  0.6117579  -0.24550903 -1.7703543  -0.15784205  1.4430538  -0.34757274
  0.11009146  0.48898312 -0.51853216 -1.197322    0.75012606  0.9821387
 -2.375241   -0.3542031  -0.7309223   0.6814472  -0.38843694  0.15209903
  1.054004    0.6037905   0.37437782 -0.63456315 -0.21234405 -2.002     ]",10.1007/BF02740618,"['Adult', 'Animals', 'Cerebral Cortex', 'Humans', 'Mammals', 'Neuroglia', 'Neurons', 'Receptors, N-Methyl-D-Aspartate']"
364,"[-1.1297889  -1.1448349   0.25924516 -0.11128425  0.14020059  0.8536032
  0.43419877  0.70707136 -2.7484171   0.0799102   0.88988346 -0.47384107
  0.15745525  0.9731729   0.93709403 -1.3321681  -0.21785408  1.7140809
 -2.632481    0.15306675 -0.37099728  0.36572278 -0.12789124  1.0245888
  0.6739313   0.4545589  -0.67438555 -0.659304    0.14648473 -2.0986342 ]",10.1007/BF02736775,"['Animals', 'Cells, Cultured', 'Dronabinol', 'Female', 'Fetus', 'Male', 'Mesencephalon', 'Neurons', 'Piperidines', 'Pregnancy', 'Pyrazoles', 'Rats', 'Rats, Wistar', 'Receptors, Cannabinoid', 'Receptors, Drug', 'Rimonabant', 'Tyrosine 3-Monooxygenase']"
365,"[-0.37247342 -0.0656153   0.25558472  0.09639326 -0.22794631  0.35760963
  0.3372379   0.31359783 -1.24299     0.3338284   1.231849    0.42515662
  0.19774447 -0.76189685 -0.12742147 -1.0753713   0.7558005   0.8748033
 -1.7288274  -0.09917295  0.03827468 -0.1306937  -0.7365328   1.0132133
  1.0180993   0.66438955  0.01829331 -1.0137129   0.575792   -1.3298748 ]",10.1007/BF02736774,"['Aged', 'Aged, 80 and over', 'Aging', 'Alzheimer Disease', 'Apoptosis', 'Astrocytes', 'Biotin', 'Cell Nucleus', 'DNA Fragmentation', 'Female', 'Humans', 'Male', 'Neurons', 'Staining and Labeling', 'Uracil Nucleotides']"
366,"[-0.7156975  -0.02183078  0.5287351  -0.0494252  -0.3475892   0.41423655
  0.3075409   0.00838583 -0.9803856   0.5830103   1.1596333   0.6167662
  0.38191238 -1.2767413   0.05357315 -1.3892221   0.5326565   0.64927244
 -1.2107925   0.19912736  0.01831866 -0.44162035 -0.7691566   0.76363313
  1.0309491   0.5283557   0.06799936 -0.6311016   0.7058335  -0.9098113 ]",10.1007/BF02900201,"['Adult', 'Antipsychotic Agents', 'Dose-Response Relationship, Drug', 'Female', 'Haloperidol', 'Humans', 'Male', 'Middle Aged', 'Receptors, Dopamine D2', 'Schizophrenia']"
367,"[-0.25843275  0.01085095  0.2362662   0.08856128 -0.15300104  0.24846804
  0.36358458  0.17050491 -0.69723195  0.202086    1.0761648   0.46251774
  0.31447524 -0.86104566 -0.24767555 -1.0247018   0.7154585   0.6192966
 -1.3276974   0.0483922   0.37269565 -0.12479119 -0.49169052  0.56302446
  0.70285857  0.42093334  0.20514429 -0.90194577  0.45930153 -0.7505135 ]",10.1007/BF02900200,"['Adult', 'Bipolar Disorder', 'Female', 'Fluoxetine', 'Humans', 'Male', 'Middle Aged', 'Sleep Deprivation']"
368,"[-1.3894639  -0.5426637  -0.10317007 -0.04688289 -0.01235702  0.7222282
  0.6699599   0.44777068 -2.1241543  -0.05714155  1.0810056  -0.6959422
 -0.07944385  0.42607948  0.50427455 -1.1731266   0.70487905  1.195268
 -2.1698923   0.2883459  -0.3591433  -0.19101514 -0.27513114  1.1867139
  0.72029215  0.92141795 -0.16927445 -0.5519811  -0.1159663  -2.067012  ]",10.1007/BF02736777,"['Acetylcholine', 'Carcinoma, Embryonal', 'Cell Communication', 'Cell Count', 'Cell Differentiation', 'Choline O-Acetyltransferase', 'Gene Expression Regulation', 'Glutamic Acid', 'Neurons', 'Neuropeptide Y', 'Phenotype', 'Receptor, Ciliary Neurotrophic Factor', 'Receptors, Nerve Growth Factor', 'Tumor Cells, Cultured']"
369,"[-0.39726198  0.03811487  0.21621981 -0.02085408 -0.3794826   0.4767791
  0.42076078  0.29950476 -1.1368188   0.8632365   1.6704245   0.7994153
  0.04836879 -1.5734488   0.26836824 -1.4055408   0.7665511   0.7930701
 -1.3726966   0.03695253 -0.07441744 -0.50717497 -0.85030663  0.8895185
  0.99671865  0.7549006   0.14461535 -0.8142015   0.80815977 -0.9167755 ]",10.1007/BF02900202,"['Adult', 'Electroencephalography', 'Evoked Potentials', 'Evoked Potentials, Auditory', 'Female', 'Humans', 'Male', 'Panic Disorder']"
370,"[-1.3694619e+00 -4.8391554e-01  6.0244751e-01 -4.3792337e-01
  1.1541537e-01  2.3622380e-01  6.2223577e-01 -3.3006009e-01
 -1.5085193e+00  1.8443144e-03  1.0507938e+00 -9.7865313e-02
  5.6407779e-01 -7.4708939e-02 -1.9713683e-01 -8.0138153e-01
  5.3256375e-01  7.7048630e-01 -2.1218855e+00 -2.0502569e-01
 -4.4434503e-01 -1.6258574e-01 -5.5973363e-01  7.4505585e-01
  8.3528709e-01  4.8176348e-01  3.3622888e-01 -7.9510266e-01
 -3.2730224e-03 -1.4174123e+00]",10.1007/BF02761749,"['Animals', 'Biolistics', 'Humans']"
371,"[-0.6656879  -0.21743663  0.11717187  0.07155099  0.24575108  0.58816034
  0.34440896  0.23413521 -1.6647305  -0.24401206  0.88568795 -0.02138751
  0.34978107 -0.03842632  0.1238034  -1.1727073   0.5287479   1.2946334
 -2.3545406  -0.07979498 -0.38219827  0.22745103 -0.5287091   1.1554275
  0.88952804  0.76075566 -0.17841294 -1.1964015   0.27232882 -1.7362314 ]",10.1007/BF02736776,"['Animals', 'Antibody Specificity', 'Antisense Elements (Genetics)', 'Basal Ganglia', 'Cell Differentiation', 'Cell Division', 'Cells, Cultured', 'Cytoskeletal Proteins', 'DNA-Binding Proteins', 'Female', 'Gene Expression Regulation, Developmental', 'Genes, Homeobox', 'Homeodomain Proteins', 'In Situ Hybridization', 'Microtubule-Associated Proteins', 'Neurites', 'Neurons', 'Phenotype', 'Pregnancy', 'RNA-Binding Proteins', 'Rats', 'Rhombencephalon', 'Telencephalon', 'Transcription Factors']"
372,"[-2.0485694  -0.610784   -0.24473163 -0.7291397   0.0467431   0.36466148
  0.81572187 -0.00994624 -1.7104286   0.4062775   1.2137846  -0.3045224
  0.01218638  0.07875987  0.5378637  -1.1596907   0.5231656   0.70405763
 -1.7389519   0.18517129 -1.1329974  -0.17663993 -0.13315427  1.0415738
  0.83889973  0.9604632   0.3769647  -0.17408764  0.08846717 -1.7297205 ]",10.1007/BF02740621,"['Animals', 'Axons', 'Cell Adhesion Molecules', 'Extracellular Matrix Proteins', 'Humans', 'Nerve Growth Factors', 'Nerve Regeneration', 'Neurons', 'Peripheral Nerves']"
373,"[-1.3158697  -0.37200785  0.33014387 -0.38681975 -0.05751551  0.21382858
  0.5261197  -0.2698114  -1.171785    0.17055427  1.0234206  -0.07843295
  0.34636822 -0.5151861  -0.08147772 -0.8373151   0.40366977  0.49581227
 -1.467882   -0.08263207 -0.5725631  -0.23701395 -0.5282598   0.8441893
  0.8405569   0.4812893   0.29046774 -0.59569937  0.08945153 -1.1574006 ]",10.1007/BF02761753,"['Animals', 'Cryopreservation', 'Mice', 'Morula']"
374,"[ 0.08056898 -0.02798391  0.08010899  0.04265743 -0.01467669  0.06642284
  0.0114132   0.04827351 -0.15280545  0.05149041  0.25793687 -0.07536662
  0.20788616 -0.07426049 -0.19804549 -0.24161689  0.36361712  0.16448252
 -0.30410898 -0.1150438   0.21273144 -0.01299994 -0.06268445  0.1124834
  0.21876313  0.18780628 -0.0307273  -0.32291812  0.00846446 -0.30675215]",10.1007/BF02828279,"['Humans', 'Lung Diseases', 'Vasculitis']"
375,"[ 0.03925498 -0.00273425  0.03771921  0.03882209 -0.03276413  0.04304082
  0.01466487  0.02441474 -0.15417957  0.05503901  0.21424948 -0.05769503
  0.11333312 -0.10013315 -0.10999068 -0.20690003  0.1952592   0.12020775
 -0.24882798 -0.0715778   0.13774648  0.02697833 -0.05905037  0.08712403
  0.173272    0.12229913 -0.01163744 -0.22467251 -0.00042843 -0.25192624]",10.1007/BF02828278,"['Humans', 'Kidney', 'Kidney Diseases', 'Vasculitis']"
376,"[-0.00563406 -0.05254801  0.07586194  0.05011185 -0.02348399  0.07345422
  0.04534756  0.03428078 -0.23554501  0.05179893  0.27563474 -0.03888048
  0.14540349 -0.11558354 -0.12383366 -0.25661868  0.24291943  0.18029355
 -0.33763793 -0.09013793  0.12441335 -0.00103913 -0.09071079  0.13679652
  0.22604808  0.17819025 -0.01767933 -0.26963124  0.02365615 -0.32230446]",10.1007/BF02828274,"['Humans', 'Skin Diseases, Vascular', 'Vasculitis, Leukocytoclastic, Cutaneous']"
377,"[-0.47225255  0.00127088  0.16383529 -0.12043268 -0.06140503  0.27107787
  0.30852342 -0.05468014 -0.77147543  0.24642415  0.80491203  0.15584904
  0.2602547  -0.5953735  -0.02237532 -0.7653489   0.5560864   0.42664862
 -0.87912726  0.01258277 -0.11696862 -0.25520223 -0.34868976  0.5718529
  0.63794583  0.45625532  0.11607093 -0.44885886  0.17015257 -0.7982943 ]",10.1007/BF02740822,"['Animals', 'Magnetic Resonance Spectroscopy', 'Peptides', 'Protein Conformation', 'Proteins']"
378,"[-0.3859422  -0.15006727  0.20966387 -0.05763749  0.00844693  0.25558573
  0.18136905 -0.09227855 -0.71425515 -0.03886636  0.5520508  -0.08992734
  0.41602576 -0.11807414 -0.25419825 -0.52794206  0.63523954  0.44842434
 -1.1724735  -0.15568773  0.05883381 -0.07858628 -0.22087549  0.3776253
  0.5951115   0.40008956  0.01050708 -0.6232897   0.04509005 -0.85257703]",10.1007/BF02761751,"['Animals', 'Blotting, Northern', 'Gene Expression', 'Nucleic Acid Hybridization', 'Plasmids', 'Polymerase Chain Reaction', 'RNA Probes', 'Ribonucleases', 'Templates, Genetic']"
379,"[ 0.08960059 -0.00273938  0.00678606  0.12021367 -0.05059853  0.07337423
  0.01401527  0.06745056 -0.25956964  0.13384746  0.3448481   0.0290282
  0.00275368 -0.25917146  0.02360957 -0.27626774  0.13255085  0.11978774
 -0.23589918 -0.0489895   0.02954828 -0.01768061 -0.12808634  0.1814714
  0.21720624  0.18108621 -0.04437571 -0.18453138  0.08333697 -0.2530105 ]",10.1007/BF02828277,"['Animals', 'Autoantibodies', 'Biomarkers', 'Humans', 'Lupus Erythematosus, Systemic']"
380,"[-0.97964    -0.21165001  0.23867017 -0.44769794  0.11846294  0.45444253
  0.6489529   0.02463233 -1.2312903   0.22718881  1.1375163   0.04485143
  0.5217167  -0.5003651  -0.1681785  -1.2910336   1.0059597   0.84093183
 -1.6724937  -0.09561759 -0.1726038  -0.46098515 -0.4559411   0.6829655
  0.94985414  0.68120277  0.2591438  -1.0371493   0.11746053 -1.3055531 ]",10.1007/BF02761746,"['Bacteria', 'Environmental Microbiology']"
381,"[-1.5226911  -0.4503184   0.32011253 -0.16099833 -0.13487849  0.06474543
  0.65890443 -0.2792534  -1.9528091   0.5097471   1.7261919  -0.18974534
 -0.11676697 -0.83298105  0.39845347 -1.1370211   0.7054259   0.9588582
 -2.0778534  -0.42299214 -0.8214066  -0.5334819  -0.90740895  1.4338794
  0.88090473  0.70423186  0.26278105 -0.5725454   0.33520192 -1.7214413 ]",10.1007/BF02828280,"['Cryoglobulinemia', 'Humans', 'Models, Biological', 'Vasculitis']"
382,"[-2.2018328  -0.545216    0.17981769 -0.5487908  -0.11064626 -0.34088117
  0.96325254 -0.61284924 -1.819141   -0.04260569  1.9697757  -0.27030638
 -0.30845478 -0.9201602  -0.4353409  -0.8949218   0.00537498  0.38252968
 -2.077077   -0.6117275  -1.277215   -0.09077305 -1.0011274   0.87386227
  1.145524   -0.00252603  0.8150012  -0.81085193  0.2486648  -1.1874839 ]",10.1007/BF02828276,"['Autoantibodies', 'Humans', 'Retinitis', 'Uveitis']"
383,"[-0.4320121  -0.06419618  0.23255765  0.00245809 -0.13971993  0.41377845
  0.31614682  0.02848012 -1.0477026   0.20562805  0.8392948  -0.09428374
  0.4863693  -0.27719167 -0.12130384 -0.9371234   0.8264384   0.74393964
 -1.5114641  -0.1568341   0.07877927 -0.10656073 -0.37687454  0.6749616
  0.74462485  0.60108113 -0.03630117 -0.86919653  0.0774044  -1.2889986 ]",10.1007/BF02740819,"['Animals', 'Avian Sarcoma Viruses', 'Cell Line', 'Gene Expression', 'Genes, Viral', 'Genetic Vectors', 'Humans', 'Virus Replication']"
384,"[-0.9204712  -0.19406375  0.19137894 -0.3701818   0.03718295  0.45193025
  0.6633003  -0.03865121 -1.0852457   0.44392166  1.1466295   0.15858157
  0.40077472 -0.75661     0.13341825 -1.0994192   0.76177055  0.5455405
 -1.3860513  -0.08534903 -0.21719305 -0.40064827 -0.45877668  0.8145571
  0.799606    0.7399775   0.3516754  -0.78717834  0.22843054 -1.0717038 ]",10.1007/BF02740818,"['Bacteria', 'Fungi', 'Gas Chromatography-Mass Spectrometry', 'Humans']"
385,"[-0.7860794  -0.15843615  0.4170884  -0.2698523   0.04504626  0.31993997
  0.2951521  -0.30776465 -1.176932    0.12947536  0.721308   -0.18556266
  0.48262173 -0.32241976 -0.16521639 -0.7183132   0.5191759   0.5862656
 -1.5135056  -0.11136076 -0.15386596 -0.09559254 -0.40235278  0.6508041
  0.8394225   0.45244744  0.08653455 -0.7651019   0.13305426 -1.1874031 ]",10.1007/BF02740813,"['Nucleic Acid Hybridization', 'Oligonucleotide Probes', 'RNA, Messenger', 'Single-Strand Specific DNA and RNA Endonucleases']"
386,"[-0.65438616 -0.20279501  0.2572009  -0.18534827 -0.03241282  0.17923962
  0.27862293 -0.17927408 -0.8486518   0.10225394  0.7029138  -0.11053556
  0.2969723  -0.28559294 -0.05554597 -0.45307446  0.39394543  0.3697148
 -1.1246605  -0.16128758 -0.11893474 -0.091814   -0.299031    0.42966795
  0.49937803  0.35409683  0.1491133  -0.49585682  0.10130769 -0.7550823 ]",10.1007/BF02740820,"['DNA', 'Fluorescein', 'Fluoresceins', 'Genetic Techniques', 'Oligonucleotide Probes']"
387,"[-1.3110632   0.02204762  0.37135693 -0.3331332  -0.20998901  0.34412494
  0.6230872  -0.13636069 -1.5040946   0.9997646   1.4716024   0.47405285
  0.41371426 -1.4751322   0.6360077  -1.2204815   0.30678728  0.7531745
 -1.396286   -0.05235958 -0.68764544 -0.46771035 -0.7582547   1.1185328
  0.814801    0.9013575   0.19419214 -0.33145374  0.5217173  -1.0437487 ]",10.1007/BF02740812,"['DNA, Bacterial', 'False Positive Reactions', 'Heating', 'Polymerase Chain Reaction', 'RNA, Bacterial', 'RNA, Ribosomal, 16S', 'Reagent Kits, Diagnostic']"
388,"[-0.46650675 -0.6048608   0.46693933  0.5884305   0.03452163  0.45309705
  0.10495971  0.2459     -2.3485227   0.09057844  1.2296193   1.0461941
 -0.15283    -0.8670476   1.0644656  -1.4204743  -0.18607132  1.5039604
 -2.6616385   0.1160589  -0.6083244  -0.21036088 -0.8169845   1.3514189
  0.96036583  1.0209931  -0.6518069  -0.8839064   0.93895096 -1.5149106 ]",10.1007/BF02740814,"['Animals', 'CHO Cells', 'Cloning, Molecular', 'Cricetinae', 'DNA, Complementary', 'Gene Amplification', 'Gene Expression', 'Genetic Vectors', 'Globins', 'Granulocyte Colony-Stimulating Factor', 'Humans', 'Rabbits', 'Recombinant Fusion Proteins', 'Simian virus 40', 'Tetrahydrofolate Dehydrogenase', 'Transfection']"
389,"[-0.02854018 -0.05416784  0.05417997  0.02625745 -0.01655295  0.06894871
  0.04203349  0.02834094 -0.18321775  0.03348821  0.209705   -0.028523
  0.11828851 -0.08308731 -0.06923229 -0.18437253  0.15836301  0.14140533
 -0.23246908 -0.04145222  0.06817893  0.01027575 -0.05158513  0.11629304
  0.17905036  0.12540564 -0.00070337 -0.20017274  0.0371826  -0.20254286]",10.1007/BF02828275,"['Animals', 'Antibodies, Antineutrophil Cytoplasmic', 'Environmental Exposure', 'Humans', 'Kidney Diseases', 'Lung Diseases, Interstitial', 'Silicon Dioxide', 'Vasculitis']"
390,"[-1.2978367  -0.36522347  0.33470544 -0.35936403 -0.02523105  0.16087578
  0.41700125 -0.3813632  -1.2110643   0.17622223  0.88543576 -0.3160231
  0.22773181 -0.22628693  0.0075364  -0.53255814  0.21682082  0.4312834
 -1.4429903  -0.32990327 -0.70308375 -0.05637013 -0.38218823  0.66843116
  0.6080246   0.35231775  0.3600721  -0.47967786 -0.00262224 -1.029558  ]",10.1007/BF02740815,"['Acquired Immunodeficiency Syndrome', 'Animals', 'Anti-HIV Agents', 'Disease Models, Animal', 'Drug Delivery Systems', 'Genetic Therapy', 'HIV', 'Humans', 'Mice', 'Nucleic Acid Conformation', 'RNA, Catalytic', 'RNA, Viral', 'Virus Replication']"
391,"[-1.1602262   0.16619708  0.16391002 -0.00860761 -0.02049428  0.9232543
  0.8955936   0.30982432 -1.5794556   0.67359436  1.3687975   0.4020542
 -0.09105742 -1.0453856   0.7357838  -1.3601371   0.51842606  0.7735328
 -1.7210382   0.43835974 -0.6168317  -0.7663041  -0.84801906  1.5669705
  0.80924064  0.8813215  -0.22204682 -0.40426302  0.41861454 -1.7099274 ]",10.1007/BF02738798,"['Adenoma', 'HSP70 Heat-Shock Proteins', 'Humans', 'Immunohistochemistry', 'Pituitary Hormones', 'Pituitary Neoplasms']"
392,"[ 1.4382927   0.61756897 -0.7843476   1.1688738  -0.4475649   0.89931
  0.06293663  1.2737288  -1.9952437   2.410966    3.105641    1.2991341
 -1.3168954  -3.2915528   2.6586294  -2.5187833   0.2865935   0.77603436
 -0.26243296  0.2618216  -1.1682291  -0.17796266 -1.347692    2.113079
  0.5861324   1.4281946  -0.7124332   0.02549231  1.1102904  -0.6273138 ]",10.1007/BF02738808,"['Animals', 'Bucladesine', 'Cells, Cultured', 'Gastrointestinal Hormones', 'Glucagon-Like Peptide 1', 'Glucagon-Like Peptide 2', 'Intestinal Mucosa', 'Intestines', 'Peptide Fragments', 'Peptides', 'Rats', 'Somatostatin', 'Somatostatin-28', 'Stimulation, Chemical']"
393,"[-0.58897984 -1.7084113  -0.09923583 -0.35055366 -0.43451655  1.1350362
  1.1078191   0.91897535 -2.62084     0.48660508  1.166386   -0.48064402
 -0.45391256 -0.5733907   1.4676442  -0.75441223 -0.5289407   1.5522343
 -2.251654    0.8294628   0.15802497  0.567611   -0.7864393   1.2470165
  0.23127979  1.6466538   0.14682783 -1.6356984   0.59840757 -1.8383106 ]",10.1007/BF02738802,"['Animals', 'Dopamine', 'Estrogens', 'Female', 'Hypothalamo-Hypophyseal System', 'Hypothalamus, Middle', 'Immunization, Passive', 'Ovariectomy', 'Pituitary Gland, Anterior', 'Pituitary Gland, Posterior', 'Rats', 'Rats, Wistar', 'Vasoactive Intestinal Peptide']"
394,"[ 0.09397836 -0.00204162  0.03601778  0.07197417 -0.04514882  0.0326493
 -0.0183275   0.07027805 -0.10277469  0.04768894  0.17519914 -0.00739939
  0.09680285 -0.10754981 -0.07886823 -0.16834943  0.17365426  0.09540436
 -0.14509775 -0.05176622  0.12221832 -0.00211462 -0.05129132  0.05560438
  0.14153354  0.12579367 -0.02723003 -0.17146046  0.03650393 -0.17968206]",10.1007/BF02742940,"['Diagnostic Imaging', 'Female', 'Humans', 'Infant', 'Kidney', 'Kidney Diseases, Cystic', 'Kidney Neoplasms', 'Wilms Tumor']"
395,"[ 0.28743756  0.8601257   0.01651037 -1.0016515  -0.2145321   1.4144951
  0.5116774  -0.3357232  -2.890153    2.9578865   1.7805738   0.9096246
  0.4366684  -2.810193    0.31042898 -0.969979   -1.305442    1.919464
 -0.97072726  0.22606148 -0.5985245  -0.8131993  -2.6317976  -0.16297822
  1.8815154   0.7977752   0.05290819  1.1443386   1.0711931  -1.6508194 ]",10.1007/BF02738801,"['Animals', 'Blood Glucose', 'Glucose Clamp Technique', 'Growth Hormone', 'Humans', 'Hyperinsulinism', 'Infusions, Intravenous', 'Insulin Resistance', 'Male', 'Peptide Fragments', 'Radioimmunoassay', 'Rats']"
396,"[-0.7362444   0.14339001  0.30243242  0.03113643 -0.39983654  0.52210724
  0.4216006   0.11987516 -1.2922313   0.8186742   1.5776953   0.64128035
  0.02772644 -1.6345916   0.28109884 -1.4650418   0.4562727   0.70431185
 -1.3720326   0.08203583 -0.35204095 -0.42647195 -0.6420193   0.94998765
  1.0673909   0.82129204  0.14743736 -0.65063405  0.75445706 -0.95189553]",10.1007/BF02832666,"['Adult', 'Analysis of Variance', 'Attitude to Health', 'Chi-Square Distribution', 'Follow-Up Studies', 'Group Homes', 'Humans', 'Illinois', 'Male', 'Patient Dropouts', 'Prospective Studies', 'Self-Help Groups', 'Social Support', 'Substance-Related Disorders', 'Treatment Outcome']"
397,"[-1.6226201  -1.0819404   0.43544456 -0.26307392 -0.26346907  0.10041527
  0.9531654   0.22411492 -2.6166747   0.50881153  1.8498849   0.10190588
  0.11450186 -0.90709275  1.5218204  -1.2413993  -0.8032788   1.4668136
 -1.2726833   0.18415198 -1.5085893   0.07292502 -0.6455025   1.5262346
  1.1306736   0.58392495  0.23614657 -0.2184623   0.5724448  -0.9498365 ]",10.1007/BF02738959,"['Adrenal Glands', 'Adrenalectomy', 'Animals', 'Corticosterone', 'Hormone Antagonists', 'Immobilization', 'Male', 'Mifepristone', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, Glucocorticoid', 'Stress, Physiological', 'Transcortin']"
398,"[-1.080643   -0.5003923  -0.2026314  -0.6592373  -0.469995    0.33044276
  0.5083527   0.8210214  -2.3882582   0.4805175   1.5100557  -0.23071574
 -0.23804477  0.24679157  0.3585731  -0.9931993   0.51924956  1.2889205
 -2.168648   -0.6477234  -0.51641226  0.5699511  -0.8547477   0.9163029
  1.0885252   0.85446626 -0.2734939  -0.24586475  0.18135867 -2.0527558 ]",10.1007/BF02738960,"['Animals', 'Antineoplastic Agents, Hormonal', 'Buserelin', 'Estradiol', 'Estrus', 'Female', 'Gonadotropin-Releasing Hormone', 'Iodine Radioisotopes', 'Kinetics', 'Luteoma', 'Organ Culture Techniques', 'Ovarian Neoplasms', 'Progesterone', 'Rats', 'Rats, Sprague-Dawley', 'Receptors, LHRH', 'Superovulation', 'Tumor Cells, Cultured']"
399,"[-1.9730902  -0.24931088  0.73180085 -0.8176932  -0.1193442   0.5595851
  1.3203301   0.08020892 -1.0130488   0.4444257   1.1575547   0.7858542
  0.80597085 -1.1134043   0.10065927 -1.3535583   0.7876789   0.71678156
 -1.2389413   0.15099692 -0.560722   -0.5411403  -0.3645344   0.6870404
  1.3198223   0.8323001   0.5945431  -0.37660637  0.6643265  -1.0537463 ]",10.1007/BF02832663,"['Adult', 'Costs and Cost Analysis', 'Female', 'Group Homes', 'Ill-Housed Persons', 'Housing', 'Humans', 'Male', 'Massachusetts', 'Mental Disorders', 'Mental Health Services', 'Program Evaluation', 'Prospective Studies', 'Public Housing', 'Random Allocation', 'Regression Analysis', 'Self Care', 'Social Work']"
400,"[-0.33251378  0.07325446  0.33983007 -0.04144197 -0.12052377  0.48570824
  0.13078648  0.24337988 -1.8867406   0.59928405  0.67206955  0.3994188
 -0.09305958 -0.45610845 -0.41800898 -0.8474977   0.87318456  0.3451831
 -0.50734156  0.65905446  0.2628206  -0.75754476  0.12126388  1.1424416
  0.781763    0.7442136   0.11780186  0.03879162  0.6890958  -1.3506138 ]",10.1128/jcm.30.12.3286-3287.1992,"['AIDS-Related Opportunistic Infections', 'Adult', 'DNA, Protozoan', 'Evaluation Studies as Topic', 'Female', 'Humans', 'Male', 'Nucleic Acid Hybridization', 'Repetitive Sequences, Nucleic Acid', 'Toxoplasmosis, Cerebral']"
401,"[-0.25550115  0.03915214  0.548546   -0.23717043 -0.21386875  0.46184352
  0.21639612  0.18740045 -1.3165777   0.2723298   0.7697332   0.35767025
 -0.07438726 -0.25012958 -0.23122773 -0.5994663   0.68972147  0.55153227
 -0.4268395   0.63484097  0.05895113 -0.3740933  -0.1541848   0.82068235
  0.49440843  0.6787957   0.19753464  0.19364624  0.60672736 -1.1772835 ]",10.1002/14651858.CD003867,"['Acute Disease', 'Anti-Inflammatory Agents, Non-Steroidal', 'Colic', 'Dipyrone', 'Humans', 'Injections, Intramuscular', 'Injections, Intravenous', 'Kidney Diseases']"
402,"[-0.14275292 -0.02799355  0.3022804  -0.12189329 -0.07593048  0.13564712
  0.0480103   0.05705951 -0.45500636  0.07653195  0.31404287  0.15913528
 -0.01922019 -0.06858386 -0.06321555 -0.19510356  0.26594612  0.27077836
 -0.14504692  0.29812032 -0.01496195 -0.10315274 -0.1727086   0.33996534
  0.19425909  0.30731437  0.07503711  0.13555403  0.3390414  -0.5449555 ]",10.1007/s00894-005-0044-4,"['Catalysis', 'Epoxy Compounds', 'Ethylenes', 'Hydrogen Bonding', 'Hydrogen Peroxide', 'Molecular Structure']"
403,"[-0.36848542 -0.04363595  0.60484535 -0.21209033 -0.18020658  0.49468955
  0.11974858  0.2071171  -1.3274685   0.29359505  0.6926348   0.277761
 -0.13519122 -0.2664255  -0.2016329  -0.6611398   0.7171058   0.63128865
 -0.46820682  0.61826944  0.06564921 -0.41139373 -0.22931018  0.91409856
  0.5116867   0.7256044   0.10273883  0.25272107  0.72087145 -1.2703531 ]",10.1200/JCO.1999.17.5.1474,"['Adult', 'Aged', 'Biomarkers, Tumor', 'Breast Neoplasms', 'Chemotherapy, Adjuvant', 'Female', 'Humans', 'Immunohistochemistry', 'Ligands', 'Middle Aged', 'Predictive Value of Tests', 'Prognosis', 'Reagent Kits, Diagnostic', 'Receptors, Estrogen', 'Statistics as Topic']"
404,"[-1.0650430e-04 -4.5825221e-02  3.3248174e-01  5.0376806e-02
 -3.6859795e-01  5.4363298e-01  2.6594168e-01  7.8413159e-02
 -1.2364500e+00  1.8080117e-01  9.7192800e-01  1.6957146e-01
  1.3368522e-01 -2.3395227e-01 -2.5145707e-01 -4.8397371e-01
  6.0739779e-01  7.0595175e-01 -7.2648317e-01  4.7490898e-01
  1.9861050e-01 -4.9455878e-01 -2.3575020e-01  7.0330858e-01
  3.7657419e-01  7.9005146e-01  4.3596512e-01  2.1431516e-01
  3.9082783e-01 -1.3060716e+00]",10.1023/a:1010243318426,"['Adolescent', 'Adult', 'Aged', 'California', 'Child', 'Child Abuse, Sexual', 'Female', 'Heterosexuality', 'Homosexuality, Female', 'Homosexuality, Male', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Self-Assessment', 'Surveys and Questionnaires']"
405,"[-0.2260919   0.03786594  0.38859448 -0.1966591  -0.10880449  0.50915426
  0.23870957  0.22223938 -1.1479295   0.34844217  0.7529065   0.35591346
 -0.04752258 -0.39292085 -0.40867877 -0.642495    0.62771916  0.23551624
 -0.29271445  0.5315575   0.2732119  -0.4589829   0.04523757  0.9364203
  0.5641075   0.61245304  0.24476819  0.08790798  0.4326416  -1.0654539 ]",10.1111/j.1872-034X.2008.00336.x,[]
406,"[ 0.50608796  0.38872957  0.13814914 -1.5082889  -0.59777164  1.7046372
  1.2791708   0.46574646 -2.390715    0.8523651   1.6152155   2.0935242
  1.3592718   1.3745536  -0.8324081  -0.5156079   1.1692611  -0.11378495
  0.25402316  2.0524125  -0.5475882  -1.0497501   1.2930512   0.6663246
  2.445033    1.0795037   1.5705931  -0.9420852   1.0186207  -1.3079164 ]",10.1002/cne.902800208,"['Animals', 'Basal Ganglia', 'Brain Mapping', 'Choline O-Acetyltransferase', 'Enkephalins', 'Frontal Lobe', 'Galanin', 'Immunohistochemistry', 'Macaca', 'Macaca mulatta', 'Male', 'Neuropeptide Y', 'Neuropeptides', 'Peptides', 'Somatostatin', 'Substantia Innominata']"
407,"[-0.2181655  -0.06025819  0.3366673  -0.23032849 -0.10496615  0.22883415
  0.08948942  0.08660226 -0.7048301   0.12570806  0.45628837  0.24788114
  0.01415051 -0.02296046 -0.18084449 -0.27199244  0.436237    0.38634768
 -0.21292657  0.41323125  0.0552817  -0.23221934 -0.121197    0.4420858
  0.2604738   0.4749729   0.09481198  0.1233942   0.4308985  -0.7422076 ]",10.1016/s0029-7844(02)02086-0,"['Adolescent', 'Adult', 'Cognition', 'Consumer Product Safety', 'Contraceptives, Postcoital', 'Drug Labeling', 'Female', 'Humans', 'Middle Aged', 'Nonprescription Drugs', 'Population Surveillance', 'Risk Assessment', 'Risk Factors', 'Sensitivity and Specificity', 'Surveys and Questionnaires', 'United States']"
408,"[-0.2591139  -0.00946207  1.011481   -0.4942315  -0.35838652  0.8199012
  0.38178012  0.5927374  -2.0441637   0.44870797  1.2251813   0.6178224
 -0.06410174 -0.3214773  -0.64230263 -0.63128996  1.1522945   0.7081474
 -0.45042056  1.2344753   0.49445295 -0.27954134  0.18145056  1.3648559
  1.0765241   1.404851    0.6991402   0.30412164  0.93560344 -1.6070526 ]",10.1007/s00894-005-0096-5,"['Bacterial Proteins', 'Databases, Nucleic Acid', 'Evolution, Molecular', 'Phylogeny', 'Sigma Factor', 'Structural Homology, Protein', 'Structure-Activity Relationship']"
409,"[-0.3158785  -0.08010959  0.5221364  -0.27608058 -0.08598801  0.3464765
  0.07975384  0.20522954 -1.0802569   0.22535126  0.69914806  0.3884227
 -0.04985081 -0.0530187  -0.26639253 -0.4347557   0.6229711   0.4698056
 -0.39463562  0.6271273   0.00620803 -0.3268295  -0.19678974  0.770373
  0.5685862   0.7370884   0.14150627  0.2186419   0.59322804 -1.161835  ]",10.1016/j.ajog.2007.09.042,"['Animals', 'Disease Models, Animal', 'Infectious Disease Transmission, Vertical', 'Mycoplasma Infections', 'Mycoplasma pulmonis', 'Rats', 'Rats, Sprague-Dawley']"
410,"[ 0.03726379  0.26863068  0.2604624  -0.15661441 -0.35573018  0.7134125
  0.5931691   0.33749795 -2.1207025   0.72924185  1.1551028   0.5458784
  0.41806862 -0.01075586 -0.742499   -0.7101154   1.2798084   0.4535175
 -0.57984763  1.1236682   0.18822755  0.04663964  0.26692918  1.2192152
  0.9401766   1.1517154   0.4840896  -0.1678027   0.5524015  -1.5595262 ]",10.1080/14764170410003002X,"['Hair Removal', 'Humans', 'Informed Consent', 'Laser Therapy', 'Lasers', 'Patient Selection']"
411,"[-0.1248456  -0.05344814  0.2669421  -0.06095781 -0.06238652  0.1477651
  0.02852986  0.06259357 -0.39867252  0.03078085  0.29306453  0.10328364
 -0.05293513 -0.09597639 -0.02684495 -0.19553775  0.24022175  0.20118922
 -0.16189685  0.22920771  0.00967831 -0.11371076 -0.12359641  0.27672184
  0.12284938  0.25814247  0.07981083  0.12577556  0.23256503 -0.4430136 ]",10.1111/j.1537-2995.2006.00850.x,[]
412,"[-0.06659625 -0.02486575  0.19908826 -0.02192878 -0.04811006  0.07272408
 -0.00860421  0.02688551 -0.24195538 -0.03964067  0.18044282  0.03867614
 -0.04591686 -0.02241962 -0.00877463 -0.08939938  0.18662974  0.19823112
 -0.13749452  0.15891066 -0.06730411 -0.05012582 -0.12663426  0.19611053
  0.05889098  0.15484655 -0.00334091  0.11765358  0.1666265  -0.3122014 ]",10.1016/j.echo.2008.11.029,"['Aortic Valve Stenosis', 'Echocardiography', 'Europe', 'Humans', 'Mitral Valve Stenosis', 'Practice Guidelines as Topic', ""Practice Patterns, Physicians'"", 'Pulmonary Valve Stenosis', 'United States']"
413,"[-0.31123668 -0.07127523  0.28616425  0.20023221  0.0037206   0.82367164
  0.40409145  0.5042715  -1.6786371   0.6795458   0.80486155  0.34478348
 -0.39767382 -0.8584371  -0.47029635 -0.6317152   0.592214    0.3573715
 -0.47181457  0.6102791   0.59713733 -0.7200132   0.3757686   1.1002233
  0.76116854  1.018437    0.11798953  0.06854918  0.62082666 -1.0540336 ]",10.1016/j.virol.2008.04.037,"['Active Transport, Cell Nucleus', 'Animals', 'Cell Line', 'Cell Nucleolus', 'Cell Nucleus', 'Cytoplasm', 'Green Fluorescent Proteins', 'Microscopy, Confocal', 'Nucleocapsid Proteins', 'Photobleaching', 'Porcine respiratory and reproductive syndrome virus', 'Protein Transport', 'Recombinant Fusion Proteins', 'Swine']"
414,"[-0.11953031 -0.07977648  0.96256775 -0.89591557 -0.4328152   1.0819438
  0.74579597  0.5439616  -2.1932209   0.9509383   1.3717207   1.1434214
  0.30079767  0.27043805 -0.64498746 -0.87636644  1.107209    0.71339965
 -0.26589656  1.4211724  -0.02312562  0.00795304 -0.08828963  1.2334936
  1.0995861   1.3047194   0.8385196  -0.08664256  0.8996918  -1.7001565 ]",10.1007/s00439-008-0591-8,"['Amino Acid Sequence', 'Animals', 'Base Sequence', 'COS Cells', 'Chlorocebus aethiops', 'Cyclic AMP', 'DNA Mutational Analysis', 'DNA Primers', 'Evolution, Molecular', 'Genetic Variation', 'Humans', 'Molecular Sequence Data', 'Mutation', 'Obesity', 'Phylogeny', 'Primates', 'Receptor, Melanocortin, Type 4', 'Recombinant Proteins', 'Selection, Genetic', 'Sequence Homology, Amino Acid', 'Species Specificity', 'Transfection']"
415,"[-0.24241608 -0.06930799  0.37233812 -0.087515   -0.10133407  0.18976463
 -0.03263451  0.0935232  -0.58974266  0.04468263  0.47693747  0.10322008
 -0.07491412 -0.10863664 -0.03550535 -0.2823988   0.39789557  0.3791149
 -0.2331958   0.32449275  0.04937309 -0.19591855 -0.21997975  0.46651214
  0.17062949  0.44100982  0.06685159  0.23662372  0.41918173 -0.7833653 ]",10.1016/j.ajog.2005.06.062,"['Aged', 'Anthrax', 'Disease Outbreaks', 'Female', 'Gynecology', 'Humans', 'Obstetrics', 'Pregnancy', 'Pregnancy Complications, Infectious', 'Severe Acute Respiratory Syndrome', 'West Nile Fever']"
416,"[-0.76765555  0.13544123  0.5515509  -0.39711922 -0.05327073  0.45633152
  0.12003854  0.4752872  -2.3505151   1.2121881   0.9179506   0.53797567
  0.0928238  -0.7144943  -0.59735143 -0.96645635  0.6316895   0.5483479
 -0.6464584   0.70618474  0.2255497  -1.1582618  -0.07423066  1.7599611
  1.2605816   1.3795779  -0.06639706  0.21810465  0.9925364  -1.6993912 ]",10.1016/j.virol.2008.11.006,"['Animals', 'Cats', 'Cell Nucleus', 'Cytokines', 'Enzyme Activation', 'Feline Infectious Peritonitis', 'Feline Panleukopenia Virus', 'Inflammation', 'Leukocytes, Mononuclear', 'Virus Replication', 'p38 Mitogen-Activated Protein Kinases']"
417,"[-0.31542698  0.769713    0.13855147  0.22076383 -0.02513803  0.98633397
  0.38046017  0.60106534 -2.4265494   1.1842467   0.4742572  -0.01930788
 -0.4732688  -1.5595814  -0.7434249  -1.3305728   0.61032903 -0.60704005
 -0.88639385  0.42135727  0.9785793  -1.8379341   0.7792301   1.7540572
  1.4166776   0.8478395   0.06957008 -0.39211836  0.49607143 -1.2965826 ]",10.1016/j.tvjl.2009.12.012,"['Acute-Phase Proteins', 'Animals', 'Bronchoalveolar Lavage Fluid', 'Cytokines', 'Influenza A Virus, H1N1 Subtype', 'Influenza Vaccines', 'Orthomyxoviridae Infections', 'Swine', 'Swine Diseases']"
418,"[-0.49130538 -0.20944148  0.96587056 -0.6121156  -0.06131581  0.7165261
  0.4065143   0.27666295 -1.6660647   0.65343606  1.2892677   1.0920141
  0.26952684 -0.05291113 -0.541661   -0.77183884  0.8670097   0.99267584
 -0.39536148  1.0497087   0.01283522 -0.3183855  -0.34990922  1.0593433
  0.96871376  0.95627755  0.3615429   0.12316003  1.1920515  -1.5784054 ]",10.2174/187152011796011019,"['Adaptor Proteins, Signal Transducing', 'Antibodies, Monoclonal', 'Carcinoma, Hepatocellular', 'Dishevelled Proteins', 'Frizzled Receptors', 'Gene Knockdown Techniques', 'Humans', 'Liver Neoplasms', 'Molecular Targeted Therapy', 'Phosphoproteins', 'Signal Transduction', 'Wnt Proteins', 'beta Catenin']"
419,"[-0.26043734 -0.19939531  0.51335317 -0.3004769  -0.04051699  0.15848918
 -0.06993497  0.1597352  -0.32334214 -0.14043666  0.7436271   0.28092602
 -0.09391944  0.12844035 -0.15932088 -0.20082958  0.41373152  0.48205173
 -0.05392905  0.41579297  0.05956671  0.03902867 -0.15041403  0.4797414
  0.15259667  0.52434313  0.36746222  0.30040118  0.23923846 -0.76889724]",10.1016/j.ajem.2012.12.028,"['Aged', 'Chicago', 'Elder Abuse', 'Emergency Service, Hospital', 'Female', 'Humans', 'Male', 'Poisson Distribution', 'Residence Characteristics']"
420,"[-0.12264195 -0.0470143   0.20821464 -0.02787872 -0.03650083 -0.02733142
 -0.08217593 -0.00640691 -0.12702401 -0.09099324  0.12130101  0.00723345
 -0.09119076 -0.01799591  0.0470875  -0.0942497   0.13609663  0.22035867
 -0.12257293  0.14002158 -0.07831689 -0.02767183 -0.20417373  0.1156108
 -0.03304462  0.10450029 -0.03405889  0.14939015  0.18433699 -0.31288096]",10.1016/j.jaci.2011.11.027,"['Anti-Bacterial Agents', 'Drug Eruptions', 'Exanthema', 'Female', 'Humans', 'Male', 'Penicillins']"
421,"[-0.22972532  0.3991224   0.20635876  0.24043739 -0.04980491  0.7272601
  0.27181765  0.27361318 -1.9418858   0.8382931   0.73679066  0.12128586
 -0.2800363  -1.1118033  -0.4505031  -1.1854684   0.7649886  -0.32270432
 -0.5470113   0.47583482  0.63906777 -1.4799292   0.6908559   1.3809618
  0.97071564  0.9948315   0.23159944 -0.04001771  0.48731467 -1.2535996 ]",10.1016/j.virol.2011.04.016,"['Adolescent', 'Adult', 'Age Distribution', 'Aged', 'Aged, 80 and over', 'Child', 'Child, Preschool', 'Female', 'Human bocavirus', 'Humans', 'Infant', 'Influenza, Human', 'Italy', 'Male', 'Metapneumovirus', 'Middle Aged', 'Orthomyxoviridae', 'Paramyxoviridae Infections', 'Parvoviridae Infections', 'Phylogeny', 'Prospective Studies', 'Respiratory Tract Infections', 'Young Adult']"
422,"[-0.08264226 -0.01012755  0.14892608 -0.03164138 -0.05123855  0.02157555
 -0.03413986  0.02007066 -0.12650223 -0.05278728  0.09208303  0.01924146
 -0.07479596 -0.02217079  0.04020561 -0.06440585  0.11244813  0.1350052
 -0.08698681  0.12074742 -0.05362653 -0.04840229 -0.12006708  0.11640571
 -0.00684665  0.07728718 -0.00885554  0.1108692   0.1237077  -0.24259366]",10.1161/CIRCRESAHA.111.252627,"['Animals', 'Cell Differentiation', 'Humans', 'MicroRNAs', 'Mitosis', 'Myocardium', 'Myocytes, Cardiac']"
423,"[-0.40517628  0.08276617  0.34355813 -0.35205954 -0.07137612  0.3899002
  0.5231319   0.2952716  -2.0817413   0.8665201   0.9612567   0.6444483
 -0.17906052 -0.41265017 -0.6936875  -0.76877224  0.91800904  0.38630393
 -0.34348258  0.77642906  0.32290086 -0.8148949   0.06836763  1.2005255
  0.8909259   1.1559323   0.02031485  0.17011833  0.7209793  -1.6701713 ]",10.1016/j.virol.2009.11.001,"['Animals', 'Antibodies, Neutralizing', 'Antibodies, Viral', 'Cytokines', 'Female', 'Mice', 'Mice, Inbred BALB C', 'Microscopy, Electron, Transmission', 'Moloney murine leukemia virus', 'Rats', 'Rats, Inbred WF', 'Rift Valley Fever', 'Rift Valley fever virus', 'Survival Analysis', 'T-Lymphocytes', 'Vaccines, Virosome', 'Viral Proteins', 'Virosomes', 'Virus Replication']"
424,"[-0.46372244 -1.1033571   1.2270572  -1.8801966  -0.29232678 -0.00598826
  0.2586137   0.81303716 -0.08200333 -0.5997705   3.0736449   1.7701712
  0.3023057   1.8226981  -1.0385596  -0.7988268   1.0843987   1.4284793
  0.8926998   1.5332073   0.30902264  0.77307713  0.27023834  1.462213
  0.99714524  2.1778724   1.8322772   0.6800525   0.28613555 -1.6179284 ]",10.1377/hlthaff.2013.1261,"['Aged', 'Caregivers', 'Dementia', 'Elder Abuse', 'Humans', 'Prevalence', 'Risk Factors', 'United States']"
425,"[-0.3164806   0.03381313  0.5094178  -0.19941102 -0.17127909  0.5271306
  0.35759616  0.20544694 -1.8973235   0.69835305  1.0804605   0.5405206
 -0.05598262 -0.29156846 -0.56063646 -0.90681654  1.030631    0.42417747
 -0.369164    0.8577273   0.10395277 -0.6258755   0.0534937   1.1612589
  0.9272316   1.2063426   0.28288743  0.21502557  0.81360996 -1.5636225 ]",10.1016/j.virol.2010.02.029,"['Animals', 'Antibodies, Monoclonal', 'Antibodies, Neutralizing', 'Antibodies, Viral', 'Ebolavirus', 'Epitopes', 'Haplorhini', 'Humans', 'Neutralization Tests', 'Protein Binding', 'Viral Envelope Proteins']"
426,"[-0.19810256 -0.01146988  0.4830949  -0.1629522  -0.17059469  0.4368979
  0.19210538  0.17438467 -1.1557946   0.21565233  0.68229485  0.33394295
 -0.09880042 -0.22877553 -0.22249375 -0.5069818   0.66008574  0.463748
 -0.3353432   0.5865109   0.06059846 -0.35086417 -0.17910682  0.77625483
  0.4079908   0.6811431   0.17991512  0.21126986  0.6198331  -1.0826448 ]",10.1038/jp.2010.47,"['Cardiovascular Agents', 'Ductus Arteriosus, Patent', 'Echocardiography', 'Female', 'Gestational Age', 'Humans', 'Indomethacin', 'Infant, Extremely Low Birth Weight', 'Infant, Newborn', 'Infant, Premature, Diseases', 'Infant, Very Low Birth Weight', 'Male', 'Natriuretic Peptide, Brain', 'Predictive Value of Tests']"
427,"[-0.10985814 -0.14272039  0.7711767  -0.7462231  -0.18645209  0.72810507
  0.5315606   0.4217954  -1.544686    0.75843143  1.5127696   1.1282233
  0.2475146   0.41317362 -0.53815264 -0.62163085  0.75964814  0.9148816
 -0.3174978   1.08906     0.1160263  -0.12577981 -0.05842348  1.0912405
  0.9981242   1.1427494   0.5688191   0.0708118   0.891263   -1.6025609 ]",10.1016/B978-0-12-416749-0.00009-9,"['Animals', 'Enzyme Inhibitors', 'Humans', 'rho-Associated Kinases', 'rhoA GTP-Binding Protein']"
428,"[-0.4926478   0.09509107  0.23470008 -0.10747498 -0.1325835   0.6512627
  0.5502797   0.4339549  -2.3119512   0.81325465  1.0314425   0.3512488
 -0.54583913 -0.8038178  -0.52846014 -0.88554215  0.9798066   0.36232173
 -0.6163153   0.7785678   0.4710102  -0.9180714   0.03139876  1.2537104
  0.9267981   1.0626854   0.19186826 -0.01976456  0.8667942  -1.8781456 ]",10.1016/j.tvjl.2010.07.010,"['Animals', 'Antibodies, Neutralizing', 'Base Sequence', 'Escherichia coli', 'Gene Products, env', 'Molecular Sequence Data', 'Porcine Reproductive and Respiratory Syndrome', 'Porcine respiratory and reproductive syndrome virus', 'Sequence Analysis, Protein', 'Sus scrofa', 'Swine', 'Swine Diseases', 'Vaccination']"
429,"[-0.49309754  0.032915    0.45123148 -0.22093372 -0.03210326  0.6432214
  0.38912696  0.46908396 -1.9690113   0.72122157  0.94559294  0.57053995
  0.09782349 -0.539977   -0.6616153  -0.9480721   1.0246809   0.14650087
 -0.24012202  0.9750963   0.09028643 -0.5808908   0.24459639  1.4885405
  1.185383    1.1825461   0.17228386  0.10334092  0.7180849  -1.6096396 ]",10.1016/j.virol.2009.09.023,"['Animals', 'Antiviral Agents', 'Cytokines', 'Female', 'Gene Expression Regulation', 'Genome, Viral', 'Lung', 'Mice', 'Mice, Inbred BALB C', 'Mutation', 'Severe acute respiratory syndrome-related coronavirus', 'Severe Acute Respiratory Syndrome', 'Viral Proteins']"
430,"[-0.03123538  0.6459195   0.02723891  0.38470826 -0.1693761   1.2637998
  0.5884317   0.15648441 -2.7731574   0.99523634  0.75897557  0.09927951
 -0.26199412 -1.8875883  -0.56155205 -1.3150938   0.87984234 -0.73421144
 -0.6259562   0.38629413  1.01784    -1.8947713   0.94702125  1.7543776
  1.0504779   0.8019853   0.3224341  -0.2961979   0.3571843  -1.1940947 ]",10.1016/j.rvsc.2011.05.009,"['Animals', 'Animals, Newborn', 'Anti-Infective Agents', 'Buffaloes', 'Diarrhea', 'Drug Resistance, Bacterial', 'Enterotoxigenic Escherichia coli', 'Escherichia coli', 'Escherichia coli Infections', 'Microbial Sensitivity Tests', 'Shiga-Toxigenic Escherichia coli', 'Virulence Factors']"
431,"[-0.51483035 -0.0249983   0.9198091  -0.3916351  -0.5230318   0.9896247
  0.4671929   0.23441145 -2.0467494   0.41832194  1.4284579   0.893317
 -0.15259063 -0.10687797 -0.4873025  -0.69435877  1.1688825   1.043064
 -0.44791904  1.1380025   0.42613015 -0.93386644 -0.1775882   1.449115
  1.0138564   1.1514701   0.24057642  0.3947292   1.170957   -2.1887887 ]",10.1016/j.virol.2011.05.012,"['Cell-Free System', 'Frameshifting, Ribosomal', 'Gene Expression Regulation, Viral', 'Mutagenesis, Site-Directed', 'Open Reading Frames', 'Protein Biosynthesis', 'RNA, Viral', 'RNA-Dependent RNA Polymerase', 'Tombusviridae']"
432,"[-0.49533185 -0.11682466  0.6250066  -0.33557814 -0.09889549  0.7201332
  0.3490086   0.45918155 -1.879848    0.6469205   1.2875358   0.73370665
 -0.13753748 -0.22564825 -0.60423815 -0.6504505   0.9980533   0.48996204
 -0.3852169   0.92355794  0.08319791 -0.6155694   0.04712937  1.2290297
  0.90472794  1.236729    0.5371016   0.14770214  0.93647003 -1.6779946 ]",10.1016/j.rvsc.2011.07.018,"['Animals', 'Apoptosis', 'Cell Proliferation', 'Ileum', 'Intestinal Mucosa', 'Intestine, Large', 'Intestine, Small', 'Jejunum', 'Male', 'Plant Extracts', 'Plant Leaves', 'Rabbits', 'Solanum glaucophyllum']"
433,"[-0.22259428 -0.14024605  0.6512037  -0.44897187 -0.18637586  0.73514587
  0.3597304   0.3228065  -2.1247404   0.5579648   1.3121833   0.6502113
  0.28600645 -0.12762444 -0.6992143  -0.623384    1.2721363   0.87135565
 -0.23488618  1.2510273  -0.01898665 -0.18524587 -0.02149813  1.1245335
  0.94702965  1.0575205   0.45936257  0.2682907   0.69395804 -1.6307771 ]",10.2967/jnumed.111.098947,"['Fluorodeoxyglucose F18', 'Humans', 'Medicaid', 'Medicare', 'Positron-Emission Tomography', 'Radiopharmaceuticals', 'United States', 'United States Food and Drug Administration']"
434,"[-0.19470672 -0.06748605  0.39888397 -0.19287598 -0.1363776   0.17123125
 -0.0056845   0.09883133 -0.62823755 -0.00761499  0.5031245   0.21167347
 -0.0722112  -0.01715662 -0.1071777  -0.3057206   0.4409992   0.42299595
 -0.23726647  0.42484656 -0.00990078 -0.15887669 -0.20710342  0.5133693
  0.20899507  0.4636027   0.11579775  0.23567624  0.44678065 -0.8136053 ]",10.1002/14651858.CD008586.pub2,"['Adult', 'Anticonvulsants', 'Brain Neoplasms', 'Drug Substitution', 'Humans', 'Levetiracetam', 'Phenytoin', 'Piracetam', 'Randomized Controlled Trials as Topic', 'Seizures']"
435,"[-0.3123205   0.03898068  0.7173535  -0.32952335 -0.13269563  0.90333706
  0.4054202   0.3148781  -2.186472    0.6995715   1.2609512   0.7146308
 -0.06146362 -0.5887843  -0.5382046  -0.9196214   1.0228567   0.4465877
 -0.42392734  0.95777166  0.31752202 -0.85997856  0.22485042  1.5598443
  0.97533417  1.3777133   0.20721418  0.21249372  0.8605105  -1.7456145 ]",10.1016/j.virol.2011.12.002,"['Amino Acid Sequence', 'Down-Regulation', 'Fluorescence Resonance Energy Transfer', 'Gastroenteritis', 'Genotype', 'Humans', 'Kinetics', 'Molecular Sequence Data', 'Norovirus', 'Norwalk virus', 'Oligopeptides', 'Peptide Hydrolases', 'Protease Inhibitors', 'Sequence Alignment', 'Viral Proteins']"
436,"[-0.33899096 -0.14169961  0.61912143 -0.35239714 -0.2126503   0.12407869
 -0.07160863  0.10397524 -0.47966605 -0.10153305  0.7734406   0.32330787
 -0.03611256  0.20399822 -0.02206728 -0.35404918  0.56574905  0.70441943
 -0.22315593  0.54735637 -0.08132184 -0.23920524 -0.34906867  0.62461054
  0.15391287  0.6887247   0.13290434  0.46428174  0.5926243  -0.9922456 ]",10.1177/0898264314533722,"['Age Distribution', 'Aged', 'Aged, 80 and over', 'Asian', 'Chicago', 'China', 'Cohort Studies', 'Female', 'Humans', 'Independent Living', 'Loneliness', 'Male', 'Middle Aged', 'Prevalence', 'Risk Factors', 'Sex Distribution']"
437,"[-0.20313405 -0.14573811  0.50883085 -0.40961304 -0.11030681  0.35787815
  0.34036896  0.26593295 -1.335328    0.3236295   0.8937247   0.51000357
  0.10283553  0.03198982 -0.4069729  -0.48329353  0.7568968   0.7201365
 -0.355331    0.7948136  -0.05441299  0.02998496 -0.3086934   0.723075
  0.6134621   0.7046884   0.3196878   0.10667492  0.50237083 -1.1581498 ]",10.1002/14651858.CD003267.pub2,"['Decision Making', 'Health Behavior', 'Humans', 'Medical Staff', 'Medicine', 'Nursing Staff', 'Patient Participation', 'Patient Satisfaction', 'Patient-Centered Care', 'Physician-Patient Relations', 'Randomized Controlled Trials as Topic']"
438,"[-0.29719415  0.41346171  0.89818686  0.52310705  0.5179212   1.520579
  0.37671953  0.23967569 -2.6779473   1.8138196   1.6229793   1.1407106
  0.61877155 -0.75683284 -1.4095463  -0.52497375  0.66160965  0.5503112
 -0.19456992  0.9969615  -0.8031718  -0.32444844  0.75204974  1.5666462
  0.9185334   1.93811     0.18345147  0.2781      1.1803863  -1.1115395 ]",10.1371/journal.pone.0111575,"['Animals', 'Annexin A5', 'Antineoplastic Agents', 'Apoptosis', 'Benzofurans', 'Carcinogenesis', 'Cell Adhesion', 'Cell Line, Tumor', 'Cell Movement', 'Cell Nucleus', 'Cell Proliferation', 'G1 Phase', 'Humans', 'Lichens', 'Mice, Inbred BALB C', 'Mice, Nude', 'Phosphorylation', 'Proto-Oncogene Proteins c-akt', 'Secondary Metabolism']"
439,"[-0.23019232 -0.29850814  0.43751794 -0.4264994  -0.11243674  0.07854405
 -0.0558014   0.21522363 -0.11900427 -0.2553777   0.83416206  0.40253323
 -0.07389882  0.3175352  -0.25366414 -0.23071368  0.44455993  0.6144251
  0.08160844  0.48208624  0.04824876  0.11175245 -0.14785954  0.50029874
  0.20234293  0.64493334  0.4447571   0.37971604  0.22708344 -0.78564644]",10.1177/0898264315571106,"['Aged', 'Aged, 80 and over', 'Chicago', 'Cross-Sectional Studies', 'Depression', 'Elder Abuse', 'Female', 'Humans', 'Male', 'Risk Factors', 'Urban Population']"
440,"[-0.12305998 -0.0588975   0.3274084  -0.08980073 -0.08704241  0.04118303
 -0.02335012  0.03410209 -0.31061473 -0.08068566  0.26532447  0.04571158
 -0.09162113 -0.01059211  0.00112495 -0.13363597  0.2736635   0.30243948
 -0.18396994  0.24378596 -0.09044135 -0.05098284 -0.24642344  0.26616466
  0.044799    0.2346989   0.01858651  0.19028892  0.27254072 -0.46593305]",10.1016/j.jpeds.2013.01.028,"['Health Personnel', 'Humans', 'Immunization', 'Risk Assessment']"
441,"[-0.14411367 -0.19744056  0.374045   -0.2859912  -0.07261213  0.20358495
  0.052476    0.20519044 -0.388335   -0.02889763  0.72164726  0.31648237
 -0.01925276  0.11486322 -0.23211709 -0.2462041   0.40271568  0.32318196
 -0.01205575  0.42344806  0.08098977  0.05524493 -0.01876489  0.5152589
  0.26081175  0.51567405  0.42572537  0.16120732  0.17427118 -0.7062921 ]",10.1177/0898264312467373,"['Aged', 'Chicago', 'Elder Abuse', 'Female', 'Humans', 'Independent Living', 'Male', 'Proportional Hazards Models', 'Prospective Studies', 'Risk Assessment', 'Risk Factors', 'Self Care', 'Social Work', 'Time Factors']"
442,"[-0.17212988 -0.05422045  0.3484807  -0.14899953 -0.10342516  0.24795158
  0.13237423  0.10122108 -0.7302244   0.15722886  0.4982237   0.26609898
  0.0127388  -0.09161138 -0.15314314 -0.31200197  0.43520632  0.3610265
 -0.27728462  0.42925295  0.03929697 -0.18206753 -0.13212556  0.50560737
  0.2635386   0.4890335   0.15133414  0.18215142  0.36623448 -0.80227375]",10.1007/s00404-012-2579-9,"['Adult', 'Clomiphene', 'Female', 'Fertility Agents, Female', 'Humans', 'Infertility, Female', 'Insemination, Artificial', 'Letrozole', 'Nitriles', 'Ovulation Induction', 'Pilot Projects', 'Pregnancy', 'Prospective Studies', 'Treatment Outcome', 'Triazoles']"
443,"[-0.3030687  -0.04082532  0.67013437 -0.2562907  -0.20872244  0.5099966
  0.22635533  0.22015846 -1.3116167   0.17673533  0.8795612   0.40135628
 -0.06621787 -0.17616735 -0.28685766 -0.6074419   0.7951473   0.700442
 -0.50226545  0.69706094 -0.01572319 -0.37776932 -0.2623102   0.87728524
  0.6130246   0.6545885   0.16170274  0.22254594  0.69410664 -1.22475   ]",10.7860/JCDR/2014/9624.4946,[]
444,"[-0.6074536  -0.21921752  0.6961096   0.20502499  0.01473355  0.98575556
  0.5128152   0.55723447 -2.7469602   1.0549284   1.0133052   0.67893016
 -0.30688146 -1.5358905  -0.58784616 -1.237115    0.43660915  0.14315549
 -0.57323265  0.78877044  0.71115    -1.3265513   0.21387233  1.4875298
  1.1992285   0.9132551   0.42194197 -0.30096346  1.2102075  -1.5154045 ]",10.1177/1535370213494558,"['Animals', 'Brain Injuries', 'Cell Hypoxia', 'Cell Proliferation', 'Cells, Cultured', 'Cerebral Ventricles', 'Ephrin-B3', 'Hypoxia-Inducible Factor 1, alpha Subunit', 'Male', 'Mice', 'Neural Stem Cells', 'Nitroimidazoles', 'Receptor, EphB3', 'Signal Transduction', 'Stem Cell Transplantation']"
445,"[-0.24030076 -0.00569159  0.47736028 -0.16272655 -0.14622794  0.3809136
  0.10819861  0.14649409 -0.96533626  0.23769717  0.66431284  0.2691425
 -0.06324061 -0.2112444  -0.2213563  -0.41376972  0.590836    0.39367616
 -0.30926102  0.5266312   0.12252869 -0.3292632  -0.08190196  0.70497555
  0.36408427  0.69994617  0.22961546  0.23742022  0.52773905 -1.0416191 ]",10.1007/s11095-015-1739-6,"['Amino Acids', 'Animals', 'Antibodies, Monoclonal', 'Antibodies, Monoclonal, Humanized', 'Buffers', 'Humans', 'Particle Size', 'Phase Transition', 'Salts', 'Scattering, Small Angle', 'Solutions', 'Viscosity', 'X-Ray Diffraction']"
446,"[-0.35524955 -0.03657387  0.64092934 -0.21142958 -0.21342932  0.37585115
  0.08961175  0.12770557 -1.1434346   0.14611971  0.78471583  0.3597573
 -0.13525632 -0.10102814 -0.16610378 -0.5370921   0.7431861   0.69473237
 -0.4612601   0.65610904 -0.01275906 -0.36998385 -0.27478388  0.86430407
  0.45858875  0.69816273  0.14088929  0.30908853  0.7616938  -1.296623  ]",10.1002/14651858.CD009950.pub3,"['Amines', 'Analgesics', 'Carbamazepine', 'Constipation', 'Cyclohexanecarboxylic Acids', 'Gabapentin', 'Guillain-Barre Syndrome', 'Humans', 'Immunoglobulins, Intravenous', 'Methylprednisolone', 'Nausea', 'Pain', 'Pain Measurement', 'Randomized Controlled Trials as Topic', 'gamma-Aminobutyric Acid']"
447,"[-0.04810169 -0.59290254  0.97896105 -1.1171712  -0.4595793   0.571339
  0.6434261   0.42749324 -1.7965724   0.38773814  1.5610781   1.0589889
  0.5232838   0.7102331  -0.68854326 -0.3718556   1.3464205   1.0369015
 -0.37236124  1.4631469   0.04369761  0.34736902  0.08590276  1.1534362
  1.4200358   1.4712281   0.8153244  -0.06031373  0.6309673  -1.5056286 ]",10.1016/j.jbi.2015.07.007,"['Delivery of Health Care', 'Environment', 'Humans', 'Medical Informatics', 'Virtual Reality']"
448,"[-0.20980178  0.26014173  0.8301865  -0.50455135  0.16708967  1.6902453
  0.2889584   0.04529099 -2.7360625   1.1997727   0.838554    0.44436556
  0.171688   -1.7175951  -0.65921247 -0.9228983   0.9920105  -0.37964818
 -0.5048435   0.3813373   0.5680218  -1.486346    0.09312294  1.7096431
  0.9739582   1.7284559   0.5938236   0.36138198  0.6930846  -2.2028263 ]",10.1111/ajt.13599,"['Adult', 'Blood Circulation', 'Brain Death', 'California', 'Female', 'Follow-Up Studies', 'Graft Rejection', 'Graft Survival', 'Humans', 'Incidence', 'Lung', 'Lung Diseases', 'Lung Transplantation', 'Male', 'Middle Aged', 'Postoperative Complications', 'Prognosis', 'Registries', 'Risk Factors', 'Tissue Donors', 'Tissue and Organ Procurement']"
449,"[-0.3616957  -0.16669422  0.77785563 -0.8599823  -0.1066759   0.7632633
  0.5877328   0.4220709  -1.8461014   0.49843046  1.4686451   0.918252
  0.19778462  0.14697324 -0.6864919  -0.7113943   1.0365021   0.8852879
 -0.3597175   1.4125267   0.06346032 -0.06902304 -0.03714625  1.2411983
  1.0492432   1.3133671   0.56666064  0.22719406  0.90437365 -1.9000235 ]",10.1016/j.pediatrneurol.2016.09.004,"['Animals', 'Brain', 'Cannabinoids', 'Cannabis', 'Fatal Outcome', 'Humans', 'Male', 'Marijuana Abuse', 'Middle Aged', 'Psychoses, Substance-Induced']"
450,"[-0.7443254  -0.17294517  0.99744445 -0.8228182  -0.56452894  0.657263
  0.5429179  -0.02946878 -2.7225182   1.3892081   0.6817318   0.4805802
 -0.78694206 -0.8412224  -1.1187243  -1.6751794   0.8715107   0.42448783
 -0.28648308  1.1349864   0.73184466 -1.2318192  -0.10132523  2.367027
  1.4681258   1.9235159   0.26935667 -0.2554482   2.0455625  -2.1420693 ]",10.1016/j.bbr.2017.07.043,"['Anemia, Iron-Deficiency', 'Animals', 'Animals, Newborn', 'Choline', 'Dietary Supplements', 'Female', 'Hippocampus', 'Iron', 'Male', 'Neurocognitive Disorders', 'Neuronal Plasticity', 'Pregnancy', 'Prenatal Exposure Delayed Effects', 'Rats', 'Rats, Sprague-Dawley']"
451,"[-0.13507202 -0.10636706  0.39295986 -0.1983632  -0.10360213  0.14931253
  0.03445875  0.1649586  -0.56636983  0.08445664  0.45355976  0.19777702
 -0.047826    0.02254437 -0.12195218 -0.2684985   0.42311835  0.34743297
 -0.1428165   0.43755275 -0.04134001 -0.09372288 -0.18240009  0.510232
  0.2693548   0.38417965  0.12372011  0.17311537  0.3745039  -0.6602937 ]",10.1371/journal.pntd.0004858,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Agglutination Tests', 'Animals', 'Antibodies, Bacterial', 'Cattle', 'Female', 'Humans', 'Leptospira', 'Leptospirosis', 'Logistic Models', 'Male', 'Middle Aged', 'Multivariate Analysis', 'Risk Factors', 'Rural Population', 'Seroepidemiologic Studies', 'Serogroup', 'Uganda', 'Young Adult']"
452,"[-0.5254777   0.32285643  1.2034396  -0.19317046 -0.69667876  1.1694028
  0.30136853  0.08459098 -2.0606472   0.47901502  1.4595984   0.82293797
  0.71593094  0.33478662 -0.38020912 -1.0895149   1.6950643   0.34011453
 -0.9537158   0.8431734   0.8448941  -0.5981365   0.22960174  1.1503388
  0.85506684  1.5536883   0.9304463   0.11451752  1.2446098  -1.7946594 ]",10.1016/j.chemosphere.2016.06.047,"['Environmental Monitoring', 'India', 'Pharmaceutical Preparations', 'Seasons', 'Sewage', 'United States', 'Waste Disposal, Fluid', 'Wastewater', 'Water Pollutants, Chemical']"
453,"[-0.2575719  -0.10378508  0.6155808  -0.33151695 -0.26110554  0.38887206
  0.1766219   0.17977077 -1.2555331   0.3071434   0.87455505  0.38438296
 -0.02836045 -0.09830017 -0.26215792 -0.5749484   0.69351125  0.6893923
 -0.4657109   0.7199354   0.02002315 -0.33949524 -0.2055673   0.80548126
  0.5029954   0.74858     0.24420089  0.22622901  0.6788076  -1.3737643 ]",10.1002/14651858.CD007387.pub4,"['Drainage', 'Female', 'Genital Neoplasms, Female', 'Humans', 'Lymph Node Excision', 'Lymphocele', 'Pelvis', 'Randomized Controlled Trials as Topic', 'Retroperitoneal Space', 'Suction']"
454,"[-0.2014785  -0.09196173  0.5680285  -0.23875968 -0.17332613  0.29249185
  0.16836393  0.10380861 -0.9831947   0.18960406  0.78745043  0.31622195
  0.00805752  0.01248213 -0.15773818 -0.40910274  0.6208395   0.6452666
 -0.45348594  0.6238735  -0.06597912 -0.22795168 -0.33070683  0.6597281
  0.4143921   0.6363276   0.25858748  0.21073325  0.50881684 -1.1109481 ]",10.1002/14651858.CD011516.pub2,"['Anesthesia, Conduction', 'Anesthesia, Epidural', 'Apgar Score', 'Cesarean Section', 'Delivery, Obstetric', 'Female', 'Home Childbirth', 'Hospitalization', 'House Calls', 'Humans', 'Infant, Newborn', 'Labor, Obstetric', 'Midwifery', 'Parturition', 'Pregnancy', 'Randomized Controlled Trials as Topic', 'Telephone', 'Time Factors', 'Triage']"
455,"[-0.22087984 -0.12871651  0.52577543 -0.30574253 -0.16535988  0.5030752
  0.23732048  0.16378048 -1.1699355   0.3047999   0.8471581   0.428336
  0.077962   -0.08195993 -0.3355524  -0.46278068  0.69223     0.54398227
 -0.3409392   0.6786341   0.05175335 -0.20989259 -0.11376704  0.7996335
  0.5443888   0.80798566  0.3337243   0.17761159  0.5915698  -1.1638576 ]",10.1016/j.ajog.2017.07.024,"['Adult', 'Contraceptive Agents, Female', 'Cost-Benefit Analysis', 'Decision Trees', 'Endometrial Ablation Techniques', 'Female', 'Health Care Costs', 'Humans', 'Hysterectomy', 'Intrauterine Devices, Medicated', 'Levonorgestrel', 'Menorrhagia', 'Middle Aged', 'Quality of Life', 'Quality-Adjusted Life Years']"
456,"[ 0.5283861  -0.9590986   0.22769004 -0.53340846 -0.43602648  0.93130904
  1.6864005   0.30645835 -3.4519603   0.44685793  2.8402333   1.151555
  1.4082947  -1.2286848  -0.44117248  0.42650124 -0.07297205  2.3575974
 -2.040167    1.7043443  -0.01674641  0.64024806 -0.5770788   0.19295691
  1.1697755   1.1553291   1.0171883  -0.4269542   0.5191657  -1.2781147 ]",10.1177/1524838016663935,"['Abortion, Induced', 'Coercion', 'Contraception', 'Cross-Sectional Studies', 'Female', 'Humans', 'Intimate Partner Violence', 'Male', 'Personal Autonomy', 'Pregnancy', 'Pregnancy, Unplanned', 'Reproductive Rights', 'Sexual Behavior']"
457,"[-0.35843208  0.5229298   0.48432752  0.1430641   0.08706693  0.97585535
  0.13531595  0.4807463  -2.6575098   0.75553036  1.1659383   0.23127033
 -0.34118187 -1.1155826  -0.5676103  -1.2568707   1.0602481  -0.13619402
 -0.8333568   0.71002007  0.35110658 -1.3590201   0.56037915  2.1548548
  1.502631    1.148905    0.28211483  0.30278265  0.87335867 -1.6965299 ]",10.1371/journal.pntd.0005634,"['Adult', 'Animals', 'Antiretroviral Therapy, Highly Active', 'CD4 Lymphocyte Count', 'CD4-Positive T-Lymphocytes', 'Cohort Studies', 'Coinfection', 'Female', 'HIV Infections', 'Helminths', 'Hookworm Infections', 'Humans', 'Linear Models', 'Male', 'Rural Population', 'Uganda']"
458,"[-0.22093199 -0.22226636  0.55756515 -0.5276153  -0.19741379  0.5549547
  0.26554978  0.45401967 -1.3371276   0.2950676   1.1034771   0.52651066
  0.01596416  0.02969237 -0.40894634 -0.5455066   0.8337086   0.7380795
 -0.25972125  0.8624199   0.09023374 -0.01540291 -0.26539066  0.9964669
  0.72745425  0.87161577  0.42757913  0.1096173   0.63538927 -1.341933  ]",10.1093/eurheartj/ehw151,"['Acute Disease', 'Air Pollutants', 'Air Pollution', 'Climate', 'Climate Change', 'Cold Temperature', 'Environmental Exposure', 'Humans', 'Myocardial Infarction', 'Public Health', 'Risk Factors']"
459,"[-0.6849048  -0.22996536  0.9800021   0.21010864  0.26509655  1.0209969
  0.15070409  0.71323884 -2.6176562   1.3778106   1.3529042   0.6719147
  0.02325864 -0.88242775 -0.6228894  -1.1597762   0.59973025  0.41669098
 -0.79280925  1.0139912  -0.08315944 -0.7186072   0.23082101  1.8616679
  1.1651123   1.3289938   0.24412319 -0.02948409  1.3140851  -1.5937303 ]",10.1172/jci.insight.93411,[]
460,"[-0.15953422 -0.14078768  0.39434895 -0.2461833  -0.16623557  0.05367121
 -0.03670114  0.06013572 -0.26686174 -0.11413447  0.54083973  0.21564223
 -0.02934265  0.17561467 -0.02185282 -0.19493084  0.42016923  0.41296315
 -0.09029593  0.31310934 -0.06311326 -0.09339625 -0.2122714   0.45025995
  0.03577078  0.501443    0.18931207  0.31309292  0.34092477 -0.61492354]",10.1177/0898264316661829,"['Aged', 'Aged, 80 and over', 'Asian', 'Chicago', 'Female', 'Health Status', 'Humans', 'Logistic Models', 'Male', 'Mental Health', 'Middle Aged', 'Residence Characteristics', 'Self Report']"
461,"[-0.05959203 -0.45574927  0.21363762 -0.10390995  0.03628432  1.056807
  1.3107957   1.0120943  -3.3360257   1.6872691   0.85535675  0.8347918
  0.31738016 -1.4838421  -0.61867434 -1.9126248   0.8831102   0.11966261
 -0.5180513   0.9413896   0.92623556  0.04183212 -0.7958218   0.54613423
  0.47298482  1.13969     1.3843704   0.05825636  0.54171103 -1.9591408 ]",10.1080/08964289.2017.1375455,"['Adult', 'Case-Control Studies', 'Communication', 'Female', 'Health Knowledge, Attitudes, Practice', 'Health Personnel', 'Humans', 'Insurance Coverage', 'Insurance, Health', 'Male', 'Middle Aged', 'Smoking Cessation', 'Young Adult']"
462,"[-0.22626567  0.03958805  0.34826288 -0.03271127 -0.08352791  0.38950834
  0.10718986  0.23087162 -1.1174409   0.26694277  0.5876368   0.12517084
 -0.10981305 -0.3664506  -0.19878648 -0.5106193   0.5534612   0.28105426
 -0.36973685  0.47200644  0.15791832 -0.46410203 -0.05492988  0.79629856
  0.39989045  0.51907027  0.09151931  0.13767363  0.4659947  -0.91769165]",10.1002/ejhf.1091,"['Aged', 'Cause of Death', 'Echocardiography', 'Female', 'Follow-Up Studies', 'Heart Failure', 'Heart Ventricles', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Prognosis', 'Prospective Studies', 'Risk Assessment', 'Stroke Volume', 'Survival Rate', 'United States']"
463,"[-0.13327311 -0.23632394  0.57396257 -0.53839296  0.08957513  1.1791582
  0.5816242   0.30175778 -1.9517266   0.6332715   1.5637412   0.4490446
  0.05562158 -0.10259865 -0.8524753  -0.8145523   1.5223246   0.9440508
 -0.51273906  1.0473899   0.09550261 -0.14557609  0.09091814  1.2513928
  0.93249136  1.4150038   0.9675607   0.23428668  0.5820507  -2.283679  ]",10.1111/adb.12511,"['Adult', 'Alcoholism', 'Behavior', 'Craving', 'Female', 'Humans', 'Male', 'Middle Aged', 'Motivation', 'Stress, Psychological', 'Young Adult']"
464,"[-0.1076689  -0.21666183  0.6170784  -0.5266968  -0.168661    0.55345684
  0.38344193  0.45045358 -1.8392872   0.60827863  1.1810943   0.7949586
  0.00737752  0.5057394  -0.51172894 -0.7745866   1.1575812   0.9229946
 -0.38555557  1.2190235  -0.13894612 -0.04673436 -0.00432049  1.1725996
  0.8634615   0.89478093  0.3100187   0.12209859  0.81745934 -1.5831996 ]",10.1200/JOP.2017.020909,"['Anemia, Sickle Cell', 'Carcinoma, Medullary', 'Humans', 'Kidney Neoplasms', 'Practice Guidelines as Topic', 'Registries']"
465,"[-0.62324405 -0.48200968  0.90409815 -0.5442296  -0.06254916  0.33353847
  0.5226123   0.3803834  -2.0275476   0.969896    1.0534285   1.0336033
  0.2431649   0.27420393 -0.78370345 -0.8357846   0.8750692   0.87641454
 -0.425002    1.1098516  -0.10135212 -0.56700504 -0.07248537  1.3338488
  0.9456046   1.2854697   0.0606792   0.14861515  1.0488534  -1.9148134 ]",10.1097/CJI.0000000000000212,"['Animals', 'Cancer Vaccines', 'Chemokine CCL20', 'Cytokines', 'Dendritic Cells', 'Disease Models, Animal', 'Female', 'Immunotherapy', 'Interferon Type I', 'Interleukin-10', 'Lymphocytes, Tumor-Infiltrating', 'Melanoma, Experimental', 'Mice', 'Mice, Knockout', 'Treatment Outcome', 'Vaccination', 'gp100 Melanoma Antigen']"
466,"[-0.2672752  -0.11202733  0.47262996 -0.2165849  -0.10326385  0.30036992
  0.05887925  0.17623135 -0.76769364  0.1433759   0.572806    0.20407254
 -0.07317086 -0.09491088 -0.09448007 -0.3958963   0.5098146   0.43656677
 -0.26817694  0.4801031   0.03043885 -0.25570905 -0.23502499  0.5935725
  0.34918714  0.5433982   0.1578983   0.19887984  0.5390941  -0.9275428 ]",10.1513/AnnalsATS.201707-571OC,"['Atherosclerosis', 'Cross-Sectional Studies', 'Diet', 'Female', 'Follow-Up Studies', 'Forced Expiratory Volume', 'Humans', 'Lung', 'Male', 'Middle Aged', 'Morbidity', 'Pulmonary Disease, Chronic Obstructive', 'Retrospective Studies', 'Risk Factors', 'Survival Rate', 'United States', 'Vital Capacity']"
467,"[-0.00356142 -0.00797756  0.34280977 -0.35779282 -0.43149796  0.55961996
  0.5805304   0.27578261 -1.7736769   0.82076496  1.368231    0.58504295
  0.2782488   0.18634453 -0.7643413  -0.7526824   0.96322304  0.76067007
 -0.6820283   1.0698613   0.382337   -0.28008235 -0.13914841  1.0144924
  0.91336036  1.2931254   0.49106207  0.0715712   0.48659992 -1.6439558 ]",10.1177/0956462418755224,"['Adolescent', 'Adult', 'Anti-HIV Agents', 'Black People', 'Focus Groups', 'HIV Infections', 'Health Knowledge, Attitudes, Practice', 'Homosexuality, Male', 'Humans', 'London', 'Male', 'Middle Aged', 'Patient Acceptance of Health Care', 'Patient Preference', 'Pre-Exposure Prophylaxis', 'Qualitative Research', 'Young Adult']"
468,"[-0.35517734 -0.0141041   0.44260865 -0.06195497 -0.09153571  0.31013262
 -0.06613125  0.20279844 -0.6587608   0.00573649  0.46083316  0.07326216
 -0.22172852 -0.3075899   0.00819309 -0.38782138  0.46374035  0.4486154
 -0.31491566  0.35852626  0.14640889 -0.40422532 -0.21652831  0.6382813
  0.09877013  0.390275    0.0131313   0.28251404  0.49822003 -0.871902  ]",10.1161/CIRCIMAGING.117.007241,"['Aged', 'Aged, 80 and over', 'Atherosclerosis', 'Cross-Sectional Studies', 'Ethnicity', 'Female', 'Follow-Up Studies', 'Humans', 'Incidence', 'Liver', 'Liver Cirrhosis', 'Magnetic Resonance Imaging', 'Male', 'Middle Aged', 'Population Surveillance', 'Prospective Studies', 'Risk Factors', 'United States']"
469,"[-0.24427801  0.03488698  0.44337282 -0.33454317 -0.24285112  0.6047605
  0.32280412  0.2749983  -1.8900957   0.6258914   1.0596192   0.51405585
 -0.06176576 -0.4143214  -0.55818254 -0.77987134  1.0507355   0.4149271
 -0.34345746  0.81170255  0.14442693 -0.6080292  -0.03106931  1.1454399
  0.8683184   1.0849639   0.20446077  0.13521492  0.8408363  -1.4356352 ]",10.1093/cid/cix943,"['Antibodies, Bacterial', 'Antigens, Bacterial', 'Bacterial Proteins', 'Borrelia burgdorferi', 'Enzyme-Linked Immunosorbent Assay', 'Europe', 'Humans', 'Immunoenzyme Techniques', 'Immunoglobulin G', 'Immunoglobulin M', 'Lyme Disease', 'Recombinant Proteins', 'Sensitivity and Specificity', 'Serologic Tests', 'United States']"
470,"[-0.12769257 -0.06617785  0.24318765 -0.02757956 -0.03588907  0.12612182
 -0.04422667  0.08043696 -0.3044312  -0.01418104  0.2424235   0.05354045
 -0.04703341 -0.08168876  0.00436624 -0.14305468  0.16497335  0.24093455
 -0.1470172   0.18273146 -0.03451441 -0.05686631 -0.1476603   0.25430343
  0.04693928  0.21808363  0.04466511  0.15327181  0.22216898 -0.39928856]",10.1158/1055-9965.EPI-17-0696,"['Aged', 'Atherosclerosis', 'Cohort Studies', 'Epidemiological Monitoring', 'Female', 'Humans', 'Incidence', 'Male', 'Middle Aged', 'Neoplasms', 'Registries', 'Risk Factors', 'United States']"
471,"[-0.20239106  0.02401623  0.25375995  0.0445149  -0.0229423   0.31268343
 -0.05734359  0.19673069 -0.66317225  0.09332534  0.3529331  -0.04312278
 -0.1352514  -0.40629473 -0.05714813 -0.3427906   0.35312533  0.22233294
 -0.15798052  0.23796928  0.1820667  -0.2406047  -0.11796681  0.5740669
  0.16039816  0.2686407   0.08750457  0.15832116  0.31989485 -0.6233245 ]",10.1002/pds.4393,"['Aged', 'Aged, 80 and over', 'Atherosclerosis', 'Cholesterol, HDL', 'Cholesterol, LDL', 'Coronary Disease', 'Ethnicity', 'Female', 'Follow-Up Studies', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'Lipid Metabolism', 'Male', 'Metabolic Networks and Pathways', 'Middle Aged', 'Prospective Studies', 'Risk Factors', 'Treatment Outcome', 'Triglycerides', 'United States']"
472,"[-0.5013373  -0.23764597  0.28170475 -0.6487494   0.03024286  0.33122241
  0.994174    0.29004806 -1.3243151   1.1059643   1.087617    1.3779867
  0.5291374  -0.22780256 -1.1268654  -1.1664741   0.9339137   0.20969114
 -0.05292358  1.2215936  -0.010358   -0.02987467  0.49726558  1.4938413
  1.6389707   1.1960849   0.22214529 -0.30404007  1.0218992  -1.3609071 ]",10.1038/s41388-018-0162-y,"['Animals', 'Cell Line, Tumor', 'Cell Proliferation', 'Databases, Genetic', 'Epithelial-Mesenchymal Transition', 'Feedback, Physiological', 'Gene Expression Regulation, Neoplastic', 'Humans', 'Lung Neoplasms', 'Mice', 'MicroRNAs', 'NADPH Oxidases', 'NF-kappa B', 'Neoplasm Transplantation', 'Prognosis', 'Promoter Regions, Genetic', 'RNA, Long Noncoding', 'Signal Transduction', 'Stomach Neoplasms', 'Survival Analysis']"
473,"[-0.14754616 -0.11461167  0.40772223 -0.15637726 -0.12075052  0.17011817
  0.04740234  0.06277072 -0.58304876  0.02269816  0.52252114  0.18846776
 -0.02179078 -0.01767363 -0.08707441 -0.2577523   0.39582396  0.45729557
 -0.29906514  0.42743292 -0.11051494 -0.05669676 -0.25554407  0.4321174
  0.2258384   0.41441548  0.14253035  0.19269164  0.3997056  -0.7336535 ]",10.1002/14651858.MR000013.pub6,"['Humans', 'Patient Education as Topic', 'Patient Selection', 'Randomized Controlled Trials as Topic', 'Reminder Systems', 'Sample Size', 'Telephone']"
474,"[-0.20675692 -0.02976832  0.28627113 -0.09564584 -0.0755235   0.2068399
  0.04612676  0.1381204  -0.66696674  0.12389473  0.45882508  0.15972415
 -0.10281831 -0.16050783 -0.16121043 -0.31178543  0.3963182   0.2924941
 -0.16523263  0.36050305  0.06624401 -0.2504524  -0.13501723  0.500876
  0.17884453  0.36447385  0.07776652  0.1706824   0.40186897 -0.75816005]",10.1016/j.jpeds.2017.11.058,"['Enteral Nutrition', 'Female', 'Humans', 'Incidence', 'Infant', 'Infant, Newborn', 'Intestinal Diseases', 'Intestines', 'Liver Diseases', 'Logistic Models', 'Male', 'Postoperative Care', 'Postoperative Complications', 'Practice Guidelines as Topic', 'Prospective Studies', 'Retrospective Studies', 'Risk Factors', 'Severity of Illness Index', 'Treatment Outcome']"
475,"[-0.08322768 -0.51114124  0.66605335 -1.093417   -0.3047496   0.42223015
  0.27366558  0.6611352  -0.8349466   0.4251339   1.4377675   1.2588619
 -0.01080142  0.6998695  -0.31406268 -0.9935348   1.3877401   0.68742365
  0.01141895  0.95268655  0.27893502 -0.16333316  0.3186957   1.4726511
  1.0090684   1.6845757   0.965394    0.4441153   0.85058033 -1.8904907 ]",10.1016/j.socscimed.2018.01.007,"['Aged', 'Aged, 80 and over', 'Atherosclerosis', 'Cognition', 'Educational Status', 'Environment Design', 'Ethnicity', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Middle Aged', 'Residence Characteristics', 'Urban Population']"
476,"[-0.35950366  0.27990136  0.59355307  0.11798473 -0.19226368  0.72704446
 -0.06760041  0.27200755 -1.7604182   0.42436582  0.92423356  0.00770498
 -0.16457708 -0.8134989  -0.26846084 -0.7943219   0.82894105  0.17760344
 -0.5211536   0.5799836   0.47759157 -0.8245502   0.08085299  1.3358377
  0.482759    0.7139661   0.21220659  0.2534449   0.5966702  -1.5242994 ]",10.1161/HYPERTENSIONAHA.117.10648,"['Adult', 'Aged', 'Blood Flow Velocity', 'Blood Pressure', 'Carotid Arteries', 'Cause of Death', 'Disease Progression', 'Female', 'Glomerular Filtration Rate', 'Humans', 'Hypertension', 'Male', 'Middle Aged', 'Pulse Wave Analysis', 'Renal Insufficiency, Chronic', 'Retrospective Studies', 'Survival Rate', 'United States', 'Young Adult']"
477,"[-0.7092321   1.2047993  -0.25169334 -1.1567819  -0.68247044  0.17222871
  0.03239748 -0.32871687 -1.7899777   0.39503428  2.3387485   1.0736952
  0.6246529   0.45252785 -1.3056692  -0.6879541   2.4528382   0.14729045
  0.3280825   0.48748764 -0.38091764 -1.315916    0.8917357   0.9871673
 -0.2991179   2.9551303   0.39949372  0.90781206  1.2184299  -1.8893434 ]",10.1080/09593985.2018.1434708,"['Adolescent', 'Adult', 'Dancing', 'Female', 'Humans', 'Male', 'Physical Therapy Modalities', 'Reproducibility of Results', 'Young Adult']"
478,"[-0.25068533 -0.06447573  0.4443844  -0.13915834 -0.1873173   0.38991672
  0.059627    0.18245281 -0.8989515   0.15585206  0.6711845   0.23445249
 -0.08399888 -0.17850648 -0.18892401 -0.4112745   0.611631    0.5055162
 -0.32074863  0.51220024  0.07229393 -0.28612128 -0.13362458  0.68699366
  0.3368828   0.7032197   0.19018301  0.2718397   0.46348864 -0.96715707]",10.1097/PSY.0000000000000555,"['Depression', 'Diabetes Mellitus, Type 2', 'Genetic Loci', 'Genetic Pleiotropy', 'Genome-Wide Association Study', 'Humans', 'Polymorphism, Single Nucleotide']"
479,"[-0.16757317  0.3410995   0.31239274  1.6771746   0.20055757  1.6209662
  0.25181562  0.0107541  -3.6023037   2.3026521  -0.5496367  -0.90151787
 -0.7277038  -4.4719586   0.1703181  -2.5915825   0.15165515 -2.121932
 -0.65825987 -0.36137336  2.23925    -3.2990978   1.9292135   2.86576
 -0.0294587   0.84829915  0.38255313 -0.11455046  0.5371195  -1.951454  ]",10.1002/ajh.25051,"['Adolescent', 'Anemia, Sickle Cell', 'Blood Preservation', 'Cell Survival', 'Child', 'Child, Preschool', 'Erythrocyte Transfusion', 'Erythrocytes', 'Erythropoiesis', 'Female', 'Glucose-6-Phosphate', 'Glucosephosphate Dehydrogenase Deficiency', 'Hemoglobin A', 'Humans', 'Male', 'Prospective Studies', 'Young Adult']"
480,"[-0.21677959  0.0034779   0.25175735 -0.10801767 -0.17095049  0.42677155
  0.00986729  0.32473266 -1.2359546   0.2039573   0.6460982   0.15854229
 -0.12607585 -0.4503543  -0.28935814 -0.50005156  0.70438534  0.3255894
 -0.21102442  0.44703454  0.185755   -0.37118134 -0.16925362  0.9122829
  0.40082836  0.56953037  0.12071892  0.12523274  0.5450099  -1.0070395 ]",10.1161/CIRCOUTCOMES.117.004171,"['Aged', 'Atherosclerosis', 'Clinical Decision-Making', 'Cost-Benefit Analysis', 'Decision Support Techniques', 'Decision Trees', 'Drug Costs', 'Dyslipidemias', 'Female', 'Gene Expression Profiling', 'Genetic Association Studies', 'Genetic Markers', 'Genetic Predisposition to Disease', 'Health Status', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'Lipids', 'Male', 'Markov Chains', 'Middle Aged', 'Models, Economic', 'Phenotype', 'Polymorphism, Single Nucleotide', 'Predictive Value of Tests', 'Primary Prevention', 'Quality-Adjusted Life Years', 'Risk Assessment', 'Risk Factors', 'Time Factors', 'Treatment Outcome']"
481,"[-0.11985426 -0.10139284  0.40873146 -0.26891547 -0.13525237  0.24692641
  0.11750454  0.14553119 -0.6948228   0.20055819  0.5524911   0.31661353
  0.01235071  0.0511129  -0.15394124 -0.30967328  0.43922198  0.3906031
 -0.21054034  0.45739442  0.00823452 -0.10557094 -0.16696441  0.5242795
  0.38139325  0.48675382  0.15349251  0.1543841   0.39117008 -0.74300104]",10.1007/s40572-018-0197-9,"['Animal Husbandry', 'Animals', 'Cattle', 'Dairying', 'Dietary Exposure', 'Hormones', 'Humans', 'Milk', 'Red Meat', 'Somatostatin', 'United States']"
482,"[-0.24103603  0.12009037  0.21199004 -0.092832   -0.22156021  0.80590326
  0.70797807  0.2819328  -2.4120598   0.94109905  1.060074    0.46586344
 -0.156882   -0.7486217  -0.915114   -1.2589886   0.752996    0.14225669
 -0.2154894   0.6521994   0.30656362 -1.2471882   0.30972707  1.5682416
  1.3434906   1.0649527   0.08002643 -0.26512983  0.57510066 -1.3608134 ]",10.1186/s12868-018-0406-3,"['Alzheimer Disease', 'Amyloid beta-Peptides', 'Animals', 'Anti-Inflammatory Agents', 'Curcumin', 'Disease Models, Animal', 'Hippocampus', 'Mice, Transgenic', 'Neurofibrillary Tangles', 'Neurons', 'Neuroprotective Agents', 'Plaque, Amyloid']"
483,"[-0.4814957   0.03218565  0.54354495 -0.3653325  -0.4294348   0.5168486
  0.20988268  0.20695767 -1.6297368   0.40781054  0.70870954  0.6238301
  0.21954456  0.01518582 -0.5445139  -0.5245906   0.9148803   0.9066515
 -0.5127959   0.98742896  0.21786682 -0.33614445 -0.13122727  0.9024937
  0.81101453  0.5923414   0.0868156   0.00276529  1.0104331  -1.4172195 ]",10.12788/jhm.2892,"['Adult', 'Anti-Bacterial Agents', 'Antimicrobial Stewardship', 'Bacteriuria', 'Decision Support Systems, Clinical', 'Female', 'Humans', 'Inappropriate Prescribing', 'Middle Aged', 'Pregnancy', 'Prospective Studies', 'Quality Improvement', 'Urinalysis']"
484,"[-0.05544417 -0.02949356  0.16804017 -0.08165151 -0.06223504  0.18568313
  0.07182609  0.08228309 -0.43381342  0.09842946  0.31419098  0.1055951
 -0.00110079 -0.06877545 -0.09573931 -0.17453071  0.2668355   0.17571323
 -0.12450873  0.23513664  0.02814854 -0.12715504 -0.05215311  0.30230436
  0.19160372  0.27027068  0.12621172  0.06390423  0.1603381  -0.39857328]",10.1080/13557858.2018.1493433,"['Adolescent', 'Adult', 'Black or African American', 'Cardiometabolic Risk Factors', 'Cardiovascular Diseases', 'Community-Based Participatory Research', 'Ethnicity', 'Female', 'Hispanic or Latino', 'Humans', 'Interviews as Topic', 'Postpartum Period', 'Poverty', 'Pregnancy', 'Racial Groups', 'United States', 'White People', 'Young Adult']"
485,"[-0.14571126  0.46781194  0.3628413  -0.03274366 -0.1444239   0.81715804
  0.28280053  0.15261284 -2.2006907   0.7840515   0.64310646  0.1620792
 -0.09133156 -1.0037868  -0.596166   -0.9503979   0.9800664  -0.17519005
 -0.6207626   0.7091745   0.59564394 -1.2441001   0.660314    1.5628461
  0.9827725   0.84936225  0.31168547 -0.00286463  0.7135484  -1.2777152 ]",10.1038/s41598-018-27555-2,"['DNA, Bacterial', 'Female', 'Humans', 'Leptospira interrogans', 'Leptospirosis', 'Male', 'Nucleic Acid Denaturation', 'Real-Time Polymerase Chain Reaction', 'Spain']"
486,"[-0.28748262  0.11956497  0.31832424  0.05248434 -0.08925722  0.32804647
 -0.0395894   0.2931596  -1.2326972   0.20388001  0.58225155 -0.00207054
 -0.21103972 -0.47233254 -0.1947777  -0.52532464  0.6397306   0.18383515
 -0.23601873  0.40499917  0.172669   -0.47313422 -0.0710861   0.94347054
  0.34535134  0.40833834  0.05927584  0.23769446  0.4784503  -1.1088811 ]",10.1016/j.kint.2018.01.009,"['Adult', 'Aged', 'Cardiovascular Diseases', 'Decision Support Techniques', 'Disease Progression', 'Female', 'Glomerular Filtration Rate', 'Humans', 'Kidney', 'Male', 'Markov Chains', 'Middle Aged', 'Monte Carlo Method', 'Prognosis', 'Renal Insufficiency', 'Renal Insufficiency, Chronic', 'Renal Replacement Therapy', 'Risk Assessment', 'Risk Factors', 'Severity of Illness Index', 'Time Factors']"
487,"[-0.1916002  -0.02364131  0.45528978 -0.31807104 -0.19251616  0.3852977
  0.15814653  0.23221841 -0.9960127   0.39932978  0.7625695   0.37040675
  0.05240827 -0.13528195 -0.23334484 -0.54181206  0.6510229   0.36562213
 -0.28028136  0.5974775   0.09746429 -0.3237945  -0.01623051  0.7780873
  0.41454294  0.8112102   0.27006337  0.20778438  0.5054347  -1.1122569 ]",10.1097/PHH.0000000000000790,"['Asthma', 'Baltimore', 'Child', 'Child, Preschool', 'Cohort Studies', 'Environmental Exposure', 'Family Characteristics', 'Female', 'Humans', 'Male', 'Smokers', 'Tobacco Smoke Pollution', 'Urban Population']"
488,"[-0.25006768 -0.04553488  0.4241615  -0.19352794 -0.15088464  0.29915452
  0.0537697   0.1852277  -0.8385766   0.19039467  0.55449015  0.24725755
 -0.08865971 -0.14325553 -0.12933584 -0.463069    0.53996426  0.36878717
 -0.2920166   0.46953696  0.08829285 -0.2855368  -0.05868903  0.6062472
  0.30156016  0.62738556  0.1647033   0.18959753  0.5107347  -0.9525731 ]",10.1016/j.ijrobp.2018.04.037,"['Adolescent', 'Anisotropy', 'Behavior', 'Brain', 'Brain Neoplasms', 'Case-Control Studies', 'Child', 'Child, Preschool', 'Cognition', 'Corpus Callosum', 'Diffusion Tensor Imaging', 'Female', 'Humans', 'Male', 'Neurons', 'Neuropsychological Tests', 'Prospective Studies', 'White Matter']"
489,"[-0.52585703  0.27686745  0.2166731  -0.553088    0.07995885  0.9227614
  1.3659651   0.2720799  -2.635847    1.5796156   1.0036976   1.3590833
  0.02355346 -1.256878   -1.5717957  -1.0513979   0.6769795   0.17794509
 -0.21860062  1.7307826   0.72641736 -0.9322749   0.97966236  1.6657788
  1.6618491   0.5426728  -0.14930873 -0.8729395   0.8677793  -1.5163627 ]",10.1096/fj.201800351R,[]
490,"[-0.08066542 -0.01689294  0.18984571 -0.02189461 -0.05089002 -0.01753729
 -0.11138662 -0.01413421 -0.03711508 -0.1093844   0.09904526 -0.00460032
 -0.07320679  0.05055552  0.0532864  -0.01959028  0.12566762  0.18291119
 -0.07550604  0.09177361 -0.07773453 -0.00150732 -0.18786763  0.08611324
 -0.09913491  0.0937036  -0.01725649  0.18232673  0.15836367 -0.2318023 ]",10.1093/jtm/tay039,"['Adult', 'Antimalarials', 'Chemoprevention', 'Endemic Diseases', 'Female', 'Humans', 'Malaria', 'Male', 'Middle Aged', ""Practice Patterns, Physicians'"", 'Travel']"
491,"[ 0.1637902   0.82672393  0.34353453  0.3264448  -0.12592477  1.3649032
  0.22454876 -0.09310277 -2.0187874   0.8592382   1.0573866  -0.2756761
  0.09571198 -1.6593422   0.03362871 -1.3485208   1.0696955  -0.75981545
 -1.0939276   0.37343878  1.0082555  -1.8158652   0.59793085  1.6119955
  0.62745565  1.1937684   0.21989588 -0.18888839  0.51817375 -1.4326756 ]",10.1038/s41370-018-0042-0,"['Adult', 'Arsenic', 'Atherosclerosis', 'Environmental Exposure', 'Ethnicity', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Middle Aged', 'United States']"
492,"[-0.29920828  0.03646744  0.55228007 -0.09774449 -0.2200254   0.6208975
  0.20528828  0.27410457 -1.5424938   0.4874293   0.88689053  0.24595079
 -0.12490074 -0.5592231  -0.2500181  -0.7570515   0.72083116  0.5358766
 -0.5457484   0.63726896  0.30802876 -0.7227998  -0.12758175  1.126278
  0.53396535  0.86844057  0.16064203  0.24774244  0.703084   -1.432882  ]",10.1016/j.sleep.2018.05.005,"['Aged', 'Electrocardiography', 'Female', 'Heart Rate', 'Humans', 'Hypoxia', 'Male', 'Polysomnography', 'Pulse Wave Analysis', 'Radial Artery', 'Sleep Apnea Syndromes', 'Vascular Stiffness']"
493,"[ 0.4630324  -0.6302645   0.5260123  -0.32657418 -0.649083    1.0564661
  0.6154478  -0.14711934 -1.5282422   0.46222806  1.4369105  -0.06881834
  0.4678144  -0.6110828  -0.14970437 -0.57038814  1.1125568  -0.08026606
 -0.8990986   0.8020435   0.62175083 -0.48928797  0.7171204   1.7229551
  0.5373984   2.0491107   1.2653966  -0.3300517  -0.07056868 -1.5515598 ]",10.1007/s10865-018-9931-x,"['Adult', 'Black or African American', 'Attitude to Health', 'Demography', 'Ethnicity', 'Exercise', 'Female', 'Health Behavior', 'Hispanic or Latino', 'Humans', 'Mothers', 'Postpartum Period', 'Poverty', 'Prospective Studies', 'Rural Population', 'Socioeconomic Factors', 'White People', 'Young Adult']"
494,"[-0.22992148 -0.18955274  0.61419713 -0.3124572  -0.14545527  0.25420517
  0.06617072  0.20258032 -0.8075462   0.08663049  0.7022701   0.38473013
 -0.01704151  0.03695269 -0.08038776 -0.4396221   0.54188937  0.5865939
 -0.31078622  0.6347949   0.04238602 -0.21578105 -0.24929406  0.68447626
  0.31762332  0.7206886   0.23432308  0.30657667  0.5972774  -1.0698684 ]",10.1016/j.socscimed.2018.04.007,"['Adult', 'Biomarkers', 'C-Reactive Protein', 'Female', 'Fibrinogen', 'Humans', 'Inflammation', 'Interleukin-6', 'Loneliness', 'Male', 'Middle Aged', 'United States']"
495,"[ 0.30652994 -0.00383081 -0.25157654  0.23312671 -0.5470968   1.1991433
  0.88217205  0.14531697 -2.2378905   0.87634903  0.9922152  -0.16674529
 -0.1743068  -1.7155983  -0.5469133  -0.9798205   0.55113477  0.30950585
 -0.8322152   0.33644286  0.91688627 -1.5383164   0.1301495   1.3774346
  0.8208297   1.4592844   0.55515534 -0.07076237  0.04665792 -1.6300782 ]",10.1007/s10865-018-9950-7,"['Adult', 'Anxiety', 'Depression', 'Depression, Postpartum', 'Depressive Disorder', 'Female', 'Humans', 'Longitudinal Studies', 'Postpartum Period', 'Pregnancy', 'Psychiatric Status Rating Scales', 'Sleep Initiation and Maintenance Disorders', 'Young Adult']"
496,"[-0.01248954  0.14782743  0.9081437  -0.4124944  -0.12476712  0.7481478
  0.623196    0.91246784 -1.7368963   0.9409833   1.083832    0.9575915
 -0.13764328 -0.17835256 -0.76874584 -1.0577322   0.69088054  0.42098927
 -0.265736    1.6160725  -0.32680696 -0.4875067   0.3288165   1.2347976
  1.7231275   1.4007945   0.19789079 -0.00177233  0.22288065 -1.4688993 ]",10.1152/ajplung.00033.2018,"['Aging', 'Animals', 'Cell Line', 'Cilia', 'Epithelial Cells', 'Female', 'Humans', 'Lung', 'Mice', 'Mice, Inbred BALB C', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Mucociliary Clearance', 'Oxidative Stress', 'Pneumonia', 'Protein Kinase C-epsilon', 'Trachea']"
497,"[-0.23633061 -0.19748092  0.49620298 -0.23723845 -0.20633532  0.37345088
  0.10200809  0.31818467 -0.86529964  0.11780656  0.6814507   0.23912378
  0.00251854 -0.0468492  -0.16919918 -0.38207382  0.53642565  0.61583805
 -0.2411536   0.526042    0.12209164 -0.07398713 -0.2590853   0.68256885
  0.39879283  0.43936852  0.18908978  0.14654307  0.53100103 -0.95891285]",10.1111/jrh.12306,"['Adult', 'Aged', 'Cardiovascular Diseases', 'Evidence-Based Practice', 'Female', 'Focus Groups', 'Humans', 'Male', 'Middle Aged', 'Nebraska', 'Qualitative Research', 'Risk Reduction Behavior', 'Rural Population']"
498,"[-0.11406105  0.19638358  0.21413705  0.08544992 -0.24866141  0.4698265
  0.29315725  0.17657043 -1.4255396   0.4539775   0.6753111   0.11626287
  0.00926026 -0.49165675 -0.39431    -0.59588414  0.5800542   0.28127146
 -0.4717321   0.40659425  0.2801867  -0.6249847  -0.06089668  0.81806743
  0.41095045  0.6958128   0.10147643  0.11401835  0.40659124 -1.0822277 ]",10.1016/j.epidem.2018.08.006,"['Adult', 'Biomarkers', 'Cohort Studies', 'HIV Infections', 'HIV-1', 'Homosexuality, Male', 'Humans', 'Male', 'Middle Aged', 'Sexual Behavior', 'Sexual Partners', 'Viral Load']"
499,"[-0.32698655 -0.17702734  0.70030755 -0.20827334 -0.0869056   0.36135682
  0.0988201   0.19639347 -1.0793687   0.21076283  0.71050006  0.3817739
 -0.08612035 -0.02588569 -0.21245539 -0.46338418  0.5393738   0.7606442
 -0.3775374   0.68650657 -0.1610054  -0.11754289 -0.24296667  0.81570643
  0.3118785   0.76772046  0.1790922   0.31437263  0.7398699  -1.1981299 ]",10.1007/s00520-018-4418-4,"['Adult', 'Aged', 'Breast Neoplasms', 'Cancer Survivors', 'Cost of Illness', 'Employment', 'Female', 'Health Expenditures', 'Humans', 'Income', 'Insurance, Health', 'Lymphedema', 'Male', 'Middle Aged', 'New Jersey', 'Pennsylvania', 'Prospective Studies', 'Socioeconomic Factors', 'Surveys and Questionnaires']"
500,"[-0.07507397 -0.05682243  0.15625279 -0.03725789 -0.07231681 -0.03766249
  0.07808568 -0.03420916 -0.20105737 -0.05906651  0.1600477  -0.01245957
  0.03165312 -0.10963567 -0.0503628  -0.10223125  0.11955766  0.08387228
 -0.08834329  0.08073595 -0.14445442 -0.0319318  -0.04660456  0.10458557
 -0.06705798  0.0585847   0.1286361   0.04074683  0.00449714 -0.14607754]",10.1002/clc.4960210320,"['Cardiology', 'History, 18th Century', 'History, 19th Century', 'Humans', 'United Kingdom', 'Vascular Surgical Procedures']"
501,"[-0.51584977 -0.10477129  0.24139687 -0.36280748 -0.19763826  0.31701866
  0.44958943 -0.3249293  -0.9789337  -0.18048027  0.3761796  -0.38385236
 -0.0142456  -0.47985306 -0.28155994 -0.57725227  0.31603307  0.311777
 -0.77904963  0.3895806  -0.4629649  -0.36009356  0.06247428  0.473131
 -0.03646238  0.673701    0.2562728  -0.12104747 -0.24624746 -0.5891434 ]",10.1002/clc.4960200320,"['Aged', 'Aorta, Abdominal', 'Aortic Diseases', 'Atrial Fibrillation', 'Cor Triatriatum', 'Echocardiography, Transesophageal', 'Embolism', 'Female', 'Humans', 'Mitral Valve Insufficiency']"
502,"[-0.17806904 -0.10526232  0.22691649 -0.09043213 -0.12877972 -0.0352313
  0.15670511 -0.02084447 -0.3455769  -0.09961753  0.24696489 -0.0210345
  0.01339178 -0.20298085 -0.08815205 -0.17660427  0.20696795  0.14356288
 -0.1817216   0.14611039 -0.22964124 -0.06149934 -0.08925601  0.18467584
 -0.08422696  0.1103313   0.24668215  0.04930103  0.03041638 -0.2855944 ]",10.1002/clc.4960200503,"['Aged', 'Cardiac Pacing, Artificial', 'Cardiomyopathy, Hypertrophic', 'Catheter Ablation', 'Disease Progression', 'Follow-Up Studies', 'Humans']"
503,"[-0.5782964  -0.05133016  0.22511475 -0.40705296 -0.1918668   0.47902697
  0.5743954  -0.28865507 -0.9820175  -0.21685095  0.3881812  -0.46485192
  0.00470366 -0.48012453 -0.3112441  -0.6587772   0.2754216   0.3919673
 -0.9022309   0.43369704 -0.49467847 -0.4652135   0.04453583  0.59541243
  0.02074315  0.8331754   0.2887911  -0.15195614 -0.12126609 -0.58789176]",10.1002/clc.4960201105,"['Acute Disease', 'Adolescent', 'Child', 'Child, Preschool', 'Diagnosis, Differential', 'Echocardiography, Doppler', 'Humans', 'Mitral Valve Insufficiency', 'Myocarditis', 'Observer Variation', 'Prospective Studies', 'Recurrence', 'Rheumatic Heart Disease', 'Sensitivity and Specificity']"
504,"[-0.5349302  -0.11833708  0.26526126 -0.33917922 -0.22545198  0.42796797
  0.4731389  -0.298692   -1.0002714  -0.25826728  0.42399406 -0.42716873
  0.04525856 -0.4980074  -0.3795049  -0.64943045  0.2959355   0.38717547
 -0.8842445   0.39308593 -0.415649   -0.48066303  0.08185805  0.5724042
 -0.01784826  0.74000716  0.29632083 -0.11536927 -0.15573947 -0.6699698 ]",10.1002/clc.4960201112,"['Aorta', 'Aortic Aneurysm', 'Aortic Coarctation', 'Aortic Diseases', 'Aortic Stenosis, Subvalvular', 'Humans', 'Necrosis', 'Sinus of Valsalva']"
505,"[-0.2034457  -0.07135268  0.21683404 -0.13512385 -0.1121579  -0.01736556
  0.1830925  -0.09764218 -0.36441183 -0.09163483  0.27185583 -0.05285068
  0.05881931 -0.17607887 -0.12299881 -0.15273504  0.19756262  0.1250837
 -0.2531195   0.18280162 -0.27551928 -0.08774418 -0.05220364  0.19338922
 -0.0898318   0.11608972  0.21577081  0.0216453   0.00259188 -0.28042993]",10.1002/clc.4960210202,"['Angina Pectoris', 'Chronic Disease', 'Counterpulsation', 'Humans']"
506,"[-0.76269054 -0.0685825   0.12177452 -0.4961991  -0.09029418  0.7124109
  0.77897674 -0.62367827 -0.97239184 -0.17618725  0.3789483  -0.434525
  0.03176681 -0.4670944  -0.6358266  -0.74074423  0.09576609  0.21791907
 -1.2640703   0.46494445 -0.5767414  -0.78809303  0.21275984  0.67526686
  0.36459863  0.9172094   0.26006532 -0.47831774 -0.37752426 -0.43482345]",Unknown,"['Adolescent', 'Adult', 'Anthropometry', 'Body Height', 'Body Weight', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Male', 'Prader-Willi Syndrome', 'Reference Values']"
507,"[-0.94521844  0.35957682  0.1727925  -1.0937549  -0.61781067  1.3354173
  0.67452884 -0.01714553 -1.4653242  -0.5014816   0.18624148 -1.4963356
  0.15422103 -0.15842284 -1.2730577  -1.2243944   0.649578    0.7908149
 -1.2688287   0.833003   -0.6934162  -0.9994706   0.5314771   0.5954925
  0.3360482   2.0405421   0.16497122 -0.46984658 -0.52658355 -1.5583818 ]",10.1002/clc.4960200604,"['Coronary Disease', 'Echocardiography', 'Humans', 'Magnetic Resonance Imaging', 'Sensitivity and Specificity', 'Tomography, Emission-Computed', 'Tomography, Emission-Computed, Single-Photon']"
508,"[-0.6827168  -0.11367177  0.4294626  -0.4457956  -0.27165717  0.60833573
  0.5742969  -0.23202743 -1.1495898  -0.3333336   0.3652797  -0.56488997
  0.06377735 -0.5032954  -0.5537281  -0.7788993   0.4241544   0.46992445
 -0.98121893  0.60083896 -0.48807687 -0.5172803   0.08582953  0.7168965
  0.01607359  1.1030375   0.46460125 -0.06974848 -0.08192345 -0.9701457 ]",10.1002/clc.4960200213,"['Angioplasty, Balloon', 'Atherectomy, Coronary', 'Coronary Disease', 'Coronary Vessels', 'Graft Occlusion, Vascular', 'Humans', 'Saphenous Vein', 'Treatment Outcome']"
509,"[-0.6415456  -0.05093862  0.4676974  -0.4054263  -0.28441194  0.67901284
  0.58760387 -0.18647397 -1.1232071  -0.36425042  0.40082854 -0.6174383
  0.02183121 -0.47034058 -0.55466914 -0.83172154  0.4573153   0.47043636
 -0.99396545  0.63433886 -0.4528375  -0.5574332   0.13816285  0.74944705
 -0.03332627  1.1972644   0.4518663  -0.0144943  -0.02391923 -0.9894532 ]",10.1002/clc.4960200114,"['Angioplasty, Balloon, Coronary', 'Arteriosclerosis', 'Atherectomy', 'Coronary Artery Bypass', 'Coronary Disease', 'Graft Occlusion, Vascular', 'Humans', 'Recurrence', 'Saphenous Vein', 'Stents']"
510,"[-0.54748183 -0.13587798  0.2690527  -0.33595523 -0.23270543  0.2523359
  0.43211186 -0.27530238 -0.9180203  -0.20159659  0.34357777 -0.37565655
  0.04650925 -0.4190278  -0.36870506 -0.5488449   0.31679308  0.30229905
 -0.72027093  0.39302063 -0.44795915 -0.3862274   0.05042947  0.5174276
  0.03878912  0.6223541   0.33701557 -0.08780745 -0.13881373 -0.63458246]",10.1002/clc.4960210914,"['Adult', 'Arrhythmias, Cardiac', 'Bundle-Branch Block', 'Electrocardiography', 'Female', 'Follow-Up Studies', 'Heart Transplantation', 'Humans', 'Male', 'Middle Aged', 'Predictive Value of Tests', 'Survival Rate']"
511,"[-0.09418975 -0.06479769  0.16978936 -0.02233145 -0.0859094  -0.05468113
  0.09424576 -0.00367314 -0.1814927  -0.05725742  0.17801356  0.01061819
  0.03229256 -0.12170805 -0.0143216  -0.07661188  0.1304461   0.07205182
 -0.0642733   0.07800819 -0.13854545  0.00163266 -0.07925143  0.10374095
 -0.06272071  0.01261442  0.16832763  0.03871598  0.04497548 -0.15101956]",10.1002/clc.4960210717,"['Cardiology', 'Edema', 'England', 'Heart Failure', 'History, 18th Century', 'History, 19th Century', 'Humans']"
512,"[-0.43769982 -0.01728805  0.26424682 -0.3577156  -0.2292206   0.32227576
  0.41316572 -0.2331308  -0.6905759  -0.1858971   0.24657555 -0.61219984
 -0.13434078 -0.24331525 -0.49461675 -0.46081987  0.4586315   0.11561857
 -0.5720167   0.45348167 -0.39441985 -0.42075068  0.07198697  0.4796584
 -0.03141661  0.7368227   0.2575008   0.08834453 -0.05616361 -0.72493   ]",10.1002/clc.4960210308,"['Coronary Disease', 'Electrocardiography', 'Exercise Test', 'Feasibility Studies', 'Humans', 'Medical Records', 'Myocardial Ischemia', 'Patient Selection', 'Pilot Projects', 'Research Design']"
513,"[-0.91281104 -0.12199715  0.17527023 -0.51560545 -0.24831288  0.95283645
  0.6873153  -0.36004087 -1.5260592  -0.22656557  0.2964614  -0.78426105
  0.04582226 -0.8161496  -0.71139157 -1.1261389   0.29153872  0.5014679
 -1.6582469   0.67290735 -0.5591823  -0.7550486   0.24613903  0.9122323
  0.24686669  1.3864181   0.21303084 -0.48772314 -0.42895103 -0.756742  ]",Unknown,"['Information Storage and Retrieval', 'MEDLINE', 'National Library of Medicine (U.S.)', 'Unified Medical Language System', 'United States']"
514,"[-0.49628785 -0.127298    0.2969141  -0.35292912 -0.25407127  0.3256323
  0.44778702 -0.2287979  -1.0126351  -0.1727102   0.35785675 -0.32002994
  0.03674639 -0.4438765  -0.3308986  -0.5876632   0.3189513   0.35135308
 -0.87538916  0.40872702 -0.56404185 -0.33519804  0.03430962  0.48691997
 -0.06102202  0.6434757   0.3165246  -0.16100428 -0.16345061 -0.5863455 ]",10.3928/0279-3695-19940401-07,"['Clinical Competence', 'Community Health Nursing', 'Curriculum', 'Education, Nursing, Graduate', 'Geriatric Nursing', 'Humans', 'Long-Term Care', 'Nurse Clinicians', 'Program Development', 'Psychiatric Nursing', 'Specialties, Nursing']"
515,"[-0.6522466  -0.15232834  0.12570101 -0.4783165  -0.28211257  0.68471956
  0.82130146 -0.5145447  -1.2250203  -0.0755839   0.33652952 -0.62750006
  0.03693517 -0.54312724 -0.57504725 -0.8183806   0.35025594  0.5316717
 -1.0489796   0.50293803 -0.44126537 -0.7541742   0.11887633  0.7646774
  0.20700337  1.1246462   0.13771355 -0.5479365  -0.39052272 -0.81167805]",10.1002/clc.4960200405,"['Fibrinolytic Agents', 'Humans', 'Myocardial Infarction', 'Pericarditis', 'Thrombolytic Therapy']"
516,"[-0.6833183  -0.10860261  0.28828275 -0.40249068 -0.13757148  0.4330741
  0.5296761  -0.40699267 -1.1637636  -0.20925419  0.32724375 -0.50542396
  0.09264299 -0.53941983 -0.39318338 -0.6616758   0.31732804  0.3571415
 -1.0606009   0.46773696 -0.47914672 -0.5990183   0.08290224  0.6159008
  0.07556955  0.8297821   0.27522603 -0.19782849 -0.24400707 -0.6668638 ]",10.1002/clc.4960210406,"['Aged', 'Angiotensin-Converting Enzyme Inhibitors', 'Captopril', 'Drug Prescriptions', 'Enalapril', 'Female', 'Heart Failure', 'Hospitalization', 'Humans', 'Male', 'Patient Discharge', 'Patient Education as Topic', 'Retrospective Studies', 'Treatment Outcome', 'Ventricular Function, Left']"
517,"[-1.1095288  -0.07972503  0.30080107 -0.4096792  -0.02643269  0.8570454
  0.73383784 -0.52211857 -1.5721567  -0.10260643  0.7664246  -0.71452683
 -0.05586863 -0.77992666 -0.6166719  -1.076098    0.00847883  0.47195393
 -1.8213481   0.561052   -0.5951649  -0.8138818   0.32610646  0.8931154
  0.09354206  1.1069219   0.31692585 -0.3140375  -0.42543495 -0.66464055]",10.1002/clc.4960210220,"['Adult', 'Child, Preschool', 'Chronic Disease', 'Colchicine', 'Echocardiography', 'Female', 'Follow-Up Studies', 'Gout Suppressants', 'Humans', 'Male', 'Pericardial Effusion', 'Pericarditis', 'Recurrence']"
518,"[-0.47217628 -0.1360558   0.24034663 -0.33456552 -0.17002112  0.36653754
  0.4506333  -0.23827358 -0.8676719  -0.1451081   0.39421007 -0.32365146
 -0.03499915 -0.40866685 -0.31461197 -0.5773546   0.31836304  0.34573266
 -0.6778434   0.35563394 -0.3675028  -0.3560415   0.0618754   0.5098775
 -0.06006102  0.61888003  0.28905785 -0.13248451 -0.16077167 -0.5544704 ]",10.1002/clc.4960200419,"['Adult', 'Clinical Enzyme Tests', 'Creatine Kinase', 'Echocardiography, Doppler', 'Echocardiography, Transesophageal', 'Electrocardiography', 'Humans', 'Isoenzymes', 'Male', 'Subarachnoid Hemorrhage', 'Ventricular Dysfunction']"
519,"[-2.4490783   0.36864865 -1.7951182  -1.7542012   0.9729162   1.153673
  1.3582944  -3.5635924  -2.2006311   1.3532742   0.1360973  -1.7891898
  0.13816926 -0.01653288 -2.5275257   0.6035848  -1.4523529  -1.9084353
 -3.4071164   0.03656406 -1.6079999  -1.7874248   1.0108639   1.283277
  0.7767769   0.7922645  -1.1650046  -1.7635922  -1.7356896   0.85756105]",10.1111/j.1365-2036.1993.tb00095.x,"['Adult', 'Aged', 'Anti-Ulcer Agents', 'Endoscopy, Gastrointestinal', 'Female', 'Gastric Acid', 'Gastrinoma', 'Humans', 'Male', 'Middle Aged', 'Prospective Studies', 'Radiography', 'Sex Characteristics', 'Vagotomy', 'Zollinger-Ellison Syndrome']"
520,"[-0.846793   -0.12977372  0.22931644 -0.57204646 -0.25760618  0.6709975
  0.67358    -0.48334962 -1.3266526  -0.14976446  0.36862633 -0.58996946
  0.16151953 -0.5206454  -0.68407404 -0.8346436   0.2977092   0.44635382
 -1.298254    0.49950927 -0.538113   -0.7434313   0.17517842  0.8472029
  0.2050406   1.1536776   0.31574142 -0.43976542 -0.3980078  -0.81640154]",10.1002/clc.4960200207,"['Adult', 'Aged', 'Cardiac Catheterization', 'Defibrillators, Implantable', 'Electrophysiology', 'Female', 'Fluoroscopy', 'Follow-Up Studies', 'Humans', 'Male', 'Middle Aged', 'Postoperative Complications', 'Retrospective Studies', 'Stroke Volume', 'Tachycardia, Ventricular', 'Treatment Outcome']"
521,"[-0.33404708 -0.06751683  0.25484887 -0.3393653  -0.21327135  0.1111073
  0.28673884 -0.18105726 -0.60782915 -0.14603007  0.22114202 -0.36489075
 -0.11541665 -0.20390895 -0.3994204  -0.38250205  0.32947862  0.12853836
 -0.28394526  0.37436453 -0.36679417 -0.3241359   0.03670142  0.3623645
  0.02429037  0.5357855   0.24868178  0.03455025 -0.05483618 -0.5523084 ]",10.1002/clc.4960210508,"['Adult', 'Aged', 'Analysis of Variance', 'Biomarkers', 'Coronary Disease', 'Diastole', 'Exercise Test', 'Female', 'Gated Blood-Pool Imaging', 'Humans', 'Male', 'Middle Aged', 'Technetium', 'Thallium Radioisotopes', 'Ventricular Dysfunction, Left']"
522,"[-0.69112784  0.08130684  0.11377399 -0.60647    -0.38219246  0.67252684
  0.6411549  -0.33043632 -1.2177619  -0.15801722  0.34087473 -0.74714845
  0.1115271  -0.4026061  -0.6958708  -0.7542107   0.3194068   0.47044036
 -1.0288976   0.5192984  -0.68486357 -0.6346862   0.16926134  0.77290803
  0.14336781  1.2153816   0.17264098 -0.46819136 -0.37875548 -0.8109018 ]",10.1002/clc.4960201307,"['Contrast Media', 'Echocardiography', 'Humans', 'Image Processing, Computer-Assisted']"
523,"[-4.2257705e-01 -8.1969067e-02  2.4454515e-01 -2.1884558e-01
 -2.1947457e-01  6.3645072e-02  3.4035695e-01 -2.4965574e-01
 -7.3121476e-01 -1.9997407e-01  2.9883161e-01 -3.0228075e-01
 -3.3023831e-02 -3.3894885e-01 -2.5873318e-01 -3.7563646e-01
  3.1284133e-01  1.6468745e-01 -5.1320231e-01  2.7700374e-01
 -3.9037591e-01 -2.8455999e-01 -6.0939399e-04  3.3569762e-01
 -4.6840110e-03  3.9095789e-01  2.7289671e-01  1.5915975e-02
 -5.7946607e-02 -4.7563902e-01]",10.1002/clc.4960210208,"['Aged', 'Angiotensin-Converting Enzyme Inhibitors', 'Diastole', 'Drug Prescriptions', 'Drug Utilization', 'Female', 'Follow-Up Studies', 'Heart Failure', 'Hospital Mortality', 'Hospitals, Community', 'Humans', 'Male', 'Multivariate Analysis', 'Retrospective Studies', 'Stroke Volume']"
524,"[-0.48457786 -0.10051082  0.22895636 -0.38174817 -0.193508    0.2995196
  0.463534   -0.3325371  -0.89878035 -0.2086914   0.36070526 -0.43108055
  0.00300803 -0.32873526 -0.37784266 -0.46600673  0.36484298  0.24211898
 -0.7412727   0.38719234 -0.46699318 -0.43184784  0.10046882  0.4942643
 -0.02444419  0.6472573   0.20047268 -0.07129533 -0.1808781  -0.6034419 ]",10.1002/clc.4960201010,"['Adult', 'Aged', 'Aortic Valve', 'Aortic Valve Insufficiency', 'Aortic Valve Stenosis', 'Bioprosthesis', 'Female', 'Follow-Up Studies', 'Heart Valve Prosthesis', 'Heart Valve Prosthesis Implantation', 'Humans', 'Male', 'Middle Aged', 'Postoperative Complications', 'Survival Rate', 'Time Factors', 'Transplantation, Homologous', 'Treatment Outcome']"
525,"[-0.45562616  0.283939   -0.07209828 -0.73439497 -0.72074807  0.6073401
  0.8843701  -0.6360199  -1.1974126  -0.1864604   0.3196526  -1.5208439
 -0.17726393  0.01538893 -1.1827462  -0.5757573   0.8223617   0.31168702
 -0.76164     0.90593255 -0.9171771  -0.8239569   0.39519674  0.6058906
  0.03594536  1.4811528   0.11987624 -0.14925458 -0.19271812 -1.1853085 ]",10.1002/clc.4960210504,"['Algorithms', 'Angina, Unstable', 'Disease Progression', 'Humans', 'Myocardial Infarction', 'Risk Factors', 'Syndrome']"
526,"[-0.5727705  -0.11094618  0.32735056 -0.49054298 -0.3100355   0.45390427
  0.60503906 -0.29302275 -1.1055716  -0.25610596  0.4210947  -0.51473695
 -0.02214382 -0.48320952 -0.4791328  -0.6656129   0.4660135   0.41110528
 -0.8501668   0.5582089  -0.6173048  -0.49880195  0.12180524  0.63208055
  0.01327905  0.8614366   0.33755878 -0.15325154 -0.18567845 -0.8466728 ]",10.1002/clc.4960201013,"['Adult', 'Biomarkers', 'Cardiac Catheterization', 'Chagas Cardiomyopathy', 'Chronic Disease', 'Discriminant Analysis', 'Electrocardiography', 'Electrolytes', 'Endocardium', 'Female', 'Fructose-Bisphosphate Aldolase', 'Glycoproteins', 'Humans', 'Male', 'Myocardium']"
527,"[-0.48849    -0.14287175  0.37638193 -0.5174755  -0.2102858   0.8774915
  0.77848876 -0.57499635 -1.1955729  -0.31240234  0.5728846  -0.5158816
 -0.06903874 -0.6302052  -0.24867901 -1.0415548   0.1049347   0.57130075
 -1.7591194   0.27324867 -0.55570525 -0.6851481   0.14099647  0.87006617
  0.2033924   1.2585232   0.2932103  -0.37905094 -0.179209   -0.6065066 ]",10.1016/0888-7543(95)80018-h,"['Animals', 'Base Sequence', 'Brain Chemistry', 'Chromosome Mapping', 'Chromosomes, Human, Pair 4', 'Cricetinae', 'DNA Primers', 'Humans', 'Hybrid Cells', 'Mice', 'Mice, Inbred BALB C', 'Molecular Sequence Data', 'Polymerase Chain Reaction', 'Receptor, Cholecystokinin A', 'Receptor, Cholecystokinin B', 'Receptors, Cholecystokinin', 'Receptors, Dopamine', 'Stomach']"
528,"[-0.72126067 -0.33430162  0.44624352 -0.275777   -0.25825638  0.3252306
  0.60656786 -0.23427594 -1.3172132  -0.3177655   0.5266266  -0.3438129
  0.00286809 -0.63769656 -0.321214   -0.6222679   0.47579315  0.48496687
 -0.80324984  0.50583625 -0.4985268  -0.5259032  -0.06861277  0.6864136
 -0.05385087  0.7206792   0.5405573  -0.08289997 -0.16577525 -0.8594584 ]",10.1002/clc.4960201009,"['Animals', 'Cytokines', 'Heart', 'Heart Failure', 'Humans', 'Myocardium', 'Nitric Oxide', 'Nitric Oxide Synthase']"
529,"[-0.40899143 -0.151378    0.27809763 -0.210317   -0.10365176  0.18029995
  0.35825962 -0.19435799 -0.7806786  -0.16569617  0.3122952  -0.20507033
 -0.03361242 -0.33336967 -0.19978024 -0.37132692  0.24676532  0.2544328
 -0.5696898   0.3103637  -0.43826175 -0.25096038  0.0418571   0.45004392
  0.01086212  0.43187842  0.21077888 -0.01317193 -0.1358813  -0.46967816]",10.1002/clc.4960200609,"['Adult', 'Aged', 'Cardiomyopathy, Dilated', 'Case-Control Studies', 'Discriminant Analysis', 'Echocardiography', 'Female', 'Follow-Up Studies', 'Heart Atria', 'Hemodynamics', 'Humans', 'Italy', 'Life Tables', 'Male', 'Middle Aged', 'Prognosis', 'Risk Factors']"
530,"[-1.0072017  -0.02996514 -0.25493804 -0.8128738  -0.12839635  0.7332815
  0.5294982  -1.0497972  -1.8814924   0.13131675 -0.1063914  -0.8646265
 -0.02223387 -0.21128042 -0.9917728  -0.86975825 -0.01869734 -0.02379294
 -1.6166124   0.31917498 -0.36174902 -1.1888967   0.6343354   1.0977677
  0.66307086  1.3592479  -0.2615894  -0.7674028  -0.8775099  -0.59890246]",10.1002/clc.4960200706,"['Amiodarone', 'Anti-Arrhythmia Agents', 'Arrhythmias, Cardiac', 'Atrial Fibrillation', 'Chronic Disease', 'Controlled Clinical Trials as Topic', 'Dose-Response Relationship, Drug', 'Heart Failure', 'Humans', 'Myocardial Infarction', 'Treatment Outcome', 'Ventricular Fibrillation']"
531,"[-0.55687267 -0.32860702  0.5715146  -0.2957093  -0.3094793   0.21505849
  0.5944566  -0.3579594  -1.1705024  -0.33869052  0.664108   -0.27594987
  0.09959001 -0.5522627  -0.267908   -0.5126249   0.49800694  0.46689656
 -0.89847314  0.54665184 -0.64591634 -0.43564627 -0.10212678  0.6215181
 -0.17076682  0.5926221   0.56985307  0.01724531 -0.08533767 -0.8481702 ]",10.1002/clc.4960210705,"['Animals', 'Arteries', 'Arteriosclerosis', 'Cell Division', 'Endothelium, Vascular', 'Enzyme Inhibitors', 'Gene Transfer Techniques', 'Humans', 'Muscle, Smooth, Vascular', 'NG-Nitroarginine Methyl Ester', 'Nitric Oxide', 'Nitric Oxide Synthase', 'Nitric Oxide Synthase Type II', 'Vasoconstriction']"
532,"[-0.5447136   0.05745062  0.13272686 -0.64215714 -0.35359034  0.43960112
  0.5872609  -0.13963467 -0.92619026 -0.06342398  0.3618451  -0.66153425
 -0.07956037 -0.35810086 -0.72200304 -0.5557183   0.40095922  0.385098
 -0.55917716  0.47976774 -0.5573652  -0.4896318   0.11048264  0.6164724
  0.05387359  1.0478086   0.32638997 -0.25472984 -0.2212685  -0.74495167]",10.1002/clc.4960200410,"['Coronary Angiography', 'Coronary Circulation', 'Coronary Disease', 'Dobutamine', 'Echocardiography', 'Female', 'Heart', 'Humans', 'Male', 'Middle Aged', 'Myocardial Contraction', 'Myocardial Infarction', 'Predictive Value of Tests', 'Radionuclide Imaging', 'Sensitivity and Specificity', 'Thallium Radioisotopes']"
533,"[-0.73801553 -0.1919935   0.16787018 -0.50553674  0.05147935  0.9300905
  0.67577225 -0.56603897 -1.6512489  -0.13948196  0.32763475 -1.3222252
  0.1823122  -0.3981073  -0.8742961  -0.6069533   0.46428636  0.1992225
 -1.4507881   0.73599845 -0.53417426 -1.073292    0.37658307  0.7950355
  0.06578672  1.4568858  -0.03507569 -0.35983136 -0.5541846  -0.9186198 ]",10.1002/clc.4960200506,"['Angioplasty, Balloon', 'Anticoagulants', 'Combined Modality Therapy', 'Coronary Artery Bypass', 'Coronary Disease', 'Diabetes Mellitus, Type 2', 'Fibrinolytic Agents', 'Humans', 'Hypolipidemic Agents', 'Morbidity', 'Risk Factors', 'Survival Rate', 'United States', 'Vascular Diseases']"
534,"[-0.6649484  -0.07397515  0.08073159 -0.55470884 -0.4088612   0.4587885
  0.6588287  -0.5151069  -1.3829845  -0.2997128   0.31215578 -0.7435018
 -0.0613618  -0.5215169  -0.6473832  -0.62242323  0.46466556  0.28755334
 -1.1482017   0.6188531  -0.59537846 -0.7462759   0.12396703  0.65748835
  0.15840949  1.0520455   0.25934532 -0.27631038 -0.23272902 -0.863812  ]",10.1002/clc.4960200504,"['Ethanol', 'Fibrinolysis', 'Flavonoids', 'France', 'Humans', 'Incidence', 'Lipoproteins, HDL', 'Myocardial Ischemia', 'Platelet Aggregation', 'Risk Factors', 'Survival Rate', 'Wine']"
535,"[-0.5774478  -0.08007375  0.33867294 -0.50351906 -0.17884782  0.98422235
  0.70121014 -0.51463544 -1.1900036  -0.39043096  0.29880714 -0.8448623
 -0.02687993 -0.48633072 -0.6226437  -0.9178784   0.40276873  0.29446962
 -1.2469722   0.7796327  -0.44132265 -0.741214    0.310953    0.7848123
  0.11281867  1.489086    0.17598403 -0.16320643 -0.2130765  -1.083592  ]",10.1002/clc.4960201104,"['Angioplasty, Balloon, Coronary', 'Animals', 'Constriction, Pathologic', 'Coronary Disease', 'Coronary Vessels', 'Endothelium, Vascular', 'Homeostasis', 'Humans', 'Nitric Oxide', 'Vasoconstriction']"
536,"[-0.38752204  0.0137445   0.26119003 -0.39966336 -0.25826168  0.41984177
  0.51892626 -0.2663773  -0.7295012  -0.22054039  0.41639963 -0.52949023
 -0.10595471 -0.24601813 -0.43737045 -0.4973084   0.42045453  0.19908112
 -0.5976924   0.46989226 -0.4689153  -0.37447992  0.09017348  0.44016457
 -0.11052772  0.7149301   0.30227643  0.06143979 -0.1005722  -0.74636966]",10.1002/clc.4960210108,"['Adult', 'Aortic Dissection', 'Coronary Angiography', 'Coronary Disease', 'Coronary Vessels', 'Cyclophosphamide', 'Electrocardiography', 'Female', 'Follow-Up Studies', 'Glucocorticoids', 'Humans', 'Immunosuppressive Agents', 'Infusions, Intravenous', 'Myocardial Infarction', 'Postpartum Period', 'Recurrence']"
537,"[-0.704858    0.14798462 -0.16603087 -0.801248   -0.39148346  0.51950526
  0.99455374 -1.0955698  -1.6396946   0.36179286  0.1845741  -1.1861044
 -0.29947978 -0.3939043  -1.1962733  -0.78638613  0.514624    0.19717474
 -0.9603077   0.70587015 -0.7975753  -1.1859963   0.20372014  1.0790565
  0.51207453  1.3545048  -0.1523142  -0.7176608  -0.6117799  -0.9592089 ]",10.1002/clc.4960200908,"['Anti-Arrhythmia Agents', 'Cardiac Pacing, Artificial', 'Combined Modality Therapy', 'Death, Sudden', 'Electrocardiography, Ambulatory', 'Humans', 'Myocardial Infarction', 'Prognosis', 'Risk Factors', 'Tachycardia, Ventricular']"
538,"[-0.4092207  -0.07406287  0.23141988 -0.22991484 -0.15547378  0.10759649
  0.37817943 -0.24988727 -0.6230743  -0.13472201  0.32768038 -0.2534565
 -0.06170524 -0.29025313 -0.30923802 -0.25967956  0.23347963  0.11718131
 -0.4684318   0.2993504  -0.44789055 -0.23097156  0.01640676  0.34056512
 -0.01197047  0.28404927  0.25119832 -0.00511    -0.0636824  -0.43556964]",10.7326/0003-4819-119-3-199308010-00004,"['Adult', 'Aged', 'Diagnostic Imaging', 'Female', 'Gastrins', 'Humans', 'Male', 'Middle Aged', 'Predictive Value of Tests', 'Prognosis', 'Prospective Studies', 'Recurrence', 'Secretin', 'Zollinger-Ellison Syndrome']"
539,"[-0.16454753 -1.482706    1.2161025  -1.1360329   2.5292292   4.624193
  1.0920144   0.274392   -1.67267    -1.6884638  -0.21176863  2.1673813
  4.194917   -0.9433698   0.01574501 -2.624495    1.5467931   1.3453298
 -2.7008336   0.5499907   1.079836   -0.8506617   0.19201683  1.7694387
 -0.60016996  1.8842882   0.87574065 -3.1585312  -1.0994719  -1.7618608 ]",10.1074/jbc.271.46.29182,"['Amino Acid Sequence', 'Animals', 'Carrier Proteins', 'Caveolin 1', 'Caveolins', 'Cell Line', 'Cytosol', 'Dogs', 'Enzyme Activation', 'GTP-Binding Proteins', 'Membrane Proteins', 'Molecular Sequence Data', 'Protein Binding', 'Proteins', 'Recombinant Proteins', 'Spodoptera', 'ras Proteins', 'src-Family Kinases']"
540,"[-0.9580677   0.07792562 -0.03635778 -0.6311807  -0.24876311  1.3753215
  1.3254145  -1.066981   -1.3413347  -0.48534855  0.85237336 -1.1003455
 -0.18078634 -0.83096    -0.3141119  -1.1453825   0.17887932  0.23676246
 -2.50336     0.18477643 -0.75196797 -1.0450298   0.47416568  1.0868523
  0.2105367   1.8952272   0.07585044 -0.4108121  -0.6288585  -0.56502014]",10.1093/hmg/2.2.143,"['Alleles', 'Angelman Syndrome', 'Base Sequence', 'Chromosome Deletion', 'Chromosome Mapping', 'Chromosomes, Fungal', 'Chromosomes, Human, Pair 15', 'Female', 'Gene Library', 'Genetic Markers', 'Genome, Human', 'Genotype', 'Humans', 'Male', 'Meiosis', 'Models, Genetic', 'Molecular Sequence Data', 'Polymerase Chain Reaction', 'Polymorphism, Genetic', 'Prader-Willi Syndrome', 'Repetitive Sequences, Nucleic Acid']"
541,"[-0.7271398   0.7565701  -0.3845366  -1.4364758  -1.2505397   1.1963463
  1.4300973  -0.58768624 -1.1909974  -0.16186498  0.45158646 -1.9366696
 -0.40847796  0.20078304 -1.7211429  -1.2018548   0.80688244  0.70790166
 -0.6187129   0.9366359  -1.5591673  -0.9781254   0.31090322  1.171115
  0.21502277  2.1216896   0.09936758 -0.9256302  -0.45677722 -1.4497161 ]",10.1002/clc.4960210402,"['Animals', 'Coronary Disease', 'Electrocardiography', 'Humans', 'Myocardial Reperfusion', 'Myocardium', 'Organophosphorus Compounds', 'Organotechnetium Compounds', 'Radiopharmaceuticals', 'Technetium Tc 99m Sestamibi', 'Tomography, Emission-Computed, Single-Photon', 'Ventricular Dysfunction, Left']"
542,"[-0.54803836 -0.116716    0.225352   -0.3156905  -0.11746011  0.3159348
  0.44916946 -0.3371138  -0.96694756 -0.17388527  0.2720096  -0.4320008
  0.04927996 -0.397387   -0.35335752 -0.5155816   0.2734908   0.25086936
 -0.77073044  0.42360058 -0.42160708 -0.46518224  0.09048072  0.49981928
  0.03639764  0.66116565  0.18668458 -0.14459398 -0.20645308 -0.5887937 ]",10.1002/clc.4960200210,"['Anti-Bacterial Agents', 'Aortic Valve Insufficiency', 'Cerebral Angiography', 'Drug Therapy, Combination', 'Echocardiography, Transesophageal', 'Endocarditis, Bacterial', 'Female', 'Follow-Up Studies', 'Gram-Negative Bacterial Infections', 'Gram-Positive Bacterial Infections', 'Humans', 'Male', 'Middle Aged', 'Mitral Valve Insufficiency', 'Morbidity', 'Retrospective Studies', 'Survival Rate', 'Thromboembolism', 'Treatment Outcome']"
543,"[-1.2961295  -0.33255494  0.3306975  -0.56077933 -0.28333503  0.71099824
  0.9136812  -0.45811254 -1.7628604  -0.34560588  0.42231703 -1.0912215
 -0.06146654 -0.8989664  -0.8934776  -0.9692319   0.34225535  0.567007
 -1.5642793   0.5400734  -0.82311815 -1.1172395   0.24356681  1.2110215
  0.4539206   1.3705478   0.26425916 -0.5404588  -0.48488358 -0.8944173 ]",10.1002/clc.4960210704,"['Acquired Immunodeficiency Syndrome', 'Biopsy', 'Diagnosis, Differential', 'Echocardiography', 'Electrocardiography', 'Heart Diseases', 'Humans', 'Incidence', 'Survival Rate']"
544,"[-1.1392316  -0.0473186  -0.24365005 -0.6779032  -0.02123838  0.80365926
  0.8161774  -0.9548186  -1.3915291   0.0744599   0.20861076 -0.95311433
  0.07034025 -0.5078544  -1.0416569  -0.5228805  -0.11952327 -0.08733433
 -1.617736    0.45302278 -0.6145966  -0.9146228   0.32395592  0.92404824
  0.45279115  1.1084121   0.01800961 -0.8452132  -0.5160373  -0.4447517 ]",10.1007/BF01655106,"['Gastric Acid', 'Humans', 'Zollinger-Ellison Syndrome']"
545,"[-0.7240507  -0.04416342  0.08481351 -0.5052549  -0.19336982  0.49275625
  0.656341   -0.65836865 -1.0389102  -0.10183853  0.30600736 -0.5290826
  0.0300038  -0.39022878 -0.45186082 -0.5918938   0.17145854  0.09945901
 -1.3102505   0.3859762  -0.5437851  -0.57822764  0.20783652  0.5909405
  0.09750802  0.85346556  0.10421615 -0.36706948 -0.4146033  -0.48149827]",Unknown,"['Chromosome Aberrations', 'Humans', 'Infant, Newborn', 'Kidney', 'Male', 'Monosomy', 'Sex Chromosome Aberrations', 'Trisomy', 'Urinary Tract']"
546,"[-4.17061299e-01 -1.71688825e-01  3.61934900e-01 -4.62095976e-01
 -1.42435385e-02  1.05780232e+00  7.18587697e-01 -7.20822155e-01
 -1.18068516e+00 -2.13282540e-01  4.94584292e-01 -3.76734942e-01
 -5.70330098e-02 -5.97524464e-01 -2.57030427e-01 -1.13125086e+00
  1.24774687e-03  5.14721513e-01 -1.87437320e+00  2.41378024e-01
 -3.78247678e-01 -6.48629785e-01  1.12606660e-01  8.84518564e-01
  3.66918713e-01  1.32054853e+00  1.98921844e-01 -5.97332954e-01
 -1.74313962e-01 -4.72996652e-01]",10.1016/0006-291x(92)91557-7,"['Amino Acid Sequence', 'Animals', 'Base Sequence', 'Binding, Competitive', 'Blotting, Northern', 'Brain', 'Cell Line', 'Chromosome Mapping', 'Chromosomes, Human, Pair 11', 'Cloning, Molecular', 'DNA', 'Dogs', 'Gastric Mucosa', 'Humans', 'Kinetics', 'Molecular Sequence Data', 'Oligodeoxyribonucleotides', 'Poly A', 'Polymerase Chain Reaction', 'RNA', 'RNA, Messenger', 'Rats', 'Receptors, Cholecystokinin', 'Sequence Homology, Amino Acid', 'Transfection']"
547,"[-0.637077   -0.3034397   0.5134787  -0.8083526  -0.42043927  0.3900409
  0.53557473 -0.71463454 -2.0876565  -0.5405152   0.08699013 -1.0639192
  0.16611192 -0.17338842 -0.74584407 -0.585861    0.5863929   0.3167102
 -1.4435765   0.67921376 -0.52559733 -0.9503718   0.41990238  0.9184282
  0.3310753   1.3598243   0.08254886 -0.24259987 -0.461194   -1.2299885 ]",10.1002/clc.4960211004,"['Amiodarone', 'Anti-Arrhythmia Agents', 'Atrial Fibrillation', 'Clinical Trials as Topic', 'Coronary Artery Bypass', 'Death, Sudden, Cardiac', 'Electric Countershock', 'Humans', 'Meta-Analysis as Topic', 'Monitoring, Physiologic', 'Postoperative Care', 'Postoperative Complications', 'Procainamide', 'Quinidine', 'Recurrence', 'Risk Factors', 'Time Factors']"
548,"[-0.399476   -0.10769926  0.38987583 -0.40029904 -0.21715105  0.2932204
  0.32046732 -0.26910082 -0.9311578  -0.2544239   0.29759887 -0.4887643
 -0.148214   -0.29987803 -0.49499923 -0.53870314  0.4715372   0.22260919
 -0.5193527   0.4935586  -0.3428044  -0.44275674  0.11569034  0.37842545
 -0.00431343  0.73515993  0.32193133  0.10464312 -0.07010062 -0.8482497 ]",10.1002/clc.4960211213,"['Coronary Angiography', 'Coronary Disease', 'Coronary Vessels', 'Diagnosis, Differential', 'Heart Transplantation', 'Humans', 'Male', 'Middle Aged', 'Myocardial Reperfusion', 'Stents', 'Ultrasonography']"
549,"[-0.7297966  -0.06372909  0.24986209 -0.50730246 -0.18563865  0.5997433
  0.5603142  -0.48034906 -1.2353655  -0.15497312  0.24982804 -0.59959036
 -0.09706601 -0.5189252  -0.5773234  -0.7820469   0.36098868  0.35586926
 -1.171137    0.5992216  -0.4420184  -0.5823658   0.19649552  0.6995055
  0.14000425  1.0661038   0.16606528 -0.22788496 -0.2981129  -0.7960307 ]",10.1002/clc.4960220304,"['Angina Pectoris', 'Counterpulsation', 'Hemodynamics', 'Humans', 'Myocardial Infarction', 'Shock, Cardiogenic']"
550,"[-0.9104044  -0.14240544  0.33677405 -0.69373375 -0.18366395  0.6230512
  0.58661795 -0.5697696  -1.3093479  -0.23069601  0.19977577 -0.9472085
 -0.12844309 -0.47284925 -0.77885914 -0.87301743  0.47232282  0.20973027
 -1.2244086   0.5916114  -0.4867492  -0.952376    0.08672696  0.8482672
  0.21915281  1.4468403   0.19774656 -0.1891728  -0.30349562 -0.92611814]",10.1002/clc.4960211205,"['Cardiomyopathy, Dilated', 'Diabetes Complications', 'Humans']"
551,"[-0.3413315  -0.05323687  0.19564879 -0.3023646  -0.27412373  0.32602912
  0.61800313 -0.19033746 -0.7487277  -0.11726749  0.38881862 -0.3765959
 -0.07454961 -0.3252873  -0.354959   -0.48061407  0.45229968  0.31491956
 -0.44847843  0.47419336 -0.5227588  -0.34513682  0.00587888  0.5125228
 -0.10856022  0.56617856  0.310157   -0.13107726 -0.03048256 -0.6422326 ]",10.1002/clc.4960211012,"['Aged', 'Aminophylline', 'Atropine', 'Cardiotonic Agents', 'Drug Resistance', 'Female', 'Heart Block', 'Hemodynamics', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction', 'Parasympatholytics', 'Recurrence', 'Time Factors']"
552,"[-0.10346817 -0.07082263  0.1558551  -0.02514114 -0.0756039  -0.07876173
  0.07882734 -0.02180519 -0.18530689 -0.07470284  0.17054166  0.02940021
  0.0319027  -0.11305244 -0.0230513  -0.09212965  0.13145651  0.08753844
 -0.07507778  0.10307077 -0.14637168 -0.00158246 -0.06636333  0.08654886
 -0.07712638  0.00963639  0.1671926   0.06469365  0.04200886 -0.18202674]",10.1002/clc.4960220118,"['Cardiology', 'France', 'Heart Diseases', 'History, 19th Century', 'History, 20th Century']"
553,"[-0.08456399 -0.08544429  0.20600505 -0.03909046 -0.10985219 -0.08839966
  0.09173489  0.00369179 -0.21831594 -0.07880708  0.21023776  0.02878133
  0.04043623 -0.1555265  -0.0025038  -0.08239264  0.17369862  0.09678534
 -0.06386501  0.10236517 -0.17958593  0.01443903 -0.09444582  0.11573574
 -0.07973831 -0.00852756  0.2015841   0.08106937  0.05925691 -0.2197188 ]",10.1002/clc.4960220223,"['Auscultation', 'England', 'Heart Diseases', 'History, 20th Century', 'Humans', 'Phonocardiography']"
554,"[-0.33533952 -0.04525682  0.22950485 -0.32143217 -0.29424098  0.29395676
  0.58700293 -0.15051974 -0.70960164 -0.09361891  0.44226247 -0.324352
 -0.0816182  -0.35838753 -0.34250644 -0.51840574  0.42671815  0.37111124
 -0.45373178  0.41798705 -0.49704874 -0.37586182 -0.04307739  0.5357324
 -0.05394812  0.576257    0.37062204 -0.12482197 -0.04022196 -0.64051545]",10.1002/clc.4960220113,"['Aged', 'Cardiac Catheterization', 'Coronary Angiography', 'Coronary Care Units', 'Creatine Kinase', 'Diagnosis, Differential', 'Electrocardiography', 'Female', 'Follow-Up Studies', 'Heart Ventricles', 'Humans', 'Male', 'Myocardial Infarction', 'Prognosis', 'Prospective Studies', 'Radionuclide Ventriculography', 'Stroke Volume']"
555,"[-0.91808236 -0.14358637  0.34469637 -0.45697284 -0.28660342  0.95857245
  0.92972744 -0.7721045  -1.3965802  -0.51448727  0.80871814 -0.6219801
 -0.00441961 -0.8648873  -0.24935499 -1.204464    0.27600685  0.71211094
 -1.8262855   0.5180036  -0.8912998  -0.56937873  0.15532593  0.91869074
 -0.14631383  1.3716614   0.5602461  -0.25455296 -0.44497916 -0.8254806 ]",Unknown,"['9,10-Dimethyl-1,2-benzanthracene', 'Animals', 'Carcinogens', 'Cell Culture Techniques', 'Cell Division', 'Cells, Cultured', 'Chromosomes', 'Cloning, Molecular', 'Cricetinae', 'Desmosomes', 'Epithelial Cells', 'Female', 'Flow Cytometry', 'Karyotyping', 'Keratins', 'Microscopy, Electron', 'Pregnancy', 'Tetradecanoylphorbol Acetate', 'Trachea']"
556,"[-0.46684766 -0.0462012   0.19199738 -0.346116   -0.1996782   0.2993689
  0.5457162  -0.33572695 -0.8580498  -0.23345678  0.36131704 -0.39626485
 -0.05351976 -0.38433072 -0.40512192 -0.4708485   0.29099077  0.29131037
 -0.6538741   0.41483736 -0.51717436 -0.3568151   0.08221153  0.4528194
 -0.01798283  0.6136544   0.24673745 -0.10189225 -0.11955999 -0.51671773]",10.1002/clc.4960220406,"['Aged', 'Chest Pain', 'Cross-Sectional Studies', 'Female', 'Humans', 'Male', 'Microvascular Angina', 'Middle Aged', 'Quality of Life', 'Reproducibility of Results', 'Sampling Studies', 'Statistics, Nonparametric', 'Surveys and Questionnaires']"
557,"[-0.24392174 -0.11640149  0.27540565 -0.13960277 -0.17609611  0.01225493
  0.23325683 -0.05958479 -0.446416   -0.14840858  0.3188109  -0.0925543
  0.03846588 -0.24859491 -0.10913343 -0.2507576   0.2264279   0.20222941
 -0.2598106   0.21503593 -0.32289022 -0.06661092 -0.07943045  0.2568138
 -0.08954784  0.18203941  0.30493113  0.04780732  0.00809847 -0.37628672]",10.1002/clc.4960220226,"['Administration, Inhalation', 'Echocardiography, Transesophageal', 'Embolectomy', 'Embolism, Paradoxical', 'Follow-Up Studies', 'Humans', 'Nitric Oxide', 'Pulmonary Embolism', 'Vasodilator Agents']"
558,"[-0.8343243  -0.07388153  0.18832433 -0.6426884  -0.21510443  1.0326682
  0.831642   -0.6989698  -1.4484091  -0.42548758  0.6305953  -0.68554795
  0.05702676 -0.8178896  -0.47909394 -1.0763915   0.14507404  0.52809054
 -1.8597044   0.45200846 -0.7388348  -0.64032125  0.21409237  0.93567127
  0.16164285  1.3110076   0.36042854 -0.50445867 -0.36779663 -0.7495922 ]",10.1111/j.1749-6632.1998.tb11173.x,"['3T3 Cells', 'Animals', 'Blotting, Western', 'Cloning, Molecular', 'Enterochromaffin Cells', 'Gastric Mucosa', 'Humans', 'Immunohistochemistry', 'Mice', 'Molecular Weight', 'Rats', 'Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide', 'Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I', 'Receptors, Pituitary Hormone', 'Receptors, Vasoactive Intestinal Peptide, Type II', 'Receptors, Vasoactive Intestinal Polypeptide, Type I', 'Reverse Transcriptase Polymerase Chain Reaction', 'Transfection']"
559,"[-0.25924626 -0.11634086  0.15087241 -0.13088493 -0.14101754  0.0610017
  0.21768434 -0.07624821 -0.4062707  -0.09929547  0.21511813 -0.15232052
 -0.00925594 -0.2246079  -0.17605515 -0.2537796   0.16667157  0.13620517
 -0.302225    0.21423388 -0.23617996 -0.15365732  0.01071408  0.2794267
  0.00733958  0.29200175  0.23069437 -0.04848215 -0.03216763 -0.27857605]",10.1002/clc.4960220609,"['Adult', 'Electrocardiography', 'Exercise Test', 'Female', 'Heart', 'Humans', 'Male']"
560,"[-0.6411234  -0.16287147  0.33145338 -0.5231459  -0.23895904  0.6100279
  0.58629084 -0.33511892 -1.1727395  -0.20076805  0.33098722 -0.53547317
  0.02299477 -0.49619472 -0.48786196 -0.74649894  0.33247435  0.40600526
 -1.0633234   0.48074877 -0.4891718  -0.6046593   0.12646742  0.7737033
  0.12174545  1.0239346   0.17799234 -0.23091562 -0.20483139 -0.74480265]",10.1002/clc.4960220303,"['Humans', 'Metalloendopeptidases', 'Myocardial Infarction', 'Plasminogen Activators', 'Recombinant Proteins', 'Thrombolytic Therapy', 'Tissue Plasminogen Activator', 'Urokinase-Type Plasminogen Activator']"
561,"[-1.1619879  -0.07822421 -0.06789937 -0.33748972  0.21444292  1.210762
  1.062269   -0.56349796 -1.8501287   0.02113813  0.16707343 -0.91476166
  0.30844545 -0.9802509  -0.5066536  -1.7373     -0.03307648  0.52633184
 -2.2038572   0.69300103 -0.5084664  -0.56264454  0.27978498  0.5727321
  0.08358609  1.5364056   0.10893022 -0.74081945 -0.7418812  -0.62661713]",10.1111/j.1365-2184.1998.tb01198.x,"['Anaphase', 'Animals', 'Aphidicolin', 'Cleavage Stage, Ovum', 'DNA Replication', 'Dose-Response Relationship, Drug', 'Embryo, Nonmammalian', 'Emetine', 'Feedback', 'Fertilization', 'Microscopy, Video', 'Mitosis', 'Nuclear Envelope', 'Ovum', 'Protein Biosynthesis', 'Protein Synthesis Inhibitors', 'Sea Urchins']"
562,"[-1.1014354  -0.42104605  0.36961725 -0.32455954  0.7694893   2.3150418
  1.0971942  -0.31304008 -1.7344455   0.7752854   0.08632085 -1.8940333
  0.33033553 -0.53990793 -1.0235523  -1.1293834   0.34346247  0.03214315
 -2.6491523   1.2527596   0.00753719 -1.604081    0.88675857  1.2445501
  0.12065227  2.2898815  -0.3222917  -0.7871768  -1.0586567  -0.9948613 ]",10.1002/clc.4960221502,"['Blood Pressure', 'Diet', 'Dietary Supplements', 'Exercise', 'Humans', 'Hypertension', 'Life Style', 'Potassium', 'Weight Loss']"
563,"[-0.15600693 -0.09254625  0.22934641 -0.10169766 -0.10776299 -0.01330602
  0.16509408 -0.03097006 -0.3273459  -0.10891879  0.24944894 -0.01832037
  0.03846185 -0.20765361 -0.06244996 -0.16626608  0.18408147  0.12067049
 -0.20046076  0.13884732 -0.23180553 -0.06161502 -0.05183882  0.17384359
 -0.06907471  0.12689854  0.21846049  0.06199421  0.025462   -0.27153078]",Unknown,"['Echocardiography, Transesophageal', 'Embolism, Paradoxical', 'Heart Septal Defects, Atrial', 'Humans']"
564,"[-1.2460787  -0.41404682  0.03174102 -0.06080225  0.29266605  1.1002271
  0.95898014 -0.64529514 -2.0490265  -0.00848279  0.81703013 -1.0433038
 -0.23942862 -0.71526307 -0.39136574 -1.4972506  -0.05847272  0.8884582
 -2.3245428   0.68822736 -0.42359436 -0.7683887   0.6074664   0.9379717
 -0.17739269  1.2775526  -0.01510687 -0.0186759  -0.7384561  -0.4742736 ]",10.1002/clc.4960221310,"['Aged', 'Aged, 80 and over', 'Cardiac Surgical Procedures', 'Catheterization', 'Equipment Design', 'Female', 'Fluoroscopy', 'Humans', 'Injections', 'Male', 'Middle Aged', 'Minimally Invasive Surgical Procedures', 'Needles', 'Paracentesis', 'Pericardium', 'Pharmaceutical Preparations', 'Radiography, Interventional', 'Safety', 'Sternum', 'Thoracotomy', 'Treatment Outcome']"
565,"[-0.99230653 -0.13381547  0.26429278 -0.79085845 -0.4311159   0.64683694
  0.63237894 -0.53590465 -1.6305664  -0.05865505  0.08380607 -0.7015694
  0.28376362 -0.3465036  -0.86504364 -0.75743353  0.20317708  0.4971151
 -1.7196484   0.56413645 -0.57777786 -1.0127792   0.30214444  1.0643051
  0.5348257   1.4035577   0.07318073 -0.7139485  -0.53082186 -0.7734116 ]",10.1002/clc.4960221005,"['Animals', 'Atrial Fibrillation', 'Defibrillators, Implantable', 'Electric Countershock', 'Electrodes', 'Electroencephalography', 'Humans', 'Treatment Outcome']"
566,"[-0.6208338  -0.08671604  0.23358732 -0.35600713 -0.14143738  0.6964191
  0.5955323  -0.31822154 -0.91974187 -0.1705903   0.33693528 -0.51749504
  0.0346882  -0.48749214 -0.37943786 -0.77465516  0.2376277   0.30601424
 -1.1255593   0.41086325 -0.38757977 -0.48702362  0.15509978  0.6056805
  0.02112049  0.9612037   0.3174704  -0.23779042 -0.21286832 -0.62828463]",10.1002/clc.4960220808,"['Aged', 'Aged, 80 and over', 'Arteriosclerosis', 'Cytophotometry', 'Female', 'Flow Cytometry', 'Fluorescence Polarization', 'Humans', 'Leukocytes, Mononuclear', 'Lipoproteins, LDL', 'Lymphocyte Activation', 'Lymphocyte Subsets', 'Male', 'Middle Aged', 'Oxidation-Reduction', 'Pilot Projects', 'Statistics, Nonparametric']"
567,"[-0.773014   -0.19750035  0.20497684 -0.3261869  -0.17324355  0.5632936
  0.62841177 -0.28780782 -1.3745807  -0.10227263  0.35359165 -0.65985817
  0.01078469 -0.5607651  -0.5874439  -0.81306964  0.2707905   0.54159707
 -1.2164304   0.6134791  -0.4791632  -0.60646445  0.1795844   0.718633
  0.1584952   1.0354105   0.22014093 -0.29952544 -0.38106284 -0.6972055 ]",10.1002/clc.4960220703,"['Cardiac Tamponade', 'Drainage', 'Echocardiography, Doppler', 'Echocardiography, Transesophageal', 'Hemodynamics', 'Humans', 'Pericardial Effusion']"
568,"[-1.057684   -0.37905926  0.25111344 -0.24468145 -0.11056884  0.7952909
  0.7578082  -0.34435138 -1.6091448  -0.3720209   0.65532804 -0.6392343
 -0.17086111 -0.99240774 -0.3812284  -1.1253906   0.26091117  0.7175758
 -1.4086864   0.70287067 -0.5494179  -0.81781876  0.12538452  0.8927548
 -0.04842352  1.1549077   0.3661788  -0.3204098  -0.45752028 -0.94456613]",10.1002/clc.4960220509,"['Adult', 'Echocardiography, Doppler, Color', 'Electrocardiography', 'Hemodynamics', 'Humans', 'Magnetic Resonance Imaging', 'Male', 'Pericardiectomy', 'Pericarditis, Constrictive', 'Radiography, Thoracic', 'Tomography, X-Ray Computed']"
569,"[-0.42159832 -0.01470564  0.06671475 -0.33841994 -0.29883516  0.36048183
  0.52894187 -0.23320721 -0.7785327  -0.03531902  0.29888663 -0.40542626
 -0.00351164 -0.3698276  -0.42564437 -0.4964368   0.31484294  0.33998764
 -0.6106701   0.36742023 -0.43384624 -0.4256148   0.06511298  0.45971647
  0.07943301  0.66953474  0.19862859 -0.23840472 -0.16415438 -0.5510699 ]",10.1002/clc.4960220806,"['Cardiac Care Facilities', 'Cardiac Catheterization', 'Cardiology Service, Hospital', 'Coronary Angiography', 'Female', 'Health Maintenance Organizations', 'Health Services Accessibility', 'Humans', 'Insurance, Health', 'Logistic Models', 'Male', 'Medicaid', 'Medically Uninsured', 'Medicare', 'Myocardial Infarction', 'Registries', 'United States']"
570,"[-0.47684017 -0.09730134  0.18812646 -0.29320803 -0.16032495  0.31905457
  0.41319486 -0.25593862 -0.7827644  -0.13092193  0.26978162 -0.31288034
  0.04299085 -0.3856383  -0.3260016  -0.5098194   0.23315379  0.22843997
 -0.7128085   0.32426417 -0.3633375  -0.3772859   0.04630656  0.45710954
  0.03155366  0.60409385  0.23408602 -0.17675401 -0.18010393 -0.5003545 ]",10.1002/clc.4960221008,"['Adenosine', 'Aged', 'Anti-Arrhythmia Agents', 'Clinical Competence', 'Electrocardiography', 'Female', 'Humans', 'Male', 'Middle Aged', 'Tachycardia']"
571,"[-0.28104928 -0.03447611  0.21123078 -0.25422493 -0.16128866  0.22045116
  0.3282456  -0.14339049 -0.6113136  -0.17753676  0.3256391  -0.25827473
  0.00595986 -0.26793277 -0.2077778  -0.40122822  0.2613104   0.2515801
 -0.4360362   0.28474963 -0.36778563 -0.23998326  0.00516156  0.37612242
 -0.03657218  0.47341153  0.24190892 -0.07994288 -0.07051522 -0.46016055]",10.1002/clc.4960230205,"['Adult', 'Aged', 'Aged, 80 and over', 'Albumins', 'Blood Flow Velocity', 'Cardiomyopathies', 'Chronic Disease', 'Contrast Media', 'Diastole', 'Echocardiography, Doppler', 'Fluorocarbons', 'Humans', 'Lung Diseases', 'Middle Aged', 'Pulmonary Veins', 'Systole']"
572,"[-0.10261501 -0.07229707  0.1798925  -0.0251451  -0.11259992 -0.08573179
  0.10583236 -0.00949081 -0.19367656 -0.06870269  0.1813574   0.02007899
  0.03540413 -0.1290247  -0.03165787 -0.07832935  0.16688903  0.09635055
 -0.08237913  0.10027999 -0.17406985 -0.00385281 -0.08208627  0.11646003
 -0.09599777 -0.01242792  0.18900162  0.05193071  0.03661877 -0.17720573]",10.1002/clc.4960231404,"['Advance Directives', 'Ethics, Medical', 'Humans', 'Medical Futility', 'Patient Advocacy', 'Resuscitation Orders', 'Terminal Care', 'Treatment Refusal']"
573,"[-0.82103056 -0.08739509  0.08244348 -0.48461586 -0.23425287  0.87526226
  0.75885946 -0.61114705 -1.4436744  -0.2667339   0.4719174  -0.71360534
  0.16700928 -0.80432534 -0.5907132  -1.0607116   0.14082214  0.48121905
 -1.7655494   0.5689982  -0.589496   -0.6170914   0.2915937   0.8577797
  0.29580808  1.1701108   0.2140213  -0.6545848  -0.5227766  -0.65245   ]",10.1046/j.1365-2184.1999.3250321.x,"['Animals', 'CDC2-CDC28 Kinases', 'Cell Cycle', 'Cell Cycle Proteins', 'Computer Simulation', 'Cyclin E', 'Cyclin-Dependent Kinase 2', 'Cyclin-Dependent Kinase Inhibitor p27', 'Cyclin-Dependent Kinases', 'Feedback', 'G1 Phase', 'Humans', 'Kinetics', 'Microtubule-Associated Proteins', 'Models, Biological', 'Phosphorylation', 'Protein Serine-Threonine Kinases', 'Retinoblastoma Protein', 'S Phase', 'Tumor Suppressor Proteins', 'cdc25 Phosphatases']"
574,"[-0.219091   -0.07675879  0.18786389 -0.08964017 -0.0825701   0.12790905
  0.17659082 -0.10803702 -0.45764047 -0.04784867  0.18192776 -0.143231
 -0.04092885 -0.19455838 -0.15271902 -0.32020566  0.15674132  0.19025671
 -0.27939487  0.20574448 -0.19784151 -0.16265257  0.04328857  0.2618048
 -0.00169042  0.3132496   0.15713505  0.00939044 -0.05984842 -0.32848477]",10.1002/clc.4960220707,"['Adult', 'Antihypertensive Agents', 'Echocardiography, Doppler, Pulsed', 'Female', 'Heart Rate', 'Humans', 'Hypertension', 'Male', 'Middle Aged', 'Mitral Valve', 'Regional Blood Flow', 'Retrospective Studies', 'Ventricular Dysfunction, Left', 'Ventricular Function, Left']"
575,"[-0.42507318 -0.05131665  0.18010134 -0.35673285 -0.2583026   0.31891185
  0.47168428 -0.20833474 -0.7981139  -0.18713874  0.3332982  -0.45341977
 -0.03662462 -0.36532396 -0.37197492 -0.5576411   0.35889474  0.2841517
 -0.62854946  0.36877927 -0.46066532 -0.35144296  0.12061504  0.50412095
  0.00300937  0.70105076  0.29471752 -0.08981255 -0.1010491  -0.6061974 ]",10.1002/clc.4960230411,"['Coronary Angiography', 'Electrocardiography', 'Exercise Test', 'Female', 'Humans', 'Male', 'Middle Aged', 'Myocardial Infarction', 'Myocardial Ischemia', 'Observer Variation', 'Radionuclide Angiography', 'Reproducibility of Results', 'Sensitivity and Specificity']"
576,"[-0.08868494 -0.07934715  0.20624378 -0.03079393 -0.08157369 -0.11225681
  0.07556383  0.01296809 -0.18791674 -0.07710437  0.22103006  0.04243231
  0.05584233 -0.14056735  0.00170546 -0.06157362  0.1435142   0.08666515
 -0.06102208  0.10065434 -0.16420874  0.01204454 -0.07638901  0.09966108
 -0.0756712  -0.02338091  0.20203923  0.07156432  0.06308113 -0.19017713]",10.1002/clc.4960231405,"['Advance Directives', 'Decision Making', 'Humans', 'Informed Consent', 'Living Wills', 'Mental Competency', 'Terminal Care']"
577,"[-0.33158094 -0.09388455  0.20645677 -0.22926377 -0.18400037  0.21486714
  0.37511072 -0.17429872 -0.63580894 -0.11782338  0.30735913 -0.33975446
 -0.04619674 -0.28738242 -0.320952   -0.3757606   0.31249782  0.22524971
 -0.50329685  0.36745527 -0.3374092  -0.29608217  0.08961431  0.34673962
 -0.04870858  0.5144843   0.2640181  -0.06303091 -0.05086008 -0.5095775 ]",10.1002/clc.4960230306,"['Aged', 'Diabetic Angiopathies', 'Female', 'Fibrinogen', 'Fibrinolysis', 'Humans', 'Hypoglycemic Agents', 'Infusions, Intravenous', 'Insulin', 'Male', 'Middle Aged', 'Myocardial Ischemia', 'Plasminogen Activator Inhibitor 1', 'Tissue Plasminogen Activator']"
578,"[-0.11611447 -0.10525144  0.23987001 -0.06397223 -0.10024502 -0.05627472
  0.10938377 -0.00340284 -0.24864577 -0.08555418  0.22673212  0.02660087
  0.07928451 -0.1682668  -0.02903618 -0.12860638  0.2007359   0.11952887
 -0.09927541  0.11939028 -0.16817354 -0.0126849  -0.09208311  0.13631837
 -0.08228735  0.03606172  0.2360798   0.06638782  0.0146345  -0.25518262]",10.1002/clc.4960220416,"['Eponyms', 'France', 'History, 19th Century', 'Humans', 'Tetralogy of Fallot']"
579,"[-0.51461494 -0.07404571  0.23441166 -0.3520916  -0.21556176  0.39654025
  0.49716538 -0.30543435 -0.82999504 -0.16529861  0.30178085 -0.46913227
  0.02244274 -0.4031747  -0.47457424 -0.62380624  0.30726886  0.22670893
 -0.7311947   0.4114898  -0.4359307  -0.42188475  0.1524089   0.5751981
  0.0359753   0.78936934  0.2920782  -0.09953147 -0.12036502 -0.64699167]",10.1002/clc.4960221010,"['Aged', 'Angioplasty, Balloon, Coronary', 'Coronary Disease', 'Electrocardiography', 'Exercise Test', 'Female', 'Heart Conduction System', 'Humans', 'Male', 'Middle Aged', 'Predictive Value of Tests', 'Recurrence', 'Risk Factors']"
580,"[-0.40304497 -0.1257256   0.26088127 -0.2104515  -0.1659083   0.18846038
  0.4054819  -0.19701846 -0.79745775 -0.16755933  0.38212487 -0.2235368
  0.04912665 -0.39068782 -0.2460042  -0.45058826  0.25842732  0.27728236
 -0.617797    0.3096713  -0.4742638  -0.24732322  0.02381545  0.42475015
 -0.05674765  0.4838783   0.28407922 -0.10506999 -0.0674696  -0.4732644 ]",10.3928/0022-0124-19990501-04,"['Education, Nursing, Continuing', 'Humans', 'Long-Term Care', 'Nursing Staff', 'Program Evaluation', 'Psychiatric Nursing', 'Student Dropouts']"
581,"[-0.49394262 -0.07278593  0.17972076 -0.32231617 -0.20003316  0.20414051
  0.3396096  -0.27178216 -0.6911535  -0.07863601  0.2707596  -0.36949363
 -0.00424727 -0.31942788 -0.35322842 -0.4173191   0.24157132  0.18155858
 -0.6297511   0.32693124 -0.40307307 -0.34469682  0.02530718  0.4598983
  0.03745476  0.5335171   0.20479092 -0.06875559 -0.12001241 -0.49674118]",10.1002/clc.4960220905,"['Algorithms', 'Arteriosclerosis', 'Aspirin', 'Brain Ischemia', 'Clinical Trials as Topic', 'Clopidogrel', 'Critical Pathways', 'Evidence-Based Medicine', 'Humans', 'Platelet Aggregation Inhibitors', 'Practice Guidelines as Topic', 'Risk', 'Ticlopidine']"
582,"[-0.5524525  -0.0874145   0.4043734  -0.56262696 -0.43174323  0.62224317
  0.7134778  -0.3554798  -1.2439166  -0.34974024  0.558884   -0.7567719
 -0.17138861 -0.41818285 -0.7133602  -0.8013499   0.60210955  0.3897336
 -0.891538    0.69879013 -0.593392   -0.5678526   0.10623296  0.6316031
 -0.05164539  1.0745127   0.4417559  -0.04283166 -0.16011876 -1.0966431 ]",10.1002/clc.4960221018,"['Adult', 'Aortic Dissection', 'Coronary Aneurysm', 'Coronary Angiography', 'Female', 'Humans', 'Postmenopause', 'Recurrence']"
583,"[-0.86113685  0.4387512  -0.10532518 -0.64987195 -0.7562306   0.9462249
  0.8805007  -0.44931665 -1.2813756  -0.18761948  0.1356778  -1.050597
 -0.09073333 -0.5257366  -0.88632894 -0.91462374  0.6058056   0.63975775
 -1.574843    0.81891876 -0.7366803  -0.7872885   0.35877872  0.87276345
  0.13181654  1.4361813   0.18336637 -0.60365343 -0.15508449 -1.0084939 ]",10.1002/clc.4960221703,"['Acute Disease', 'Clinical Medicine', 'Controlled Clinical Trials as Topic', 'Coronary Disease', 'Electrocardiography', 'Humans', 'Myocardial Infarction', 'Platelet Aggregation Inhibitors', 'Platelet Glycoprotein GPIIb-IIIa Complex', ""Practice Patterns, Physicians'"", 'Survival Rate', 'Syndrome', 'United States']"
584,"[-0.8841971   0.08974478  0.03534805 -0.8889315   0.01805134  1.4987683
  1.1285651  -0.85349756 -1.5733136  -0.52019995  0.38404557 -0.83449644
  0.27279857 -0.85398406 -0.3221886  -1.4534596   0.00615909  0.37112895
 -2.0315392   0.5062359  -0.64619786 -0.9426901   0.3050431   1.0668101
  0.07419229  1.8030388   0.36424583 -0.7636551  -0.5424882  -0.6222145 ]",10.1046/j.1365-2184.1999.3250249.x,"['Aminolevulinic Acid', 'Animals', 'Biogenic Polyamines', 'Cell Line', 'Chenopodiaceae', 'Cytokinins', 'Ethylenes', 'Indoleacetic Acids', 'Peroxidases', 'Plant Growth Regulators', 'Plant Tumors']"
585,"[-0.08460344 -0.05211657  0.15665497 -0.02805516 -0.06723752 -0.04779646
  0.10048206 -0.02079385 -0.19810763 -0.0765461   0.15055652  0.00438461
  0.04192917 -0.1243395  -0.02521153 -0.10662996  0.13654166  0.07670341
 -0.08615424  0.08360954 -0.15142721 -0.01586464 -0.06849791  0.10840312
 -0.0550501   0.0488802   0.14279166  0.0329799   0.01221539 -0.15927127]",10.1002/clc.4960230322,"['Cardiology', 'History, 19th Century', 'History, 20th Century', 'United States']"
586,"[-0.09530339 -0.10775978  0.26318887 -0.03870757 -0.15553659 -0.13146298
  0.11731082  0.00524021 -0.26050702 -0.12793492  0.2784164   0.03739005
  0.05808159 -0.19072764  0.00280625 -0.09149124  0.21404065  0.09107402
 -0.05664818  0.13756801 -0.22673258 -0.00036574 -0.10747007  0.11552958
 -0.11833992 -0.00967656  0.2741716   0.11779779  0.05344023 -0.23667891]",10.1002/clc.4960231403,"['Advance Directives', 'Humans', 'Living Wills', 'Medical Futility', 'Palliative Care', 'Practice Guidelines as Topic', 'Resuscitation Orders', 'Terminal Care']"
587,"[-0.9200261  -0.09481583  0.19324663 -0.51686496 -0.24115445  0.6796951
  0.69315135 -0.35610285 -1.4226822  -0.11116365  0.3906457  -0.5980213
  0.12399158 -0.74670124 -0.6575447  -0.870468    0.14399332  0.5322644
 -1.3207744   0.6030028  -0.596378   -0.68028957  0.13716371  0.9038803
  0.06581346  1.4040186   0.21881594 -0.42546263 -0.35080963 -0.80211663]",10.1093/gerona/54.9.m434,"['Aged', 'Aged, 80 and over', 'Analysis of Variance', 'Caregivers', 'Cross-Sectional Studies', 'Female', 'Humans', 'Immunocompetence', 'Interleukin-6', 'Middle Aged', 'Mood Disorders', 'Psychometrics', 'Reference Values', 'Stress, Physiological']"
588,"[-0.82297367 -0.14967893 -0.02493556 -0.5098017  -0.18771859  0.83634645
  0.72570914 -0.8425758  -1.816645   -0.35154015  0.16934903 -0.886411
 -0.06514219 -0.7870635  -0.6262384  -1.1381515  -0.01397729  0.5907041
 -1.7790197   0.39746064 -0.8226106  -1.1664093   0.54266113  0.8030051
  0.37742177  1.7486929  -0.36662626 -0.8120368  -0.41948864 -0.3917598 ]",10.1002/clc.4960231504,"['Adrenergic beta-Antagonists', 'Cardiotonic Agents', 'Dobutamine', 'Drug Therapy, Combination', 'Heart Failure', 'Hemodynamics', 'Humans', 'Phosphodiesterase Inhibitors', 'Signal Transduction']"
589,"[-0.1945632  -0.10880689  0.28016475 -0.11383403 -0.13355543  0.00410504
  0.1881452  -0.04977628 -0.3825965  -0.12413649  0.25502318 -0.05617485
 -0.00931793 -0.20877948 -0.13373768 -0.2105      0.24132143  0.13955164
 -0.19328852  0.22842792 -0.24551348 -0.09291359 -0.08031525  0.20786272
 -0.08407803  0.18280667  0.27065548  0.07109831  0.03860142 -0.35793272]",10.1002/clc.4960230106,"['Angina Pectoris', 'Case-Control Studies', 'Confounding Factors, Epidemiologic', 'Coronary Angiography', 'Coronary Circulation', 'Coronary Vasospasm', 'Coronary Vessels', 'Dipyridamole', 'Exercise Test', 'Female', 'Humans', 'Male', 'Middle Aged', 'Thallium Radioisotopes', 'Tomography, Emission-Computed, Single-Photon', 'Vasodilator Agents']"
590,"[-0.55370855  0.18593001  0.13238081 -0.49088347 -0.5980893   0.5166843
  0.78569514 -0.40835556 -1.0417078  -0.17731534  0.3546384  -0.77634215
 -0.14360602 -0.3832671  -0.64493006 -0.71604836  0.58589345  0.54435354
 -0.8131421   0.6517345  -0.8003224  -0.52648985  0.18574195  0.6120203
 -0.00395049  0.9892983   0.29940686 -0.26745695 -0.06516016 -0.9330255 ]",10.1002/clc.4960221606,"['Abciximab', 'Angina, Unstable', 'Angioplasty, Balloon, Coronary', 'Antibodies, Monoclonal', 'Cost-Benefit Analysis', 'Critical Pathways', 'Humans', 'Immunoglobulin Fab Fragments', 'Myocardial Infarction', 'Platelet Aggregation Inhibitors', 'Platelet Glycoprotein GPIIb-IIIa Complex', 'Risk Factors', 'Stents']"
591,"[-0.84742826  0.10066087 -0.12695362 -0.5446175   0.17345685  1.4882946
  1.1509334  -0.8414573  -1.2909908   0.07058889  0.80405176 -1.0396978
  0.2303949  -0.9224987  -0.07426955 -1.4925263   0.03904674  0.2819997
 -2.4666855   0.4670589  -0.33319718 -0.7901242   0.55965626  0.70363325
 -0.2992101   1.7317417  -0.01787981 -0.557043   -0.56347865 -0.70341206]",10.1002/(sici)1097-4636(200005)50:2<160::aid-jbm10>3.0.co;2-m,"['Anti-Bacterial Agents', 'Bacterial Adhesion', 'Biocompatible Materials', 'Biofilms', 'Equipment and Supplies', 'Membranes, Artificial', 'Plasma', 'Pseudomonas Infections']"
592,"[-0.09854241 -0.06290492  0.16670221 -0.04530743 -0.09878571 -0.05966067
  0.10513214 -0.02207942 -0.19024651 -0.05793653  0.18942767  0.01840162
  0.0276561  -0.13207988 -0.02621235 -0.08031912  0.1517874   0.09941113
 -0.07796817  0.09715777 -0.14793831 -0.00156416 -0.05402902  0.09318902
 -0.0501133   0.00539038  0.1692126   0.05523343  0.01829738 -0.17618093]",10.1002/clc.4960231406,"['Caregivers', 'Decision Making', 'Education, Professional', 'Family', 'Hospice Care', 'Humans', 'Palliative Care', 'Patient Care Management', 'Quality of Life', 'Suicide, Assisted']"
593,"[-0.34992692 -0.05804832  0.612476   -0.6100581  -0.52130026  1.0951828
  0.66590947 -0.02854543 -0.76337415 -0.26913938  0.26554728 -1.4562837
 -0.37242374 -0.00808419 -0.78754526 -0.4731408   0.8825273   0.36187863
 -0.5161075   1.1558342  -0.05408547 -0.8529905   0.31522515  0.5791079
 -0.29601783  1.5613403   0.50750834  0.25027934 -0.06809101 -1.7100182 ]",10.1002/clc.4960221205,"['Coronary Circulation', 'Endothelium, Vascular', 'Humans', 'Hypertension', 'Myocardial Ischemia', 'Nitric Oxide', 'Vasoconstrictor Agents', 'Vasodilator Agents']"
594,"[-0.35325173 -0.06136904  0.18724486 -0.24685302 -0.13627304  0.08902623
  0.2709099  -0.20365942 -0.5399298  -0.07582022  0.22094102 -0.24042524
 -0.02883566 -0.23549159 -0.29215175 -0.24039274  0.23297785  0.12763134
 -0.37489346  0.2808543  -0.34073284 -0.20889214  0.01493388  0.30745938
 -0.03104539  0.31878117  0.18425013 -0.01490619 -0.0390712  -0.4195247 ]",10.1002/clc.4960230504,"['Analysis of Variance', 'Angina Pectoris', 'Angina, Unstable', 'Chlamydia Infections', 'Chlamydophila pneumoniae', 'Coronary Artery Disease', 'Female', 'Humans', 'Immunoglobulin A', 'Immunoglobulin G', 'Male', 'Probability', 'Prospective Studies', 'Sensitivity and Specificity', 'Serologic Tests', 'Severity of Illness Index']"
595,"[-0.2998574  -0.04910616  0.15157594 -0.16796792 -0.11613628  0.16643749
  0.24221739 -0.12951714 -0.5017038  -0.09582877  0.19752784 -0.19397016
  0.01842278 -0.2343289  -0.196929   -0.28241366  0.14360677  0.18067905
 -0.42045552  0.21872006 -0.28853637 -0.20169383  0.03100086  0.2695573
  0.00883783  0.3518016   0.14608158 -0.10148215 -0.10301533 -0.3279677 ]",10.1002/clc.4960230910,"['Adult', 'Aged', 'Analysis of Variance', 'Anticholesteremic Agents', 'Atorvastatin', 'Cross-Over Studies', 'Drug Administration Schedule', 'Female', 'Heptanoic Acids', 'Humans', 'Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'Hypercholesterolemia', 'Lipids', 'Lipoproteins', 'Male', 'Middle Aged', 'Pyrroles', 'Simvastatin', 'Statistics, Nonparametric']"
596,"[-0.5317846  -0.05850255  0.18628284 -0.30511695 -0.18122445  0.37921417
  0.43306765 -0.27202097 -0.7897423  -0.10979372  0.2835733  -0.3315391
  0.07731415 -0.3983599  -0.34029427 -0.54002404  0.22432312  0.26733726
 -0.7383017   0.33579803 -0.39223102 -0.41536725  0.03015015  0.5471976
  0.06863122  0.70332056  0.23136237 -0.2568894  -0.17259897 -0.5007163 ]",10.1002/clc.4960230712,"['Animals', 'Calcium Channel Blockers', 'Cell Hypoxia', 'Cells, Cultured', 'Glucose', 'Magnesium', 'Magnesium Sulfate', 'Myocardial Contraction', 'Myocardial Reperfusion Injury', 'Myocardium', 'Poisons', 'Rats', 'Sodium Cyanide']"
597,"[-0.4010612  -0.15758508  0.27309147 -0.27366403 -0.12154054  0.3150233
  0.394831   -0.18264337 -0.8307493  -0.14574702  0.32536852 -0.33314785
  0.03036905 -0.3281585  -0.29644322 -0.4924035   0.3313742   0.27181354
 -0.59928685  0.3819742  -0.37188408 -0.3352869   0.04978177  0.43497664
 -0.03636485  0.57118046  0.25454134 -0.08338671 -0.15849945 -0.5749499 ]",10.1002/clc.4960230612,"['Adult', 'Angiotensin-Converting Enzyme Inhibitors', 'Antihypertensive Agents', 'Atrial Natriuretic Factor', 'Cardiac Volume', 'Diastole', 'Echocardiography, Doppler, Pulsed', 'Female', 'Humans', 'Hypertension', 'Hypertrophy, Left Ventricular', 'Male', 'Middle Aged', 'Perindopril', 'Ventricular Function, Left']"
598,"[-0.7520575   0.40403205 -0.16440448 -0.6386783  -0.49111998  0.9033733
  1.2099415  -0.51123506 -1.4029388  -0.16174072  0.3296414  -1.1168132
 -0.32459763 -0.35159498 -0.8827778  -0.8531542   0.67383856  0.5418217
 -1.6383674   0.6469695  -0.80910265 -0.7039913   0.33618155  0.7311998
 -0.1557124   1.3417412   0.19423495 -0.33924532 -0.15553473 -0.8820695 ]",10.1002/clc.4960230902,"['Angina, Unstable', 'Eptifibatide', 'Female', 'Heart', 'Heart Conduction System', 'Humans', 'Male', 'Middle Aged', 'Multicenter Studies as Topic', 'Myocardial Infarction', 'Peptides', 'Platelet Aggregation Inhibitors', 'Platelet Glycoprotein GPIIb-IIIa Complex', 'Randomized Controlled Trials as Topic', 'Research Design', 'Survival Analysis', 'Syndrome', 'Treatment Outcome']"
599,"[-0.303303   -0.09885157  0.20165783 -0.21034802 -0.0857005   0.17665023
  0.27771863 -0.1529844  -0.5892803  -0.1496918   0.20773402 -0.23027883
  0.0745515  -0.23800024 -0.1876346  -0.31954587  0.21636498  0.18098821
 -0.45276526  0.27220574 -0.2889133  -0.24279523  0.01897426  0.3101918
 -0.02340851  0.35833892  0.16390482 -0.08116603 -0.10833898 -0.36860883]",10.1002/clc.4960231108,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Aging', 'Analysis of Variance', 'Arteries', 'Blood Pressure', 'Carotid Arteries', 'Data Interpretation, Statistical', 'Echocardiography', 'Female', 'Hemodynamics', 'Humans', 'Male', 'Middle Aged', 'Pulse', 'Syncope', 'Tilt-Table Test', 'Ultrasonography, Doppler, Transcranial']"
600,"[-0.03149657  0.12679707  0.11637795 -0.17030856  0.04080981  0.24573757
  0.25222683  0.13259652 -0.5148071   0.03406329  0.56180817 -0.01005376
  0.10063397 -0.04380675 -0.17302439 -0.15040845  0.32231975  0.08092636
 -0.51464605  0.25020102 -0.11419114 -0.28572097  0.03842821  0.15049787
  0.22586384  0.36085036 -0.04598181  0.10334015 -0.16174227 -0.5088772 ]",10.1111/j.1741-6787.2010.00198.x,"['Critical Care', 'Evidence-Based Nursing', 'Humans', 'Organizational Policy', 'Patient Care Team', 'Ventilator Weaning']"
601,"[-0.2473913   0.33476523  0.20282264 -0.23191701  0.06440854  0.33443975
  0.22752482 -0.07158547 -0.4267368   0.20133583  0.5274195  -0.00904573
  0.0456473  -0.15139343 -0.17105162 -0.17062715  0.15473996  0.15590663
 -0.39515817  0.4428762  -0.2508865  -0.3276336  -0.00911631  0.27688965
  0.22333226  0.49148712 -0.11143952  0.14254545 -0.23918061 -0.3897398 ]",10.1002/14651858.CD002278,"['Adolescent', 'Child', 'Dental Caries', 'Fluorides', 'Humans', 'Randomized Controlled Trials as Topic', 'Toothpastes']"
602,"[ 0.17042956 -0.12543604 -0.02365677 -0.01480932  0.04335682 -0.00033582
  0.19066013  0.23560178 -0.27435023 -0.13474293  0.2322036   0.00557269
  0.11273601  0.08092442 -0.0478658  -0.03128591  0.28252494  0.03151549
 -0.27029175 -0.04249672  0.0852086  -0.08662616  0.09277318 -0.07665855
  0.09686065  0.0204754   0.08583249  0.03011914  0.05027052 -0.3142027 ]",10.1016/j.jht.2011.06.005,"['Adolescent', 'Adult', 'Aged', 'Child', 'Exercise Therapy', 'Female', 'Hand Injuries', 'Hand Strength', 'Humans', 'Male', 'Middle Aged', 'Orthopedic Procedures', 'Pain Measurement', 'Postoperative Care', 'Prospective Studies', 'Randomized Controlled Trials as Topic', 'Range of Motion, Articular', 'Recovery of Function', 'Retrospective Studies', 'Splints', 'Tendon Injuries', 'Treatment Outcome', 'Young Adult']"
603,"[-1.4381247   1.6315837   0.7838623  -1.0793417  -0.27138585  1.2711681
  0.275449   -0.7943875  -0.62699455  0.96397746  1.2186667  -0.2649232
 -0.27368045 -0.35709754 -0.8419328  -0.8042719  -0.17144059  0.8137602
 -0.61756545  1.6617211  -1.2031951  -1.0211242  -0.02320637  0.92286825
  0.86523426  1.0752348  -0.8756683   0.36462587 -0.5130829  -0.58541507]",10.2353/ajpath.2008.080252,"['Adult', 'DNA, Mitochondrial', 'Endothelial Cells', 'Esophagus', 'Female', 'Gastrointestinal Diseases', 'Gastrointestinal Motility', 'Gastrointestinal Tract', 'Humans', 'Male', 'Microdissection', 'Mitochondrial Encephalomyopathies', 'Myocytes, Smooth Muscle', 'Point Mutation', 'Sequence Deletion']"
604,"[-1.27567     1.9440783   0.52943504 -0.6726024  -0.3469838   0.9857029
 -0.03754718 -1.2389873  -0.8039198   0.95958954  1.1445457   0.14801073
 -0.10939661 -0.1945844  -0.744536   -0.56066906 -0.06706575  0.37316698
 -1.168577    1.3105547  -0.9298964  -1.1115535   0.11497258  0.5612927
  0.14965259  1.4807614  -0.5224881   0.71200204 -1.1466151  -0.8466009 ]",10.1152/ajplung.00067.2010,"['Aerosols', 'Animals', 'Bronchoalveolar Lavage Fluid', 'Cytokines', 'Goblet Cells', 'Inflammation', 'Inflammation Mediators', 'Intracellular Signaling Peptides and Proteins', 'Leukocyte Elastase', 'Lung', 'Male', 'Membrane Proteins', 'Metaplasia', 'Methacholine Chloride', 'Mice', 'Mice, Inbred BALB C', 'Mucin 5AC', 'Myristoylated Alanine-Rich C Kinase Substrate', 'Peptide Fragments', 'Respiratory Hypersensitivity', 'Respiratory System', 'Serotonin']"
605,"[-0.29863304  0.41666466  0.20248348 -0.25536248  0.02450279  0.42129317
  0.25440082 -0.05407782 -0.443316    0.25248966  0.6017306   0.07848994
  0.08159373 -0.23918289 -0.22031191 -0.157692    0.15121068  0.16175
 -0.48381355  0.46893573 -0.25989616 -0.36781514  0.0260044   0.2836192
  0.25004783  0.59235644 -0.06477547  0.10313757 -0.25237006 -0.45182586]",10.1310/hct1001-13,"['Adolescent', 'Adult', 'Anti-Retroviral Agents', 'Child', 'Clinical Protocols', 'Clinical Trials, Phase III as Topic', 'Clinical Trials, Phase IV as Topic', 'Consent Forms', 'Developed Countries', 'Developing Countries', 'Female', 'HIV Infections', 'Health Services Accessibility', 'Humans', 'Male', 'United States']"
606,"[-0.29272413  0.49356183  0.26685753 -0.39403284  0.0055479   0.5878332
  0.378449    0.05877608 -0.68569857  0.3438305   0.8019826   0.09799849
  0.15193254 -0.29192203 -0.3078301  -0.16371073  0.40820917  0.16005698
 -0.70861304  0.5736935  -0.37962973 -0.597902    0.13959648  0.4351168
  0.41072375  0.7926871  -0.0697636   0.20040737 -0.3241845  -0.70956796]",10.3238/arztebl.2010.0279,"['Clinical Trials as Topic', 'Conflict of Interest', 'Drug Industry', 'Ethics, Pharmacy', 'Germany', 'Humans', 'Publication Bias', 'Research Support as Topic']"
607,"[-0.3413398   0.49310306  0.30101952 -0.42518252  0.08990607  0.50165135
  0.5221236  -0.02801139 -0.7875246   0.20729876  0.93368554 -0.01553535
  0.13321225 -0.14093834 -0.4187593  -0.24594986  0.5477604   0.28638008
 -0.90539473  0.73357075 -0.35096788 -0.64535165  0.09718665  0.374886
  0.39838162  0.92163336 -0.11299473  0.22497042 -0.38557848 -0.8705862 ]",10.1097/PRS.0b013e318208d28e,"['Exercise Therapy', 'Finger Injuries', 'Humans', 'Orthopedic Procedures', 'Quality of Life', 'Range of Motion, Articular', 'Rupture', 'Tendon Injuries']"
608,"[-0.4871902   0.69203156  0.40304798 -0.40560603 -0.01141596  0.5837672
  0.26939803 -0.23334068 -0.65371275  0.3337746   0.80780196 -0.06000301
  0.03558622 -0.1990448  -0.32444093 -0.25495878  0.14896373  0.42060342
 -0.5864225   0.7317751  -0.39235112 -0.51040596 -0.01258313  0.5096219
  0.32349342  0.8443469  -0.1576562   0.26382616 -0.367474   -0.5732294 ]",10.1099/jmm.0.058248-0,"['Bacteriological Techniques', 'Carrier State', 'Cohort Studies', 'Culture Media', 'Humans', 'Nasal Mucosa', 'RNA, Bacterial', 'Sensitivity and Specificity', 'Staphylococcal Infections', 'Staphylococcus aureus']"
609,"[-1.2704872e+00  1.3716881e+00  4.3645978e-01 -7.3161900e-01
  1.9294873e-01  9.5560086e-01 -5.4537386e-02 -6.5385264e-01
 -1.0897908e+00  7.4220961e-01  8.1777775e-01  2.4829018e-01
 -5.4727513e-02 -4.7450092e-01 -6.8985307e-01 -9.4238046e-04
 -7.4635237e-04  3.8203874e-01 -9.7613055e-01  1.2158742e+00
 -8.6507839e-01 -1.0586525e+00 -1.8864806e-01  9.4950992e-01
  8.4047097e-01  1.4059029e+00 -4.4818771e-01  2.4355982e-01
 -5.4700851e-01 -1.0426518e+00]",10.1182/blood-2012-09-457374,"['Animals', 'Gene Expression Regulation, Neoplastic', 'HSP70 Heat-Shock Proteins', 'Humans', 'Immunoblotting', 'Immunoprecipitation', 'In Situ Nick-End Labeling', 'Leukemia', 'Lymphoma', 'Mass Spectrometry', 'Mice', 'Mice, Inbred BALB C', 'Proto-Oncogene Proteins', 'Transfection', 'Transplantation, Heterologous']"
610,"[-0.08583269  0.2912451   0.16357133 -0.24853536  0.08633619  0.311866
  0.39571196  0.14528127 -0.65423864  0.05613818  0.72221184 -0.02876148
  0.14758934 -0.0613649  -0.25586697 -0.25497147  0.48947212  0.16749358
 -0.7210027   0.45576373 -0.2013469  -0.4287665   0.12505724  0.22925617
  0.25442863  0.54601216  0.01336816  0.16001754 -0.22601068 -0.70245355]",10.1111/j.1600-0501.2011.02331.x,"['Alveolar Bone Loss', 'Alveolar Ridge Augmentation', 'Bone Substitutes', 'Bone Transplantation', 'Dental Implantation, Endosseous', 'Dental Implants', 'Humans', 'Membranes, Artificial', 'Tooth Extraction', 'Wound Healing']"
611,"[-0.13561733  0.1720917   0.11908788 -0.11100553  0.00069641  0.18513139
  0.13455936 -0.01599653 -0.27340585  0.09046821  0.32553855  0.00049346
  0.02485785 -0.03830165 -0.10364105 -0.12783496  0.06098589  0.13136931
 -0.21637745  0.20758657 -0.10050163 -0.13814579  0.00118184  0.09388185
  0.10224432  0.21473037 -0.01072911  0.07722253 -0.09118588 -0.2800103 ]",10.1007/s10620-012-2537-1,"['Antimetabolites, Antineoplastic', 'Antineoplastic Agents', 'Biomarkers, Tumor', 'Blotting, Western', 'Carcinoma, Hepatocellular', 'Cell Line, Tumor', 'Dose-Response Relationship, Drug', 'Down-Regulation', 'Drug Resistance, Neoplasm', 'Fluorescent Antibody Technique', 'Fluorouracil', 'Humans', 'Liver Neoplasms', 'Multidrug Resistance-Associated Proteins', 'NF-E2-Related Factor 2', 'Niacinamide', 'Phenylurea Compounds', 'Protein Kinase Inhibitors', 'Reverse Transcriptase Polymerase Chain Reaction', 'Sorafenib']"
612,"[-1.1459659e+00  1.6052035e+00  6.3019627e-01 -7.7404058e-01
 -1.6871101e-03  1.1952224e+00  1.8006524e-01 -7.3845971e-01
 -1.2196981e+00  1.0288421e+00  1.0719519e+00 -1.0604357e-01
 -1.5374982e-01 -7.1729225e-01 -3.7104729e-01 -4.0895697e-01
  3.0860206e-01  2.7643913e-01 -1.0353987e+00  1.8631091e+00
 -1.1472416e+00 -1.0897636e+00 -2.8908882e-01  1.1899971e+00
  4.4145158e-01  1.8394053e+00 -5.1196551e-01  5.6549263e-01
 -1.0354401e+00 -9.6499276e-01]",10.1016/j.neuroscience.2008.08.047,"['Aging', 'Animals', 'Attention', 'Cerebral Cortex', 'Cognition', 'Discrimination, Psychological', 'Macaca mulatta', 'Male', 'Psychomotor Performance', 'Reversal Learning', 'Visual Perception']"
613,"[-0.5371112   0.767205    0.37375364 -0.54276997 -0.02459097  0.6950369
  0.27607152 -0.18872708 -0.73229533  0.41332713  0.931543   -0.04892382
  0.07647862 -0.2422199  -0.46589926 -0.38038668  0.19376078  0.4239427
 -0.7454053   0.85555166 -0.5796742  -0.623541    0.07596537  0.560954
  0.45870933  0.8835298  -0.29179114  0.23204644 -0.42140454 -0.65460044]",10.1016/j.nmd.2007.12.007,"['Chromosomes, Human, Pair 2', 'DNA Mutational Analysis', 'Humans', 'Indians, North American', 'Italy', 'Membrane Transport Proteins', 'Mitochondrial Diseases', 'Myelin Proteins', 'Myelin and Lymphocyte-Associated Proteolipid Proteins', 'Polymorphism, Single Nucleotide', 'Proteolipids']"
614,"[-0.999605    1.2327616   0.6351477  -0.7544597  -0.01826349  1.0300289
  0.40193874 -0.546601   -1.0069305   0.767672    1.3755975   0.02991574
  0.01283006 -0.4056632  -0.40815783 -0.3978365   0.23996256  0.51277447
 -0.8821954   1.3836805  -0.8309226  -0.8664725  -0.16505454  0.7797946
  0.47086802  1.4682665  -0.31317574  0.39133057 -0.7169971  -0.9451919 ]",10.1111/j.1530-0277.2008.00652.x,"['Alcohol Drinking', 'Animals', 'Ethanol', 'Kinetics', 'Macaca nemestrina', 'Male', 'Models, Animal', 'Motor Skills', 'Self Administration']"
615,"[-0.13420612  0.2186529   0.15063009 -0.1803046   0.02210906  0.26399264
  0.2455735   0.01747111 -0.4474272   0.09249864  0.5230606   0.00795684
  0.05211815 -0.03648414 -0.14260535 -0.18708108  0.20782058  0.12649041
 -0.4244599   0.31873506 -0.14164561 -0.2540526   0.05769998  0.12226451
  0.1967023   0.40291268 -0.01243358  0.10108071 -0.16202581 -0.4644253 ]",10.1111/jcpe.12165,"['Bias', 'Gingival Recession', 'Humans', 'Periodontal Attachment Loss', 'Periodontal Index', 'Periodontal Pocket', 'Periodontitis', 'Prevalence', 'Reproducibility of Results', 'Sensitivity and Specificity']"
616,"[-0.92553526  1.1731874   0.48696497 -1.0665896   0.15311797  0.7640844
  0.4409349  -0.77528495 -1.0432489   0.76838183  1.2526151  -0.23768796
  0.21457283 -0.71510416 -0.67288095 -0.2713961   0.08951572  0.55302113
 -1.00886     1.2068143  -1.0659727  -1.2117759  -0.12337707  0.9092707
  0.7242835   1.4751451  -0.53633076  0.39968845 -1.0225745  -0.73892283]",10.1111/j.1432-2277.2011.01335.x,"['Adrenal Cortex Hormones', 'Graft Rejection', 'Graft Survival', 'Heart Transplantation', 'Humans', 'Immunosuppressive Agents', 'Liver Transplantation', 'Organ Transplantation', 'Pancreas Transplantation', 'Randomized Controlled Trials as Topic', 'Risk Factors']"
617,"[ 0.07144859  0.13042517  0.26847687 -0.16591036  0.16216347  0.3219772
  0.3579267   0.28444275 -0.6213011  -0.03017103  0.6489098  -0.01026178
  0.10775505  0.06153091 -0.24045348 -0.29845193  0.51235163  0.13131116
 -0.8200873   0.42452055 -0.02662861 -0.43125343  0.16886677  0.17704187
  0.23887102  0.40241623  0.08020486  0.23468861 -0.10003208 -0.69008744]",10.1111/j.1708-8208.2009.00152.x,"['Humans', 'Controlled Clinical Trials as Topic', 'Dental Implants', 'Dental Prosthesis, Implant-Supported', 'Dental Restoration Failure', 'Dental Stress Analysis', 'Denture, Overlay', 'Mandible', 'Time Factors']"
618,"[ 0.01231104  0.06064368  0.06538673 -0.08311784  0.02798336  0.09126376
  0.12954926  0.05245614 -0.261331    0.01094248  0.2826191   0.01260159
  0.07101208 -0.00334141 -0.06447859 -0.08712196  0.12704267  0.10704228
 -0.24097206  0.11878555 -0.05352663 -0.11698161 -0.00084231  0.07289703
  0.09104259  0.14136754  0.01772195  0.07132567 -0.02883296 -0.27434966]",10.1212/01.wnl.0000307756.15383.fc,"['Amino Acid Sequence', 'Amyotrophic Lateral Sclerosis', 'Central Nervous System', 'DNA Mutational Analysis', 'Genetic Predisposition to Disease', 'Genetic Testing', 'Humans', 'Mutation, Missense', 'Protein Structure, Tertiary', 'Vesicular Transport Proteins']"
619,"[-1.7459483   1.8472408   0.30913436 -1.0143296   0.01471248  1.1828984
  0.03145102 -1.6967405  -0.74675     1.3375943   1.4561418   0.04846012
  0.26717257 -0.17848067 -0.8189568  -0.14652923 -0.54901695  0.22283953
 -1.0333493   1.6915889  -1.4391879  -1.1937178  -0.21885334  0.89518166
  0.33989194  1.4994065  -0.846861    0.48055482 -1.4247502  -0.67085713]",10.1371/journal.pone.0027137,"['Animals', 'Hyaluronic Acid', 'Lung', 'Membrane Glycoproteins', 'Mice', 'Mice, Inbred C57BL', 'Mice, Knockout', 'Myeloid Differentiation Factor 88', 'Ozone', 'Receptors, Interleukin-1', 'Signal Transduction', 'Toll-Like Receptor 4']"
620,"[-0.3495373   0.5272811   0.30774918 -0.44355968  0.09011878  0.5285655
  0.34674698 -0.11390249 -0.79495424  0.29550055  0.87306577 -0.03341207
  0.15171456 -0.08684009 -0.36220768 -0.17317072  0.390261    0.21986233
 -0.7573147   0.644586   -0.33186305 -0.58546376  0.10211269  0.39136374
  0.4140157   0.7275483  -0.10611914  0.2773345  -0.35644782 -0.7990783 ]",10.1186/2046-4053-2-57,"['Adult', 'Brain Injuries', 'Fatigue', 'Humans', 'Longitudinal Studies', 'Meta-Analysis as Topic', 'Research Design']"
621,"[-0.9902417   1.332125    0.56070316 -0.7921735  -0.08664895  0.9283106
  0.30607298 -0.5152644  -0.73954904  0.76243967  1.1862152  -0.0958917
 -0.09209205 -0.40086475 -0.75583506 -0.6452328  -0.018097    0.5493137
 -0.7511993   1.3402754  -0.9930095  -0.9653676   0.06987294  0.7876493
  0.747995    1.2907504  -0.5662636   0.32993478 -0.6861854  -0.76277274]",10.1093/hmg/ddn073,"['Adolescent', 'Base Sequence', 'DNA, Mitochondrial', 'Fibroblasts', 'Humans', 'Male', 'Mitochondria', 'Mitochondrial Diseases', 'Muscle, Skeletal', 'Point Mutation', 'Protein Biosynthesis', 'RNA, Transfer, Trp']"
622,"[-1.2650743   1.6401575   0.5140681  -0.71022105 -0.08944408  1.1759834
  0.40635946 -0.832843   -0.78434867  0.9361631   1.2263044  -0.11287812
 -0.12440737 -0.35851055 -0.46187893 -0.44655445 -0.04585377  0.4478552
 -0.6352672   1.5517418  -0.84846777 -0.9267596  -0.09311482  0.9319654
  0.48055997  1.7066475  -0.5278332   0.500585   -0.97170025 -0.649022  ]",10.1038/mt.2013.241,"['Animals', 'Astrocytes', 'Bone Marrow Cells', 'Cell Movement', 'Cell Proliferation', 'Encephalomyelitis, Autoimmune, Experimental', 'Gene Expression', 'Genes, Reporter', 'Glial Cell Line-Derived Neurotrophic Factor', 'Immunomodulation', 'Inflammation', 'Interleukin-10', 'Mice', 'Mucolipidoses', 'Myelin Basic Protein', 'Myelin Sheath', 'Neural Stem Cells', 'Neurons', 'Neurotrophin 3', 'Oligodendroglia', 'Transduction, Genetic']"
623,"[-0.85043544  1.0992537   0.5511367  -0.65501994  0.04265616  0.82390386
  0.42544925 -0.50129926 -0.9760781   0.6544456   1.2744106   0.00611299
  0.02778021 -0.36650607 -0.55653894 -0.46197     0.28292924  0.5269712
 -0.948792    1.184537   -0.7022706  -0.8738197  -0.05180607  0.7457029
  0.5778156   1.2614713  -0.3435715   0.39417118 -0.6244043  -0.9240268 ]",10.1093/brain/awp221,"['Base Sequence', 'Cytochrome-c Oxidase Deficiency', 'Diagnosis, Differential', 'Female', 'Genotype', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Mitochondria', 'Mitochondrial Encephalomyopathies', 'Molecular Biology', 'Molecular Sequence Data', 'Muscle, Skeletal', 'Nucleic Acid Conformation', 'Pedigree', 'Phenotype', 'Point Mutation', 'Prognosis']"
624,"[-0.30692068  0.44424707  0.31867555 -0.39987302  0.07397355  0.5054383
  0.46859306  0.07745696 -0.8223453   0.20537992  0.93894625 -0.03730388
  0.11637147 -0.14745954 -0.3087027  -0.26326424  0.4379048   0.24546073
 -0.75020957  0.58262604 -0.30583027 -0.54280543  0.06912898  0.3923123
  0.4236643   0.80790585 -0.11141762  0.26430783 -0.35378984 -0.78365964]",10.1308/147870811X605219,"['Clinical Protocols', 'Clinical Trials as Topic', 'Colon', 'Humans', 'Laparoscopy', 'Length of Stay', 'Perioperative Care', 'Postoperative Complications', 'Rectum', 'Recurrence', 'Reoperation']"
625,"[-0.88404244  1.0213686   0.5242369  -0.36581987  0.09201892  0.77263445
  0.48846722 -0.655448   -0.8311477   0.5617352   1.1472942  -0.19707778
  0.12339324 -0.22542328 -0.53332627 -0.56561846  0.33497626  0.590116
 -0.78317165  1.267391   -0.63787514 -0.61978275 -0.02973912  0.70038986
  0.30450875  1.4326274  -0.21211399  0.50168425 -0.60687935 -0.6716282 ]",10.1002/14651858.CD007565.pub2,"['Adolescent', 'Adult', 'Aged', 'Carcinoma, Ovarian Epithelial', 'Female', 'Humans', 'Middle Aged', 'Neoplasm, Residual', 'Neoplasms, Glandular and Epithelial', 'Ovarian Neoplasms', 'Retrospective Studies', 'Survival Analysis', 'Tumor Burden', 'Young Adult']"
626,"[-0.99341697  1.4213908   0.6164569  -0.62222993  0.00607126  0.77955496
  0.46804813 -0.3778285  -0.48669574  0.76206356  0.56389046 -0.09448521
 -0.10388475 -0.6186364  -0.5205938  -0.32937905  0.4358369   0.12427208
 -0.32926166  1.2915989  -0.87814206 -0.9138525   0.20643339  0.9372988
  0.2509311   1.6851233  -0.7065832   0.4875921  -1.101385   -0.5673553 ]",10.1016/j.ijom.2007.05.012,"['Animals', 'Mandible', 'Maxilla', 'Models, Animal', 'Osteogenesis, Distraction', 'Practice Guidelines as Topic', 'Reaction Time', 'Time Factors', 'Treatment Outcome']"
627,"[ 0.10132248  0.08610113  0.22695155 -0.16214463  0.10797224  0.28973925
  0.32767618  0.22761855 -0.62084156 -0.02360161  0.5994402  -0.00330154
  0.14898013  0.04983729 -0.1714962  -0.26295593  0.47833303  0.14291449
 -0.7892917   0.38546625 -0.06695629 -0.37104964  0.10631718  0.13092043
  0.19175293  0.37545657  0.06648437  0.24739835 -0.07945924 -0.65784746]",10.11607/jomi.2014suppl.g4.3,"['Humans', 'Dental Implantation, Endosseous', 'Dental Implants', 'Dental Prosthesis Design', 'Dental Prosthesis, Implant-Supported', 'Dental Restoration Failure', 'Immediate Dental Implant Loading', 'Jaw, Edentulous', 'Mandible', 'Maxilla', 'Mouth, Edentulous', 'Prospective Studies', 'Randomized Controlled Trials as Topic', 'Retrospective Studies', 'Time Factors']"
628,"[-0.239006    0.3925133   0.26156935 -0.4046254   0.05290249  0.4622101
  0.4758986   0.07559031 -0.7760158   0.21620607  0.83275026 -0.02253705
  0.05999004 -0.12761882 -0.27545658 -0.2527472   0.46097648  0.24513645
 -0.7458051   0.57391137 -0.2797113  -0.5197816   0.04639446  0.29455417
  0.34659284  0.6808411   0.00134475  0.16857488 -0.30803642 -0.819682  ]",10.1016/j.ijporl.2014.01.021,"['Female', 'Humans', 'Infant, Newborn', 'Male', 'False Positive Reactions', 'Hearing Loss', 'Hearing Tests', 'Neonatal Screening', 'Otoacoustic Emissions, Spontaneous', 'Prevalence', 'Quebec', 'Referral and Consultation', 'Sensitivity and Specificity', 'Severity of Illness Index', 'Clinical Protocols']"
629,"[-0.35639256  0.41935     0.20874514 -0.27155617  0.0073097   0.4171129
  0.24045406 -0.11153334 -0.52508765  0.26144952  0.6089963  -0.02382458
  0.06299975 -0.15400016 -0.20201863 -0.2030056   0.15672189  0.18400164
 -0.4500433   0.519802   -0.31155613 -0.3776456  -0.00857344  0.30265287
  0.26255977  0.59936386 -0.0744625   0.19095139 -0.28295323 -0.50366056]",10.1002/pds.1821,"['Aged', 'Aged, 80 and over', 'Algorithms', 'Anti-Inflammatory Agents, Non-Steroidal', 'Cohort Studies', 'Female', 'Humans', 'Incidence', 'Male', 'Medicaid', 'Middle Aged', 'Myocardial Infarction', 'Retrospective Studies', 'Tennessee', 'United States']"
630,"[-0.06887407  0.16501875  0.16239521 -0.17635044  0.03168664  0.24968223
  0.24145034  0.06663394 -0.48345998  0.06425074  0.4674176  -0.00915898
  0.06813343 -0.04446993 -0.1360626  -0.14153302  0.2466063   0.14505462
 -0.4156071   0.26491025 -0.13267814 -0.2638165   0.01987682  0.17670427
  0.20418109  0.3236877   0.00494426  0.12175205 -0.09839007 -0.4624963 ]",10.1111/wvn.12036,"['Critical Care Nursing', 'Critical Illness', 'Enteral Nutrition', 'Humans', 'Malnutrition']"
631,"[-0.4316525   0.6399375   0.41908818 -0.42477605  0.14477943  0.6176385
  0.46854222 -0.10081284 -0.90576154  0.27914032  1.0497886  -0.03914484
  0.13328761 -0.17817254 -0.43089515 -0.2990931   0.3603599   0.39624247
 -0.85244304  0.81745905 -0.42255238 -0.637908   -0.01551873  0.49661636
  0.4055151   0.89456135 -0.14739008  0.25102797 -0.37965584 -0.8781542 ]",10.1590/s1413-35552012005000148,"['Accidental Falls', 'Aged', 'Clinical Protocols', 'Exercise', 'Humans', 'Muscle Strength']"
632,"[-0.7541709   1.0001806   0.37855393 -0.81793076  0.01473352  0.91015416
  0.703052   -0.1365752  -1.232846    0.5810975   1.5819054  -0.03698595
  0.0805307  -0.38930014 -0.6842762  -0.3055871   0.7780808   0.3897019
 -1.210638    1.1500926  -0.788471   -0.9328881   0.1853181   0.7809883
  0.6538495   1.625732   -0.17437853  0.35781556 -0.8214932  -1.1431926 ]",10.1007/s00270-011-0296-6,"['Angiography', 'Angioplasty', 'Aortic Aneurysm, Abdominal', 'Blood Vessel Prosthesis Implantation', 'Female', 'Follow-Up Studies', 'Humans', 'Imaging, Three-Dimensional', 'Male', 'Patient Selection', 'Preoperative Care', 'Risk Assessment', 'Survival Analysis', 'Tomography, X-Ray Computed', 'Treatment Outcome']"
633,"[ 0.16390899 -0.00086828  0.14694282 -0.1274169   0.09499192  0.16479257
  0.2897529   0.2835948  -0.5040127  -0.08793462  0.4485802   0.00162549
  0.14570773  0.0371461  -0.12677556 -0.17975143  0.48252025  0.03824428
 -0.5840721   0.21921901 -0.02362767 -0.27538335  0.14486381  0.0511767
  0.15498525  0.2598134   0.05691444  0.16411722 -0.06167032 -0.54523927]",10.1111/clr.12344,"['Dental Implantation, Endosseous', 'Dental Implants', 'Epithelium', 'Humans', 'Jaw', 'Mouth Mucosa', 'Nerve Fibers', 'Nerve Regeneration', 'Osseointegration']"
634,"[-0.20041505  0.31514284  0.21042307 -0.32009435  0.03951812  0.3860669
  0.29941735  0.01564484 -0.61916703  0.14830267  0.7251335  -0.01350297
  0.06310356 -0.12115305 -0.21739572 -0.1952853   0.3226883   0.16841654
 -0.6326654   0.48077214 -0.2318019  -0.40563092 -0.00225923  0.26971453
  0.26269928  0.5670801  -0.04385565  0.15680346 -0.20357531 -0.62655723]",10.1136/bmj.c7237,"['Adult', 'Clinical Protocols', 'Costs and Cost Analysis', 'Critical Care', 'Critical Illness', 'Hospital Mortality', 'Humans', 'Length of Stay', 'Randomized Controlled Trials as Topic', 'Risk Factors', 'Selection Bias', 'Time Factors', 'Ventilator Weaning']"
635,"[-0.03423448  0.23713428  0.26252636 -0.2265509   0.11613744  0.39045277
  0.31093165  0.08757912 -0.6416026   0.08836746  0.6922165   0.02137349
  0.12298799 -0.02533988 -0.23202647 -0.27503917  0.41068143  0.16841307
 -0.7624078   0.48964334 -0.17735985 -0.42767927  0.07316677  0.2536826
  0.24489184  0.5210069   0.00098811  0.26381564 -0.19782715 -0.6432115 ]",10.11607/jomi.2014suppl.g4.1,"['Female', 'Humans', 'Middle Aged', 'Alveolar Bone Loss', 'Bone Density', 'Crowns', 'Dental Implantation, Endosseous', 'Dental Implants, Single-Tooth', 'Dental Restoration Failure', 'Gingival Recession', 'Immediate Dental Implant Loading', 'Mandible', 'Maxilla', 'Patient Satisfaction', 'Randomized Controlled Trials as Topic', 'Time Factors', 'Torque']"
636,"[-0.17880917  0.3434325   0.14384045 -0.27396864 -0.03938291  0.39591482
  0.32620242  0.02545086 -0.6572367   0.15332104  0.7504269   0.00816548
  0.08626904 -0.09396205 -0.22466591 -0.28538743  0.28073415  0.15333174
 -0.56184214  0.4533398  -0.23170193 -0.33129334  0.09147173  0.1812195
  0.2919976   0.56963974 -0.00790877  0.17007138 -0.25140977 -0.66458243]",10.3109/09513590.2014.895984,"['Chorionic Gonadotropin', 'Drug Administration Schedule', 'Embryo Transfer', 'Estradiol', 'Evidence-Based Medicine', 'Female', 'Fertility Agents, Female', 'Fertilization in Vitro', 'Gonadotropin-Releasing Hormone', 'Humans', 'Infertility, Female', 'Oocyte Retrieval', 'Ovulation Induction', 'Pregnancy', 'Pregnancy Outcome', 'Progesterone', 'Randomized Controlled Trials as Topic', 'Sperm Injections, Intracytoplasmic']"
637,"[-0.23260081  0.31403688  0.1790591  -0.21470083  0.01425415  0.31051177
  0.1942218  -0.10812112 -0.4483839   0.19745442  0.49779442 -0.01617369
  0.04514123 -0.11690135 -0.17303705 -0.172221    0.14270736  0.18297501
 -0.37428448  0.41898492 -0.21291026 -0.26713738 -0.00889487  0.22193398
  0.1796662   0.41832083 -0.0913791   0.14023165 -0.19858763 -0.39024487]",10.3945/ajcn.112.057943,"['Adult', 'Beverages', 'Carbonated Beverages', 'Cross-Sectional Studies', 'Diet', 'Dietary Sucrose', 'Energy Drinks', 'Energy Intake', 'Female', 'Fruit', 'Humans', 'Male', 'Middle Aged', 'Nutrition Surveys', 'Sweetening Agents', 'United States', 'Young Adult']"
638,"[-1.1365886   2.2447827   0.917082   -0.11188426  0.27799508  1.6637689
 -0.11999594 -0.2921065  -1.003102    0.96028495  1.1833583   0.2462762
  0.18052547 -1.8883551  -0.5577508  -0.05254745 -0.16980849 -0.41700223
 -0.18738477  0.99979144 -1.3720058  -0.19733459 -0.4829438   0.78942823
  0.54505736  2.455871   -0.6189232   0.40704495 -1.1797686  -0.36626095]",10.1186/1757-7241-21-9,"['Databases, Bibliographic', 'Emergency Medical Services', 'Emergency Service, Hospital', 'Evidence-Based Emergency Medicine', 'Global Health', 'Guideline Adherence', 'Humans', 'Organizational Policy', 'Practice Guidelines as Topic', 'Quality of Health Care']"
639,"[ 0.04590103  0.02584167  0.08951074 -0.13213158  0.05680696  0.18852946
  0.33218873  0.18051061 -0.4979209  -0.07019914  0.47277093 -0.01745936
  0.11135571  0.02708335 -0.18290947 -0.16332522  0.40961888  0.11076999
 -0.5144256   0.2559824  -0.05932706 -0.24732754  0.10380497  0.10742364
  0.21168754  0.29513127  0.01849124  0.08040196 -0.1143294  -0.5293968 ]",10.1016/j.jhsa.2013.06.025,"['Clinical Protocols', 'Finger Injuries', 'Humans', 'Physical Therapy Modalities', 'Postoperative Care', 'Range of Motion, Articular', 'Rupture', 'Suture Techniques', 'Tendon Injuries']"
640,"[-0.12078244  0.29576302  0.18886063 -0.21469769  0.05988766  0.39292878
  0.3096388   0.06604622 -0.6079355   0.10022878  0.6728695  -0.01291004
  0.08062832 -0.08335881 -0.20471036 -0.28052384  0.34768695  0.1291931
 -0.66201323  0.5099336  -0.20962279 -0.4054365   0.08758584  0.20711713
  0.26219586  0.6133363  -0.02208616  0.25038043 -0.24574678 -0.5919547 ]",10.1111/clr.12347,"['Acid Etching, Dental', 'Dental Implants', 'Dental Polishing', 'Dental Prosthesis Design', 'Dental Restoration Failure', 'Humans', 'Immediate Dental Implant Loading', 'Prospective Studies', 'Randomized Controlled Trials as Topic', 'Surface Properties']"
641,"[-0.7668381   1.2336231   0.54143006 -0.8641488   0.03347656  0.8960291
  0.75996894 -0.33102465 -1.087886    0.6265707   1.3638097  -0.16869806
  0.02420038 -0.29250842 -0.7841288  -0.47846487  0.6638421   0.52594554
 -1.2744068   1.2962841  -0.89161396 -0.9897556   0.20693141  0.9707179
  0.56100476  1.5108318  -0.27029485  0.28292656 -0.6646323  -1.2219929 ]",10.1111/sms.12208,"['Achilles Tendon', 'Exercise Therapy', 'Humans', 'Resistance Training', 'Tendinopathy']"
642,"[ 0.09279671  0.11581026  0.17938878 -0.1814152   0.12481321  0.24877918
  0.39635307  0.25517517 -0.6315235  -0.06387247  0.6038464   0.00669631
  0.18478385  0.02297882 -0.23058772 -0.22182487  0.57228917  0.14167319
 -0.7396398   0.35085765 -0.04813492 -0.3876183   0.18675512  0.12881774
  0.24286512  0.43315962  0.06768979  0.1835745  -0.13522355 -0.67817247]",10.1111/j.1600-0501.2011.02339.x,"['Alveolar Ridge Augmentation', 'Clinical Protocols', 'Dental Implantation', 'Dental Implants', 'Dental Implants, Single-Tooth', 'Humans', 'Time Factors', 'Tooth Extraction', 'Tooth Socket']"
643,"[ 0.0450349   0.04977041  0.2009568  -0.17495227  0.11090328  0.23841946
  0.38481238  0.2439901  -0.5990227  -0.00220154  0.6166904  -0.02741591
  0.15544711  0.00191035 -0.17261584 -0.1975311   0.44268546  0.12503289
 -0.6491116   0.24982798 -0.10737034 -0.37993026  0.13678856  0.15080559
  0.278281    0.34208903  0.04145115  0.1666916  -0.15618926 -0.62392503]",10.11607/jomi.2014suppl.g4.4,"['Humans', 'Dental Implantation, Endosseous', 'Dental Implants', 'Dental Prosthesis, Implant-Supported', 'Dental Restoration Failure', 'Denture, Overlay', 'Immediate Dental Implant Loading', 'Jaw, Edentulous', 'Mandible', 'Maxilla', 'Mouth, Edentulous', 'Prospective Studies']"
644,"[-0.21295218  0.37673226  0.22453642 -0.31896272  0.03695899  0.42779815
  0.37225834  0.07640125 -0.70332444  0.19320035  0.7712183  -0.02919858
  0.07833717 -0.17957301 -0.2762124  -0.24419689  0.3603838   0.18323708
 -0.62628925  0.46871296 -0.26876676 -0.45546982  0.06200461  0.28893536
  0.34924182  0.6701401  -0.05404491  0.14909445 -0.2690276  -0.6561694 ]",10.1111/ans.12417,"['Blood Transfusion', 'Clinical Protocols', 'Hemorrhage', 'Humans', 'Length of Stay', 'Platelet Transfusion', 'Respiration, Artificial', 'Treatment Outcome', 'Wounds and Injuries']"
645,"[ 0.09843072  0.06771693  0.22627279 -0.17468616  0.1125128   0.2631593
  0.3940214   0.29812622 -0.684705   -0.07498252  0.6770064   0.01792954
  0.1796539   0.07448938 -0.21652365 -0.29032826  0.542768    0.14683716
 -0.8297072   0.33566943 -0.06146779 -0.4347351   0.16778158  0.12514912
  0.2428025   0.35540822  0.05471908  0.20098247 -0.09967416 -0.7143281 ]",10.11607/jomi.2014suppl.g4.2,"['Dental Implantation, Endosseous', 'Dental Implants', 'Dental Prosthesis, Implant-Supported', 'Dental Restoration Failure', 'Humans', 'Immediate Dental Implant Loading', 'Jaw, Edentulous, Partially', 'Mandible', 'Maxilla', 'Time Factors']"
646,"[-0.21230675  0.3788905   0.31100655 -0.36295664  0.08279498  0.4738646
  0.44136432  0.0010291  -0.78491354  0.15793486  0.7980914  -0.02976021
  0.1133133  -0.09140649 -0.31816682 -0.2777547   0.45969278  0.30674127
 -0.79703224  0.5603446  -0.29593715 -0.47426715  0.04331002  0.38011828
  0.34948984  0.67799944 -0.03871458  0.2499983  -0.2541836  -0.7451343 ]",10.1371/journal.pone.0065484,"['Echocardiography', 'Fetus', 'Heart Diseases', 'Humans', 'Ultrasonography, Prenatal']"
647,"[-0.20088142  0.6715097   0.6782376  -0.75053555  0.33500585  0.34330946
  0.48238733 -0.06259467 -1.1816882  -0.06139255  1.0630411  -0.26368523
  0.300959   -0.1396926  -0.6826391  -0.05998858  0.51966655  0.37760758
 -1.1977416   0.8607575  -0.5761195  -0.920245    0.39984033  0.5850931
  0.42844445  1.1644722  -0.3041326   0.28406855 -0.46276876 -1.0459707 ]",Unknown,"['Arthritis, Rheumatoid', 'Clinical Protocols', 'Equipment Design', 'Hand Strength', 'Humans', 'Physical Examination']"
648,"[-0.291868    0.4656518   0.2540652  -0.34181577  0.06529223  0.43557352
  0.32682285 -0.08659294 -0.60316986  0.286149    0.69739926 -0.03071819
  0.0890339  -0.21581076 -0.28374952 -0.22669663  0.24766073  0.2302513
 -0.5522608   0.5136182  -0.31963092 -0.44829282  0.00143563  0.36887473
  0.30282572  0.63842624 -0.10982025  0.2048595  -0.30855137 -0.58939964]",10.1002/14651858.CD010609,"['Adult', 'Amines', 'Anticonvulsants', 'Carbamates', 'Cyclohexanecarboxylic Acids', 'Gabapentin', 'Humans', 'Migraine Disorders', 'Pregabalin', 'Randomized Controlled Trials as Topic', 'gamma-Aminobutyric Acid']"
649,"[-7.29877176e-03  1.69684574e-01  1.49374425e-01 -1.83431014e-01
  5.62784150e-02  2.38315806e-01  2.69482315e-01  1.36587352e-01
 -4.54054594e-01  4.07149680e-02  4.81802821e-01 -3.63508327e-04
  1.24847829e-01 -6.21900260e-02 -1.52257368e-01 -1.25056371e-01
  3.01227331e-01  8.38780254e-02 -4.66148347e-01  2.47761890e-01
 -1.08780518e-01 -2.45970219e-01  5.45485020e-02  1.26701087e-01
  1.83610126e-01  3.37416172e-01 -1.73225682e-02  1.11957133e-01
 -1.21647924e-01 -4.86115754e-01]",10.1097/PCC.0000000000000255,"['Algorithms', 'Clinical Protocols', 'Critical Illness', 'Dose-Response Relationship, Drug', 'Humans', 'Hypnotics and Sedatives', 'Intensive Care Units, Pediatric', 'Length of Stay', 'Outcome and Process Assessment, Health Care', 'Respiration, Artificial']"
650,"[-0.7354783   0.8795563   0.409355   -0.51404023  0.06363582  0.79129577
  0.22560571 -0.4733216  -0.8461301   0.62192357  1.0930272  -0.04887573
  0.01406637 -0.47463727 -0.27385724 -0.2664937   0.07890762  0.3254036
 -0.6059152   1.0112195  -0.61158085 -0.48102215 -0.34587753  0.73556805
  0.6311777   1.1345391  -0.10690722  0.33450663 -0.4536775  -0.7175701 ]",10.18553/jmcp.2015.21.1.13,"['Delivery of Health Care', 'Female', 'Humans', 'Motivational Interviewing', 'Pharmaceutical Services']"
651,"[-0.4410888   0.6210697   0.3931652  -0.41114858  0.0937897   0.57857156
  0.35843062 -0.2152304  -0.6767493   0.33935022  0.87550557 -0.02587263
  0.10933211 -0.28846264 -0.33525124 -0.25015804  0.22087903  0.3275671
 -0.6569212   0.7278428  -0.4285672  -0.46895206 -0.06499877  0.46510965
  0.333163    0.8220424  -0.15568629  0.24783579 -0.35352978 -0.6661938 ]",10.18553/jmcp.2015.21.1.76,"['Adult', 'Drug Compounding', 'Female', 'Humans', 'Male', 'Physical Phenomena', 'Prescription Drugs', 'Reference Standards', 'Tablets']"
652,"[-0.4931038   0.6469308   0.3503206  -0.37460163  0.05110594  0.61807597
  0.37151933 -0.15625577 -0.7106553   0.34087098  0.8718679  -0.00457035
  0.07737867 -0.21942963 -0.29824188 -0.29180384  0.26931283  0.26740286
 -0.6576098   0.73332494 -0.40729752 -0.5019425  -0.02487941  0.4548508
  0.32568115  0.86147445 -0.10648088  0.27325195 -0.37360886 -0.6743755 ]",10.18553/jmcp.2015.21.1.56,"['Administration, Oral', 'Aged', 'Cost-Benefit Analysis', 'Diphosphonates', 'Female', 'Fractures, Bone', 'Health Care Costs', 'Humans', 'Linear Models', 'Middle Aged', 'Osteoporosis', 'Patient Acceptance of Health Care', 'Patient Compliance', 'Retrospective Studies', 'Treatment Outcome', 'United States']"
653,"[-0.6661229   1.0105147   0.58680636 -0.6413604  -0.1561207   0.85728085
  0.61644524 -0.06944225 -1.284281    0.6469979   1.7490237  -0.14702675
  0.09382437 -0.33764693 -0.63773555 -0.7140258   0.53906703  0.5819512
 -1.230911    1.171349   -0.66181487 -1.1593746   0.40144196  0.27222198
  0.7566992   1.2909038  -0.00371014  0.32123417 -0.6556559  -1.5244201 ]",10.1016/j.ejca.2014.07.001,"['Carcinoma, Squamous Cell', 'Chemoradiotherapy', 'Clinical Protocols', 'Humans', 'Oropharyngeal Neoplasms', 'Papillomaviridae', 'Papillomavirus Infections', 'Randomized Controlled Trials as Topic', 'Survival Analysis', 'Treatment Outcome']"
654,"[-1.6647196   1.8220199   0.6509146  -0.8456276  -0.11539051  1.0743054
  0.16979465 -0.9832467  -0.6888409   0.9795173   1.4300154   0.22304107
 -0.2733579  -0.7148573  -0.12694569 -0.38099363 -0.17695832  0.40793103
 -0.55213034  1.4734339  -1.0276148  -0.7768469  -0.22611739  0.71213907
  0.4474102   1.7525862  -0.3402494   0.22290358 -0.7469609  -0.67602605]",10.18553/jmcp.2015.21.1.08,"['Adult', 'Community Pharmacy Services', 'Female', 'Hospitals, Military', 'Humans', 'Kentucky', 'Male', 'Medication Errors', 'Middle Aged', 'Polypharmacy', 'Program Development', 'Young Adult']"
655,"[-0.10030299  0.2256885   0.16666748 -0.20672882  0.03020375  0.29453182
  0.27742845  0.07015751 -0.52033746  0.07772221  0.6074109  -0.04067474
  0.07573715 -0.07178699 -0.17340583 -0.20522225  0.31021526  0.13998295
 -0.50229937  0.37111244 -0.1723487  -0.3240816   0.02658042  0.2108705
  0.18414032  0.46636412 -0.01906959  0.16245086 -0.19877394 -0.54306495]",10.1111/jcpe.12321,"['Anti-Infective Agents, Local', 'Dental Implants', 'Dental Plaque', 'Dental Prophylaxis', 'Humans', 'Oral Hygiene', 'Self Care', 'Stomatitis', 'Toothbrushing', 'Treatment Outcome']"
656,"[-0.44344747  0.62141544  0.34966505 -0.39851463  0.03842003  0.57887596
  0.39810085 -0.16359922 -0.7900054   0.37586007  0.89889055 -0.01205779
  0.09275911 -0.23933358 -0.3573115  -0.31561968  0.2113763   0.37441245
 -0.7200179   0.76140547 -0.40793595 -0.54916906  0.04363127  0.42743564
  0.3651336   0.8372952  -0.12095698  0.20684798 -0.34122902 -0.71209806]",10.18553/jmcp.2015.21.2.114,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Clinical Trials as Topic', 'Female', 'Fusion Proteins, bcr-abl', 'Humans', 'Leukemia, Myelogenous, Chronic, BCR-ABL Positive', 'Male', 'Middle Aged', 'Mutation', 'Protein Kinase Inhibitors', 'Protein-Tyrosine Kinases']"
657,"[-0.17248338  0.30452272  0.2456449  -0.24141361  0.07450227  0.3614009
  0.33081657  0.09452569 -0.6209822   0.14124463  0.7020929   0.01562368
  0.07189275 -0.14453846 -0.22242478 -0.21323557  0.29329965  0.20198168
 -0.5869201   0.4189555  -0.21160838 -0.3499253   0.04013538  0.22220066
  0.30760765  0.49040353 -0.02331751  0.10488674 -0.17459512 -0.60406595]",10.7326/M13-2567,"['Adult', 'Cholesterol', 'Chronic Disease', 'Clinical Protocols', 'Diabetes Mellitus', 'Glycated Hemoglobin', 'Humans', 'Hyperlipidemias', 'Hypertension', 'Patient Care Team']"
658,"[-0.46085387  0.5243114   0.29074404 -0.3287243   0.0590996   0.50785816
  0.2505658  -0.22295018 -0.49468657  0.32751948  0.7165275   0.01265737
  0.03697676 -0.2072537  -0.21689071 -0.21723692  0.0886841   0.27490595
 -0.45370173  0.5919859  -0.3662525  -0.37727702 -0.0957498   0.38845104
  0.31156245  0.6705479  -0.11490992  0.16735135 -0.31734896 -0.5109992 ]",10.18553/jmcp.2015.21.2.124,"['Adult', 'Aged', 'Female', 'Humans', 'Male', 'Medication Adherence', 'Middle Aged', 'Prospective Studies', 'Telephone']"
659,"[-0.14360496  0.219566    0.23514806 -0.16096853  0.07347365  0.29391015
  0.14573713  0.0262199  -0.42391667  0.07630613  0.577882   -0.02713213
  0.08233865 -0.13699147 -0.09111625 -0.14734489  0.1055963   0.14117777
 -0.3605422   0.31858954 -0.17864707 -0.22623913 -0.09538864  0.17357107
  0.2204392   0.37180758 -0.01409566  0.0719652  -0.12849587 -0.37750676]",10.18553/jmcp.2015.21.2.135,"['Adult', 'Aged', 'Arthritis, Rheumatoid', 'Blood Sedimentation', 'C-Reactive Protein', 'Female', 'Humans', 'Male', 'Methotrexate', 'Middle Aged', 'Process Assessment, Health Care', 'Quality of Health Care']"
660,"[-0.66247845  0.7620218   0.39309746 -0.46596706 -0.08851193  0.7205401
  0.3060693  -0.35518423 -0.75789857  0.5792027   0.91137403 -0.02115821
  0.02235047 -0.43071875 -0.25128275 -0.39301687  0.17368782  0.28093222
 -0.5154855   0.9031403  -0.5064448  -0.68413556 -0.15685946  0.6118675
  0.36086577  1.002391   -0.2081318   0.35330176 -0.5909803  -0.686811  ]",10.18553/jmcp.2015.21.1.88,"['Adolescent', 'Adult', 'Aged', 'Child', 'Diphtheria-Tetanus Vaccine', 'Diphtheria-Tetanus-acellular Pertussis Vaccines', 'Disease Management', 'Health Care Costs', 'Humans', 'Middle Aged', 'Models, Economic', 'United States', 'Vaccination', 'Whooping Cough', 'Wounds and Injuries', 'Young Adult']"
661,"[-0.58145505  0.72451556  0.37437704 -0.2733579   0.09608854  0.6192445
  0.27816594 -0.25302812 -0.56229156  0.4356571   0.7251241  -0.01799175
  0.02059138 -0.3916602  -0.2870279  -0.332798    0.03591703  0.21943974
 -0.43474516  0.6957431  -0.48743907 -0.40859804 -0.08449852  0.36526644
  0.2556173   0.8388707  -0.14847744  0.22253    -0.39963317 -0.47612587]",10.18553/jmcp.2015.21.2.153,"['Adult', 'Antiretroviral Therapy, Highly Active', 'Coinfection', 'Female', 'HIV Infections', 'Hepatitis C', 'Humans', 'Male', 'Medication Adherence', 'Middle Aged', 'Prospective Studies']"
662,"[-0.33415088  0.431084    0.27035487 -0.28689283  0.06176741  0.39432904
  0.20744441 -0.14309204 -0.46393034  0.29029673  0.6121856  -0.02708321
  0.03051552 -0.1725176  -0.2231145  -0.20288986  0.17273708  0.21275748
 -0.47847575  0.5214175  -0.29600218 -0.3658689  -0.03120331  0.3588192
  0.21233393  0.5962519  -0.13195996  0.1949429  -0.30828896 -0.46026504]",10.18553/jmcp.2015.21.3.188,"['Attitude of Health Personnel', 'Biosimilar Pharmaceuticals', 'Data Collection', 'Drug Approval', 'Humans', 'Pharmacists', 'Terminology as Topic', 'United States']"
663,"[-0.65396744  0.8109764   0.35841903 -0.40714085  0.02570489  0.8082832
  0.45456558 -0.37780994 -0.82514346  0.46622413  1.1276071  -0.08218667
  0.00918114 -0.3013548  -0.44496882 -0.47012204  0.1534631   0.49864388
 -0.71351945  0.98797345 -0.55432504 -0.6331437  -0.08728307  0.4904503
  0.35742173  1.0241206  -0.08779107  0.3565719  -0.50058705 -0.79911226]",10.18553/jmcp.2015.21.1.46,"['Carcinoma, Renal Cell', 'Cost-Benefit Analysis', 'Female', 'Health Care Costs', 'Humans', 'Indazoles', 'Indoles', 'Kidney Neoplasms', 'Male', 'Middle Aged', 'Models, Economic', 'Pyrimidines', 'Pyrroles', 'Quality of Life', 'Quality-Adjusted Life Years', 'Sulfonamides', 'Sunitinib', 'Survival Analysis', 'United States']"
664,"[ 0.26984313  0.0139187   0.21947332 -0.20689763  0.15855029  0.29000932
  0.4339936   0.38797483 -0.6873905  -0.09607586  0.70032024  0.04421876
  0.17853782  0.04859413 -0.23688623 -0.30242637  0.67777956  0.11650515
 -0.9699203   0.40780675 -0.05980764 -0.44424093  0.20004289  0.14391239
  0.24154487  0.4376514   0.08114213  0.24079429 -0.10451452 -0.7688118 ]",10.1111/clr.12428,"['Alveolar Bone Loss', 'Dental Implantation, Endosseous', 'Dental Implants', 'Dental Restoration Failure', 'Humans', 'Immediate Dental Implant Loading', 'Outcome and Process Assessment, Health Care', 'Randomized Controlled Trials as Topic']"
665,"[-0.39515325  0.5148465   0.38181522 -0.38929364  0.10719499  0.49741757
  0.37357774 -0.11482605 -0.71947026  0.26472345  0.86931556  0.02225879
  0.1282535  -0.19640793 -0.31681395 -0.20032635  0.27541173  0.33416903
 -0.68802965  0.6820237  -0.35495678 -0.5069254  -0.08562835  0.44513172
  0.36022153  0.86797255 -0.09002016  0.24961066 -0.3081341  -0.6978332 ]",10.1186/1472-6947-14-82,"['Humans', 'Asthma', 'Clinical Protocols', 'Practice Guidelines as Topic', 'Reminder Systems']"
666,"[-0.2641854   0.25731182  0.18412927 -0.17225337  0.0345993   0.27563494
  0.18035899 -0.09219096 -0.2991778   0.15607937  0.42025825 -0.01950416
  0.01818882 -0.12162218 -0.11368297 -0.15554748  0.06949978  0.13673832
 -0.2753403   0.3229349  -0.20129353 -0.23471758 -0.03663377  0.2078618
  0.15726842  0.3664245  -0.06284001  0.13444725 -0.15338835 -0.31928557]",10.18553/jmcp.2015.21.3.201,"['Adalimumab', 'Adult', 'Antirheumatic Agents', 'Cross-Sectional Studies', 'Databases, Factual', 'Dose-Response Relationship, Drug', 'Drug Costs', 'Etanercept', 'Female', 'Humans', 'Male', 'Middle Aged', 'Psoriasis', 'Retrospective Studies', 'Severity of Illness Index', 'United States', 'Ustekinumab']"
667,"[-0.77953434  0.93544567  0.44535094 -0.5168395  -0.03771736  0.88799345
  0.3879281  -0.33566654 -0.95123017  0.62873375  1.399761   -0.06204426
  0.01482126 -0.40319058 -0.4365137  -0.4619932   0.25972766  0.41028938
 -0.8840645   1.1803155  -0.61131513 -0.7120751  -0.15856515  0.63256305
  0.502798    1.317159   -0.24661937  0.29502672 -0.6752884  -0.73924536]",10.18553/jmcp.2015.21.2.144,"['Bias', 'Humans', 'Netherlands', 'Outcome and Process Assessment, Health Care', 'Pharmacies', 'Quality Indicators, Health Care']"
668,"[-0.37438717  0.4755902   0.29650602 -0.21431509  0.04939925  0.48857525
  0.26456842 -0.09399503 -0.6171464   0.24386871  0.7818682  -0.00950185
  0.07024181 -0.23415965 -0.20406339 -0.24566786  0.1602547   0.32662192
 -0.54451287  0.64176136 -0.29713976 -0.38381448 -0.12663837  0.35648173
  0.2923524   0.6887788  -0.11946444  0.20362474 -0.29599935 -0.5954952 ]",10.18553/jmcp.2015.21.1.66,"['Aged', 'Brazil', 'Cost-Benefit Analysis', 'Developing Countries', 'Diabetes Mellitus', 'Female', 'Health Care Costs', 'Humans', 'Hypertension', 'Male', 'Middle Aged', 'Patient Acceptance of Health Care', 'Pharmaceutical Services', 'Primary Health Care', 'Quality-Adjusted Life Years', 'Treatment Outcome']"
669,"[-0.5090663   0.62672675  0.29833135 -0.27389827  0.0352426   0.62322086
  0.28955778 -0.18629375 -0.6284045   0.34979042  0.90869987 -0.03430565
  0.03129746 -0.28305742 -0.3137923  -0.32658178  0.11341787  0.34392792
 -0.5508395   0.7351317  -0.40557083 -0.47206596 -0.12585695  0.34824184
  0.2835981   0.80388755 -0.09316685  0.19925575 -0.37653735 -0.54120165]",10.18553/jmcp.2015.21.1.37,"['Carcinoma, Renal Cell', 'Female', 'Health Care Costs', 'Health Services', 'Humans', 'Indazoles', 'Indoles', 'Kidney Neoplasms', 'Male', 'Middle Aged', 'Pyrimidines', 'Pyrroles', 'Sulfonamides', 'Sunitinib', 'United States']"
670,"[-0.17397875  0.30564708  0.22080107 -0.2415381   0.04474188  0.33967456
  0.27012613 -0.01942267 -0.59813344  0.10875844  0.63450545 -0.05361902
  0.13601494 -0.07667388 -0.1845267  -0.21367174  0.16073236  0.16455002
 -0.51033694  0.39016578 -0.24932016 -0.30933142  0.02667671  0.19584529
  0.21431614  0.47841343 -0.02143857  0.15018712 -0.16993468 -0.521395  ]",10.3785/j.issn.1008-9292.2015.01.007,"['Animals', 'Apoptosis', 'Arthritis, Rheumatoid', 'Caspase 3', 'Disease Models, Animal', 'Echinops Plant', 'Fibroblasts', 'Flavonoids', 'Rats', 'Rats, Sprague-Dawley', 'Synovial Membrane', 'bcl-2-Associated X Protein']"
671,"[-0.5037025   0.6899254   0.4135162  -0.37559173  0.09999109  0.5882145
  0.3708609  -0.18713881 -0.79854906  0.34007895  0.99504876 -0.04332832
  0.02141665 -0.30569547 -0.33877796 -0.3625786   0.23915815  0.42074686
 -0.7096035   0.87067896 -0.44614613 -0.5637458  -0.05310307  0.4403633
  0.31783324  0.9071268  -0.1508576   0.18769915 -0.36805424 -0.699962  ]",10.18553/jmcp.2015.21.3.220,"['Adult', 'Aged', 'Diabetes Mellitus, Type 2', 'Female', 'Health Care Costs', 'Humans', 'Hypoglycemia', 'Hypoglycemic Agents', 'Insulin', 'Male', 'Managed Care Programs', 'Middle Aged', 'Retrospective Studies']"
672,"[-0.2510792   0.30250594  0.1601108  -0.13630354  0.06979457  0.30645093
  0.16375618 -0.11808763 -0.28841013  0.18842317  0.47488248  0.048955
  0.05043453 -0.17862873 -0.05776058 -0.11713156  0.04112012  0.12693661
 -0.2301578   0.2645496  -0.20677483 -0.15860732 -0.0977459   0.21899778
  0.16789927  0.39243093 -0.01763467  0.10923944 -0.13518076 -0.32569396]",10.18553/jmcp.2015.21.3.229,"['Adult', 'Age Factors', 'Cross-Sectional Studies', 'Databases, Factual', 'Diabetes Mellitus', 'Female', 'Glycated Hemoglobin', 'Humans', 'Hypoglycemic Agents', 'Logistic Models', 'Male', 'Managed Care Programs', 'Medication Adherence', 'Middle Aged', 'Safety-net Providers']"
673,"[-0.5303675   0.7033063   0.5275287  -0.48826894  0.03747434  0.6068874
  0.3333493  -0.2972837  -0.7101936   0.43418598  0.9818234  -0.05330694
  0.11356893 -0.36389834 -0.4122921  -0.35857102  0.23734982  0.39460215
 -0.761541    0.90577376 -0.5323036  -0.5378086  -0.06921616  0.5832671
  0.40189487  0.9670781  -0.19764747  0.3021518  -0.4873715  -0.65226424]",10.18553/jmcp.2015.21.2.110,"['Antihypertensive Agents', 'Humans', 'Hypertension', 'Practice Guidelines as Topic', 'Randomized Controlled Trials as Topic']"
674,"[-0.8574351   0.9799363   0.5400975  -0.5731407   0.08912566  0.9321539
  0.36330026 -0.36939195 -0.8246519   0.670893    1.1327648  -0.04646826
  0.04582357 -0.39998037 -0.48514247 -0.33819315  0.19530594  0.43606564
 -0.8039209   1.0675638  -0.66768366 -0.81685585 -0.0484124   0.76014745
  0.39835614  1.2560166  -0.32618952  0.33916265 -0.64377636 -0.83664465]",10.18553/jmcp.2015.21.1.23,"['Biosimilar Pharmaceuticals', 'Data Collection', 'Drug Approval', 'Humans', 'Pharmaceutical Services', 'United States', 'United States Food and Drug Administration']"
675,"[-0.7964948   0.91893363  0.46551877 -0.6360062   0.05656675  0.7859909
  0.265827   -0.3901688  -0.7555477   0.54110765  1.0285394   0.06809426
 -0.00925616 -0.32531172 -0.39017025 -0.31123745  0.30922577  0.37372148
 -0.7545586   1.000558   -0.5867934  -0.71695715 -0.07887913  0.74666333
  0.5074773   1.1829005  -0.2532412   0.3625277  -0.5703028  -0.7866037 ]",10.1063/1.4906425,[]
676,"[-0.8468133   0.971295    0.5484509  -0.53980386  0.06435323  0.85795426
  0.3423409  -0.41010308 -0.8842624   0.5481804   1.2767754   0.01644535
  0.08270203 -0.42791533 -0.3397592  -0.3259672   0.1681855   0.4060004
 -0.7994978   1.0890273  -0.6515715  -0.6775111  -0.11751689  0.7124022
  0.46545875  1.181421   -0.21620844  0.3132358  -0.56469995 -0.8274283 ]",10.18553/jmcp.2015.21.4.281,"['Blue Cross Blue Shield Insurance Plans', 'Drug Prescriptions', 'Electronic Health Records', 'Humans', 'Insurance Benefits', 'Medicaid', 'Mobile Applications', 'Pharmacy', 'Retrospective Studies', 'United States']"
677,"[-0.16527283  0.27001062  0.13332857 -0.19439259 -0.01121266  0.28921252
  0.18716744 -0.05977783 -0.4742642   0.12865154  0.5348993  -0.00289906
  0.08171397 -0.08573347 -0.14853917 -0.14793898  0.14174022  0.1375016
 -0.41532072  0.31959787 -0.22258613 -0.262587   -0.00316178  0.16935755
  0.1811651   0.39343727 -0.0402633   0.13744989 -0.14692256 -0.45640823]",10.3785/j.issn.1008-9292.2015.01.006,"['Animals', 'Disease Models, Animal', 'Flavonoids', 'Glycyrrhiza', 'Kainic Acid', 'Male', 'Mice', 'Mice, Inbred ICR', 'Mossy Fibers, Hippocampal', 'Neurogenesis', 'Seizures', 'Status Epilepticus']"
678,"[-0.76616675  0.90731835  0.6036225  -0.44333723  0.1293582   1.0142967
  0.5474066  -0.35153994 -1.2278507   0.22719453  1.2206407  -0.25563002
  0.03707357 -0.01155124 -0.4857881  -0.6514152   0.6041015   0.667048
 -1.1456078   1.3008903  -0.61674994 -0.9041426   0.23542823  0.72443914
  0.3936772   1.4506712  -0.2071431   0.598916   -0.57318383 -0.8327397 ]",10.3785/j.issn.1008-9292.2015.01.002,"['China', 'Early Detection of Cancer', 'Humans', 'Stomach Neoplasms']"
679,"[-0.5291593   0.6883863   0.4094942  -0.37783283  0.06626966  0.63947105
  0.32055995 -0.19595806 -0.79769665  0.38631794  0.8747534  -0.09851468
  0.04248844 -0.29925328 -0.32637638 -0.32411054  0.18860549  0.31807387
 -0.6837809   0.7995434  -0.4570844  -0.5657355   0.01153066  0.5054928
  0.3657452   0.86265326 -0.16622889  0.2876852  -0.41644064 -0.7870122 ]",10.18553/jmcp.2015.21.4.288,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Belgium', 'Choice Behavior', 'Consumer Behavior', 'Drug Costs', 'Drugs, Generic', 'Female', 'Health Care Sector', 'Humans', 'Male', 'Middle Aged', 'Nonprescription Drugs', 'Surveys and Questionnaires', 'Young Adult']"
680,"[-0.1031324   0.17584656  0.14958782 -0.16424194  0.01598913  0.23174612
  0.2161434   0.04583268 -0.4486984   0.06991938  0.47990167 -0.00556097
  0.05805207 -0.01509892 -0.14634946 -0.15927437  0.21100028  0.14540508
 -0.413846    0.24138516 -0.16902445 -0.22479203  0.01261033  0.08937535
  0.16656107  0.28737813  0.02836535  0.10104027 -0.10251292 -0.4555233 ]",10.3785/j.issn.1008-9292.2015.01.005,"['1-Methyl-4-phenylpyridinium', 'Acetophenones', 'Animals', 'Apoptosis', 'Caspase 3', 'Cell Survival', 'Down-Regulation', 'Fluoresceins', 'Neuroprotective Agents', 'PC12 Cells', 'Parkinson Disease', 'Proto-Oncogene Proteins c-bcl-2', 'Rats', 'Reactive Oxygen Species', 'bcl-2-Associated X Protein']"
681,"[-0.4955092   0.57137656  0.39892682 -0.34029838  0.03358218  0.47975436
  0.2606846  -0.3019767  -0.5358014   0.40511316  0.70554197 -0.04648183
  0.0020702  -0.23343389 -0.24904592 -0.25353128  0.07604852  0.32263646
 -0.5145116   0.6868015  -0.4523276  -0.4954498  -0.06818476  0.4314792
  0.2710968   0.7231866  -0.1549546   0.2700549  -0.3552043  -0.40362784]",10.1378/chest.14-2714,"['Aged', 'Autoimmune Diseases', 'Case-Control Studies', 'Female', 'Humans', 'Hypothyroidism', 'Idiopathic Pulmonary Fibrosis', 'Illinois', 'Male', 'Radiography', 'Retrospective Studies', 'Risk Factors', 'Survival Analysis']"
682,"[-0.35588092  0.48283717  0.32224825 -0.31989953  0.09001298  0.5080323
  0.3037147  -0.18398684 -0.58785594  0.24651724  0.7122938  -0.04560266
  0.07974101 -0.20432627 -0.26415965 -0.22671913  0.08683895  0.24350034
 -0.51435924  0.55548245 -0.36179492 -0.4383187   0.00097859  0.38494912
  0.2463271   0.6731972  -0.0952477   0.16843185 -0.29343942 -0.49037394]",10.18553/jmcp.2015.21.4.318,"['Adolescent', 'Adult', 'Antirheumatic Agents', 'Arthritis, Rheumatoid', 'Biological Products', 'Cohort Studies', 'Cost-Benefit Analysis', 'Female', 'Humans', 'Insurance Claim Review', 'Male', 'Managed Care Programs', 'Middle Aged', 'Young Adult']"
683,"[-0.06830711  0.13132964  0.11196252 -0.16513507 -0.02008026  0.22567764
  0.20469725  0.02794762 -0.43364453  0.04530727  0.4791448  -0.00760308
  0.09627724 -0.04568624 -0.12414137 -0.12160729  0.17365876  0.13727418
 -0.3834808   0.2231378  -0.17405663 -0.1743153  -0.01678307  0.12177885
  0.1717985   0.25064862 -0.02540713  0.07806254 -0.09043161 -0.41771752]",10.3785/j.issn.1008-9292.2015.01.008,"['Animals', 'Dioscorea', 'Disease Models, Animal', 'Hyperuricemia', 'Male', 'Mice', 'Mice, Inbred ICR', 'Plant Extracts', 'Plant Roots', 'Uric Acid']"
684,"[-0.15929998  0.24893835  0.21055631 -0.21633783  0.05470271  0.294365
  0.2893325   0.03038312 -0.4771902   0.1073512   0.5250915  -0.03717999
  0.09076605 -0.05079904 -0.1578633  -0.16455288  0.24775809  0.16405109
 -0.45239866  0.33160147 -0.1791062  -0.30204353  0.01415128  0.22220486
  0.19537978  0.42424637 -0.0072814   0.15498881 -0.18647458 -0.4521124 ]",Unknown,"['Animals', 'Cryopreservation', 'Cryoprotective Agents', 'Embryo, Nonmammalian', 'Fishes', 'Vitrification']"
685,"[-0.24447246  0.4019621   0.24140835 -0.29070997  0.05475624  0.38525862
  0.302296   -0.0670105  -0.58187526  0.25963116  0.6143319  -0.01134723
  0.07876416 -0.17872165 -0.23702653 -0.19375564  0.19613875  0.21447548
 -0.48954666  0.49408466 -0.2720211  -0.35767072 -0.00109777  0.31133875
  0.28794533  0.54060906 -0.0452735   0.16384917 -0.23498687 -0.5483427 ]",10.18553/jmcp.2015.21.3.210,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Databases, Factual', 'Female', 'Follow-Up Studies', 'Hospitalization', 'Humans', 'Immunologic Factors', 'Infant', 'Male', 'Medication Adherence', 'Middle Aged', 'Multiple Sclerosis, Relapsing-Remitting', 'Natalizumab', 'Retrospective Studies', 'Young Adult']"
686,"[-0.97706884  0.9888241   0.6054641  -0.40835336  0.03314142  0.7259181
  0.16866393 -0.60440093 -0.5246807   0.5771869   0.9771127  -0.0703989
 -0.03983126 -0.34784663 -0.28497988 -0.30854034 -0.02889478  0.44520965
 -0.5091979   1.0263193  -0.55646455 -0.6510858  -0.2758224   0.6213878
  0.27548456  1.0785635  -0.26286942  0.38213512 -0.5211449  -0.46516186]",10.18553/jmcp.2015.21.2.158,"['Adult', 'Aged', 'Antineoplastic Agents', 'Cost of Illness', 'Female', 'Health Care Costs', 'Humans', 'Male', 'Melanoma', 'Middle Aged', 'Neoplasm Metastasis']"
687,"[-0.85068184  1.0065461   0.55090374 -0.6069215   0.04618904  0.87144995
  0.36923215 -0.31574994 -0.84524465  0.65536827  1.2474327   0.07507995
  0.02340363 -0.5752215  -0.3680801  -0.27600366  0.18625769  0.45743856
 -0.8088726   1.0443884  -0.6747761  -0.6826577  -0.16745931  0.7411872
  0.47695005  1.3501756  -0.26392472  0.3161648  -0.53781134 -0.8123774 ]",10.18553/jmcp.2015.21.4.330,"['Accountable Care Organizations', 'Group Practice', 'Humans', 'Medical Order Entry Systems', 'Patient Safety', 'Retrospective Studies']"
688,"[-0.4062904   0.5214177   0.36736944 -0.35299224  0.08546499  0.5081091
  0.2912359  -0.11300637 -0.7336651   0.25153175  0.82399553 -0.03770042
  0.03003026 -0.22620139 -0.256094   -0.29279143  0.23809992  0.37596315
 -0.6644957   0.6939338  -0.34743544 -0.50196004 -0.00464438  0.36906102
  0.2502828   0.7313038  -0.14247486  0.14786851 -0.26860285 -0.6529397 ]",10.18553/jmcp.2015.21.3.243,"['Accidental Falls', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Cohort Studies', 'Cost of Illness', 'Databases, Factual', 'Diabetes Mellitus, Type 2', 'Female', 'Hospitalization', 'Humans', 'Hypoglycemia', 'Hypoglycemic Agents', 'Logistic Models', 'Male', 'Retrospective Studies', 'Risk Factors', 'Time Factors', 'United States']"
689,"[-0.51015663  0.5843444   0.47494808 -0.40123114  0.08231121  0.5590753
  0.40298113 -0.18815902 -0.72641546  0.36554557  0.90541774  0.01301372
  0.06168927 -0.27705118 -0.344726   -0.24457932  0.12749842  0.4620746
 -0.6483564   0.83396673 -0.36669528 -0.4942976  -0.08228725  0.45014533
  0.2946806   0.7161984  -0.16155364  0.22511953 -0.27538875 -0.70744544]",10.18553/jmcp.2015.21.2.165,"['Allopurinol', 'Chronic Disease', 'Cost-Benefit Analysis', 'Febuxostat', 'Gout', 'Gout Suppressants', 'Humans', 'Markov Chains', 'Thiazoles', 'Uric Acid']"
690,"[ 4.1576903e-02 -1.7396845e-02  4.9870349e-02 -4.4051398e-02
  4.0043276e-02  7.2894976e-02  1.4086387e-01  1.0019215e-01
 -2.7074978e-01 -1.7589005e-02  2.7174497e-01 -2.0460557e-02
  7.2662301e-02  1.4309588e-02 -1.9007428e-02 -9.0466283e-02
  1.1462556e-01  9.2166074e-02 -2.1899217e-01  3.7715144e-02
  2.5597803e-04 -6.5827042e-02  5.6336648e-03  1.4250915e-02
  7.2999910e-02  8.2534835e-02  5.3981993e-02  5.2694909e-02
  2.0261539e-02 -2.6637018e-01]",10.3785/j.issn.1008-9292.2015.01.001,"['Hemorrhagic Fever, Ebola', 'Humans']"
691,"[-0.5167319   0.55114055  0.3627196  -0.34470466  0.07125089  0.5503497
  0.2776876  -0.24704938 -0.5260234   0.37869623  0.74644446 -0.03436597
  0.05709018 -0.3237768  -0.19772951 -0.21977097  0.06461213  0.28997442
 -0.4721322   0.62513715 -0.39561698 -0.3706828  -0.15857458  0.4254037
  0.3212837   0.71444273 -0.13361284  0.17156243 -0.31194907 -0.45918554]",10.18553/jmcp.2015.21.3.256,"['Adult', 'Aged', 'Aged, 80 and over', 'Continuity of Patient Care', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Medication Errors', 'Middle Aged', 'Outcome Assessment, Health Care', 'Patient Care Team', 'Patient Discharge', 'Patient Protection and Affordable Care Act', 'Patient Readmission', 'Pharmacists', 'Pharmacy Service, Hospital', 'Retrospective Studies', 'United States']"
692,"[-0.06827576  0.12022752  0.06615797 -0.13421607  0.03710252  0.18130632
  0.15049621  0.01560664 -0.341949    0.05801958  0.42282945 -0.02896512
  0.08204538 -0.00051206 -0.07502163 -0.12451805  0.15437037  0.10770313
 -0.3299451   0.18698433 -0.11051169 -0.14918792  0.02118709  0.08379709
  0.12644398  0.18767297  0.01242511  0.098285   -0.08747842 -0.36925128]",10.3785/j.issn.1008-9292.2015.01.003,"['Alkalies', 'Animals', 'Burns, Chemical', 'Catechin', 'Cornea', 'Corneal Neovascularization', 'Disease Models, Animal', 'Eye Burns', 'Inflammation', 'Mice', 'Mice, Inbred C57BL', 'Neutrophils', 'RNA, Messenger', 'Vascular Endothelial Growth Factor A']"
693,"[-0.13336167  0.20599292  0.14119537 -0.18833409  0.046077    0.28474274
  0.2386232   0.00551886 -0.48046297  0.09712741  0.55767405 -0.01619265
  0.08836161 -0.06014686 -0.14359097 -0.15428637  0.16733344  0.1537136
 -0.44706005  0.30775368 -0.16114978 -0.23247735  0.00970098  0.16676298
  0.17542164  0.36227712 -0.01844598  0.11066259 -0.13122801 -0.49053293]",10.3785/j.issn.1008-9292.2015.01.011,"['Animals', 'Apoptosis', 'Astrocytes', 'Cell Communication', 'Cell Hypoxia', 'Cells, Cultured', 'Gap Junctions', 'Oxygen', 'Rats']"
694,"[-0.19808441  0.2692732   0.2238558  -0.2263953   0.0514923   0.30847758
  0.26692927 -0.03711211 -0.4840243   0.13876796  0.5429168  -0.00376629
  0.06427331 -0.12272767 -0.15769696 -0.1962191   0.14630342  0.18610021
 -0.4422837   0.40393823 -0.21552502 -0.27446955 -0.02975425  0.2147869
  0.19594996  0.43114936 -0.00457299  0.16599032 -0.14811125 -0.44544253]",10.3785/j.issn.1008-9292.2015.01.009,"['Atrial Fibrillation', 'Blood Pressure', 'Humans', 'Retrospective Studies', 'Risk Factors', 'Stroke', 'Thrombolytic Therapy', 'Treatment Outcome']"
695,"[-0.7222874   0.7800203   0.43018842 -0.4003301   0.03409184  0.7382658
  0.33141673 -0.37085837 -0.7112466   0.53350055  0.9061161  -0.05226669
  0.03171006 -0.40097174 -0.28639266 -0.31740242  0.02288485  0.3552105
 -0.56246746  0.8502016  -0.49920142 -0.52175105 -0.20298018  0.5289304
  0.38662195  1.010889   -0.16773553  0.27900395 -0.44616622 -0.55452037]",10.18553/jmcp.2015.21.4.308,"['Antiviral Agents', 'Female', 'Health Care Costs', 'Health Resources', 'Hepatitis C, Chronic', 'Humans', 'Male', 'Middle Aged', 'Oligopeptides', ""Practice Patterns, Physicians'"", 'Proline', 'Retrospective Studies', 'United States']"
696,"[-0.33287805  0.47552097  0.2739367  -0.21380544  0.06141571  0.4460803
  0.15796039 -0.10390583 -0.5592986   0.24045752  0.6860285   0.01170021
  0.04399227 -0.27400187 -0.21682562 -0.20161235  0.12413973  0.21340752
 -0.44636017  0.46369323 -0.33702633 -0.28193867 -0.12537889  0.3091127
  0.27518398  0.6064038  -0.08933105  0.13781776 -0.26609302 -0.4779697 ]",10.18553/jmcp.2015.21.4.298,"['Adult', 'Aged', 'Cohort Studies', 'Cooperative Behavior', 'Emergency Service, Hospital', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Medication Reconciliation', 'Medication Therapy Management', 'Middle Aged', 'Patient-Centered Care', 'Pharmacists', 'Physicians', 'Prospective Studies']"
697,"[-0.93085     1.0628555   0.65683335 -0.6836601  -0.00680263  0.98605204
  0.5051452  -0.47368988 -0.7111221   0.78308934  1.3085648   0.24043399
  0.05197827 -0.64736986 -0.2863444  -0.26233783 -0.05351519  0.55696684
 -0.69910616  1.2644703  -0.6822103  -0.77510834 -0.10162421  0.9196576
  0.39607936  1.1823032  -0.27093944  0.28532457 -0.60163605 -0.6311983 ]",10.18553/jmcp.2015.21.4.269,"['Blue Cross Blue Shield Insurance Plans', 'Chemistry, Pharmaceutical', 'Cost-Benefit Analysis', 'Drug Costs', 'Drug Utilization Review', 'Humans', 'Insurance, Pharmaceutical Services', 'Value-Based Purchasing']"
698,"[-0.203093    0.33825737  0.23506808 -0.24450697  0.03064282  0.36631817
  0.30596742 -0.01635945 -0.5970755   0.15380013  0.6878042  -0.01566932
  0.09312514 -0.10734904 -0.20423104 -0.25164184  0.23533204  0.23200622
 -0.5657995   0.435827   -0.21160194 -0.33891046  0.01210153  0.24448088
  0.24836853  0.5378124  -0.06836245  0.19352855 -0.20610036 -0.5898189 ]",10.3785/j.issn.1008-9292.2015.01.013,"['Hernia, Inguinal', 'Herniorrhaphy', 'Humans', 'Laparoscopy', 'Length of Stay', 'Retrospective Studies']"
699,"[-0.25540036  0.3590847   0.2082557  -0.31493285  0.0481615   0.37036914
  0.30759552 -0.03539811 -0.59633106  0.15553539  0.67439145 -0.03840625
  0.11632648 -0.10268506 -0.22121038 -0.25944924  0.1833009   0.19852212
 -0.5126901   0.46069545 -0.28393394 -0.31651732  0.01405251  0.2440495
  0.23181471  0.49186343 -0.05305833  0.16008255 -0.22389655 -0.572015  ]",10.3785/j.issn.1008-9292.2015.01.004,"['Animals', 'Apoptosis', 'Caspase 3', 'Caspase 9', 'Cell Hypoxia', 'Cell Line', 'Cell Survival', 'Cobalt', 'Down-Regulation', 'Grape Seed Extract', 'Proanthocyanidins', 'Proto-Oncogene Proteins c-bcl-2', 'Reactive Oxygen Species', 'Up-Regulation']"
700,"[-0.4149158   0.2652658   0.9940978  -0.06888061 -0.07943745  0.41379148
  0.6109162  -0.04232408 -1.3330778  -0.07664909  1.1301525   0.36618775
  0.05166708 -0.5318907   0.2913102  -0.8122668   0.6735778   0.26370913
 -1.0870012   0.27050307 -0.17675203 -0.5505332  -0.14145271  0.88741237
  0.6071254   1.082499    0.03268433 -0.01338126  0.25040296 -1.151226  ]",10.1093/jscr/rjad072,[]
701,"[-0.42427337  0.33051565  1.159589   -0.12730958 -0.12163639  0.44859385
  0.7186519  -0.11655304 -1.4257457  -0.11532194  1.0292963   0.1317113
  0.18178734 -0.57683575  0.1875517  -0.80784255  0.81009036  0.29882073
 -1.0792704   0.32927898 -0.2672986  -0.65150315 -0.18364306  0.92384106
  0.52093095  1.2082226   0.07495189  0.12224659  0.1772031  -1.043641  ]",10.1093/jscr/rjad077,[]
702,"[-0.15758923  0.18273717  0.4087317  -0.09217519  0.02732306  0.1711954
  0.31885642  0.04555437 -0.4685256  -0.08421466  0.52906543  0.1668456
  0.05949199 -0.20155546  0.15149134 -0.32720235  0.22333239  0.1081843
 -0.45823207  0.17721316 -0.0247786  -0.19437294  0.00568331  0.3408963
  0.0470149   0.41199744  0.16547465  0.04454556  0.07627176 -0.4287238 ]",10.1177/17562864231154976,[]
703,"[-0.33542672  0.33138537  0.75827646 -0.19530834 -0.04985931  0.3006487
  0.6045232   0.00200983 -0.8564095  -0.14577392  0.8167955   0.21058084
  0.14776601 -0.44076058  0.07628468 -0.5820109   0.47723788  0.19029497
 -0.72116274  0.34078208 -0.09965272 -0.41872904  0.04208874  0.6298477
  0.3361114   0.7202438   0.09774619  0.03669584  0.19299738 -0.6884284 ]",10.1007/s13205-023-03495-1,[]
704,"[-0.20772055  0.26127398  0.5205189  -0.08388039  0.00568827  0.16702035
  0.39836636 -0.00834355 -0.54586405 -0.10335325  0.5966799   0.16271538
  0.09885435 -0.26631862  0.04581477 -0.4097583   0.30389735  0.14784369
 -0.5100006   0.19951758 -0.0527516  -0.24298425  0.02623782  0.47766975
  0.17499629  0.5458436   0.07524912  0.01271415  0.07249373 -0.5364057 ]",10.3389/fendo.2023.1133376,[]
705,"[-0.5095197   0.38150185  1.2926543  -0.28416467 -0.3049417   0.6699717
  0.75747085  0.2942586  -1.9619662   0.01411575  1.2456247   0.5336369
  0.3993154  -0.86245835  0.03019118 -1.0534921   0.48514837  0.03934658
 -1.488803    0.10402863 -0.20774148 -0.5275643   0.01175156  1.2012165
  1.4726009   1.1359603   0.25772524  0.10517362  0.01266244 -1.3513945 ]",10.1117/12.2612578,[]
706,"[-0.19222218  0.20852302  0.54961056 -0.05665493 -0.05258214  0.25657994
  0.29175112  0.02159753 -0.5683488  -0.0436274   0.541391    0.2138661
  0.04322712 -0.26900378  0.08713694 -0.38299036  0.36647663  0.07177102
 -0.5166364   0.23679087 -0.10174628 -0.31226015 -0.04637615  0.46275616
  0.4101275   0.56419027  0.06689065  0.04399662  0.17650878 -0.5323223 ]",10.3389/fendo.2023.1110523,[]
707,"[-0.23519279  0.29863894  0.6202616  -0.10433815  0.03299828  0.26730844
  0.44139102  0.01296315 -0.6603034  -0.12510231  0.73686963  0.22246784
  0.0946597  -0.3019579   0.15509912 -0.48257455  0.34101254  0.13083251
 -0.647861    0.28956252 -0.04525008 -0.31216878 -0.00134209  0.49447435
  0.14256325  0.6329924   0.18121657  0.02613798  0.1556548  -0.6040003 ]",10.3389/fendo.2023.1097139,[]
708,"[-0.2923982   0.45504498  1.5615819  -0.14598012 -0.37155294  0.4320949
  0.96884936  0.00380418 -1.4516256  -0.26913056  0.8625881   0.29388192
  0.11892251 -0.86578894 -0.23291573 -0.6706563   0.99823934  0.39655533
 -0.9886583   0.5946268  -0.12022333 -0.5490331  -0.03861521  1.261291
  1.1336702   1.4438524  -0.03785191  0.01344802  0.35614794 -1.1332321 ]",10.1007/s13205-023-03521-2,[]
709,"[-0.5447366   0.6268337   1.730896    0.06244051 -0.07476504  0.5536662
  0.61486375 -0.1245141  -1.5861261  -0.31017002  1.0092934   0.6718515
  0.4192699  -0.7202581   0.02926653 -0.6317128   0.90025765  0.39348978
 -1.3207344   0.7509491  -0.5673383  -0.96774936 -0.42942932  1.3190451
  1.1789942   1.652545   -0.19588931  0.0354715   0.6174051  -1.4045044 ]",10.3389/fendo.2023.1123928,[]
710,"[-0.43910286  0.2948523   1.3964957  -0.04825711 -0.26023224  0.3419181
  0.6816632   0.04902908 -0.99513566 -0.17376892  0.75764346  0.21898915
  0.3980829  -0.55608606 -0.01665158 -0.686715    0.74082965  0.28838727
 -0.80006456  0.45981678 -0.26068607 -0.42224792 -0.04525325  1.0417224
  0.73713666  1.1110529   0.04915033 -0.04561087  0.25498214 -1.1055366 ]",10.3389/fendo.2023.1127792,[]
711,"[-0.34229758  0.74910223  1.5901661   0.02769806 -0.14785531  0.5502335
  0.5692378   0.00382803 -1.1971639  -0.45418268  0.900903    0.736442
  0.37828535 -0.69805276  0.11734745 -0.7106209   0.46548617  0.54698086
 -0.8420856   0.935155   -0.4256213  -0.76179695 -0.31102204  1.5391917
  0.70609754  1.1639142  -0.2855573  -0.00442214  0.32198536 -1.0880023 ]",10.3389/fendo.2023.1075776,[]
712,"[-0.00071076  0.09197936  0.08614729 -0.03547816  0.03802843  0.05917245
  0.04549299  0.04725488 -0.10859374 -0.02318429  0.27939793  0.08947652
  0.00551111 -0.0062771   0.1603154  -0.09022677  0.07329473  0.04918987
 -0.13464658  0.10795475  0.0180604  -0.04919582 -0.00420981  0.06833724
 -0.14911076  0.08126403  0.11927117  0.05836994  0.00291704 -0.11422424]",10.3389/fendo.2023.1154547,[]
713,"[-0.05897855  0.08503925  0.15150476 -0.04892877  0.06155716  0.05898729
  0.11877123  0.04234796 -0.16525856 -0.05943996  0.35846224  0.10314138
  0.01483995 -0.04184954  0.16765058 -0.1438072   0.11238918  0.07459775
 -0.23396975  0.13486573 -0.0057223  -0.08504846  0.01250442  0.12411642
 -0.10189191  0.17223789  0.16232467  0.05916193  0.0521485  -0.21348713]",10.3389/fendo.2023.1133963,[]
714,"[-0.12351885  0.24650271  0.48792478 -0.03811214  0.01270613  0.252783
  0.3916846  -0.03229338 -0.5563853  -0.02686836  0.65624434  0.14286153
 -0.01783728 -0.18641242  0.24587648 -0.29041314  0.3101174   0.15997098
 -0.44240248  0.21194567 -0.13312854 -0.32587004 -0.08999367  0.30634728
  0.06469972  0.5692426   0.11565973 -0.04400769  0.0631211  -0.52609044]",10.3389/fendo.2023.1089190,[]
715,"[-0.37541202  0.10275049  1.7715827   0.10967255 -0.322893    0.3405259
  0.9037127  -0.01225796 -1.2801237  -0.11300076  0.8756032   0.26842308
  0.40038422 -0.63320124 -0.12107868 -0.6788253   1.0922191   0.4002341
 -0.73284686  0.34469652 -0.29574695 -0.7287673  -0.42959267  1.2534807
  1.1784391   1.615888   -0.16223882 -0.26383573  0.405031   -1.3476839 ]",10.3389/fendo.2023.1070692,[]
716,"[-0.22375973  0.29235813  0.5933721  -0.07065259 -0.02048362  0.18901086
  0.43253416 -0.00583943 -0.74361175 -0.03293804  0.718209    0.1700211
  0.10416877 -0.30010143  0.11259703 -0.4369965   0.39486092  0.2275423
 -0.5928825   0.19083962 -0.11532565 -0.35941306 -0.05315042  0.5275496
  0.20433532  0.62192553  0.10086187  0.07555963  0.06660302 -0.70812994]",10.3389/fendo.2023.1099824,[]
717,"[-0.40062475  0.37040195  1.2385626  -0.16892816 -0.08313486  0.39041135
  0.6994663   0.06822394 -1.0675851  -0.155279    1.0123993   0.31333125
  0.24551128 -0.6207234   0.05449109 -0.7444962   0.61817265  0.28580308
 -0.88486594  0.42501715 -0.17120816 -0.5084467  -0.05695152  1.0340782
  0.59054875  1.1691804   0.1411965  -0.02491437  0.28971002 -0.98208386]",10.3389/fendo.2023.1090906,[]
718,"[-0.00063098  0.07226699  0.07207253 -0.02051997  0.0450957   0.03006932
  0.06192844  0.04995428 -0.08817699 -0.02230342  0.21850443  0.07668938
 -0.00054903 -0.01451545  0.12885934 -0.09160574  0.03521952  0.00883217
 -0.11995914  0.08296344 -0.00909168 -0.02701791 -0.01446925  0.05835325
 -0.10536964  0.078738    0.12076063  0.01919088  0.01662977 -0.11384428]",10.3389/fncel.2023.1132286,[]
719,"[-1.0366218e-01  1.4212546e-01  3.0097386e-01 -8.3500259e-02
  1.8819576e-02  1.0940992e-01  1.5685809e-01  2.5122019e-02
 -3.1664148e-01 -7.3514804e-02  4.2377153e-01  1.3455176e-01
  5.0358087e-02 -1.3333803e-01  1.4180310e-01 -1.8907015e-01
  1.7999002e-01  1.1308089e-01 -3.2793206e-01  1.5529719e-01
 -3.0008443e-02 -1.7357285e-01 -1.7333303e-02  2.1013755e-01
  2.8871821e-04  2.8494453e-01  1.2551895e-01  5.4103188e-02
  6.0479917e-02 -2.9976067e-01]",10.1155/2023/2259534,[]
720,"[-0.81870884  0.15077947  1.4240053  -0.22142279 -0.27938575  0.6898697
  0.83831054 -0.04629779 -1.8883585   0.04102569  1.1646186   0.23808898
  0.4309093  -0.6732904  -0.08094569 -0.74898046  0.98788345  0.375394
 -1.3299569   0.3235116  -0.11846473 -0.9393348  -0.04884987  1.0970266
  0.9865342   1.2323314   0.32434317  0.3024163   0.02696967 -1.3912225 ]",10.3389/fdgth.2023.1078511,[]
721,"[-0.5177137   0.39953065  1.7213724  -0.2461544  -0.00317057  0.40919188
  1.5596046   0.14641131 -1.1435914  -0.32467645  1.1937358   0.28298593
  0.03799629 -1.1200129  -0.29172224 -1.3236891   1.00417     0.34112108
 -0.92553616  0.78553104 -0.33672273 -0.9361618   0.22553588  1.4647671
  1.2956958   2.180196   -0.01269688 -0.33859062  0.2091636  -1.153676  ]",10.3389/fendo.2023.1125693,[]
722,"[-0.387333    0.35725197  0.9510959  -0.16954798 -0.00580397  0.533693
  0.74404085  0.04076574 -1.1524241  -0.12131327  1.0919554   0.21098132
  0.02105173 -0.38943714  0.31893438 -0.5429906   0.6292607   0.28773263
 -0.9056183   0.43097696 -0.13181871 -0.6017604  -0.06966489  0.64202416
  0.18892998  1.0336319   0.31648546  0.0154995   0.0461994  -0.93957305]",10.3389/fpubh.2023.1063466,[]
723,"[-0.53347796  0.8981509   0.7152634  -0.41284287  0.08936885 -0.01305898
  1.0738186  -0.29478353 -1.6256086   0.04105495  1.4591599   0.26955155
  0.07585111 -0.504315   -0.5373816  -1.2484525   0.9843605   0.4397082
 -0.9602777   0.298656    0.2388964  -0.45647308 -0.0666922   1.123577
  0.54929733  1.1863112  -0.0943038   0.31734613 -0.06596871 -1.5087711 ]",10.3389/fpubh.2023.1086439,[]
724,"[-0.19065845  0.21376194  0.6673964  -0.11778925  0.02970835  0.2975996
  0.41027296  0.11250895 -0.56464374 -0.09241124  0.7092065   0.2697258
  0.04626594 -0.27412426  0.22866894 -0.34986973  0.4406017   0.23078051
 -0.52359515  0.2780909  -0.03568001 -0.35231817 -0.02459309  0.4800398
  0.19083257  0.63640106  0.0928082   0.04759895  0.09033839 -0.5688065 ]",10.3389/fpubh.2023.988961,[]
725,"[-0.2556027   0.2999154   0.77103454 -0.14172873  0.00877394  0.3418723
  0.49129036  0.00686124 -0.7250298  -0.09273119  0.8159736   0.25532568
  0.16288137 -0.32020715  0.20057286 -0.4696243   0.43272275  0.25127277
 -0.6520407   0.35037112 -0.16253129 -0.3625345  -0.06308466  0.5573582
  0.15934917  0.7114222   0.16868255  0.0264945   0.14466503 -0.6964025 ]",10.3389/fpubh.2023.1123894,[]
726,"[-0.3032181   0.2789612   0.99215466 -0.13727628 -0.12243141  0.4435223
  0.56308347  0.14985007 -0.92492247 -0.01548345  0.87275034  0.4366572
  0.04721493 -0.4739793   0.19670267 -0.5750573   0.67093414  0.1956004
 -0.64222324  0.3686902  -0.14115171 -0.4264604  -0.10281608  0.6845561
  0.5949117   0.95380765 -0.00235985  0.01844736  0.06013366 -0.83007586]",10.3389/fpubh.2023.1052077,[]
727,"[-0.16578019  0.22167218  0.6810077  -0.12775673 -0.03059476  0.23205562
  0.39305767 -0.03129486 -0.62617654 -0.08497446  0.71478945  0.2196824
  0.0927329  -0.32457176  0.1408075  -0.41693494  0.37250924  0.2267008
 -0.59418416  0.24170478 -0.0841253  -0.32716036 -0.09289504  0.5308393
  0.23767957  0.5916948   0.0963491   0.07966143  0.14855456 -0.6047232 ]",10.3389/fpubh.2023.986550,[]
728,"[-0.3181773   0.3180432   0.74406576 -0.11316776  0.04794557  0.45218813
  0.7017105  -0.00465778 -0.9134515  -0.06539964  0.97188014  0.20042215
 -0.00933876 -0.40459204  0.27217498 -0.55923057  0.5329436   0.25126535
 -0.7196425   0.3719079  -0.10638673 -0.4821112  -0.05376087  0.57841384
  0.15720339  0.864815    0.29019412 -0.0171263   0.11113497 -0.8290079 ]",10.3389/fpubh.2023.1070272,[]
729,"[-0.43824226  0.30446956  0.9722625  -0.11775178 -0.02055977  0.45612207
  0.6483685   0.07328826 -1.1084106  -0.13151623  1.0011675   0.3244098
  0.24742751 -0.42627314  0.20796281 -0.57911396  0.6229599   0.28109434
 -0.9181302   0.45526546 -0.17158103 -0.52198285 -0.05694208  0.80359906
  0.38188943  0.9902719   0.17463809  0.11302654  0.15403286 -1.0075338 ]",10.3389/fpubh.2023.1082979,[]
730,"[-2.99559414e-01  3.75808179e-01  8.67789090e-01 -1.95908621e-01
  1.23541846e-04  3.71692866e-01  7.10328698e-01  3.21834162e-02
 -1.05000305e+00 -2.28824630e-01  1.01543593e+00  3.47244292e-01
  8.02536979e-02 -3.93927068e-01  2.52824068e-01 -6.94409668e-01
  5.30505955e-01  2.40515679e-01 -8.31151307e-01  2.81468064e-01
 -8.37352872e-02 -4.75535721e-01  8.88471082e-02  7.79067457e-01
  3.11330587e-01  8.92605066e-01  1.81952134e-01  2.92189401e-02
  1.13393955e-01 -9.22176182e-01]",10.3389/fpubh.2023.1118522,[]
731,"[-0.19296029  0.3232296   0.9761241  -0.08103295 -0.02962621  0.4080771
  0.54329085  0.05848822 -0.7939122  -0.10912372  0.9578874   0.41076016
  0.0758526  -0.3587794   0.2842293  -0.4617342   0.5940746   0.35216177
 -0.579107    0.4075084  -0.09591822 -0.41303688 -0.16121504  0.7008673
  0.2691228   0.8257656   0.07647311  0.05697336  0.12319604 -0.7675157 ]",10.3389/fpubh.2023.1123736,[]
732,"[-1.3082854e-01  1.9258659e-01  4.0212813e-01 -9.0085752e-02
  3.9941169e-02  2.0331770e-01  2.8203821e-01  2.9458029e-02
 -4.6606511e-01 -6.2667459e-02  5.6578642e-01  1.4276531e-01
  2.4988256e-02 -1.5935032e-01  1.5406682e-01 -2.6668712e-01
  2.5633004e-01  1.6791520e-01 -4.1424075e-01  1.7097236e-01
 -4.9832493e-02 -2.1813098e-01 -5.5507873e-04  3.0205119e-01
  5.1486567e-02  4.0594211e-01  1.4224774e-01  1.9061375e-02
  3.5476837e-02 -4.4019195e-01]",10.3389/fpubh.2023.1102507,[]
733,"[-0.19116192  0.21095878  0.6842303  -0.08690625  0.03204018  0.29359648
  0.38027242  0.02155817 -0.6918362  -0.08255181  0.6520128   0.2548691
  0.11944058 -0.26266494  0.1828234  -0.36069652  0.3731071   0.24034716
 -0.565477    0.31373274 -0.0933129  -0.3423939  -0.03364677  0.54495823
  0.1258195   0.6022719   0.1449721   0.08030947  0.11147407 -0.5853382 ]",10.3389/fpubh.2023.1022616,[]
734,"[-0.09012698  0.12015052  0.23598187 -0.06233962  0.04617837  0.08800129
  0.14250948  0.03159062 -0.27896112 -0.04498446  0.4129294   0.12144971
  0.02932949 -0.06421538  0.14217466 -0.19874953  0.17689735  0.08571653
 -0.29203779  0.14073214  0.00213081 -0.08915254 -0.0113842   0.17738214
 -0.01845348  0.25026956  0.13706945  0.05186278  0.06132646 -0.28532165]",10.3389/fpubh.2023.1129399,[]
735,"[-0.15137406  0.23921874  0.5374148  -0.08580136  0.0508924   0.23722608
  0.35584876  0.03555154 -0.5632266  -0.10709309  0.66281587  0.20586722
  0.05748133 -0.22515954  0.23213069 -0.34885675  0.301658    0.17063862
 -0.54585814  0.26923358 -0.05651945 -0.27863705 -0.0314923   0.41852218
  0.0645327   0.51402515  0.14898834  0.07882077  0.07242946 -0.53239477]",10.3389/fpubh.2023.1077075,[]
736,"[-0.53382844  0.55541915  1.0067648  -0.37536004 -0.25050703  0.44574448
  0.9111853  -0.15372322 -1.3339331   0.09940528  1.394599    0.571661
  0.21344824 -0.69425434 -0.05867195 -1.1055017   1.0927804   0.25208092
 -0.95161647  0.4417245  -0.0686587  -0.68634105 -0.07588344  1.1916165
  1.0584102   1.1872689  -0.3513293   0.2614667  -0.06244757 -1.2512493 ]",10.3389/fpubh.2023.1132908,[]
737,"[-0.27261308  0.3034943   0.87958324 -0.14140734 -0.01614691  0.335533
  0.65467286  0.00089796 -0.8788783  -0.07420898  0.8807623   0.2727707
  0.05105562 -0.49176738  0.0627204  -0.61289936  0.573803    0.21571301
 -0.6925548   0.3992612  -0.1564042  -0.31912848 -0.0494437   0.74999166
  0.4620935   0.8414404  -0.01080035 -0.06429628  0.02902711 -0.8397966 ]",10.3389/fpubh.2023.1047723,[]
738,"[-0.31551838  0.3159776   1.0392972  -0.09292311  0.01558758  0.42455664
  0.66041815  0.04765199 -0.85705674 -0.1103977   0.91643244  0.32350177
  0.08291733 -0.56858385  0.01619884 -0.6231086   0.5951282   0.19229358
 -0.67079604  0.3885268  -0.23699687 -0.38966638 -0.06077719  0.7974748
  0.5464514   1.0707289   0.03212595 -0.00759135  0.08283419 -0.832836  ]",10.3389/fpubh.2023.1130099,[]
739,"[-4.2596221e-02  9.0978645e-02  1.5759626e-01 -3.7693717e-02
  3.7002236e-02  7.7819750e-02  1.0662551e-01  4.8212521e-02
 -1.6552563e-01 -2.6146673e-02  3.0767632e-01  1.1011548e-01
  4.9564638e-03 -3.0623319e-02  1.4885840e-01 -1.0650893e-01
  1.0666984e-01  7.7341922e-02 -1.9674282e-01  1.2249991e-01
  1.5376801e-04 -5.0613549e-02  5.1756445e-03  1.2370905e-01
 -7.9053722e-02  1.6459520e-01  1.2675758e-01  6.9061548e-02
  3.6153454e-02 -1.7936967e-01]",10.3389/fpubh.2023.1144910,[]
740,"[-0.07365989  0.13883835  0.24181986 -0.06005028  0.04908952  0.10218269
  0.17923097  0.03827577 -0.27259693 -0.04151636  0.42759398  0.11949679
  0.05388956 -0.08725372  0.17203505 -0.1903752   0.15650785  0.06892477
 -0.3203274   0.16116284 -0.02545551 -0.09965785 -0.0153252   0.20134033
 -0.07561348  0.26211902  0.15364467  0.05240444  0.04852856 -0.26621515]",10.3389/frma.2023.1146039,[]
741,"[-0.5822414   0.49702582  1.431223   -0.22194277 -0.09961787  0.6214084
  0.9706753  -0.05042109 -1.5871944  -0.08288559  1.1888018   0.2641177
  0.08425193 -0.5500099   0.09563214 -0.8866133   0.8229711   0.45792794
 -1.246907    0.548392   -0.31777442 -0.713494   -0.15618245  1.1680962
  0.69857246  1.3923112   0.17164902  0.02203611  0.14591026 -1.395843  ]",10.3389/fpubh.2023.1073581,[]
742,"[-0.37189922  0.39646384  0.9503419  -0.13361453 -0.03667424  0.37913594
  0.65179265  0.08222397 -0.9303934  -0.12329924  0.9300984   0.3115027
  0.14546885 -0.44720066  0.16539231 -0.638301    0.6088908   0.33080783
 -0.87185955  0.4517133  -0.14343211 -0.4351128  -0.06989942  0.8187948
  0.37155944  1.0006859   0.1520515   0.14452803  0.01151961 -0.8790335 ]",10.3389/fpubh.2023.1030391,[]
743,"[-0.22855921  0.21795696  0.6466678  -0.09971727 -0.00151565  0.27065143
  0.35279024  0.0767215  -0.65486014 -0.09615236  0.6889203   0.29253435
  0.07867614 -0.26343563  0.2825618  -0.33638403  0.33783087  0.22189635
 -0.6430726   0.2256255  -0.11623073 -0.3969808  -0.02596856  0.44044694
  0.15635781  0.54273367  0.07214714  0.0929876   0.14623146 -0.55279154]",10.3389/fpubh.2023.1073612,[]
744,"[-0.26804468  0.2620726   0.8339724  -0.07230975  0.01962838  0.38623467
  0.49493957  0.06992473 -0.87624073 -0.04798207  0.91976976  0.31017125
  0.03113158 -0.3300445   0.2118091  -0.4885078   0.5713604   0.2856294
 -0.70688087  0.38039374 -0.0498306  -0.5132617  -0.06392168  0.62164676
  0.30703026  0.76329356  0.17659116  0.06640349  0.10300986 -0.78088915]",10.3389/fpubh.2023.1136596,[]
745,"[-0.9837639   0.19215427  1.9808825  -0.15595815 -0.3142273   0.6369899
  0.6447448   0.17796554 -1.6044285  -0.20103806  1.1403606   0.47697446
  0.5882336  -0.41769603  0.28033945 -0.9463324   1.1266497   0.28871349
 -1.5249156   0.7925829  -0.39469528 -0.4872014   0.06340979  0.96956855
  0.5334749   1.3975731   0.58834285  0.13966548  0.16645756 -1.6802183 ]",10.1016/j.dib.2023.108948,[]
746,"[-0.2584674   0.4361534   1.105905   -0.10977297  0.00511857  0.49951378
  0.64638174  0.09243619 -1.0779153  -0.07287357  1.0600764   0.5175761
  0.10192803 -0.49377528  0.28452203 -0.66608125  0.7436152   0.36734942
 -0.9682472   0.48778203 -0.08766749 -0.5623621  -0.10638262  0.84945077
  0.38234785  1.0315357   0.16251333  0.10474003  0.21289922 -1.0816886 ]",10.3389/fpubh.2023.1079877,[]
747,"[ 0.04430084  0.0314781  -0.0212895  -0.02062676  0.07039668 -0.01725733
 -0.05021165  0.03975821  0.01242736 -0.00022713  0.12481783  0.03466935
 -0.00099139  0.05200592  0.12164285  0.00948718 -0.01913956  0.01774753
 -0.06105019  0.00784642  0.0453064  -0.0109664  -0.00549682 -0.04075126
 -0.17862335 -0.03766947  0.11059533  0.06726025  0.01478658 -0.03554904]",10.1016/j.dib.2023.108968,[]
748,"[-0.11226064  0.22536917  0.41307393 -0.10338983  0.04053914  0.1603298
  0.27753314 -0.00173547 -0.4282345  -0.0786863   0.52918637  0.16000728
  0.0973798  -0.21468824  0.10685002 -0.31766438  0.21510674  0.16463067
 -0.38338986  0.15517052 -0.0127753  -0.20735233  0.0312466   0.36121252
  0.05901955  0.38651657  0.08754019  0.04252466  0.10608441 -0.4141946 ]",10.3389/fpubh.2023.1015202,[]
749,"[-0.25887448  0.2667221   0.8386594  -0.11781958 -0.08175893  0.30250785
  0.5554232  -0.01261071 -0.8220555  -0.12399916  0.69348764  0.176232
  0.18598455 -0.43268323  0.06308435 -0.49863285  0.4414585   0.17697449
 -0.67487043  0.30724293 -0.11351936 -0.338837   -0.0018535   0.69952893
  0.38139254  0.79899544  0.08693922  0.03354996  0.16890353 -0.7223374 ]",10.1155/2023/5262729,[]
750,"[-9.48939696e-02  1.63881525e-01  2.94347882e-01 -6.11765012e-02
  2.38489415e-02  1.17538631e-01  2.06561148e-01  2.57792454e-02
 -3.57110947e-01 -5.20848036e-02  4.36827093e-01  1.27266511e-01
  5.23353815e-02 -1.22807674e-01  1.35445863e-01 -2.17705041e-01
  1.91442207e-01  1.23752855e-01 -3.50673437e-01  1.52846679e-01
 -1.74064487e-02 -1.48951471e-01 -1.93322934e-02  2.37550229e-01
 -7.37883529e-05  3.20042819e-01  1.51874587e-01  5.97695187e-02
  5.83264790e-02 -3.49168479e-01]",10.3389/fpubh.2023.1133330,[]
751,"[-0.6351599   0.448178    1.2040796  -0.31729743  0.07865296  0.4024511
  0.8445755   0.15091935 -1.4028393  -0.15277943  1.4109584   0.46225926
  0.03121815 -0.5667448   0.32407734 -0.8467904   0.6586602   0.17190829
 -1.1261969   0.43378037 -0.20321031 -0.67744833  0.1246545   1.0137888
  0.43384367  1.2905266   0.29909098  0.11016433  0.22866336 -1.3143951 ]",10.1016/j.dib.2023.108972,[]
752,"[-0.0315459   0.08631099  0.10289153 -0.01155935  0.01818018  0.05346666
  0.04449383  0.03735407 -0.11877529 -0.01625926  0.20697328  0.06022123
  0.01072829 -0.0186486   0.10230359 -0.07069355  0.05911302  0.03664669
 -0.13544889  0.07499663 -0.01832082 -0.06917732 -0.01862868  0.08830545
 -0.04059734  0.10118643  0.06339491  0.05385525  0.01080377 -0.12585871]",10.1016/j.dib.2023.108977,[]
753,"[-0.0505772   0.09612618  0.11717232 -0.04534018  0.04506845  0.04490297
  0.04383487  0.02570808 -0.17996499 -0.01677665  0.25464705  0.09713469
  0.01640485 -0.02557361  0.13989106 -0.08678506  0.06630687  0.06505657
 -0.19693772  0.08113662  0.00540336 -0.05430737 -0.02456987  0.05971618
 -0.07588784  0.11457718  0.10481054  0.06478138  0.02628124 -0.164795  ]",10.1016/j.dib.2023.108950,[]
754,"[-0.539309    0.42719916  1.2742932  -0.3198745  -0.08737933  0.37672362
  0.80894685 -0.01271738 -1.3776847  -0.22260241  1.3031338   0.49195713
  0.19752628 -0.57410717  0.10665718 -0.7351562   0.8121944   0.34172425
 -1.1722516   0.39603117 -0.11974087 -0.6086443   0.02610282  0.9900994
  0.6668825   1.1128626   0.02971068  0.07833795  0.2674071  -1.2830068 ]",10.1016/j.dib.2023.108984,[]
755,"[-0.6474173   0.5253426   1.1727959  -0.17598765 -0.03674442  0.4917903
  0.9480396  -0.05833635 -1.4675905  -0.21232492  1.4138948   0.32039455
  0.1664611  -0.58542985  0.03269857 -1.0816101   0.7501974   0.35278004
 -1.1249985   0.3612285  -0.04409806 -0.44380987  0.03616579  1.130543
  0.5403178   1.229655    0.27804062  0.12036848  0.17903763 -1.5139493 ]",10.1016/j.dib.2023.108961,[]
756,"[-0.51978576  0.36757496  1.4198271  -0.16253687 -0.1215182   0.48286837
  1.0396531   0.01258786 -1.5508484  -0.09960618  1.2115752   0.4145609
  0.31668732 -0.70263946 -0.00393855 -0.95707095  0.7510973   0.37477642
 -1.184343    0.45922196 -0.18071772 -0.46092156 -0.09444156  1.1382958
  0.76200795  1.3058491   0.15477298 -0.05047351  0.25055036 -1.279997  ]",10.1016/j.dib.2023.108957,[]
757,"[-0.90651953  0.75051564  1.0358069  -0.4633771  -0.18195564  0.92078316
  1.0754876   0.02774532 -3.0108206  -0.6876124   1.4405115   0.22570258
  0.15789796 -0.91983646 -1.1201428  -0.88189465  0.49584058 -0.4438321
 -1.8907902  -0.26222932 -0.87525684  0.19213052  1.2443423   2.189025
  3.565196    0.797395   -0.17270553 -0.28086302  0.253534   -2.0430794 ]",10.1016/j.dib.2023.108979,[]
758,"[-0.11542969  0.2485183   0.57718045 -0.0859787   0.09134685  0.33089408
  0.43113485  0.05171265 -0.5915578  -0.07870588  0.7430529   0.19720757
 -0.03020852 -0.27822587  0.23858316 -0.33382538  0.35727292  0.23916103
 -0.48889118  0.2547403  -0.10482723 -0.31072178 -0.06242371  0.3930785
  0.1358953   0.6156926   0.16952522 -0.01923885  0.03404344 -0.58224857]",10.1080/21642850.2023.2182306,[]
759,"[-0.5603103   0.37442097  1.4581705  -0.10940658 -0.08524837  0.5093228
  0.6246981   0.04959027 -1.3591824  -0.0910555   1.1624144   0.50407475
  0.42024508 -0.69030845  0.1637909  -0.82414144  0.71654344  0.2612383
 -1.1042676   0.51980215 -0.26967558 -0.55828685 -0.14294246  1.1876178
  0.71580493  1.2613773   0.14899518  0.10297266  0.3990148  -1.2602332 ]",10.1177/11769351231154679,[]
760,"[-0.2444098   0.34024903  1.0891871  -0.18706343 -0.05415366  0.44047293
  0.67310977  0.01987864 -1.0358746  -0.13156709  1.0933298   0.3951302
  0.15018494 -0.5621009   0.19563115 -0.69617784  0.61660564  0.3762151
 -0.86305285  0.40147838 -0.08253162 -0.5253939  -0.01247004  0.8691365
  0.29907662  0.8992272   0.12460665  0.03701696  0.18299711 -0.92658067]",10.1080/21642850.2022.2156345,[]
761,"[-1.040976    0.03034111  1.9758936   0.28863192 -0.33404657  0.6377176
  1.2547059   0.18159531 -2.5407035   0.5219921   0.8179405   0.43795153
  0.8749016  -0.9644693  -0.04322391 -1.6464367   0.88373804  0.2051312
 -1.3275424   0.39733082 -0.27698377 -0.780942   -0.6546764   1.0193561
  1.2247137   1.4982781   0.3069716   0.540536    0.23588464 -1.4549768 ]",10.1155/2023/6880172,[]
762,"[-0.24344943  0.19988534  0.60403585 -0.05508703  0.05836951  0.30195165
  0.44639307  0.08387708 -0.7488566  -0.06604718  0.7387166   0.19241644
  0.04587643 -0.26764184  0.21526359 -0.4124259   0.42371312  0.24852638
 -0.6774462   0.29368445 -0.04326661 -0.40740582 -0.00866903  0.46001
  0.15360181  0.6113892   0.17890146  0.07019764  0.02852748 -0.62093025]",10.1016/j.eucr.2023.102357,[]
763,"[-0.53635937  0.4057217   1.1009377  -0.210599   -0.03188407  0.43128374
  0.9433609  -0.19922164 -1.5417979  -0.06531837  1.1522257   0.29902384
  0.2844511  -0.48786542 -0.21784991 -1.0164059   0.89528984  0.3618768
 -1.0812165   0.29920757 -0.12181839 -0.38872716 -0.01882748  1.0376756
  0.7033319   1.0998498   0.19994159  0.18798672  0.03895148 -1.4216632 ]",10.1016/j.dib.2023.108962,[]
764,"[-0.21299364  0.20128192  0.4974732  -0.07886686  0.02768345  0.2636943
  0.2998884   0.07636264 -0.5914863  -0.04369456  0.6836541   0.20552053
  0.08776453 -0.17387526  0.26917592 -0.35227242  0.30074564  0.14237352
 -0.54148257  0.24535681 -0.06369504 -0.26248512 -0.02380748  0.3421333
 -0.02530104  0.49598423  0.21010669  0.12170586  0.05740616 -0.48393676]",10.1093/jamiaopen/ooad010,[]
765,"[-0.7082378   0.07981617  1.3826159  -0.2617814  -0.06617305  0.3810918
  0.8459226  -0.03111649 -1.307475    0.04157823  0.93602854  0.46101913
  0.45379615 -0.47731677 -0.22134851 -0.85991853  0.7446043   0.30462295
 -1.2283007   0.61443114 -0.14759517 -0.41795754 -0.15845247  1.2152557
  0.77524126  1.2917819   0.21054599 -0.08243825  0.3656588  -1.2298746 ]",10.1155/2023/6090282,[]
766,"[-0.98044     0.24010287  1.8554662  -0.2727689  -0.20174125  0.68754375
  1.2556686   0.3589631  -1.67765     0.03234769  1.2360917   0.35486028
  0.30770695 -0.74205905 -0.06463536 -1.3568949   0.653744    0.00639717
 -1.6336164   0.44194013  0.07226105 -0.7703703  -0.02945708  1.0676569
  1.2482834   1.8396208   0.20004056 -0.03827444  0.4243153  -1.5178815 ]",10.1155/2023/1263620,[]
767,"[-0.32889044  0.31355613  1.2917861  -0.1217971  -0.31959707  0.38715917
  0.7887552  -0.09400075 -1.5261931  -0.1289427   1.0879803   0.35597453
  0.15690693 -0.63605404  0.152789   -0.9122598   0.8695862   0.2917749
 -1.1227806   0.5289984  -0.1265765  -0.6037959  -0.07342695  1.0518936
  0.86820537  1.2696449  -0.12630235  0.19178002  0.2810722  -1.1902184 ]",10.1093/rb/rbad005,[]
768,"[-0.41661355  0.36087456  1.000132   -0.16830581 -0.03617259  0.41822195
  0.73571396  0.03924836 -1.2047552  -0.15087487  1.0563344   0.25128758
  0.13828549 -0.50856805  0.18363413 -0.78351605  0.6337509   0.32523385
 -1.0181258   0.44892102 -0.10390998 -0.58666354 -0.1079185   0.83191174
  0.41341537  1.074139    0.18213755  0.05888947  0.10534257 -1.093328  ]",10.1016/j.eucr.2023.102341,[]
769,"[-0.0357511   0.12350717  0.213449   -0.05790995  0.0553707   0.0865059
  0.11444436  0.04436501 -0.20952311 -0.05011775  0.36431205  0.13170673
  0.06753801 -0.06490331  0.18243201 -0.15012562  0.11796264  0.09513325
 -0.2535669   0.11856218 -0.01210319 -0.14035232  0.00316865  0.15407193
 -0.10423597  0.18509318  0.1313131   0.08692343  0.05818354 -0.20328876]",10.1155/2022/7693468,[]
770,"[-0.10467135  0.16502655  0.38390955 -0.04705095  0.0474736   0.10746476
  0.19166148  0.02816935 -0.36833513 -0.11157233  0.39515805  0.17017148
  0.11463327 -0.142582    0.11908016 -0.20099474  0.14726435  0.12629665
 -0.35041422  0.17762038 -0.09349832 -0.19845863 -0.03879704  0.29134825
  0.05554903  0.31175023  0.07776299  0.02922102  0.10515156 -0.33622536]",10.1155/2022/2640479,[]
771,"[-0.24665116  0.4786284   0.9913948  -0.10404044 -0.00265011  0.36199522
  0.55000806  0.07964247 -0.9282596  -0.22402838  0.8734741   0.29585585
  0.26666626 -0.5037659   0.22498378 -0.5535489   0.3805523   0.3199118
 -0.75135213  0.4007103  -0.16410428 -0.47917646  0.01900494  0.81603616
  0.22149634  0.821528    0.07162987  0.05613665  0.2825231  -0.7601041 ]",10.1155/2022/6082343,[]
772,"[-0.80349797  0.18622462  1.0025061  -0.4155552   0.27484098  0.2630159
  2.1141918  -0.00754665  0.03971172 -0.4752563   1.5185051   0.5062301
  0.54665774 -1.3254031  -0.34620622 -1.5544062   0.70286    -0.3862569
 -0.69223773  0.85468364 -0.40951374  0.27760825  0.6956184   1.7838428
 -0.00692135  1.5025455   0.589586   -0.91698396  0.46260458 -0.3497792 ]",10.1155/2022/4355182,[]
773,"[-0.20787495  0.2733447   0.5570875  -0.16099638  0.06247034  0.17776333
  0.39446166 -0.00408861 -0.34861606 -0.1210937   0.59723115  0.14838345
  0.2363562  -0.31821662  0.09188765 -0.37360802  0.2153174   0.17178848
 -0.45195222  0.26908106 -0.12405843 -0.18449454  0.03232609  0.51701075
 -0.0567592   0.4358624   0.21492283 -0.09839401  0.19345589 -0.33529985]",10.1155/2022/9242188,[]
774,"[-0.19648899  0.28182033  0.63333225 -0.2245094   0.04979005  0.18949804
  0.32530507  0.02138936 -0.3528749  -0.14334309  0.64404786  0.2030123
  0.27884832 -0.28193682  0.18233511 -0.2935463   0.2051557   0.25997734
 -0.47634318  0.24532424 -0.06199577 -0.3070413   0.09236165  0.52389324
 -0.14115644  0.503678    0.12289561 -0.02646365  0.22377339 -0.36083668]",10.1155/2022/9344478,[]
775,"[-0.30206302  0.27248338  0.87158716 -0.18068708  0.01103567  0.35024905
  0.5069776   0.04977423 -0.8675443  -0.11551184  0.871618    0.27285922
  0.2188279  -0.4001188   0.25002813 -0.50481254  0.4683875   0.24989083
 -0.76191175  0.29026687 -0.09818759 -0.42170483  0.03793801  0.72819906
  0.17348701  0.8066866   0.21672797  0.05563671  0.18809716 -0.7175143 ]",10.1155/2022/3499061,[]
776,"[-0.25166282  0.3090286   0.703741   -0.18308127  0.00488812  0.22131462
  0.39893776 -0.02380425 -0.41666213 -0.10967289  0.5958646   0.16359082
  0.2982278  -0.33673632  0.08340468 -0.38034967  0.25070292  0.17955834
 -0.47470617  0.304416   -0.12558271 -0.24315253  0.00873496  0.6328345
  0.03832996  0.5904414   0.1231998  -0.04126209  0.18458629 -0.3912769 ]",10.1155/2022/3288139,[]
777,"[-0.24471252  0.44158733  0.8726918  -0.29903835 -0.06500904  0.27642766
  0.3039768  -0.04418534 -0.6655255  -0.19071579  0.8001717   0.1727428
  0.3738776  -0.3540072   0.21861619 -0.33512503  0.2985194   0.14425945
 -0.64014626  0.21162845 -0.09887577 -0.4425018   0.08391173  0.68001163
  0.06529524  0.6041947   0.14615953  0.00622954  0.24110296 -0.6283059 ]",10.1155/2022/5715649,[]
778,"[-1.1655113   0.44846135  1.3179252  -0.4185825  -0.28009444 -0.02302887
  1.5509634   0.20945112 -2.4363453  -0.7859468   1.312379    0.04245206
  0.38668993 -0.5049364  -0.07602976 -0.0553508   0.48592198  1.8228761
 -2.4027987   0.8755007  -0.10699917 -1.7009372   0.6505671   0.69107306
 -0.3194289   1.4873042  -0.24005866  0.23951083  0.26770157 -1.0487512 ]",10.1155/2022/4330251,[]
779,"[-0.09488393  0.14529374  0.32733494 -0.06600784 -0.0025995   0.10403118
  0.20044544  0.01357536 -0.26333708 -0.04769988  0.37449628  0.08478013
  0.1192743  -0.15015435  0.08076494 -0.19012986  0.14815444  0.11500766
 -0.29730406  0.14857876 -0.04223031 -0.15173574  0.01274742  0.27544162
 -0.00398082  0.28611323  0.11194251  0.01330732  0.09382639 -0.26572993]",10.1155/2022/8446092,[]
780,"[-0.04780315  0.09136192  0.1316537  -0.10103644  0.06181373  0.01157916
  0.10068458  0.05669057 -0.15867    -0.05761411  0.3280496   0.08048736
  0.04155999  0.00161901  0.15260398 -0.0832907   0.03701292  0.16312782
 -0.25536945  0.08606071  0.03856711 -0.13807233  0.04116696  0.01580391
 -0.27770716  0.13073196  0.14382882  0.07697452  0.05830404 -0.12195817]",10.1155/2022/6746201,[]
781,"[ 0.03846024  0.06396325 -0.00512021 -0.03635556  0.07481746  0.04070729
 -0.07872918  0.01862576  0.00787736 -0.0086987   0.16200085  0.07257679
  0.00224187  0.04608489  0.21066476  0.01353519 -0.03731012  0.0657498
 -0.0794732   0.04353652  0.00472967 -0.05601238 -0.03045445 -0.04712154
 -0.23167105 -0.0405548   0.11125927  0.07829142  0.02296887 -0.01670659]",10.1155/2022/9858983,[]
782,"[-0.2327782   0.32063475  0.7588226  -0.2281422   0.04947796  0.2571475
  0.5325675  -0.01002777 -0.64026415 -0.1645442   0.8880465   0.21933354
  0.19312283 -0.42717293  0.14987199 -0.5356472   0.32862929  0.2520086
 -0.6518634   0.28092057 -0.13487278 -0.33182117  0.04857744  0.62714607
 -0.01241682  0.6598329   0.2446873   0.00174815  0.18891555 -0.553373  ]",10.1155/2022/1866142,[]
783,"[-0.3956244   0.40114397  1.003168   -0.17222959 -0.02521443  0.397596
  0.5378215  -0.02543882 -0.89304453 -0.15121737  0.91790783  0.3161462
  0.3875318  -0.48339123  0.18585432 -0.57646304  0.48786217  0.3290119
 -0.8299197   0.42296034 -0.14879343 -0.49325073  0.01271722  0.90061045
  0.20650147  0.8114148   0.13605718 -0.00285194  0.25530103 -0.8322776 ]",10.1155/2022/2355274,[]
784,"[-0.26819846  0.23645198  0.59454256 -0.20883268  0.15131918  0.23963898
  0.579997    0.07092648 -0.5368563  -0.1414623   0.80715567  0.20310691
  0.10012106 -0.40611807  0.17414017 -0.5448902   0.2683689   0.10321668
 -0.57919246  0.25743476 -0.0515868  -0.28748485  0.17101672  0.52058077
 -0.12496709  0.68185574  0.37309057 -0.04355336  0.17038041 -0.4980064 ]",10.1155/2022/1053556,[]
785,"[-0.35130543  0.33823687  0.89485276 -0.27622196  0.15142365  0.3631416
  0.85402375  0.02435536 -0.91180646 -0.22687297  1.1907876   0.3090591
  0.16931088 -0.59700584  0.15912937 -0.7384543   0.525513    0.22136779
 -0.9028149   0.3936264  -0.12217914 -0.43412402  0.15691207  0.8128711
  0.03009563  0.9067565   0.41454858 -0.03288647  0.24864933 -0.79236263]",10.1155/2022/4717014,[]
786,"[-0.24600656  0.43037662  0.85990494 -0.27013826 -0.01351977  0.2973408
  0.43666765 -0.09840753 -0.5491425  -0.21734445  0.8544374   0.15526444
  0.33030987 -0.45646128  0.19221324 -0.41491967  0.28322703  0.21177845
 -0.6321265   0.2443445  -0.06477746 -0.43084538  0.07478913  0.75898105
 -0.05808198  0.62810075  0.1143553  -0.14672628  0.31331256 -0.5388117 ]",10.1155/2022/2677885,[]
787,"[-0.16666622  0.33846748  0.60214394 -0.11448779  0.02963159  0.17526032
  0.25904974  0.04150822 -0.48803833 -0.1324263   0.6197625   0.28341886
  0.19339348 -0.2450904   0.24585038 -0.31236959  0.16521285  0.21876657
 -0.4346818   0.27681324 -0.09950499 -0.3100647  -0.04093303  0.49544454
 -0.06108662  0.45377204  0.11163052  0.05018446  0.18377152 -0.43453443]",10.1155/2022/4034922,[]
788,"[-1.02173015e-01  9.61958840e-02  2.58451641e-01 -6.54023811e-02
  3.72381735e-04  5.17977476e-02  2.09597185e-01  2.73792706e-02
 -3.46717864e-01 -9.16983932e-02  3.77813071e-01  7.59102926e-02
  4.13488150e-02 -1.14879839e-01  7.96706155e-02 -1.82471424e-01
  1.44385964e-01  1.18683048e-01 -3.81653190e-01  1.16784111e-01
  1.09694898e-02 -1.63070396e-01  4.09071967e-02  1.50574401e-01
 -5.78256808e-02  2.63021827e-01  7.97546580e-02  7.24265426e-02
  9.50846896e-02 -2.30629653e-01]",10.1155/2022/6992682,[]
789,"[-0.27056924  0.49308458  0.95000595 -0.14731763  0.02517238  0.31246287
  0.57483125  0.06778378 -0.89555913 -0.18209307  0.94139653  0.33100447
  0.2697157  -0.5288962   0.2236408  -0.55743754  0.3739469   0.25729948
 -0.78028995  0.40881002 -0.08525039 -0.4824083  -0.01599211  0.7983888
  0.20655796  0.8012653   0.1290824   0.03653183  0.3092921  -0.8186525 ]",10.1155/2022/8016616,[]
790,"[-0.21188739  0.29719445  0.6213197  -0.20251408  0.09709024  0.22292405
  0.43361625 -0.05444674 -0.3855955  -0.13594453  0.67462426  0.1789112
  0.25786346 -0.35871506  0.18411767 -0.43900648  0.25016895  0.20224303
 -0.47673038  0.26862893 -0.11786985 -0.22790936  0.07339956  0.5739105
 -0.14032167  0.5403764   0.21929839 -0.07377504  0.21111706 -0.41824356]",10.1155/2022/8529556,[]
791,"[-0.6056537   0.91136783  1.3803924  -0.60205674  0.15221803  0.3668805
  1.1641653  -0.3921047  -0.64848226 -0.21871124  1.5064199   0.04065201
  0.80658925 -1.2804269   0.3510388  -1.04649     0.29594353 -0.07587434
 -1.1611977   0.10980785 -0.102036   -0.6511356   0.4752562   1.3707654
 -0.35528538  1.1674738   0.10541403 -0.34279206  0.4995294  -0.62089485]",10.1155/2022/2337933,[]
792,"[ 0.03836967  0.02866865  0.01426549 -0.02856564  0.04184489  0.00022317
 -0.06854262  0.01200596  0.00213289 -0.02826544  0.11134325  0.03282354
 -0.01533963  0.05199613  0.14218764  0.04763993 -0.02561702  0.04598809
 -0.06491777  0.02390705 -0.01017258 -0.06387919 -0.01237475 -0.03189243
 -0.20631455 -0.02944253  0.09622084  0.06898346  0.02562443 -0.0052407 ]",10.1155/2022/1861761,[]
793,"[-0.11946326  0.17819728  0.46439698 -0.1208322   0.05901906  0.23010217
  0.27454364  0.01390054 -0.45066157 -0.1016172   0.581854    0.15872777
  0.07924239 -0.21821599  0.2584173  -0.2701275   0.2382071   0.16952787
 -0.49226058  0.1862949  -0.01279937 -0.2875098   0.00722661  0.32293922
 -0.07794334  0.4527793   0.20592436  0.03049375  0.1054566  -0.41912478]",10.1155/2022/7509382,[]
794,"[-0.04481359  0.22238605  0.3325065  -0.08709059  0.07812318  0.08732287
  0.08409075  0.0161891  -0.14967662 -0.1170724   0.3294937   0.17514303
  0.18026304 -0.14068855  0.21076417 -0.11656343  0.02417085  0.1700539
 -0.21885303  0.20760459 -0.0961326  -0.16635628 -0.03298187  0.2959059
 -0.1784558   0.185845    0.06782215  0.02676036  0.14137459 -0.14789952]",10.1155/2022/2222029,[]
795,"[-0.06776847  0.12668471  0.29211432 -0.09509564 -0.00192769  0.0714274
  0.16425993  0.02461313 -0.21038502 -0.06042683  0.29381505  0.10969076
  0.08223993 -0.14306128  0.04399385 -0.15907864  0.13093147  0.07606965
 -0.24869221  0.1401522  -0.03634887 -0.10032686 -0.00978881  0.23322643
  0.06851139  0.25872445  0.03585148  0.02631233  0.10236063 -0.22570904]",10.1155/2022/8947997,[]
796,"[-0.04055718  0.18785177  0.24599153 -0.07145549  0.035707    0.06232747
  0.11699924  0.02559412 -0.1079085  -0.10050172  0.26779634  0.10407952
  0.10643397 -0.13817813  0.07112712 -0.13219066  0.02820697  0.09313375
 -0.13534923  0.15121353 -0.05095793 -0.08010816 -0.0178293   0.26565695
 -0.09782581  0.2051268   0.03734327 -0.01023383  0.11884262 -0.14406112]",10.1155/2022/4347466,[]
797,"[-0.33268845  0.42167002  1.0414371  -0.26953763  0.00678837  0.34102887
  0.7420186   0.00804986 -0.7390921  -0.20086814  1.002128    0.26186624
  0.27867863 -0.5649568   0.12744045 -0.7202387   0.44826415  0.21216902
 -0.73313475  0.34910423 -0.0534422  -0.40627393  0.10837226  0.83744156
  0.12492127  0.94128644  0.20777433 -0.12985595  0.3474008  -0.6899318 ]",10.1155/2022/8517733,[]
798,"[-0.1256817   0.3533474   0.71085316 -0.19173904 -0.03889785  0.21941243
  0.2948847  -0.00800125 -0.5471514  -0.11159184  0.6156011   0.23697263
  0.21482989 -0.33049008  0.21737112 -0.33630654  0.30984157  0.25767502
 -0.50948083  0.23334005 -0.10890264 -0.3670561  -0.10045288  0.5381039
  0.08094539  0.5370019  -0.01390136  0.07937635  0.2086977  -0.44531652]",10.1155/2022/6173245,[]
799,"[-0.57055503  0.51276594  1.3215915  -0.51271814  0.10705347  0.46119517
  1.1483709   0.02008503 -0.9320156  -0.3753232   1.2767591   0.28444204
  0.41834974 -0.85505426  0.07893522 -0.9586205   0.5149112   0.29397324
 -1.0688794   0.46993792 -0.2308534  -0.48477527  0.4072717   1.1800873
 -0.01484556  1.2916238   0.3872795  -0.274535    0.38477775 -0.8400762 ]",10.1155/2022/7285851,[]